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The Role of Pharmacists and Emergency Contraception:  
An Assessment of Pharmacy School Curricula in the U.S. and the  
Knowledge, Attitudes, and Dispensing Practices of Florida Pharmacists. 
 
Alice R Richman 
 
ABSTRACT 
  
 Emergency contraception is a safe and effective form of contraception that is 
75%-89% effective in preventing pregnancies within 120 hours of unprotected 
intercourse.  Emergency contraception is a type of hormonal contraception, containing 
high doses of estrogen and progestin (ethinyl estradiol plus levonorgestrel) or progestin 
only (levonorgestrel).  Wider access to emergency contraception has the potential to 
decrease the number of unintended pregnancies and abortions in the U.S.  The Food and 
Drug Administration (FDA) has previously denied any over-the-counter (OTC) access to 
emergency contraception and only recently approved it for OTC status for women 18 
years old and over; therefore, pharmacists continue to play a critical role in providing 
access to emergency contraception.  For example, pharmacists can answer women’s 
questions, dispel misconceptions, advise medical colleagues, and provide important 
information about the medication to clients.  Although emergency contraception is a safe 
and effective medication, many pharmacists and pharmacies throughout the U.S. have 
either refused to fill prescriptions of emergency contraception or have refused to carry 
and stock emergency contraception.  Pharmacists’ perceptions and practice affect 
whether women have access to this form of contraception and whether pharmacies carry 
 xi
this medication.  In addition, pharmacists’ behavior, professional conduct, and ethical 
practice and training have major implications for public health and access to care for 
women, children, and families. 
This study has two purposes: First, because the attitudes and dispensing practices 
among pharmacists may be related to their understanding of the medication, a review of 
pharmacy school curricula in the U.S. was conducted, and involved (a) an assessment of 
course content related to emergency contraception and (b) an analysis of how this content 
is perceived by pharmacy students. The second purpose of the study is to assess 
emergency contraception knowledge, attitudes, subjective norms, perceived behavioral 
control, and dispensing practices of pharmacists and to determine if pharmacists’ 
emergency contraception knowledge, attitudes, subjective norms, and perceived 
behavioral control are predictive of their dispensing practices.  To reach these ends, a 
mixed-methods study design was employed using mixed methods data analysis 
techniques including coding methods, univariate, bivariate, and logistic regression.    
 
 1
 
 
 
 
 
Chapter One:   Introduction 
 
Statement of the Problem 
 The prevalence of unintended pregnancy among women in the United States is 
disturbingly high.  Indeed, it is the highest among all industrialized nations (Grimes, 
2002).  Approximately half of all pregnancies in the United States are unintended, with 
48% of all women aged 15-44 having at least one unintended pregnancy throughout their 
lifetime (Henshaw, 1998).  Unintended pregnancies result in consequences that have a 
profound effect on the physical, mental, social, economic, and developmental well-being 
of women, children, and their families (Misra, 2001).   
 Unintended pregnancy can be life-changing for all involved.  Of the estimated 
50% of pregnancies in the U.S. that are unintended (approximately three million 
annually), almost half (47%) result in abortion, 40% result in an unplanned birth and 13% 
result in miscarriage (Brown & Eisenberg, 1995).  Although in the U.S. the medical risks 
involved with abortion are relatively small, the psychological impact and the emotionally 
taxing decision process can be great (Major et al., 2000).   
 In general, women with unintended pregnancies are more likely to receive 
insufficient or delayed prenatal care, participate in unhealthy pregnancy behaviors like 
smoking and drinking (Hellerstedt et al., 1998), and give birth to low birth weight infants 
(Brown & Eisenberg, 1995) than women with intended pregnancies.  Likewise, women 
with unintended pregnancies are more likely to have a preterm delivery (Orr, Miller, 
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James, & Babones, 2000), report higher rates of maternal depression (Brown & 
Eisenberg, 1995), and have a greater rate of infant mortality (Brown & Eisenberg, 1995) 
than women with intended pregnancies.  Furthermore, women with unintended 
pregnancies have a greater risk of physical abuse and violence and are less likely to 
achieve educational, financial, and careers goals (Brown & Eisenberg, 1995) than women 
with intended pregnancies, all of which can result in poor pregnancy, birth, and health 
outcomes.    
 If 40% of unintended pregnancies result in an unplanned birth in the U.S., 21% of 
all pregnancies (both intended and unintended) will result in an unplanned birth.  
Children from these pregnancies are more likely to exhibit poor health and development 
and for many reasons are more likely to live apart from one or both parents, usually the 
father (Brown & Eisenberg, 1995).  Children who live with only one parent, usually the 
mother, score lower on standardized tests, have lower grade point averages, more erratic 
school attendance, behavioral problems, and consequently are more likely to drop out of 
high school, never attend college, or drop out of college, if attended, as compared with 
children from similar social class backgrounds and living arrangements (Brown & 
Eisenberg, 1995). 
The potentially negative health outcomes associated with unintended pregnancy 
coupled with the disturbingly high rates of unintended pregnancy in the U.S. should 
highlight the need for careful scrutiny of this public health problem.  Healthy People 
2010 is a set of health objectives for the nation to works towards throughout the first 
decade of this century.  Healthy People 2010 objectives are developed through scientific 
knowledge and build on objectives pursued over the past two decades.  Through Healthy 
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People 2010, the field of public health has identified a priority to decrease the rate of 
unintended pregnancies from 70% to 30% by year 2010 (US Department of Health and 
Human Services (DHHS), 2000). 
Of the 50% of the pregnancies in the United States that are unintended, half are a 
result of contraceptive failure (Henshaw, 1998).  The high rate of unintended pregnancy 
in this group highlights the need for additional methods of birth control.  While waiting 
for additional forms of birth control to be developed, a currently effective yet 
underutilized method of preventing unintended pregnancy, emergency contraception, is 
available.   
Emergency contraception is a type of hormonal contraception, containing high 
doses of estrogen and progestin (ethinyl estradiol plus levonorgestrel) or progestin only 
(levonorgestrel).  This medication is 75%-89% effective in preventing pregnancies when 
taken within 72 hours (3days) after sexual intercourse (American Medical Women’s 
Association (AMWA), 1996; Kaiser Family Foundation, 2000).  Recent studies 
conducted on the Yuzpe regimen of emergency contraception show that the 72 hour 
window may be restrictive and have extended effectiveness up to 120 hours (5 days); 
however the earlier a woman accesses emergency contraception, the more effective the 
medication will be (ACOG News Release, 2003; Ellertson et al., 2003).   
There is one dedicated product currently on the market that is packaged as 
emergency contraception in the U.S. called Plan B, a progestin-only form of 
contraception and is orally administered where one pill is taken within 120 hours of 
unprotected intercourse and a second pill is taken 12 hours later.  However, there are 20 
other forms of birth control pills that the FDA has said are safe and effective to use as 
 4
emergency contraception (Princeton University & Reproductive Health Professionals, 
2006).  These pills and their dosing regimen are shown in Appendix A.   
Post-coital contraception is typically taken orally in pill form although the 
insertion of an intrauterine contraceptive device (IUD) by a trained medical provider can 
be used as post-coital contraception as well (Princeton University & Reproductive Health 
Professionals, 2006).  Emergency contraception is not effective if the woman is already 
pregnant (Trussell, Duran, Shochet, & Moore, 2000) and is a safe form of contraception 
approved by the FDA in 1997 (FDA Federal Register, 1997), with no known 
contraindications (Grimes & Raymond, 2002).    
This form of contraception is important in that, unlike most forms of 
contraception, it is effective post sexual intercourse; it can be used as a back-up method 
of birth control when other birth control methods are not used appropriately, a condom 
slips or breaks, a pill is forgotten, or in cases of rape.  This post-coital feature of 
emergency contraception is where it received its nickname as the “morning after pill” 
because it is effective after sexual intercourse.  Because half of all unintended 
pregnancies are a result of contraception failure (Henshaw, 1998), and because this back-
up method of birth control that can be used post sexual intercourse but before pregnancy, 
it is ideal for sexually active individuals. 
 According to the American College of Obstetrics and Gynecologists (ACOG), 
wider access and acceptability of emergency contraception could reduce the number of 
unintended pregnancies by half (ACOG, 2001) and could prevent one million abortions 
annually (Trussell, Steward, Guest, & Hatcher, 1992).  However, it is within the first 24 
hours after unprotected intercourse that emergency contraception is the most effective in 
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preventing pregnancy (Downing, 2001); therefore, access is a critical issue for this type 
of contraception.  Women who have to wait for a doctor’s appointment or for the 
workweek to begin may delay treatment and thus decrease the efficacy of the medication, 
or may not be able to procure the medication at all.  Because most pharmacies are open 
late hours and are open on weekends, when most typical doctor’s offices and clinics are 
not (Boonstra, 2002), pharmacies have been suggested as critical venues for emergency 
contraception distribution (Van Riper & Hellerstedt, 2005). 
 There are three main barriers to emergency contraception access that seem to 
perpetuate a lack of awareness and utilization of this method of birth control.  First, there 
are certain misunderstandings in the public’s perception that surround emergency 
contraception.  Second, health care providers and professionals do not prescribe it or 
neglect to inform women of its availability and third, inadequate education is provided to 
women about emergency contraception.   
 Misunderstandings in the public’s perception surround emergency contraception.  
One common myth is that emergency contraception acts as an abortificient (Jackson, 
Schwarz, Freddman, & Darney, 2003) or that it is the same as RU-486, a medical 
abortion (Grimes & Raymond, 2002).  These misconceptions represent one way in which 
the definitional lines become blurred when abortion and emergency contraception are 
discussed.  Please see Appendix B for the package inserts of both Plan B and RU-486. 
   Health care providers and professionals may make emergency contraception 
difficult to obtain, primarily due to the misconceptions discussed above.  Women who are 
seeking these contraceptive pills may be forced to go through long appointments, 
unnecessary procedures such as physical exams, pregnancy tests and pelvic exams and 
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pay high prices (Trussell et al., 2000).  In addition, physicians refuse to prescribe it; many 
pharmacies refuse to stock it; and many pharmacists will not fill prescriptions of 
emergency contraceptive pills (Henderson, 2000).  In fact, up until March 3, 2006, Wal-
Mart pharmacies refused to stock emergency contraceptive pills.  This policy was 
particularly troublesome because Wal-Mart is the “world’s largest retailer and the 
nation’s fifth largest distributor of pharmaceuticals” (AMWA, 1996, p. 1) and in the case 
of some rural and poorer areas, may be the only pharmacy in town.  Therefore, a policy 
decision made by a private pharmacy can directly limit access and eliminate choice to 
one of the most vulnerable populations (AMWA, 1996).  Although long overdue, Wal-
Mart has finally begun carrying the medication due to claims that were filed against them 
for refusing to fill prescriptions and from pressure from women’s rights groups 
(CNN.com, 2006; Wal-Mart news releases, 2006)  
 Lastly, what Henderson (2000) calls the “paucity of prospective information 
provided to reproductive age women” (p. 2) refers to the inadequate education women 
receive about emergency contraception.  If women have no knowledge about emergency 
contraception, they cannot be expected to ask for it.  Part of the reason that women have 
an inadequate knowledge base regarding emergency contraception is that clinicians do 
not inform women of this option on a regular basis (Trussell et al., 2000), and 
pharmaceutical companies fail to adequately market it (Cates & Raymond, 1997).   
These barriers to emergency contraception are troubling and should be examined 
in greater detail.  Because time is such a critical factor in terms of access and 
effectiveness of emergency contraception, strategies to improve access to emergency 
contraception have been primarily focused on collaborative drug therapy agreements with 
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pharmacists or through advocating for emergency contraception to go over-the-counter 
(OTC).  Collaborative drug therapy agreements with pharmacists refer to pharmacists’ 
prescribing privileges for specific medications while following a set protocol.  Currently 
44 states in the U.S. allow these types of agreements with pharmacists for certain 
medications.  Expansion access programs such as these allow non-physicians to prescribe 
and distribute emergency contraception while working in conjunction with physicians 
and advanced registered nurse practitioners, thereby expanding the range of providers 
(Gardner, Hutchings, Fuller, & Downing, 2001).   
In total, nine states allow pharmacists to dispense emergency contraception 
without a doctor’s prescription under specific circumstances while following particular 
guidelines (Alan Guttmacher Institute (AGI), 2006).  Of those nine, seven states 
(Washington, California, Alaska, Hawaii, New Hampshire, Massachusetts, and Vermont) 
currently have collaborative drug therapy agreements where women can acquire 
emergency contraception without a prescription from pharmacies under doctor-
pharmacist agreements, and three states (California, Maine, and New Mexico) allow 
pharmacists to dispense emergency contraception without a prescription under a state-
approved protocol.  In addition, only one state, Illinois, has mandated that pharmacies 
that stock emergency contraception must fill prescriptions of the medication (AGI, 2006; 
Tanne, 2005). 
Conversely, while eight states have expanded access programs for emergency 
contraception, eight states have adopted restrictions (AGI, 2006).  Four states (Arkansas, 
Georgia, Mississippi, and South Dakota) allow pharmacists to refuse to fill prescriptions 
of contraception including prescriptions of emergency contraception.  Two states 
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(Indiana and Texas) added language under their Medicaid coverage that excluded 
emergency contraception services, and two states (Arkansas and North Carolina) 
restricted emergency contraceptives from their contraception coverage mandate (AGI, 
2006). 
History of Emergency Contraception 
A brief review of emergency contraception in the U.S. may provide further 
background on this important issue (see Appendix C for a graphic representation of its 
history).  Emergency contraception pills have been administered to women since the 
1960s.  Packets of birth control pills were typically cut up to dispense the required dose 
to women with instructions for use to avoid pregnancy after sex.  These pills were 
initially administered by feminist clinics, college health clinics, and a few Planned 
Parenthood clinics (Castle & Coeytaux, 2000).     
In 1996, one year prior to the FDA approval of emergency contraception, a 
national campaign was created and sponsored by the Reproductive Health Technologies 
Project and Princeton University to connect consumers and clinicians to useful 
information on emergency contraception through an emergency contraception hotline (1-
888-NOT-2-LATE), an emergency contraception website (not-2-late.com), and 
announcements and advertising in the media (radio, television, and outdoor events) 
(Ellertson, Shochet, Blanchard, & Trussell, 2000).  The national website and hotline are 
still active today connecting consumers to providers at the local level anywhere in the 
U.S. 
Almost three decades after emergency contraceptive pills were first administered 
to women, on February 25, 1997, the FDA approved six brands of oral contraceptives to 
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be used as emergency contraception and deemed them both safe and effective when used 
in prevention of a pregnancy (FDA Federal Register, 1997).  Even after this approval, 
there was no dedicated, labeled product manufacturer of emergency contraception until 
September 1998 and therefore few marketing efforts were initiated before this time. 
In 1997, the State of Washington began an innovative program where 
collaborative prescription agreements allowed pharmacists to prescribe emergency 
contraception to women (Wells et al., 1998).  This two year project was funded by the 
Packard Foundation, operated by the Program for Appropriate Technology in Health 
(PATH) and worked in collaboration with the Washington State Board of Pharmacy, 
Washington State Pharmacists Association, University of Washington Department of 
Pharmacy and Elgin/DDB (a public relations firm that has worked with the Reproductive 
Health Technologies Project) (Wells et al., 1998).  Their goals were to educate 
pharmacists, facilitate prescriptive protocols, help link clients with prescribers, increase 
awareness of emergency contraception to women, and to evaluate the effectiveness of the 
project.   
The Washington State project evaluators estimate that after the first four months 
of program initiation, 207 unintended pregnancies and 103 abortions have been prevented 
through this service (Wells et al., 1998).  In addition, program evaluation demonstrated 
an increase in prescriptions written per week and an increase in the number of calls 
inquiring about the medication after the initiation of this program (Wells et al., 1998).  
This project has demonstrated that pharmacist collaborative prescription agreements such 
as this one can play a vital role in making emergency contraception available and thus 
decreasing unintended pregnancy and abortion in the U.S.   
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In September 1998, Gynetics marketed Preven™, the first dedicated emergency 
contraception product for women.  In July 1999, Women’s Capital Corporation marketed 
Plan B™, the first progestin-only form of emergency contraception.     
Throughout this period, not only were researchers and pharmaceutical companies 
supporting the need for increased access to emergency contraception through advanced 
supply or OTC access, but many organizations in the field were supporting making 
emergency contraception more readily available.  The American College of Obstetrics 
and Gynecologists (ACOG) have endorsed making emergency contraception available 
OTC (2001) and the American Medical Association (AMA) has disseminated policy 
statements in support of expanding access to emergency contraception to make the pills 
“more readily available” (2002).   
In 2001, a petition was filed by the Center for Reproductive Rights to the FDA on 
behalf of over 70 organizations, including medical, public health, and others in support of 
emergency contraception for OTC access (CRR, n. d.).  In 2003, Women’s Capital 
Corporation, the makers of Plan B (a type of emergency contraception), filed a second 
petition to the FDA in support of OTC emergency contraception.   
On December 16, 2003, the FDA’s Reproductive Health Drugs Advisory and 
Nonprescription Drugs Panel supported making Plan B available OTC by a 27-4 vote—a 
major success for public health and reproductive rights advocates in the United States.  
However, on May 6th, 2004, the FDA struck down the recommendation from its own 
committee.  The rejection was based on the assumption that there was not enough 
evidence that Plan B could be used safely by adolescent women under 16 years of age 
without provider supervision.   
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The FDA rejection letter states that “before this application can be approved, you 
would have to provide data demonstrating that Plan B can be used safely by women 
under 16 years of age without the professional supervision of a practitioner licensed by 
law to administer the drug” (Galson, 2004, p. 2).  The letter also stipulated that 
alternatively, more information could be provided to support Plan B as a prescription 
only product for women under 16 years of age and a nonprescription product for women 
over 16 years of age.  
After this decision was handed down by the FDA, the makers of Plan B submitted 
an application for OTC access to emergency contraception for women 16 years and older.  
Many feel that because unintended pregnancy among adolescent women is a concern in 
the U.S., it is imperative that they too are provided with access to safe contraceptive 
choices and that they are not excluded from future emergency contraception OTC 
policies.  In fact, teens younger than 18 years old have the highest percentage (82-83%) 
of unintended pregnancy in the U.S. (Henshaw, 1998) and the U.S. has the highest teen 
pregnancy rate of all industrialized nations (Feijoo, 2001).   
For years, the FDA was criticized for dragging its feet in granting any proposals 
for OTC access despite the fact that it fit all of the requirements for an OTC drug, and 
then on August 24, 2006 to the surprise of many, the FDA approved OTC access for Plan 
B.  However, the approval of OTC access is for women 18 years and older with 
prescriptions required for those 17 years old and under (FDA News, 2006).  Plan B is to 
be stocked and held at pharmacies behind the counter so that it may be dispensed with a 
prescription for those less than 18 years of age or by proof of age for those over 17 years 
of age (FDA News, 2006).  
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Need for the Study 
Although the decision by the FDA to approve OTC access to emergency 
contraception for women over 17 years of age is a step forward, it is not enough.  
Whether emergency contraception is dispensed through a prescription to women less than 
18 years of age or OTC to women over 17 years of age, pharmacists will continue to play 
a crucial role in access to this medication.  For women over 17 years of age requesting 
emergency contraception OTC, pharmacists may be the first contact to a health care 
professional for these women as Stacie Garnett from the Emergency Contraception 
Network stated the day emergency contraception went OTC, “Training for pharmacists 
will be more important than ever as they become the first contact for women seeking EC” 
(S. Garnett, personal communication, August 24, 2006). 
In addition, for women who seek emergency contraception by prescription, 
pharmacists can either aid or inhibit the doctor/patient relationship.  Some pharmacists 
have refused to fill prescriptions of emergency contraception.  When a doctor writes a 
patient a prescription for emergency contraception, it is the intention of the doctor to give 
the patient the medication.  If the patient then takes her prescription to a pharmacist to fill 
the prescription and the pharmacist refuses to do so, the pharmacist is therefore inhibiting 
this doctor/patient relationship.  For example, in 2004, a pharmacist in Texas would not 
fill a rape survivor’s prescription for emergency contraception, citing moral objections 
for the refusal (Reuters, 2004).  In October 2005, a pharmacist in Missouri who works at 
a local Target store refused to fill a prescription of emergency contraception.  Other 
reports of pharmacist refusal have come from Ohio and New Hampshire (Cantor & 
Baum, 2004).   
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In addition to pharmacists refusing to fill prescriptions of emergency 
contraception, some pharmacies refuse to stock this medication.  Pharmacists’ 
knowledge, attitudes, and dispensing practices of emergency contraception may have an 
affect on whether women have access to emergency contraception and whether 
pharmacies carry the medication.  Lack of access to emergency contraception can result 
in unintended pregnancies, which may result in unplanned births or abortions.  Therefore, 
pharmacists’ behavior, professional conduct, and ethical practice and training all have 
major implications for public health and access to care for women, children, and families.   
Purpose of the Study 
This study has two purposes: First, because the attitudes and dispensing practices 
among pharmacists may be related to their understanding of the medication, a review of 
pharmacy school curricula in the U.S. was conducted, and involved (a) an assessment of 
course content related to emergency contraception and (b) an analysis of how this content 
is perceived by pharmacy students. The second purpose of the study is to assess 
emergency contraception knowledge, attitudes, subjective norms, perceived behavioral 
control, and dispensing practices of pharmacists and to determine if pharmacists’ 
emergency contraception knowledge, attitudes, subjective norms, and perceived 
behavioral control are predictive of their dispensing practices.   
This project provides important state-level data for Florida, country-wide data on 
curricula for the U.S., and helped to identify geographic and demographic trends in 
pharmacist practices.  This research advanced the state of knowledge, aided in 
formulating baseline data on pharmacists’ knowledge and practice, and provided a venue 
with which to make recommendations of ways to strengthen pharmacy school curricula.  
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In addition, this research may work towards the goals of mainstreaming emergency 
contraception and reducing unintended pregnancy and the need for abortion in the U.S. 
Research Questions 
Question 1: What do the 91 accredited schools of pharmacy in the U.S. teach about 
emergency contraception? 
Question 1a: What objectives, course assignments, course readings, and lectures 
concerning emergency contraception are provided in the required courses at the 
91 accredited schools of pharmacy in the U.S.? 
Question 1b: What objectives, course assignments, course readings, and lectures 
concerning emergency contraception are provided in the elective courses at the 91 
accredited schools of pharmacy in the U.S.? 
Question 2: How is emergency contraception course content taught at accredited schools 
of pharmacy as perceived by fourth year pharmacy students at the four accredited schools 
of pharmacy in Florida?    
Question 2a: What did pharmacy students learn about emergency contraception in 
their pharmacy school classes? 
Question 2b: How was emergency contraception taught in their pharmacy school 
classes? 
Question 2c: What are the projected emergency contraception dispensing 
practices of pharmacy students? 
Question 3: What is the relationship among emergency contraception knowledge, 
attitudes, subjective norms, perceived behavioral control, intention to dispense, and 
dispensing practices of Florida pharmacists registered with the Board of Pharmacy? 
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Question 3a: Is emergency contraception knowledge predictive of dispensing 
practices of Florida pharmacists?  
Question 3b: Are attitudes about emergency contraception predictive of 
emergency contraception dispensing practices of Florida pharmacists?  
Question 3c: Are subjective norms about emergency contraception (whether 
important people such as colleagues, supervisors, corporate headquarters, and 
peers think they should dispense emergency contraception) predictive of 
emergency contraception dispensing practices of Florida pharmacists? 
Question 3d: Is perceived behavioral control, the perceived ease or difficulty of 
dispensing emergency contraception, predictive of dispensing practices of Florida 
pharmacists? 
Question 3e: Is intention to dispense emergency contraception predictive of 
dispensing practices of Florida pharmacists? 
Question 3f: Are emergency contraception knowledge, attitudes, subjective 
norms, perceived behavioral control, and intention to dispense taken together, 
predictive of emergency contraception dispensing practices of Florida 
pharmacists? 
Assumptions 
1. The pharmacists will report their knowledge, attitudes, subjective norms, 
perceived behavioral control, and dispensing practices accurately. 
2. The pharmacy students will report their perceptions about the education they 
received as well as their perceptions about future dispensing practices accurately. 
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3. The academic Deans of the accredited schools of pharmacy will report what is 
covered in their curricula concerning emergency contraception accurately. 
Delimitations 
The following delimitations are imposed on this study: 
1. Results are only generalizable to English literate pharmacists registered with the 
Board of Pharmacy in the state of Florida. 
2. Results from the quantitative data are generalizable to only accredited schools of 
pharmacy in the U.S. 
3. Results from the qualitative data by definition cannot be generalized to all 
pharmacy students. 
Limitations 
The following are limitations of this study: 
1. Pharmacists who respond to the survey may be motivated to respond due to their 
attitudes about emergency contraception (both positive and negative attitudes). 
2. Results of the study cannot be generalized to all pharmacists in the U.S. or all 
pharmacy students in the U.S. 
3. Results from the study are based upon self-reports which means that reported 
behaviors and educational instruction may be a proxy for actual behavior and 
instruction.   
Definitions of Relevant Terms 
Abortion: Termination of pregnancy before the fetus is viable and capable of extrauterine 
existence, usually less than 20 weeks of gestation (or when the fetus weighs less than 
500g) (Lowdermilk & Perry, 2004). 
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Birth Control: Practices employed by couples that permit sexual intercourse with reduced 
likelihood of conception and birth. The term birth control is often used synonymously 
with such terms as contraception, fertility control, and family planning.  Birth control 
includes abortion to prevent a birth, whereas family planning methods explicitly do not 
include abortion (Population Reference Bureau, n. d.). 
Conception: Union of the sperm and ovum resulting in fertilization; formation of the one-
celled zygote (Lowdermilk & Perry, 2004). 
Contraception: Prevention of impregnation or conception (Lowdermilk & Perry, 2004). 
Depression: An intense and pervasive sadness with severe and labile mood swings 
(Lowdermilk & Perry, 2004). 
Emergency Contraception: A type of hormonal contraception, containing high doses of 
estrogen and progestin (ethinyl estradiol plus levonorgestrel) or progestin only 
(levonorgestrel).  Emergency contraception is 75%-89% effective in preventing 
pregnancies when taken within 120 hours (5 days) after sexual intercourse (Planned 
Parenthood, n. d.) 
Family Planning: The conscious effort of couples to regulate the number and spacing of 
births through artificial and natural methods of contraception. Family planning connotes 
conception control to avoid pregnancy and abortion, but it also includes efforts of couples 
to induce pregnancy (Population Reference Bureau, n. d.). 
Infant Mortality: Number of deaths per 1000 children 1 year of age or younger 
(Lowdermilk & Perry, 2004). 
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Intended Pregnancy: Where the pregnancy is reported to have happened at the “right 
time” or occurring later than desired due to infertility or other problems becoming 
pregnant (Brown & Eisenberg, 1995; Santelli, et al., 2003). 
Low Birth Weight (LBW): An infant birth weight of less than 2500g (Lowdermilk & 
Perry, 2004). 
Miscarriage: Spontaneous abortion; lay term usually referring to the loss of the fetus 
(Lowdermilk & Perry, 2004). 
Pharmacist: a health professional trained in the art of preparing and dispensing drugs 
(Word Reference, n. d.). 
Pharmacology: The science of drugs, including their composition, uses, and effects.  The 
characteristics or properties of a drug, especially those that make it medically effective 
(The Free Dictionary n. d.). 
Pregnancy: Period between conception through complete birth of the products of 
conception.  The usual duration of pregnancy in the human is 280 days, 9 calendar 
months, or 10 lunar months (Lowdermilk & Perry, 2004). 
Preterm Birth: Birth occurring before 37 weeks of gestation (Lowdermilk & Perry, 
2004). 
Plan B: Plan B consists of two white tablets, each contain glevonorgestrel .75mg.  The 
first tablet is taken within 72 hours of unprotected intercourse, and the second tablet is 
taken 12 hours later (American Pharmaceutical Association (AphA) special report, 2000).  
Preven: see Yupze Regimen of Emergency Contraception below. 
Unintended Pregnancy: Unintended pregnancy is classified as either unwanted or 
mistimed.  Unwanted refers to where the current pregnancy occurred when no children or 
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no more children were desired and mistimed refers to when the woman may have wanted 
to be pregnant at some point in her life but that the current pregnancy occurred earlier 
than desired (Brown & Eisenberg, 1995; Santelli, J et al., 2003).   
Yupze Regimen of Emergency Contraception (AKA Preven): Preven or the Yupze 
regimen consists of four blue tablets, each containing ethinyl estradiol 50ug and 
levonorgestrel .25mg.  Two tablets are taken initially, followed by a second dose of two 
tablets 12 hours later (Apha special report, 2000).  
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Chapter Two:   Literature Review 
 
Review of Related Research 
 
This literature review examines the existing and current literature on emergency 
contraception and specifically examines the literature on emergency contraception 
knowledge, attitudes, and dispensing practices of pharmacists.  The review begins with a 
brief overview of emergency contraception including mechanism of action, side effects, 
contraindications, and teratogenicity.  Next, the review focuses on the current level of 
knowledge and attitudes about emergency contraception among women followed by an 
exploration of the research conducted on the knowledge, attitudes, and prescribing 
practices of emergency contraception among health care professionals such as physicians, 
nurses, and midwives.  Because little research has been conducted on pharmacists 
specifically, examining these relationships among other health care professionals will 
help inform this study.   
Next, the literature review examines the few studies that have been conducted on 
the relationship between knowledge, attitudes, and dispensing practices of pharmacists.  
Lastly, this review introduces the reader to the Theory of Reasoned Action and Theory of 
Planned Behavior and will demonstrate how the concepts from these theories directly 
inform the hypothesis and research questions of this study. 
 
 
 21
Overview of Emergency Contraception 
Emergency contraception is a type of hormonal contraception, containing high 
doses of estrogen and progestin (ethinyl estradiol plus levonorgestrel) or progestin only 
(levonorgestrel).  This medication is 75%-89% effective in preventing pregnancies when 
taken within 72 hours (3days) after sexual intercourse (American Medical Women’s 
Association (AMWA), 1996; Kaiser Family Foundation, 2000).  Recent studies 
conducted on the Yuzpe regimen (estrogen and progestin) of emergency contraception 
show that the 72 hour window may be restrictive and have extended effectiveness up to 
120 hours (5 days); however the earlier a woman accesses emergency contraception, the 
more effective the medication will be (ACOG News Release, 2003; Ellertson et al., 
2003).   
The mechanism of action of emergency contraception is the same as oral 
contraceptives that are administered daily.  Emergency contraception works through 
inhibiting events that are necessary for a pregnancy to occur.  Emergency contraception 
can work in a number of ways to inhibit: 
1) Ovulation—can suppress luteinizing hormone that is needed for ovulation; 
2) Fertilization—can inhibit movement of egg or sperm; 
3) Transport—can inhibit the path of the fertilized egg to the uterus; or 
4) Implantation—can change the endometrium so that the blastocyst is not able 
to implant (American Pharmaceutical Association special report, 2000). 
Emergency contraception is not effective if the woman is already pregnant and 
therefore does not disrupt an existing pregnancy (Trussell, Duran, Shochet, & Moore, 
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2000).  It is a safe form of contraception approved by the FDA in 1997 (FDA Federal 
Register, 1997). 
Currently, there is only one dedicated product on the market that is packaged as 
emergency contraception in the U.S. called Plan B.  Plan B is a progestin-only form of 
contraception and is orally administered and consists of two white pills containing .75 mg 
of levonorgestrel, where one pill is taken within 120 hours of unprotected intercourse and 
a second pill is taken 12 hours later.  In the past, there was a product on the market called 
Preven (also known as the Yuzpe regimen) that was packaged as emergency 
contraception; however this product is no longer being manufactured.  In addition, there 
are 20 other forms of birth control pills that the FDA has said are safe and effective to use 
as emergency contraception (Princeton University & Reproductive Health Professionals, 
2006).   
Whether a woman uses Plan B or one of the other 20 forms of birth control pills, 
emergency contraceptives are safe to use with few side effects.  Common side effects 
include: nausea, vomiting, fatigue, breast tenderness, headache, abdominal pain, and 
dizziness.  If these side effects do occur when taking emergency contraceptives, they go 
away within a few days of treatment (American Pharmaceutical Association (AphA) 
special report, 2000).   
The side effects listed above were much more common with Preven (estrogen and 
progestin) and studies have shown that these side effects are lessened with the use of Plan 
B (progestin only).  For example, a study conducted by the World Health Organization 
found that in comparing Plan B to Preven, Plan B caused less nausea (23% vs 51%), less 
vomiting (6% vs 19%), less dizziness (11% vs 17%), and less fatigue (17% vs 29%) (n. 
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a., 1998).  In addition to these adverse effects, irregular vaginal bleeding can occur after 
use but the spotting is not serious.  In addition, a woman’s menstrual period after using 
emergency contraception may be lighter or heavier than usual depending on the woman 
(American Pharmaceutical Association (AphA) special report, 2000).   
Contraindications for the use of oral contraceptive combinations as emergency 
contraception that include ethinyl estradiol (estrogen) include an increased risk of 
thrombosis and ischemic stroke.  However, the British Medicines Control Agency found 
that over 13 years and approximately four million doses of emergency contraception, 
only three cases of thromboembolism and three cases of stroke were detected (Vasilakis, 
Jick, & Jick, 1999).  Nonetheless, it is recommended that women with a history of 
thromoembolic disease or stroke should not use emergency contraception as combined 
estrogen and progesterone and it has been suggested that perhaps they should use Plan B 
which is levonorgestrel only (American Pharmaceutical Association (AphA) special 
report, 2000; Van Look & Stewart, 1998).   
Contraindications for Plan B include: being pregnant, undiagnosed abnormal 
genital bleeding, and an allergy to progesterone.  Although being pregnant is listed as a 
contraindication of emergency contraception, it is listed for the most part because it 
would not be efficacious during a pregnancy rather than any ill effects that it may have on 
an established pregnancy.  In fact, using oral contraceptives during a pregnancy has not 
been found to hurt the fetus (American Pharmaceutical Association (AphA) special 
report, 2000).  Overall, emergency contraception is a safe form of contraception with 
very few side effects and contraindications.   
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Epidemiology: Knowledge & Attitudes of Emergency Contraception 
In order for emergency contraception to be used as a physician-prescribed, over-
the-counter (OTC), or pharmacist-provided medication, women, men, and health care 
professionals must know of its availability and must understand how it should be used.  
Recent research findings have suggested a low but increasing level of knowledge about 
emergency contraception among patients and health care providers (Conard & Gold, 
2004).   
Women’s Knowledge  
Studies in many countries, including those in Europe, Asia, Africa, Middle East, 
and North America have assessed women’s level of knowledge of emergency 
contraception and found that these rates vary greatly.  For example, in a study conducted 
in India where participants were given a paper-based questionnaire, neither the abortion 
clients surveyed (n=500) nor the college students surveyed (n=110) were familiar with 
emergency contraception (Tripathi, Rathore, & Sachdeva, 2003).  By contrast, a 
nationally representative population-based study in Switzerland administered a 
computerized questionnaire to 4,283 sexually active adolescents aged 16 to 20 years old 
and found that 89% reported having heard of emergency contraception (Ottesen, Narring, 
Renteria, & Michaud, 2002).  Similarly, in the United Kingdom, 78% of the 78 women 
who filled out a paper-based survey while attending an abortion clinic were familiar with 
emergency contraception (Mathew & Urquhart, 2005).  However, in Iran only 8% of the 
250 married women ages 15-48 interviewed knew about emergency contraception 
(Babaee, Jamali, & Ali, 2003).  See Appendix D for a list of emergency contraception 
knowledge and attitude studies in a comparative context.   
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Not only do women’s levels of knowledge about emergency contraception vary 
from place to place, but another striking finding and commonality among the knowledge-
based studies is that in most studies, a larger percentage of women report having heard of 
emergency contraception than the percentage of women who actually understand its 
correct mechanism of action.  For example, although Ottesen et al. (2002) found that 89% 
of women in Switzerland had heard of emergency contraception, another prospective 
study that employed a paper-based survey sampled women requesting emergency 
contraception in Switzerland (n=365) and found that 42% of women incorrectly thought 
that the pills had to be taken within 24 hours of unprotected intercourse and 13% of the 
women incorrectly thought that emergency contraception was 100% effective in 
preventing pregnancy (Nguyen, Bianchi-Demmicheli, & Ludicke, 2003).   
Similarly, a U. S. study provided a paper-based survey to 297 Latina women 
attending family planning clinics in Texas and found that 17% of Spanish-speaking 
women and 41% of English-speaking Latina women had heard of emergency 
contraception and 25% incorrectly believed that emergency contraception would end an 
existing pregnancy (Romo, Berenson, & Wu, 2004).  Also in the U.S., 77% of the 158 
women surveyed an inner-city emergency department had heard of emergency 
contraception, although only half of those who had heard of it knew how to use it.  In 
addition, of those who had heard of it, 26% were not aware of the correct timing, 24% 
were not aware that it was available in the U.S., and 45% were not aware that a 
prescription was required for use (Abbott, Feldhaus, Houry, & Lowenstein, 2004).   
In a similar study, 82% of the 188 women sampled from a Boston community had 
heard of emergency contraception but only about half of those women knew how 
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emergency contraception worked (Chuang & Freund, 2005).  Also, among a sample of 
post-partum women from an inner-city public hospital (n=371) in the U.S., 36% of 
women had heard of emergency contraception and only 7% understood the appropriate 
timing for use (Jackson, Schwarz, Freedman, & Darney, 2000).   
In countries where emergency contraception is available OTC such as Nigeria and 
Sweden, 58% of the 880 Nigerian female undergraduate students sampled were familiar 
with emergency contraception but only 18% knew the 72 hour protocol for use and 49% 
believed that the pills needed to be taken within 24 hours of unprotected intercourse 
(Aziken, Okonta, & Ande, 2003).  In a study conducted in Sweden, 98% of the 800 
women studied were aware of emergency contraception but 38% were not aware of the 
effectiveness of emergency contraception when taken on the first day and 59% were not 
aware of the effectiveness when taken on the third day (Larsson, Eurenius, Westerling, & 
Tyden, 2004). 
Although there is a disparity between the percentage of women who have heard of 
emergency contraception and the percentage of women who understand its mechanism, 
there is reason to believe that both of these percentages are increasing over time.  A study 
conducted in 1996 in the U.S. recruited women from a hospital-based clinic and drug 
treatment center (n=133) and then recruited a different sample of women from the same 
clinic in 2002 (n=139).  Both groups of women were interviewed and guided by almost 
identical questionnaires.  The researchers found that between 1996 and 2002, the 
percentage of clients who had ever heard of emergency contraception grew from 44% in 
1996 to 73% in 2002 and comprehension of timing for use increased from 20% in 1996 to 
51% in 2002 (Aiken, Gold, & Parker, 2005).   
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Although overall knowledge about emergency contraception has been increasing 
over the years, many misconceptions about emergency contraception still remain.  One 
U.S.-based study examined the knowledge and attitudes of emergency contraception 
among women and men ages 18-21 (n=97) attending a university through the use of a 25-
item paper-based questionnaire.  This study found that almost half of the participants 
thought that emergency contraception was the same as RU-486, an abortifacient (Corbett, 
Mitchell, Taylor, & Kemppainen, 2005).  Similarly, another U.S.-based study conducted 
a telephone survey among students attending Princeton University (n=550) and found 
that study participants were confused between emergency contraception and RU-486 
(Harper & Ellertson, 1995).   
It is clear from these studies that although women’s knowledge of emergency 
contraception varies, more women have heard of emergency contraception than know 
how to use it.  That is, women may be aware that emergency contraception exists; 
however, they are not aware of the issues of timing, effectiveness, and how to obtain it.    
This finding demonstrates the need for educational efforts to address these deficits.  
Educational efforts should not only promote awareness of emergency contraception but 
should present specific information about the medication such as correct timing for use, 
availability, level of effectiveness, proper use, and possible side effects. 
Women’s Attitudes 
Much like knowledge, women’s attitudes towards emergency contraception vary.  
In many studies, women tended to have positive attitudes about emergency contraception.  
For example, in the study of Iranian women (n=250) where 8% of women had heard of 
emergency contraception, 77% of the women surveyed were found to have a positive 
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attitude about it and reported that they would be willing to use it in the future or tell other 
people about it after they were informed of what the medication was and how it worked.  
Because the percentage of women who had heard of emergency contraception was so 
low, attitude was measured after each participant was read a paragraph explaining what it 
was and how it worked (Babaee et al., 2003).   
Positive attitudes were also found in other studies.  Among the Swedish women 
studied (n=800), 90% agreed that access to emergency contraception is positive (Larsson 
et al., 2004).  Of the 76 women surveyed in an abortion clinic in the UK, 90% of the 
women said they would consider using emergency contraception in the future (Mathew & 
Urquhart, 2005).  And in the study of women recruited from a U.S. urban hospital and 
drug treatment center (n=139), over half of the women thought that there may be a future 
need to use emergency contraception, and of those that perceived a future need, 95% 
reported that they would use it if needed (Aiken et al., 2005).   
Although most studies found positive attitudes towards emergency contraception, 
two studies found attitudes that were not as positive.  In the study conducted in the inner 
city emergency department in the U.S. (n=158), 51% of women reported that they would 
think about using emergency contraception if they needed it; however 17% reported 
moral or religious objections to its use (Abbott et al., 2004).  Also, among the university 
men and women that were surveyed in the U.S. study (n=97), 100% of the women who 
reported to be unlikely to choose emergency contraception said that they would feel 
judged or embarrassed if they had to ask for it (Corbett et al., 2005).  Unfortunately, the 
article did not mention how many women reported to be unlikely to choose emergency 
contraception.   
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Some researchers conducted further investigations into women’s attitudes about 
emergency contraception and discovered a relationship between approval of emergency 
contraception and political and religious views.  Harper and Ellertson (1995) found that 
political and religious affiliations were significant predictors of student attitudes.  
Specifically, they found that Democrats (86%) were more approving of emergency 
contraception than Republicans (71%) or Independents (63.5%).  Also, highly religious 
students were less likely to recommend emergency contraception to women than those 
who were not religious. 
Harper and Ellertson (1995) also found a positive correlation between emergency 
contraception knowledge and attitudes, that is, when the level of knowledge about 
emergency contraception increased, so did the positive attitudes about its use.  In fact, the 
odds of the favorable attitudes of emergency contraception were 148% higher among 
participants that understood the side effects when compared to those who did not.  This 
relationship between knowledge and attitudes was also demonstrated among Latina 
women surveyed in the U.S. (n=297).  These researchers found that only half of women 
who have heard of emergency contraception said that they would be willing to use it in 
the future and those who did not comprehend the action of emergency contraception were 
even less likely to say that they would use it in the future (Romo et al., 2004).   
In contrast to these findings, the U.S. based study of 371 post-partum women 
from an inner-city public hospital found that while two-thirds of these women reported a 
willingness to use emergency contraception in the future, only 7% understood the correct 
timing for use (Jackson et al., 2000).  This finding that willingness to use the medication 
was high even though comprehension of timing was low seems to conflict with the 
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previous study that found that the willingness to use emergency contraception decreased 
as the comprehension of action decreased.   
In summary, women’s attitudes about emergency contraception vary.  However, 
in most studies, women held positive attitudes about emergency contraception.  In 
addition, there seems to be little consistency in the relationship between knowledge and 
attitudes.  For example, some studies showed high knowledge and positive attitudes, 
some studies showed low knowledge and positive attitudes for future use, while other 
studies showed low knowledge and negative attitudes towards emergency contraception.  
However, one thing that can be surmised is that education should be provided to women 
who are willing to use emergency contraception but are unfamiliar with it.  It is important 
to note that in some studies approval of the birth control pill was related to political or 
religious views.  These views may account for the studies that found high knowledge and 
low attitudes about emergency contraception; however more research is needed to 
uncover these relationships. 
Healthcare Professionals’ Knowledge, Attitudes, and Practice 
 of Emergency Contraception 
 Several studies have assessed healthcare professionals’ knowledge, attitudes, and 
prescribing practices of emergency contraception.  For the purposes of this literature 
review and study, the research conducted on healthcare professionals is reported 
separately from the research conducted on pharmacists.  This section will focus on 
studies conducted on all other healthcare professionals except for pharmacists and the 
next section will focus solely on pharmacists.  In addition, the terms health care 
professionals and providers will be used interchangeably.  
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Provider Knowledge 
Overall, provider studies on knowledge about emergency contraception have 
found that while most providers have general knowledge about emergency contraception, 
detailed knowledge is low.  For example, one U.S.-based study mailed a questionnaire to 
236 pediatricians and 121 surveys were returned.  They found that all but one doctor 
responded that they had heard of emergency contraception but around half of the 
pediatricians did not know the timing of emergency contraception or that it was FDA-
approved (Sills, Chamberlain, & Teach, 2000).  See Appendix E for a list of provider 
knowledge, attitude, and prescribing practice studies in a comparative context.        
In another U.S.-based study, 954 pediatricians were mailed a five-page survey and 
233 responded.   Findings indicated that pediatricians had a lack of detailed knowledge 
about emergency contraception.  For example, 72.9% of respondents could not identify 
the FDA-approved methods for emergency contraception and roughly 72% of 
respondents could not identify the correct timing for the drug (Golden et al., 2001).   
Low levels of knowledge were also found in a study conducted on 180 family 
planning providers in Turkey where only half of the providers knew the correct timing 
and dose interval of emergency contraception.  In addition to this lack of detailed 
knowledge, these providers had major misconceptions about emergency contraception 
(Uzuner et al., 2005).  Over 39% of respondents believed that emergency contraception 
causes abortion and 31.1% thought that it was harmful for the fetus.  In addition, almost 
79% of respondents incorrectly thought that pill use may increase unprotected intercourse 
and 75% thought that use will lead to men giving up on condom use.  Interestingly, 
 32
female providers had more negative impressions regarding the above statements than 
male providers (Uzuner et al., 2005).   
Another U.S.-based study conducted on 78 providers consisting of family 
physicians and nurse providers explored provider perceived knowledge and actual 
knowledge.  Among the 78 providers, 96% reported that they were knowledgeable on the 
indications for use and 78% reported that they understood the protocols for prescribing 
emergency contraception, although knowledge inaccuracies were found between 
perceived and actual knowledge.  Also, 44% of providers inaccurately thought that 
emergency contraception was an abortifacient (Wallace, Wu, Weinstein, Gorenflo, & 
Fetters, 2004).  
Another U.S.-based study gave self-administered questionnaires to 102 providers 
including physicians, registered nurse practitioners, certified nurse midwives, and 
physician assistants and measured level of knowledge, attitudes, and practices of 
emergency contraception before and after an educational program.  The educational 
program involved a training of providers through a lecture presentation and a review of a 
clinical manual.  The clinical manual included pertinent information about emergency 
contraception and each provider was given a clinical manual to keep.  At baseline, one-
third of the sample did not know the correct timing for emergency contraception.  At 
follow-up, one year later, knowledge about emergency contraception significantly 
increased.  However, at follow-up, providers still maintained limited knowledge about the 
medication’s side effects and modes of action.  Overall this study found that an 
educational training for providers can help increase knowledge about emergency 
contraception; however the finding that there were still a few gaps in knowledge suggests 
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a need for even more education and training (Beckman, Harvey, Sherman, & Petitti, 
2001). 
In contrast to these studies where the general knowledge is high, some non-U.S. 
based studies found that even general provider knowledge about emergency 
contraception was absent.  One study conducted in Turkey found low levels of 
knowledge among 72 health care providers which included general practitioners, nurses, 
and midwives (Sevil, Yanikkerem, & Hatipoglu, 2006).  These researchers used face-to-
face interviews as well as paper-based self administered questionnaires.  They found that 
almost one in ten providers surveyed was unfamiliar with the words ‘emergency 
contraception’ and they concluded that knowledge about emergency contraception among 
health care providers is inadequate.  In addition, a study conducted on the knowledge, 
attitudes and practice of family planning among community health extension workers 
(n=232) in Nigeria found an absence of knowledge about emergency contraception 
(Onwuhafua, Kantiok, Olafimihan, & Shittu, 2005).     
Provider Attitudes 
In addition to low levels of knowledge and major misconceptions about 
emergency contraception, several studies identified negative attitudes towards emergency 
contraception.  Golden et al. (2000) surveyed 233 practicing pediatricians and found that 
68% of respondents felt uncomfortable prescribing emergency contraception, with 
inexperience cited as the most common reason (70%).  Seventeen percent did not 
prescribe due to perceived teratogenic effects and 12% did not prescribe due to moral or 
religious reasons.  In addition, 22% agreed that emergency contraception provision 
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encourages adolescent risk-taking behavior and 52% said they would place restrictions on 
how many times they would dispense the drug to a patient (Golden et al., 2000). 
Another U.S.-based study conducted on 78 providers consisting of family 
physicians and nurse providers found generally positive attitudes towards prescribing 
emergency contraception, although the actual rates of prescribing were low.  Of the 78 
providers studied, 90% thought that the pill was an appropriate topic of discussion at 
women’s exams and felt that the benefits of emergency contraception outweighed the 
risks.  However, due to fear of repeated pill use, 59% of providers said they would 
restrict how many times they prescribed emergency contraception to a woman.  Also, 
14% thought that emergency contraception use would discourage regular contraceptive 
use, 16% were uncomfortable prescribing emergency contraception for religious or 
ethical reasons, and 7% said that they would not prescribe emergency contraception 
under any circumstances (Wallace, et al., 2004).                     
Interestingly, in a 2001 in the U.S.-based study that surveyed 102 providers and 
measured levels of knowledge, attitudes, and practices of emergency contraception before 
and after an educational program, follow-up knowledge and prescribing practices 
increased while attitudes about emergency contraception showed little change (Beckman 
et al., 2001).  This finding may indicate the difficulty of producing a change in provider 
attitudes.   
Provider Prescribing Practices 
In general, research conducted on provider prescribing practices of emergency 
contraception has shown prescribing frequency among providers to be low, regardless of 
specialty.  That is, most providers have prescribed emergency contraception at one point 
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or another, but report prescribing the medication less than five times per year (Delbanco 
et al. 1998; Gold, Schein, & Coupey, 1997; Sills et al., 2000; Chuang, Waldman, Freund, 
& Ash, 2004).  Unlike the low rates of prescribing among U.S. providers, a national study 
of British health authorities found that the majority of physicians surveyed report that 
they prescribe emergency contraception a few times per week (Webb & Morris, 1993). 
A mail-based survey conducted in the northeast region of the U.S. sought to 
compare emergency contraception prescribing practices among 282 providers and found 
that 94% of obstetricians/gynecologists, 76% of family practitioners, and 63% of general 
internists had ever prescribed emergency contraception.  This study found that being 
female was a positive predictor (OR: 9.6, 95% CI: 3.2-29.1) and the Catholic religion was 
a negative predictor (OR: .39, 95% CI: .19-.79) for prescribing emergency contraception.  
In addition, 75% of the physicians surveyed (86% of general internists, 82% of family 
physicians, and 57% of obstetricians-gynecologists) reported infrequent prescribing of 
emergency contraception (less than five times a year), regardless of their specialty 
(Chuang, et al., 2004).  
A study conducted in India found a very low level of prescribing of emergency 
contraception.  Researchers found that 84% of gynecologists and 41% of general 
practitioners were vaguely familiar with emergency contraception, although among those 
who had some knowledge, most were unsure of how to prescribe it.  In fact, 51% of 
gynecologists and 17% of practitioners reported ever prescribing it (Tripathi et al., 2003).   
It is interesting to note that in both of these studies discussed above the 
prescribing frequency among providers is low; however, women health care providers 
like gynecologists tended to have a higher level of knowledge and a higher prescribing 
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frequency of emergency contraception than non-women specific health care providers 
such as pediatrics or general practitioners.   
An additional U.S.-based study conducted on 78 providers consisting of family 
physicians and nurse providers, also found low prescribing practices (Wallace et. Al., 
2004).  Of the 78 providers studied, 74% reported that they have prescribed emergency 
contraception in the past, with an average of 3.2 times in the past year. 
In a U.S.-based study that surveyed 102 providers and measured level of 
knowledge, attitudes, and practices of emergency contraception before and after an 
educational program, at baseline only 7% of providers reported prescribing emergency 
contraception once a month.  At follow-up, prescribing frequency of emergency 
contraception significantly increased (Beckman et al., 2001).  For example, providers 
who prescribed emergency contraception at least once per year rose from 30% to 49% 
and providers who reported prescribing emergency contraception at least once a month 
rose from 7% at baseline to 26% at follow-up.  These findings indicate that an 
educational program may help increase the frequency of provider prescription writing.   
Although many of these studies discussed measured knowledge, attitudes, and 
prescribing practices independently, very few studies have evaluated provider practices in 
relation to provider knowledge and attitudes.  One study found that knowledge about 
emergency contraception was significantly related to prescribing practice whereas 
attitudes about emergency contraception were not found to be significant predictors of 
prescribing it (Sills et al., 2000).  For example, two of the knowledge variables, 
knowledge of the timing of emergency contraception and knowledge that it is FDA-
approved, were predictive of emergency contraception counseling and prescribing.  In 
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contrast, none of the attitude variables including, (a) whether they thought emergency 
contraception causes a risk of congenital malformation, (b) concern about giving or 
prescribing the medication, (c) whether it should be used in rape cases, or (d) whether a 
provider thought that the side effects of were serious, were predictive of prescribing 
writing or counseling.  This study suggests that knowledge, not attitudes, is a significant 
predictor of emergency contraception prescribing.  However, another study found just the 
opposite.  Gold et al. (1997) found that four out of the eight negative attitude variables 
did correlate to failure to prescribe emergency contraception.  In addition, another study 
performed a cross-sectional survey of 96 faculty physicians and found that 42% of 
physicians intended to prescribe emergency contraception for teenagers, whereas 65-77% 
of the sample intended to prescribe to other identified groups.  This study also found that 
intention to prescribe was associated with positive attitudes but physicians’ knowledge 
about emergency contraception was not found to be significant (Sable, Schwartz, Kelly, 
Lisbon & Hall, 2006).  This discrepancy in research findings merits further inquiry into 
determining the predictors of emergency contraception prescription writing. 
Pharmacists’ Knowledge, Attitudes, & Dispensing Practices of Emergency Contraception 
In the only study of its kind, Van Riper and Hellerstedt (2005) assessed 
pharmacist knowledge, attitudes, and dispensing practices of emergency contraception 
among South Dakota pharmacists.  A 14-item survey was mailed to all registered 
pharmacists (n=810) in South Dakota to assess their attitudes, knowledge, and dispensing 
practices of emergency contraception and 62% responded.  Among respondents, only 
54% of pharmacists worked in pharmacies that carried emergency contraception.  For 
those that carried the medication, 67% of pharmacists had dispensed emergency 
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contraception in 2003 but 24% reported that they were not comfortable providing 
counseling to clients about the medication.  Dispensing practices did not vary by gender.   
Findings also suggested that there was low knowledge about emergency 
contraception among South Dakota pharmacists, as 37% were unaware that the 
medication is similar in its mechanism to oral contraceptives.  In addition, 74% of 
pharmacists either incorrectly agreed or were uncertain about whether emergency 
contraception can cause birth defects when administered to pregnant women and 85% of 
respondents either incorrectly agreed or were uncertain about the statement that repeated 
use of the medication can pose health risks.  Only 5% of the sample correctly answered 
all five of the knowledge questions on the survey (Van Riper & Hellerstedt, 2005).  In 
contrast to dispensing behaviors, knowledge and attitudes about emergency contraception 
did vary by sex where more female pharmacists opposed making emergency 
contraception over-the-counter.  
One limitation of this study is that the researchers did not include enough 
questions about attitudes towards emergency contraception and did not question whether 
the pharmacist had personal or moral objections about dispensing the medication.  In 
addition, this study did not ask questions about knowledge of other contraceptive 
medications to assess whether there was a lack of knowledge about all contraceptives or 
just emergency contraception. 
Although there have been no other published state-wide studies on the knowledge, 
attitudes, and dispensing practices of pharmacists, there have been, however, a handful of 
studies that assessed pharmacists’ knowledge and attitudes about emergency 
contraception and one study that assessed pharmacists’ knowledge, attitudes, and beliefs 
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towards prescribing emergency contraception.  These five studies will be discussed 
below in chronological order.  Please see Appendix F to view these studies in a 
comparative context.  
In 1999, a study was conducted by the Planned Parenthood of New York City.  
They conducted a phone survey of 100 retail pharmacists who practiced in New York 
City and only 3 out of 100 pharmacists surveyed provided correct information about 
emergency contraception, while 38 pharmacists did not know it was available in the U.S. 
(Draut, 1999).  In their article, Planned Parenthood compiled some interesting quotes 
provided by pharmacists upon being called and asked about emergency contraception.  
They are as follows: “…never heard of the morning-after pill…”, “Don’t have it…don’t 
know anything about it”, “There’s no morning-after pill available in this country.”, 
“…it’s used to induce periods and it starts contractions..it is abortion”, “It must be taken 
within one day, that’s why it’s called the morning-after pill.” (p. 2-3).   
The second study, conducted by Bennett, Petraitis, D’Anella, and Marcella in 
2003, randomly selected pharmacies in Pennsylvania and assessed pharmacist knowledge 
(accuracy of information provided to client) and availability of emergency contraception 
through employing “mystery callers”.  These mystery callers called the pharmacy and 
spoke to 315 pharmacists.  They asked questions that assessed knowledge and assessed 
whether the particular pharmacy could dispense emergency contraception that day.  The 
findings from the study indicated that knowledge about and access to emergency 
contraception was limited.  In fact, 30% of the pharmacists surveyed did not provide the 
correct timing required for emergency contraception administration where 23% thought it 
needed to be taken within 24 hours and 7% thought it needed to be taken within 48 hours.  
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In addition, 13% of the pharmacists said that emergency contraception would cause an 
abortion (Bennett et al. 2003).  Sixty-five percent of the pharmacists sampled reported 
that they would not be able to fill a prescription of emergency contraception that day.  Of 
those who reported that the medication could not be filled that day, 79% said the 
medication was not in stock, 6% replied that it was against store policy, 7% reported that 
it conflicted with personal beliefs, and 8% did not provide a reason.   
A potential limitation of this study is that attitude of the pharmacist was measured 
by the mystery caller recording the attitude she felt from the pharmacist toward her after 
the call ended.  This variable was measured on a 5-point graded scale, from very 
unpleasant to most pleasant (Bennett et al., 2003). 
The third study, conducted in Indiana, mailed a survey to chief pharmacists 
(n=948) at 1361 pharmacies and assessed pharmacists’ attitudes towards practice with 
adolescents (Conard, Fortenberry, Blythe, & Orr, 2003).  The study’s main goal was to 
address pharmacists’ attitudes and practice with adolescents concerning all medications, 
and although emergency contraception wasn’t the focus of the study, it was included in 
the list of medications.    
One interesting finding from this study was that although the majority of 
pharmacists dispensed medication to adolescents, 57% reported feeling inadequately 
trained for handling adolescent-related issues.  Another important finding was that 48% 
of the pharmacists surveyed did not dispense emergency contraception.  Age was found 
to be a significant factor in that pharmacists under 45 years of age were more likely to 
report dispensing emergency contraception; however no differences were found for sex 
(Conard et al., 2003).   
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Of the 59% of pharmacists who have dispensed emergency contraception to 
adolescents, 83% said that they felt uncomfortable dispensing it.  There were no 
differences in feelings of comfort based on age or sex (Conard et al, 2003).  These 
findings that emergency contraception is unavailable at pharmacies and that pharmacists 
either don’t dispense or are uncomfortable dispensing emergency contraception to 
adolescents is of concern in that it places barriers to access to emergency contraception 
for adolescents. 
A fourth study, conducted in Sweden, where emergency contraception is sold 
both over-the-counter and in clinics and hospitals, assessed attitudes towards emergency 
contraception and its OTC availability among pharmacists and pharmacy staff (n=237) 
and nurse-midwifes (n=163) through a mail-based survey (Aneblom, Lundborg, Carlsten, 
Eurenisu, & Tyden, 2004).  The reason this study chose to survey pharmacists, pharmacy 
staff, and nurse-midwives is because these individuals represent the professionals in 
Sweden that are the main providers and counselors of emergency contraception.   
The findings showed that both study groups had positive attitudes towards 
emergency contraception and towards the OTC administration of emergency 
contraception; however nurse midwives demonstrated more favorable attitudes than the 
pharmacist group.  In addition, verbal information and counseling to clients on issues of 
emergency contraception was more commonly reported by the nurse-midwife group than 
by the pharmacist group and both groups reported that they wanted more collaboration 
between health care providers (Aneblom et al., 2004).    
The fifth study, conducted in New Mexico, sought to describe pharmacists’ 
knowledge, attitudes, and beliefs towards prescribing emergency contraceptives through 
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a mail-based questionnaire (Borrego et al., 2006).  Of the 1392 questionnaires that were 
delivered, 555 (40%) were returned but only 523 (38%) could be used.  Overall, they 
found that although New Mexico pharmacists had positive attitudes and beliefs about 
prescribing emergency contraception, their knowledge about the medication was average.  
In addition, 40% of the sample had an interest in becoming certified to prescribe 
emergency contraception in their state-approved emergency contraception prescribing 
training program.   
New Mexico is one of three states (California, Maine, and New Mexico) that 
allow pharmacists to dispense emergency contraception without a prescription under a 
state-approved protocol.  Pharmacists who had an interest in becoming certified to 
prescribe emergency contraception were more likely to be male, non-Hispanic, non-
Christian, to report liberal or moderate political views, and to say that they had employer 
approval, time, and privacy at their pharmacy to prescribe emergency contraception. 
New Literature 
Since the original writing of this literature review, a few pertinent studies have 
been published and will be addressed here.  One study has been published describing the 
knowledge, attitudes, and practices among pharmacists in Puerto Rico (Fuentes & Azize-
Vargas, 2007).  Pharmacists attending a national conference were surveyed.  Although it 
was found that emergency contraception knowledge was low among these pharmacists, 
they were in support of a non-prescription emergency contraception policy. 
Another study assessed student pharmacist knowledge and attitudes surrounding 
emergency contraception (Evans, Patel, & Stranton, 2007).  A group of pharmacy 
students were sent an electronic survey measuring knowledge, attitudes, and 
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demographics.  Researchers found that religious and political views played a role in 
determining student attitudes about emergency contraception.  They also found that high 
levels of knowledge equates to more support and fewer concerns regarding use of 
emergency contraception.  This study aids in strengthening the results of this study in 
terms of need for effective teaching and efficient learning.  
Another few provider studies were published since this literature review, one 
concerning a cross-sectional survey faculty physicians about intention to educate patients 
about emergency contraception at four U.S. universities (Kelly, Sable, Schwartz, Lisbon, 
& Hall, 2008), and one study that assessed provider knowledge, attitudes, practice, and 
barriers at a military treatment facility in the U.S. (Chung-Park, 2008).  The first study 
found that attitudes and peer expectations around educating predicted intention to educate 
patients about emergency contraception among faculty physicians.  The second study 
found low knowledge among the sample of providers such that there was a discrepancy 
between what providers perceived knowing and actual knowledge.  The first study 
concludes that attitudes and beliefs should be addressed when creating interventions and 
the second study calls for better education among providers.   
Summary & Recommendations for Future Research 
Women’s Knowledge & Attitudes 
Overall, women’s knowledge and attitudes about emergency contraception vary.  
In terms of women’s knowledge, more women are aware that emergency contraception 
exists; however, they are not aware of the issues of timing, effectiveness, and how to 
obtain it.  This finding demonstrates the need for educational efforts to address these 
deficits.  Educational efforts should not only promote awareness of emergency 
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contraception but should present specific information about the medication such as 
correct timing for use, availability, level of effectiveness, proper use, and possible side 
effects. 
In terms of women’s attitudes towards emergency contraception, most women 
had positive attitudes about the medication and these attitudes were not dependent on 
level of knowledge.  In fact, there was little consistency in the relationship between 
knowledge and attitudes of emergency contraception.  For example, some studies showed 
high knowledge and positive attitudes, some studies showed low knowledge and positive 
attitudes for future use, while other studies showed low knowledge and negative attitudes 
towards the medication.  Future research could examine the relationship between 
emergency contraception knowledge and attitudes among women and determine what 
causes these inconsistencies.  However, one thing that can be surmised is that education 
should be provided to women who are willing to use emergency contraception but are 
unfamiliar with it.  Another interesting finding was that in some studies, approval of the 
pill was related to political or religious views.  These views may account for the studies 
that found high knowledge and low attitudes about emergency contraception; however 
more research is needed to uncover these relationships. 
Health Care Professionals’ Knowledge, Attitudes, & Practice 
When comparing the provider studies, it becomes evident there is a paucity of 
detailed knowledge about emergency contraception among providers and there are major 
misconceptions that seem to persist.  It seems that providers, specifically those who work 
with women of childbearing age and whose duty it is to care for the health of women, 
should have both salient and specific knowledge about emergency contraception.  
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Unfortunately, these studies show that precise knowledge among healthcare professionals 
is inadequate.  Therefore, these findings suggest that training is needed for healthcare 
professionals.  Healthcare providers need more detailed information about emergency 
contraception which would most likely increase the rate of knowledge and use by clients, 
decrease the misconceptions held by providers, and increase provider prescribing 
frequencies.  Future research could test these hypotheses. 
Although the knowledge that providers have about emergency contraception is 
generally consistent in the literature, provider attitudes tend to vary with some reporting 
positive and some reporting negative attitudes.  This finding may be due to the fact that 
people are different and there may be as many varying attitudes as there are people.  
However, more research is needed in this area. 
Another interesting finding was the gender differences detected in three of the 
health care provider studies.  One study found that women health care providers were 
more likely than male health care providers to have negative attitudes towards emergency 
contraception, the second study found that they were more likely than their male 
counterparts to say that emergency contraception should not go over-the-counter (OTC), 
and the third study found that being female was a positive predictor of prescribing 
emergency contraception.  The first two studies point towards female providers having 
more negative attitudes towards emergency contraception than male providers but the 
third study demonstrates that women providers are more likely to prescribe the 
medication.  These gender differences are noteworthy and should be explored in greater 
detail.    
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In general, results from studies show low prescribing rates of emergency 
contraception among health care providers in the U.S.  One study found that being female 
was a positive predictor and being Catholic was a negative predictor of prescribing 
emergency contraception.  Two other studies found that knowledge was a predictor of 
prescribing emergency contraception but conflicted on whether provider attitude was a 
significant predictor of emergency contraception prescription writing.  More research is 
needed to uncover these relationships and inconsistencies and to determine what predicts 
prescribing practices.  Also, given the high abortion rate in this country, efforts should be 
taken to increase the number of emergency contraception prescriptions that are written 
which may aid in a decrease in abortion and unintended pregnancy rates in the U.S.  
Pharmacists’ Knowledge, Attitudes, & Dispensing Practices 
A major finding from the pharmacist studies is that many pharmacies in the U.S. 
do not carry emergency contraception.  This finding is troublesome in that access is 
certainly limited if pharmacies do not carry the medication.  Another major finding is that 
there are many pharmacists that do not feel comfortable dispensing emergency 
contraception to adolescents and also do not feel confident in counseling women about 
emergency contraception.  Perhaps future research could test if comfort levels in 
counseling women and dispensing the medication would increase if knowledge about 
emergency contraception was increased and misconceptions were dispelled.   
Much like the health care provider literature, when viewing the pharmacist studies 
it becomes apparent that there is a lack of detailed knowledge and understanding about 
emergency contraception among pharmacists and major misconceptions persist as a 
result.  These studies show that precise knowledge among pharmacists is inadequate 
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suggesting that training is needed for pharmacists.  Pharmacists need more detailed 
information about emergency contraception which may result in an increased rate of 
knowledge and use by clients, a decrease in the misconceptions held by pharmacists, 
increased provider dispensing frequencies, as well as increased comfort in counseling 
about emergency contraception.  Future research is needed to test these hypotheses. 
Although studies have shown that the knowledge that pharmacists have about 
emergency contraception is generally low, more research is needed in determining the 
attitudes of pharmacists as they tended to vary with some reporting positive and some 
reporting negative attitudes.  In addition, given that there is only one study that measured 
the self-reported emergency contraception dispensing practices of pharmacists, more 
research is needed to understand the prescribing practices of pharmacists.   
It is also important to note that there is limited research on emergency 
contraception and pharmacists as there have only been five U.S.-based studies concerning 
these topics.  In addition, no other study except the Van Riper and Hellerstedt (2005) 
South Dakota study, assessed pharmacists’ attitudes, knowledge, and dispensing practices 
of emergency contraception.  However, Van Riper and Hellerstedt (2005) failed to 
determine whether pharmacist knowledge and attitudes about emergency contraception 
predict dispensing practices.  The proposed study will be the first to test these 
relationships.   
Given the low levels of knowledge detected among pharmacists in the few studies 
conducted, it is imperative to find out what pharmacists are learning about emergency 
contraception in school.  Therefore, this study proposes to perform a curricula review of 
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all 91 accredited schools of pharmacy in the U.S. to determine what is being taught about 
emergency contraception to pharmacy students. 
This study has two purposes: First, because the attitudes and dispensing practices 
among pharmacists may be related to their understanding of the medication, a review of 
pharmacy school curricula in the U.S. will be conducted, and will involve (a) an 
assessment of course content related to emergency contraception and (b) an analysis of 
how this content is perceived by pharmacy students. The second purpose of the study is 
to assess emergency contraception knowledge, attitudes, subjective norms, perceived 
behavioral control, and dispensing practices of pharmacists and to determine if 
pharmacists’ emergency contraception knowledge, attitudes, subjective norms, and 
perceived behavioral control are predictive of their dispensing practices.   
The Theory of Reasoned Action 
 The theory that will guide this research, the Theory of Planned Behavior (TPB), is 
an extension of the earlier Theory of Reasoned Action (TRA) which was developed by 
Ajzen and Fishbein (1980; Fishbein & Ajzen, 1975).  The Theory of Reasoned Action 
was first introduced in 1967 (Fishbein, 1967), and is based on the assumption that people 
are rational beings who make informed decisions based on available information.  Thus, 
the theory is called the Theory of Reasoned Action because it assumes that people 
consider the implications of their actions before deciding whether to perform a particular 
behavior (Ajzen & Fishbein, 1980).   
The Theory of Reasoned Action’s primary purpose is to both predict and 
understand behavior.  The Theory also postulates that behavioral intention is the most 
important predictor of behavior.  That is, people typically behave in line with their 
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intentions.  Therefore, a secondary purpose of the TRA is to understand the determinants 
of intentions.  Following in line with the theory, behavioral intention is determined by 
two factors, (a) personal attitudes toward the behavior and (b) social influence or 
subjective norms.  Personal attitudes toward a behavior refer to a person’s judgment in 
performing the behavior.  For example, whether a person believes performing a behavior 
is good or bad is a personal judgment towards a particular behavior.  Social influence or 
social norms, the second determinant of intention, refers to the perceived social pressures 
to perform or not perform a particular behavior.  In general, a person intends to perform a 
behavior when they have a positive attitude towards the behavior and when they perceive 
that important people think they should engage in the behavior (Ajzen & Fishbein, 1980). 
See Figure 1 for a graphic representation of the Theory of Reasoned Action.  
The TRA also postulates that both attitude and social norms play a role in 
behavioral intention; however the relative weights of these factors in terms of influencing 
intention differ from person to person (Ajzen & Fishbein, 1980).  For example, take two 
women who are deciding whether or not to use birth control pills.  Both women have the 
same attitudes and social norms towards using the pill; they both want to use the pill 
(attitude towards behavior) but feel social pressure not to use the pill (social norms),  
however, one woman decides to use the pill and the other does not.  This difference could 
be because one woman places more emphasis on her attitudes to determine her intention 
to use the pill and the other woman places more emphasis on social pressures to 
determine her intention to use the pill.  Either way, both of their attitudes and perception 
of social pressures were the same but the relative weights of the attitudes and social 
factors varied and thus the behavior was different (Ajzen & Fishbein, 1980).  
 50
Figure 1. Theory of Reasoned Action 
 
The Theory of Planned Behavior 
The Theory of Planned Behavior (TPB), which was developed after the Theory of 
Reasoned Action (TRA), includes an additional construct, perceived behavioral control.  
Whereas the Theory of Reasoned Action was developed to deal with volitional behaviors, 
the Theory of Planned Behavior was developed to incorporate behaviors that are not 
altogether volitional.  For example, a smoker may intend to quit smoking but when tries 
to quit, is unable to do so.  Control over behavior is thus viewed on a continuum with one 
extreme including something such as voting for a particular candidate in a voting booth 
where the selection is performed at will and the other extreme includes actions like 
sneezing or decreasing one’s blood pressure where people have limited control (Ajzen, 
1988).  Although these examples are extremes, the point is that many factors can interfere 
with the relationship between intention and behavior. 
Ajzen’s Theory of Planned Behavior was developed in an attempt to present a 
conceptual framework that addresses this incomplete volitional control (Ajzen, 1985; 
Ajzen & Madden, 1986; Schifter & Ajzen, 1985).  The TPB postulates that there are three 
(rather than the two addressed in the TRA) determinants of intention.  The two that were 
addressed in the Theory of Reasoned Action, (a) attitude toward behavior and (b) 
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subjective norms, are still present and then a third determinant, (c) perceived behavioral 
control is addressed in the Theory of Planned Behavior.  Perceived behavioral control 
refers to how difficult or easy the behavior is to perform and according to Ajzen, this 
difficulty or ease of the behavior is “assumed to reflect past experience as well as 
anticipated impediments and obstacles” (1988, p. 132).  See Figure 2 for a graphic 
representative of the Theory of Planned Behavior.  In general, there is a direct positive 
relationship between the three determinants.  That is, as attitude and subjective norms 
towards the behavior become more favorable, the perceived behavioral control becomes 
greater and the intention to perform a particular behavior increases as a result (Ajzen, 
1988).  
Figure 2. Theory of Planned Behavior 
 
 
There are two important features of perceived behavioral control.  The first is that 
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behavioral intentions even though they may have favorable attitudes toward the behavior 
and feel that people important to them would approve of the behavior.  This is why there 
is a straight line from perceived behavioral control to intention shown in figure 2, 
because attitude and subjective norm may not mediate the relationship between perceived 
behavioral control and intention (Ajzen, 1988).  
The second important feature of perceived behavioral control is that it may have a 
direct link to behavior as shown in figure 2.  Perceived behavioral control can help 
predict behavior or it can bypass behavioral intention altogether which reflects the idea 
that perceived behavioral control can be a measure for actual control.  Therefore, 
perceived behavioral control can predict behavior through intentions and can also predict 
behavior directly as a proxy measure for actual control (Ajzen, 1988).   
This third determinant of intention is particularly relevant to the proposed study 
because a pharmacists’ emergency contraception dispensing practices may vary based on 
the perceived difficulty or ease of dispensing the medication.  That is, emergency 
contraception dispensing practices of pharmacists may not be under their volitional 
control and therefore this third determinant of intention may be relevant for the study.  
For example, if a pharmacist does not want to fill a prescription of emergency 
contraception but perceives that if she or he refuses that they may be fired, the 
pharmacists may decide to dispense the medication anyway.  
Taking from the concepts, assumptions, and propositions of the TPB, it is 
hypothesized that if pharmacists intend to dispense emergency contraception then they 
will have a positive attitudes towards dispensing the medication and will perceive that 
important people think they should dispense the medication.  In addition, there will be a 
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positive relationship between attitudes, subjective norms, and perceived behavioral 
control.  For example, if positive attitudes towards dispensing are high and if subjective 
normative beliefs are high (perception that important people think they should dispense 
the medication), than perceived control over the dispensing will also increase.  As a 
result, the intention to dispense emergency contraception will increase which will 
increase the actual behavior of dispensing.  Likewise, if pharmacists do not intend to 
dispense emergency contraception, they will have negative attitudes towards dispensing 
the medication and will perceive that important people think they should not dispense 
emergency contraception.  In addition, if the attitudes and subjective norms are low, the 
perceived control over dispensing the medication should also be low.  This way, the 
intentions to dispense will be low and the actual behavior of dispensing emergency 
contraception will be low as a result.  See Figure 3 for a graphic representation of how 
this theory may be applied to the research study. 
 Although the Theory of Planned Behavior does not explicitly include knowledge 
as a predictor of behavior, it will be included in this study.  Ajzen (1988) states, “at the 
most basic level of explanation, behavior is assumed to be a function of salient 
information, or beliefs, relevant to the behavior” (p. 132).  The theory follows that 
attitude toward a behavior is determined by beliefs about that behavior.  Therefore if a 
person thinks that a certain behavior will lead to favorable outcomes, then the person will 
have a positive attitude toward the behavior and likewise, a person thinks that a certain 
behavior will lead to a negative outcome, then the person will have negative attitudes 
toward performing the behavior.  In addition, a few of the provider studies found that 
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knowledge, not attitudes, were predictive of emergency contraception prescribing 
practices and therefore, knowledge will be added to the model as shown in Figure 3. 
 
*Figure 3: Modified Theory of Planned Behavior Applied to Research Study 
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Chapter Three:   Methods 
 
 This chapter describes the methods that were used to conduct this study and has 
been divided into eight sections: (1) purpose of the study, (2) research questions, (3) 
overview of study design, (4) pharmacy school curricula review, (5) pharmacy student 
focus groups, (6) pharmacist questionnaire, (7) data collection, and (8) data analysis. 
Purpose of the Study 
This study has two purposes: First, because the attitudes and dispensing practices 
among pharmacists may be related to their understanding of the medication, a review of 
pharmacy school curricula in the U.S. was conducted, and involved (a) an assessment of 
course content related to emergency contraception and (b) an analysis of how this content 
is perceived by pharmacy students.  The second purpose of the study was to assess 
emergency contraception knowledge, attitudes, subjective norms, perceived behavioral 
control, and dispensing practices of pharmacists and to determine if pharmacists’ 
emergency contraception knowledge, attitudes, subjective norms, and perceived 
behavioral control are predictive of their dispensing practices.   
This project provided important state-level data for Florida, national data on 
curricula for the U.S., and helped to identify geographic and demographic trends in 
pharmacist practices.  Since no other studies have been conducted on these variables and 
on this topic, this research advances the state of knowledge, aided in formulating baseline 
data on pharmacists’ knowledge and practice, and provided a venue with which to make 
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recommendations of ways to strengthen pharmacy school curricula.  In addition, this 
research works towards the goals of mainstreaming emergency contraception and 
reducing unintended pregnancy and the need for abortion in the U.S. 
Research Questions 
 After a thorough review of the literature on emergency contraception knowledge, 
attitudes, and dispensing practices, a review of behavioral theories, and an understanding 
of the future recommendations suggested in the existing literature, the following research 
questions emerged: 
Question 1: What do the 91 accredited schools of pharmacy in the U.S. teach about 
emergency contraception? 
Question 1a: What objectives, course assignments, course readings, and lectures 
concerning emergency contraception are provided in the required courses at the 
91 accredited schools of pharmacy in the U.S.? 
Question 1b: What objectives, course assignments, course readings, and lectures 
concerning emergency contraception are provided in the elective courses at the 91 
accredited schools of pharmacy in the U.S.? 
Question 2: How is emergency contraception course content taught at accredited schools 
of pharmacy as perceived by third or fourth year pharmacy students at the four accredited 
schools of pharmacy in Florida?    
Question 2a: What did pharmacy students learn about emergency contraception in 
their pharmacy school classes? 
Question 2b: How was emergency contraception taught in their pharmacy school 
classes? 
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Question 2c: What are the projected emergency contraception dispensing 
practices of pharmacy students? 
Question 3: What is the relationship among emergency contraception knowledge, 
attitudes, subjective norms, perceived behavioral control, intention to dispense, and 
dispensing practices of Florida pharmacists registered with the Board of Pharmacy? 
Question 3a: Is emergency contraception knowledge predictive of dispensing 
practices of Florida pharmacists?  
Question 3b: Are attitudes about emergency contraception predictive of 
emergency contraception dispensing practices of Florida pharmacists?  
Question 3c: Are subjective norms about emergency contraception (whether 
important people think they should dispense emergency contraception) predictive 
of emergency contraception dispensing practices of Florida pharmacists? 
Question 3d: Is perceived behavioral control, the perceived ease or difficulty of 
dispensing emergency contraception, predictive of dispensing practices of Florida 
pharmacists? 
Question 3e: Is intention to dispense emergency contraception predictive of 
dispensing practices of Florida pharmacists? 
Question 3f: Are emergency contraception knowledge, attitudes, subjective 
norms, perceived behavioral control, and intention to dispense taken together, 
predictive of emergency contraception dispensing practices of Florida 
pharmacists? 
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Overview of Study Design 
  
This research study employed a mixed methods study design involving both 
survey and focus group methods.  The study involved three major research questions with 
sub-questions included within each of the three main questions.  Each major research 
question contains three separate methods crafted to address each individual but related 
research question.  Question #1 was addressed through a brief web-based survey emailed 
to the Academic Deans of the 91 accredited schools of pharmacy in the U.S.  Question #2 
was addressed through focus groups with third and fourth year Doctor of Pharmacy 
(Pharm. D.) students at the four accredited schools of pharmacy in Florida and Question 
#3 was addressed through a mixed-mode survey administered to a randomly selected 
group of pharmacists registered with the Florida Board of Pharmacy.   
 Taken together, findings demonstrated what is intended to be taught to pharmacy 
students, what is actually being learned by pharmacy students, and how practicing 
pharmacists’ perceptions of emergency contraception are associated with their dispensing 
practices.  This research study examined both the education and practice of pharmacists. 
All activities were approved by the University of South Florida Institutional 
Review Board.  All records were stored in locked filing cabinets in a locked room.  It was 
assumed that all study participants in this study including Deans, practicing pharmacists, 
and fourth year pharmacy students were able to both read and speak English and were 
able to complete the questionnaires presented to them without aid.     
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Pharmacy School Curricula Review 
Target Population & Sampling Frame 
The first research question, what do the 91 accredited schools of pharmacy in the 
U.S. teach about emergency contraception, was addressed through a short web-based 
survey to the Deans at the 91 accredited schools of pharmacy in the U.S.  The target 
population is Academic Deans at accredited schools of pharmacy in the U.S.  In this case, 
the target population, the sampling frame, and the sample are the same because the 
survey will act as a census.  Academic Deans were chosen as the target population for 
this research question as they are the individuals who are most knowledgeable and 
responsible for their school curricula.  In addition accredited schools of pharmacy were 
chosen as the target population because students must graduate from an accredited school 
of pharmacy in order to become a licensed pharmacist in the U.S. 
Sampling Plan 
The following four letters were constructed and emailed to all 91 Deans: (a) a pre-
notice, (b) an abbreviated informed consent form, (c) a cover letter and questionnaire, and 
(d) a thank you/reminder letter.  Please see Appendix G for a copy of the Academic Dean 
email pre-notice, Appendix H for a copy of the abbreviated informed consent form, 
Appendix I for a copy of the Academic Dean cover letter and questionnaire, and 
Appendix J for a copy of the Academic Dean thank you/reminder letter.   
In addition to the survey and the informed consent form, all three letters, a pre-
notice, cover letter, and thank you/reminder, were added to the survey process as 
recommended by the Dillman tailored design method (Dillman, 2000).  According to 
Dillman, the pre-notice email message should be delivered two to three days before the 
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questionnaire is emailed out.  The pre-notice has been shown to be important for email 
surveys as it alerts the recipient that the survey will be arriving shortly and to not discard 
it when it does arrive (Dillman, 2000).   
After the pre-notice is delivered, the questionnaire followed a few days later.  
Dillman (2000) suggests that a brief cover letter should be included directly before the 
survey.  It has been shown that brevity for the cover letter is best as people are more 
likely to read an email that is shorter given the mass quantities of email that people have 
to sift through on a daily basis (Dillman, 2000).  In addition to a pre-notice and cover 
letter, all email contacts were personalized as studies show that an individual is more 
likely to respond to an email addressed directly to them rather than a mass email, group, 
or listserve mailing (Dillman, 2000).    
In addition to a pre-notice and cover letter, the third letter that should be included 
in an online survey is a thank you/reminder email.  This email is designed to both thank 
individuals as well as remind them to fill out the survey.  Attached to the thank 
you/reminder letter is a replacement electronic questionnaire.  Providing a replacement 
questionnaire with the follow-up thank you/reminder letter has been shown to increase 
survey response rates (Dillman, 2000). 
A link to the web-based survey was emailed to all 91 Deans.  Email addresses 
were retrieved from school websites or by phone.  The web-based survey was held on the 
University of South Florida Ultimate Surveyor program.  Ultimate Surveyor is an 
electronic survey response program.  It was employed to ensure confidentiality so that the 
Academic Deans felt more comfortable providing accurate and truthful information about 
their programs.  Because this survey is electronic, a wavier of consent was requested and 
 61
granted from the IRB as well as a waiver of written documentation.  According to the 
IRB, a one page document including the basic elements provided in a longer informed 
consent form is all that is required for a study of this nature.   
The survey asked Dean’s questions pertaining to the curricula offered in their 
Pharm. D. programs, identified appropriate course numbers and titles, and requested an 
electronic copy of every syllabus in both required and elective courses that included 
objectives, course assignments, course readings, and/or lectures concerning emergency 
contraception.  These syllabi were retrieved, reviewed, totaled, and summarized by the 
research investigator.  The gathered data was entered into an EXCEL spreadsheet for 
analysis and reporting purposes.  Names of the particular schools and Academic Deans 
were kept confidential and were not linked to the data.  In addition, where applicable, 
curricula information was searched for and retrieved from the school websites to amplify 
and cross check the information provided by the Academic Deans.  Course content is 
assumed to be up-to-date, however it will only be as up-to-date as the faculty that create 
the content and syllabi for the courses.  
To more fully understand the feasibility of this survey, five Academic Deans from 
schools of pharmacy in the U.S. were contacted by email prior to sending out the actual 
survey.  The email explained the study and inquired as to whether they would respond to 
a survey of this nature.  Three out of five Academic Deans reported that they would 
respond to a survey of this nature, yielding a 60% response rate.  The response from these 
emails provided an estimate of the feasibility of this survey.   
The Academic Deans survey was piloted to the Academic Dean of the USF 
College of Public Health, and she said that she would complete it if it was sent to her; 
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however it is not known how Academic Deans for schools of pharmacy will respond.  A 
30% return rate was expected from the Academic Deans (N=24).  This percentage was 
estimated from a review of email surveys which both reviewed and estimated response 
rates of email surveys over time (Sheehan, 2001).  In addition, preparations were made to 
use curricula information provided on their school websites to search for emergency 
contraception course content had we not received a good response rate from Deans.  
Pharmacy Student Focus Groups 
Target Population & Sampling Frame 
The second research question, how is emergency contraception course content 
taught at accredited schools of pharmacy as perceived by fourth year pharmacy students 
at the four accredited schools of pharmacy in Florida, was answered through focus 
groups conducted at all four accredited Schools of Pharmacy in Florida: Florida 
Agricultural and Mechanical University, Nova Southeastern University, Palm Beach 
Atlantic University, and University of Florida.  These focus groups provided insight into 
how the curricula in pharmacy schools are operationalized and perceived by pharmacy 
students.   
For this research question, the target population was fourth year Pharm. D. 
students at accredited schools of pharmacy in the U.S.  The sampling frame was fourth 
year Pharm. D. students at the four accredited schools of pharmacy in the Florida and the 
samples for the focus groups were created through non-probability quota sampling.   
Focus Group Discussion Guide 
A focus group topical guide was created by an expert panel to (a) understand what 
pharmacy students learned about emergency contraception in their pharmacy school 
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classes, (b) discover how they were taught about emergency contraception in their 
pharmacy school classes, and (c) find out what their projected emergency contraception 
dispensing practices will be upon becoming a pharmacist.   
The topical guide was developed prior to the focus group discussions by the 
researcher and panel of experts.  The panel of experts consisted of pharmacy faculty, 
recent pharmacy school graduates, practicing pharmacists, and a focus group expert.  A 
list of topic areas was generated that began with non-threatening issues leading into more 
specific questions.  Topical areas and probing questions for the focus groups included but 
were not limited to the following: 
• Knowledge (What do you know about emergency contraception?  Where 
did you learn this information?  What did you learn about emergency 
contraception in your pharmacy classes?  Which classes talked about 
emergency contraception?  Were these classes required or offered as an 
elective?  How does what you learned in course instruction vary from 
what you learned or what you know from outside of class?) 
 
• Instruction (What were you taught about emergency contraception in your 
pharmacy classes?  How were you taught about emergency contraception?  
What kinds of methods of instruction taught you about emergency 
contraception (e. g. lectures, class discussions, course readings, 
assignments)? 
 
• Practice (How do you feel about dispensing emergency contraception?    
Do you feel any differently about dispensing emergency contraception 
than you do dispensing any other medications?  Where do your feelings 
about dispensing come from?  Do you think you will dispense the 
medication upon becoming a pharmacist? What do you think about the 
recent move to allow emergency contraception to be administered over-
the-counter for women over 17 years of age?  Does this change in 
administration status change your views about emergency contraception?  
Have your classes discussed the dispensing issues surrounding emergency 
contraception?  Have your classes brought up the new over-the-counter 
status of emergency contraception?)  
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The qualitative methods employed in this study best address the issue of cognitive 
understanding or perceptions of course instruction on emergency contraception in their 
pharmacy school classes because qualitative research is able to capture complex human 
behaviors such as cognitive processes.  Partnering the Academic Deans survey with the 
findings from the pharmacy student focus groups allowed for an enhanced understanding 
of pharmacy school curricula in the U.S.  Not only did this study review emergency 
contraception pharmacy school curricula but these focus groups provided insight into 
how the curriculum is operationalized or translated to the pharmacy students it aims to 
teach. 
A limitation of focus group data in general, and this research question in 
particular is that the information received from the pharmacy students is based solely on 
self-reporting, meaning that what pharmacy students report learning about in their classes 
may not be reflective of actual classroom instruction.  No two students will learn the 
same way or remember the same material exactly the same and therefore eliciting 
pharmacy students’ perceptions about what they learned or were taught in pharmacy 
school is subjective.  However, the focus groups provided an accurate picture of what 
these pharmacy students remember learning about emergency contraception and how 
they remember being taught this information.   
Sampling Plan 
Each of the four accredited schools of pharmacy in Florida were contacted and 
asked if focus groups could be conducted at their institutions.  In addition, space to 
conduct the focus groups was requested.  One focus group per institution was conducted, 
equaling a total of four focus groups.  Both flyers as well as an email were disseminated 
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to pharmacy students in an attempt to recruit study participants.  If a school of pharmacy 
did not have a listserve of pharmacy students to email, then only flyers were used for 
recruitment.  Flyers were placed into students’ mailboxes and places in convenient 
locations around the school.  The flyer and email announced the focus group date and 
time and students had the ability to contact the researcher either by email or phone to sign 
up to participate.  All four schools participated in the dissemination of the flyer to aid in 
the recruitment of students (see Appendix K for a sample of the recruitment flyer).   
The researcher held one focus group at each of the four institutions and each focus 
group attempted to recruit 8-10 students.  If more than 10 students applied for any one 
focus group, the first 10 students to make contact with the researcher were recruited for 
the focus group.  Individuals were excluded from the study if they were first or second 
year students and if they were not working towards their Pharm. D. degree.  These 
criteria were selected because the Pharm. D. degree is the only degree that allows 
students to become practitioners or pharmacists in various practice settings and this study 
sought to understand the relationships between emergency contraception practices and 
pharmacists.  In addition, first and second year Pharm. D. students were excluded from 
this study because they may not have had the course instruction that the focus groups 
explore.  The Pharm. D. degree is typically a four year and full-time program where the 
first three years are dedicated to course work and then the last year is dedicated to an 
advanced pharmacy practicum where the students apply their class room training to 
clinical settings such as hospitals, outpatient facilities, and community clinics.  Therefore, 
third and fourth year Pharm. D. students were chosen so that they will have already had 
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most of the course instruction for their degree which makes them able to answer the focus 
group questions.     
Study participants who met the eligibility criteria were asked to sign an informed 
consent form prior to participation in the focus group.  Please see Appendix L for a copy 
of the focus group informed consent form.  Students were given a $10 gift certificate to 
Starbucks for their participation.  Gift certificates were provided to study participants in 
an envelope directly before the focus group discussions.  Participants received 
compensation before participation to show that they could leave the study at any time for 
any reason, as waiting until the end of the focus group to distribute the gift certificate 
could appear coercive.   
Focus groups were conducted for approximately one hour and were tape recorded.  
Participants sat in a circle for the focus group discussions.  Two personnel were present 
throughout the focus group discussions, a moderator and a note taker.  The moderator 
was the researcher and the note taker was an individual who has at least an undergraduate 
degree and was screened by the researcher to ensure that the individual can take notes.  In 
addition, the note taker was trained by the researcher to understand the focus group 
topical guide and how to take notes properly.  
  In total, 21 third and fourth year Pharm. D. students participated in the focus 
group discussions (8 from UF, 4 from FAMU, 5 from PBA, 4 from NOVA).  Study 
participants met in a closed room, refreshments were served, and participants read and 
signed the informed consent form prior to participation in the focus group.  After 
informed consent was procured, the paper and pencil survey was administered.  Focus 
groups were conducted for approximately one hour and were tape recorded.  Participants 
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sat in a circle at a table for the discussions.  Two study personnel (a moderator and note-
taker) were present throughout the focus group discussions.  After each focus group, the 
note taker presented a summary of the main ideas that had been identified in each 
question and asked if participants had any changes or additions they would like to make 
to the summary; when changes or additions were made, this information was included.  
Debriefing between the note-taker and the moderator occurred directly after each focus 
group discussion. 
All data, audiotape, notes, and any other pertinent materials collected during focus 
groups were kept confidential.  The materials were stored in locked filing cabinets and no 
personal identifiers were used.  It should be noted that a limitation of the focus groups is 
that there was a high potential for leading and researcher bias since the moderator was 
also the researcher.  In order to reduce this bias, the moderator stayed close to the topical 
guide created by the panel of experts.  In addition, the process of self-reflexivity was 
performed where the researcher becomes aware of her own beliefs and how these beliefs 
may be impacting the interaction and interpretation of the research.   
Pharmacist Questionnaire 
Target Population & Sampling Frame 
The third research question, what is the relationship among emergency 
contraception knowledge, attitudes, subjective norms, perceived behavioral control, and 
dispensing practices of Florida pharmacists registered with the Board of Pharmacy, was 
addressed through a 58-item, mixed-mode (paper or web-based) questionnaire 
administered to a randomly selected group of Florida pharmacists.   This research 
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question will determine what variables, if any, are predictive of pharmacist emergency 
contraception dispensing practices.   
The target population for this research question was all pharmacists in Florida and 
the sampling frame was all pharmacists registered with the Florida Board of Pharmacy.  
Although national organizations such as the American Pharmaceutical Association 
(AphA) have an impact on pharmacies and pharmacists, most pharmacists are regulated 
more by state law and by their local state Board of Pharmacies.  Therefore, although the 
target population was all pharmacists in the U.S., it is better to perform research on a 
state-by-state basis because state policies and regulations vary from state-to-state.  The 
target sample was 552 Florida pharmacists that were randomly selected from all 
pharmacists (N= 29,896) registered with the Florida Board of Pharmacy.  The 
determination of the target sample size of pharmacists (N=552) for this study is discussed 
in the power analysis section below. 
Power Analysis—Sample Size 
 Target sample size (N) is determined by a confluence of factors including the 
significance criterion (α), statistical power, and population effect size (ES).  In statistical 
modeling, the relationships between these four factors are a function of each other 
(Cohen, 1992).  The significance criterion (α) equals the acknowledged risk of falsely 
rejecting the null hypothesis also referred to as Type I error.  Typically α is set at .05 and 
therefore in this study, α will set at .05 as well (Cohen, 1992).   
Statistical power is the probability of rejecting the null hypothesis when it is false.  
If the null hypothesis is false, failing to reject it is an error.  This error, failing to reject a 
false null hypothesis, is referred to as Type II error.  The probability of committing a 
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Type II error (β) is 1-power.  Cohen (1992) recommends target power of .80 for general 
use as a value smaller than .80 represents excessive risk of Type II error.  Conversely, 
power larger than .80 would require an N that would possibly be unattainable given the 
resources of the researcher (Cohen, 1992). 
 Population effect size is the most difficult of all four components to determine.  
Effect size is the degree to which the null hypothesis is false.  Cohen (1992) has proposed 
criteria for small, medium, and large effect size values based on a given statistical test.  
Since the proposed research sought a medium effect size and for most of the statistical 
tests employed in this research, an effect size of .30 will be adequate.  An effect size of 
.30 is able to detect an effect that can be visible to the naked eye of an observer (Cohen, 
1992).  This effect size is adequate for this research. 
 Given these three pieces of information, α=.05, statistical power=.80, and ES=.30, 
both Cohen’s power tables of N for small, medium, and large effect sizes as well as a 
power analysis program (performed in SAS) were employed in order to determine sample 
size (N).  First, it was necessary to determine the correct statistical tests to use.  Given the 
research questions and the levels of measurement of the survey questions, three statistical 
tests were identified: Chi-square, significant tests of a sample r, and logistic regression.  
Once the statistical tests were defined, the sample size required to get adequate power for 
a medium ES could be determined.  Each statistical test yielded a different N and the test 
with the largest N was chosen as the appropriate sample size.  Please see Table 1 for 
sample size (N) determined by the statistical test with a medium ES.   
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Table 1. Sample Size (N) for Medium ES at Power = .80 for α=.05 
Test  Measure  Sample Size (N) 
Sig r  r = .30  n = 85 
       
Chi-square (6df)   w = .30  n = 151 
       
Logistic Regression  tolerance=.5  n = 331 
 
 In order to find the sample size for Chi-square and significant tests of a sample r, 
Cohen’s power tables were employed (1992).  However, in order to determine the sample 
size required for logistical regression, a power analysis was performed in SAS (SAS 
Institute Inc, Cary, NC).  The SAS program code used is a test of a single predictor in a 
logistic model.   
Tolerance is the extent to which the predictor variable is independent of the other 
predictors.  Tolerance set at 1 means that the predictor is completely independent of the 
other predictor variables and if tolerance is smaller than 1, it means that the predictor 
variable is related to the other predictors, and therefore a larger sample size is needed.  
Tolerance was tested from 1 to .5.  These values are represented in Table 2 below. 
Table 2. Sample Size Required for Each Level of Tolerance (1 to .5) in Logistic Regression, 
α=.05. 
pi OR Tolerance N 
0.1 2 1 166
0.1 2 0.9 184
0.1 2 0.8 207
0.1 2 0.7 237
0.1 2 0.6 276
0.1 2 0.5 331
 
The model was set for power at .80, α=.05, and was set for the smallest odds ratio 
that is cared about finding (OR=2) if the predictor is unrelated to the other predictors.  It 
is preferred that a tolerance of .5 is unique meaning that half of the variability of each 
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predictor is independent of the other predictors.  This is why a sample size of 331 was 
chosen as this sample will maintain enough power to detect any differences.  However, in 
determining any sample size, response rates must be taken into consideration.  Because 
there is not a known response rate of pharmacists in existing literature, an expected 
response rate was calculated by taking the mean of response rates from the other 
pharmacist studies discussed in the literature review.  Borrego et al (2006) had a 40% 
return rate, Van Riper & Hellerstedt (2005) received a 67% response rate, and Conard et 
al (2003) had a 75% response rate.  Taking the mean of these three studies, a response 
rate of 60% is expected for this survey which means that a sample of 552 pharmacists 
will be required. 
Sampling Plan 
The power analysis determined that a target sample size of 331 would maintain 
enough power to detect any differences and a response rate of 60% was established based 
upon response rates from other studies that surveyed pharmacists.  Therefore, it was 
determined that 552 surveys should be mailed out to procure a sample of 331.   
The sample was selected through a simple random sampling method.  First, 
information on all pharmacists who were registered with the Florida Board of Pharmacy 
was downloaded from the Department of Health webpage (N=29,896) in EXCEL format.  
Both active and inactive pharmacists living in Florida and outside of Florida were 
contained in these files.  Inactive pharmacists as well as pharmacists living outside of 
Florida were sorted out of the total, leaving 17,310 pharmacists who were active and who 
lived in Florida.  A random number table was employed to generate 552 random numbers 
from 1 to 17,310.  The numbers in a number table are listed through a pure random 
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process which allows any number the equal chance of being placed in any position.  After 
the beginning number was selected, this random sampling technique chose 552 
pharmacists as participants for this study.  This procedure is described in Neuman (2003) 
as one way to approximate randomness and thus be able to yield a sample that is 
representative of the total population.  Finally, contact information on each of the 552 
pharmacists was removed from the larger list and was entered into an additional EXCEL 
spreadsheet which made up the sample. 
A sample of 552 pharmacists was randomly selected for participation in this 
study.  Each pharmacist was mailed (a) a pre-notice postcard, (b) an abbreviated 
informed consent form, (c) a cover letter (d) a questionnaire with an envelope with return 
postage included, and (e) a thank you/reminder postcard as suggested to improve 
response rates by the tailored design method (Dillman, 2000).  Please see Appendix M 
for a copy of the pre-notice postcard, Appendix N for a copy of an abbreviated informed 
consent form, Appendix O for a copy of the cover letter, Appendix P for a copy of the 
questionnaire, and Appendix Q for a copy of the thank you/reminder postcard. 
Three separate mailings occurred for this portion of the research study, one for the 
pre-notice, one for the actual questionnaire, and one for a thank you/reminder mailing 
with online survey-mode option.  Postal addresses of all pharmacists registered with the 
Florida Board of Pharmacy were obtained from the Florida Department of Health 
website.  The pre-notice letter was mailed to pharmacists a few days before the 
questionnaire was mailed.  The pre-notice alerts the pharmacist to be on the look out for 
an important survey that will be arriving within the near future and indicates that a 
response would be appreciated.  The pre-notice should be brief and personalized and is 
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not meant to provide detail about the study but just to provide notice of the upcoming 
request to complete a survey (Dillman, 2000). 
A few days after the pre-notice was mailed, another mailing was sent out which 
will included the informed consent form, cover letter, paper-based questionnaire, and a 
return envelope.  The return envelope was addressed and real stamps were usedinstead of 
a business reply as using stamps has been shown to improve study response rates 
(Dillman, 2000).  The cover letter was no longer than one page and included pertinent 
information about the study.  The cover letter explained why the study is important.  
Because this survey is a mail survey with follow-up internet survey option, a wavier of 
consent was requested and granted from the IRB as well as a waiver of written 
documentation.  According to the IRB, a one page document including the basic elements 
provided in a longer informed consent form is all that is required for a study of this 
nature.   
Regardless of whether the study participant returned the questionnaire, they 
received a thank you/reminder postcard approximately one week after the delivery of the 
questionnaire.  The main purpose of this postcard is to jog the memories of the 
individuals and increase the study response rate (Dillman, 2000).  Included in the thank 
you/reminder postcard was a link to the same survey on-line.  Each participant may 
choose to fill out the paper-based survey they received in the second mailing or an on-
line version they received a link to in the follow-up post-card.  Like the Academic Dean 
survey, the pharmacist web-based survey was held on the USF Ultimate Surveyor 
program.  If pharmacists choose to complete their survey online, the informed consent 
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form was the same as the paper-based informed consent except that participants clicked 
the check box at the bottom of the screen signifying consent to participate in the study.   
According to Dillman (2000), the type of mixed-mode format where one mode is 
used at first contact and then another mode is used at final contact only to prompt the 
completion of a survey, will improve coverage and reduce non-response rates.  Dillman 
(2000) notes, “introducing a new mode at this stage of the data collection may allow 
information to be collected that will improve coverage…it is also likely it improve 
response rates to the other mode significantly” (p. 222).  In addition, potential 
measurement differences that are found in other mixed-mode situations may be avoided 
by introducing another survey mode this way (Dillman, 2000).   
This type of mixed-mode survey design was chosen for this study as it improves 
response rates while limiting measurement differences found in other mixed survey 
modes.  It was originally thought desirable to send respondents a choice between a paper 
and pencil survey and an online version; however in practice this has not shown to 
increase response rates (Dillman, 2000).  Therefore, the current mixed-mode survey 
design with the first mode being paper-based and the follow-up or final mode being 
online was chosen for this research study. 
Originally, it was thought that a comparison of critical variables to estimate non-
respondent bias could be performed.  That is, answers from first responders were going to 
be compared to answers from those who responded after the follow-up post card to 
measure any differences in the two groups.  However, due to the low number of 
responders from the follow-up postcard (n=8), this type of bias could not be estimated.  
In an additional attempt to understand the characteristics of non-responders, the Florida 
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Board of Pharmacy was contacted to see if they collect basic demographic information on 
Florida pharmacists.  However, they do not, meaning that the demographic information 
from the responders cannot be compared to the demographic information of non-
responders and therefore the characteristics of the non-responders cannot be known. 
The pharmacist survey was developed, piloted, and tested for readability, 
reliability, and validity among a group of pharmacists.  The questionnaire inquire about 
six main variables, (1) level of knowledge about Plan B, (2) personal attitudes held about 
Plan B and about Plan B dispensing, (3) perceived social pressures around issues of 
dispensing, (4) perceived behavioral control over the behavior of dispensing Plan B, (5) 
intention or likelihood of dispensing Plan B, and (6) emergency contraception dispensing 
practices.  In addition to questions that measure these six variables, the instrument will 
include questions on basic demographics and background such as age, gender, ethnicity, 
marital status, religious and political party affiliation, type of pharmacy, and length of 
time in practice.   
Data Collection 
Instrument Development  
To guide the questionnaire development and focus group topical guide for this 
study, interviews were conducted with a panel of experts in which practicing pharmacists 
were asked general questions about being a pharmacist, their schooling and curricula, and 
their emergency contraception knowledge, attitudes, subjective norms, and perceived 
behavioral control.  Please see Appendix R to review the questions and responses from 
the expert interviews.   
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It is from these interviews as well as from the literature review and the theoretical 
underpinnings of the Theory of Planned Behavior, that instruments were developed for 
this study.  The literature review in particular brought three important studies to light that 
were influential in the creation of the pharmacist questionnaire.  Permission was 
requested to utilize parts of instruments that were employed in these studies.  Questions 
were selected from these three studies and combined to form one questionnaire however 
some questions were taken and altered to fit the proposed study.  The pharmacist survey 
instrument was developed from the surveys used in the following three studies: 
1) The most influential study in terms of survey development assessed 
pharmacist knowledge, attitudes, and dispensing practices of emergency 
contraception among South Dakota pharmacists.  A 14-item survey was 
mailed to all registered pharmacists (n=810) in South Dakota to assess 
their attitudes, knowledge, and dispensing practices of emergency 
contraception and 62% responded (Van Riper & Hellerstedt, 2005).  Many 
of the practice and workplace as well as knowledge and attitudes questions 
were taken and adapted from the survey instrument employed in the 
pharmacist survey.    
2) Another U.S.-based study examined emergency contraception knowledge, 
attitudes, and behaviors among women and men ages 18-21 (n=97) 
attending a university through the use of a 25-item paper-based 
questionnaire (Corbett, Mitchell, Taylor, & Kemppainen, 2006).  
Although this questionnaire was read to aid in the development of ideas 
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for the pharmacist survey, the only questions taken from this instrument 
were the demographic questions.    
3) A third study performed a cross-sectional survey of 96 faculty physicians 
from four universities to measure prescribing intention of emergency 
contraception (Sable, Schwartz, Kelly, Lisbon, & Hall, 2006).  Many of 
the prescribing practice and perceived behavioral control questions were 
taken from the survey instrument, adapted, and employed for use in the 
pharmacist survey.  
The pharmacist survey was piloted among a group of pharmacists not eligible for 
participation in the Florida pharmacist survey.  The Academic Deans survey was piloted 
among the Academic Dean of the USF College of Public Health as she was not eligible 
for the pharmacy school curricula review.  The feedback from this pilot was helpful in 
not only adjusting the survey but also for understanding the feasibility of the survey.  
After reviewing the survey, the Academic Dean of the USF College of Public Health 
indicated that she would respond to the survey if it had been emailed to her.  In order to 
better understand the feasibility of the Academic Deans survey, five Academic Deans 
were randomly selected and sent an email asking if they would respond to a three item 
questionnaire of this nature.  The final pharmacist and Academic Dean surveys were 
developed from the feedback provided through the pilots. 
Both instruments, the pharmacist questionnaire and the Academic Dean 
questionnaire, were tested for validity and reliability.  The focus group topical guide will 
be discussed in greater detail later in the paper.  Reliability refers to the dependability or 
consistency of the instrument and validity implies truthfulness and refers to how well the 
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construct and measure fit together (Neuman, 2003).  There are three types of reliability 
that are of concern: stability reliability, representative reliability, and equivalence 
reliability.   
Stability reliability is a measure of dependability across time.  That is, will this 
instrument yield the same answers over varying time periods?  Stability reliability can be 
measured through a test-retest method where the instrument is re-administered to the 
same group of people to see if the same results are produced multiple times (Neuman, 
2003).    
Representative reliability is dependability across different groups of individuals.  
It answers the question; will the instrument yield the same answers when administered to 
different groups?  Representative reliability can be measured through a subpopulation 
analysis in which the instrument is measured among different groups of people such as 
people of varying ages, sexes, and ethnicities.  The instrument is said to have 
representative reliability if the groups maintain the same error rate (Neuman, 2003).  
Equivalence reliability is dependability when multiple indicators are used to 
measure a construct.  It answers the question; does the construct yield consistent findings 
across the various indicators or survey items?  Cronbach’s alpha is a statistical measure 
that can determine equivalence reliability.  Cronbach’s alpha is a numerical coefficient of 
reliability ranging from 0 to 1 and the higher the score, the more reliable the scale.  A 
reliability coefficient of .7 is viewed as acceptable; however some literature has accepted 
lower coefficients (Nunnaly, 1978). 
Not only will the test-retest method, a subpopulation analysis, and Cronbach’s 
alpha be employed to test for reliability but other ways to increase reliability include: (a) 
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conceptualizing constructs clearly, (b) employing multiple indicators, and (c) running 
pilot tests (Neuman, 2003).  
Validity or more specifically, measurement validity indicates how conceptual and 
operational definitions fit with each other.  The greater the fit, the more measurement 
validity is achieved.  Validity answers the question: does the indicator measure the 
construct it is trying to measure? There are two types of measurement validity that are of 
concern for this study: face and construct validity.  Face validity is a consensus measure 
of validity which demonstrates that people agree that the indicator measures the 
construct.  Face validity answers the question; do people think that there is a fit between 
the definition and the method of measurement?  Construct validity is employed when 
measures have multiple indicators.  Construct validity answers the question, are the 
various indicators consistent?  Face validity was measured through a survey pilot test and 
construct validity was calculated through factor analysis procedures, all of which will be 
discussed in the results section below. 
Measures 
There are six main constructs measured in the survey of pharmacists, (1) 
knowledge (2) attitudes, (3) subjective norms, (4) perceived behavioral control, (5) 
intention to dispense, and (6) dispensing practices.  Each of these six constructs is 
measured by multiple indicators or survey questions.  All independent, dependent, and 
socio-demographic variables, survey questions, response options, and variable level of 
measurement are represented in Appendix S. 
1) The first construct, knowledge, is measured by 10 separate questions and is 
measured on the nominal level.  Knowledge is operationalized through a 
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comprehension of emergency contraception effectiveness, number of pills 
dispensed in Plan B packaging, mechanism of action, and health risks.  
Individual variables include: # of pills in package, hours of effectiveness, 
mechanism of action, timing for effectiveness, comprehension about OTC 
sales, health risks, birth defects, and abortifacient. 
2) The second construct, attitudes, is measured by 8 separate questions and is 
measured at the nominal and ordinal levels.  An attitude is defined by Ajzen 
(1988) as “…a disposition to respond favorably or unfavorably to an object, 
person, institution, or event.” (p. 4).  Therefore survey questions about 
attitudes measure self-reported feelings or beliefs that are positive and 
negative about emergency contraception use and dispensing.  Variables 
include: feelings about benefits and risks, beliefs about maintenance of 
contraception, feelings about promiscuity, feelings about prescribing and 
religion/ethics, feelings about repeated use, feelings about comfort level in 
dispensing, feelings about dispensing to adolescents, feelings about dispensing 
for clients, beliefs about lifetime use of emergency contraception.      
3) The third construct, subjective norms, refers to the perceived social pressures 
to perform or not perform a particular behavior.  Subjective norms are 
measured through 6 questions that query about how the participant perceives 
what important people think about emergency contraception dispensing and is 
measured at the interval level.  Variables include: partners/colleagues 
perception of emergency contraception dispensing, professional organization 
perception of emergency contraception dispensing, boss perception of 
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emergency contraception dispensing, and close friends and family perception 
of emergency contraception dispensing.  Additionally, two questions were 
asked regarding their pharmacy culture (i. e. if there is anyone who refuses to 
dispense the medication at their pharmacy and if there is a policy in place at 
their pharmacy if someone refuses to dispense Plan B).    
4) The fourth construct, perceived behavioral control is measured by 4 questions 
and refers to how difficult or easy the behavior is to perform and in this case, 
the behavior is emergency contraceptive dispensing.  Therefore, perceived 
behavioral control is measured by four questions that inquire about the ease or 
difficulty involved in dispensing emergency contraception and is measured at 
the ordinal level.  Variables include: perceived ease of counseling clients, 
perceived ease of dispensing, perceived ease of refuse to dispense, perceived 
ease of educating clients. 
5) The fifth construct, intention or likelihood to dispense Plan B, is measured by 
8 questions that query pharmacists about their intention to dispense Plan B to 
varying groups of people.  For example, pharmacists answer whether they are 
likely or unlikely to dispense Plan B to women who are raped, women who 
have experienced a problem with their birth control method etc. to test for 
differences in intention to dispense based on the situation of the woman 
requesting the medication.  Intention to dispense is divided by OTC and by 
prescription to account for any differences. 
6) The sixth construct, dispensing practices, is measured by 13 questions that 
query pharmacists about their emergency contraception dispensing practices 
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in general and by prescription and over-the-counter to varying groups of 
people.  Variables are measured on both the nominal and ordinal levels and 
include: pharmacy stock of birth control products, pharmacy dispensing of 
emergency contraception, ever filled a prescription, # of prescriptions filled in 
past 12 months, likelihood of dispensing over-the-counter to various groups, 
and likelihood of dispensing by prescription to various groups.  However, in 
the analysis, dispensing practices are only measured by two questions that ask 
pharmacists if they have ever dispensed Plan B by prescription or OTC.   
In addition to these measures, demographic information such as age, gender, 
ethnicity, marital status, religious and party affiliation, type of pharmacy, and length of 
time in practice will be collected on study participants and these variables are measured 
on the nominal, ordinal, and ratio levels.  The first five constructs, knowledge, attitudes, 
subjective norms, perceived behavioral control, and intention to dispense are the 
independent variables and dispensing practices is the dependent variable.  See Figure 4 
below for a graphic representation of these variables.  This design will aid in 
understanding which independent variables, if any, predict emergency contraception 
dispensing practices of pharmacists. 
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Figure 4: Independent and Dependent Variables  
 
     
Reliability and Validity Measures 
The pharmacist survey was developed, piloted, and tested for readability, validity, 
and reliability among a group of pharmacists.  After the pilot and tests, the survey was 
finalized as a 58 item questionnaire. 
Validity: Face, Content, and Construct 
 The pharmacist survey was piloted among a panel of experts (n=5) including 
practicing pharmacists, pharmacy faculty, and pharmacy students for face and content 
validity.  Participants were asked to rate each question on the instrument as to whether it 
looks as if it is measuring the designated topic (face validity) and were asked to provide 
comments on how to fix questions that were given low ratings.  In addition, participants 
were asked if there were important aspects of each question of the designated topic that 
the instrument was not measuring (content validity).  See Appendix T for a sample 
Knowledge 
Attitudes 
Subjective Norms 
Perceived Behavioral 
Control 
Dispensing Practices 
Independent Variables Dependent Variables 
Intention to Dispense 
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review guide that was distributed to measure face and content validity.  It was from this 
pilot among a panel of experts that the pharmacist questionnaire was fully developed (see 
appendix N for the finalized pharmacist survey).  
 Construct validity of scores was measured by exploratory factor analysis.  Survey 
questions naturally divided into the predefined construct areas of knowledge, attitudes, 
subjective norms, perceived behavioral control, and dispensing practices.  Factor analysis 
was conducted separately for each construct area to see if content area questions are only 
measuring that one factor.  Factor analysis was performed using SAS statistical 
packaging (SAS Institute Inc, Cary, NC).  Eigenvalues (the proportion of variance 
determined by each factor) were used to help decide on the number of factors (via the 
scree plot).  In addition, squared multiple correlations were used as prior communality 
estimates, principal factor analysis was used to extract factors, and an oblique rotation 
was employed.  A scree test was also used to determine meaningful factors and an item 
was said to load on a factor if the pattern coefficient was above .30.   
Knowledge: The eigenvalues and scree plot suggested that one factor was present 
among the 10 questions aimed at measuring knowledge of emergency contraception 
(Questions 22-31) as only one factor maintained an eigenvalue over 1.  The factor 
represented 22.5% of the total item variance in the set of questions.  Given the criteria of 
.30, all variables loaded at .30 or higher except for questions 24 and 25 (see Table 3).  
However, after a closer look at questions 24 and 25 in the survey, it was determined that 
they would need to stay in the analysis as they measured understanding of the mechanism 
of action and percentage of effectiveness, both of which are critical to knowledge of the 
medication.  
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Table 3. Factor Pattern matrix for Knowledge Items 
Item Factor 1  
Q22. Number of pills in Plan B package 0.52 
Q23. Timing of administration 0.64 
Q24. Mechanism of action 0.28 
Q25. Percentage of effectiveness 0.20 
Q26. Who can sell Plan B to consumers 0.53 
Q27. How to sell OTC to women (in advance of need) 0.38 
Q28. How to sell OTC to men 0.55 
Q29. Plan B can cause birth defects (True/False) 0.50 
Q30. Plan B can act as an abortifacient (True/False) 0.58 
Q31. The sooner a woman takes Plan B, the more effective it will be 
(True/False) 
0.37 
 
Attitudes: The eigenvalues and scree plot suggested that one factor was present 
among the 8 questions aimed at measuring attitudes about emergency contraception 
(Questions 32-39) as only one factor maintained an eigenvalue even over 0.  The factor 
represented 86.6% of the total item variance in the set of questions.  All items maintained 
very high loadings on the one factor with the lowest loading at 0.75 and the highest at 
0.99 (see Table 4).  
Table 4. Factor Pattern matrix for Attitude Items 
Item Factor 1  
Q32. Easy availability of Plan B will discourage regular contraceptive use 0.99 
Q33. Easy availability of Plan B promotes promiscuity 0.89 
Q34. I feel uncomfortable dispensing Plan B because of my 
religious/ethnical beliefs 
0.99 
Q35. Repeated use of Plan B is wrong 0.81 
Q36. I feel comfortable dispensing Plan B to adult women 0.99 
Q37. I feel comfortable dispensing Plan B to adolescents (teens <18 yrs old) 0.99 
Q38. I feel comfortable dispensing Plan B to men 0.99 
Q39. Should Plan B be offered to women who are raped in all hospital 
emergency rooms, regardless of hospital affiliation? 
0.75 
 
Subjective Norms:  Much like knowledge and attitudes, the eigenvalues and scree 
plot suggested that one factor was present among the 4 questions aimed at measuring 
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subjective norms (Questions 40-43) as only one factor maintained an eigenvalue over 0.  
The factor represented 78.5% of the total item variance in the set of questions.  As 
demonstrated in Table 5, all items maintained very high loadings on the one factor 
ranging from 0.83 to 0.94. 
Table 5. Factor Pattern Matrix for Subjective Norm Items 
Item Factor 1  
Q40. My partners/business colleagues think I should dispense Plan B 0.94 
Q41. The professional organization I am most active in recommends 
that I dispense Plan B 
0.83 
Q42. My supervisor thinks that I should dispense Plan B 0.86 
Q43. My close friends and family think I should dispense Plan B 0.91 
 
Perceived Behavioral Control:  The eigenvalues and scree plot suggested that one 
factor was present among the 4 questions aimed at measuring perceived behavioral 
control (Questions 46-49) as only one factor maintained an eigenvalue over 0.  The factor 
represented 96.5% of the total item variance in the set of questions.  All items maintained 
very high loadings on the one factor ranging from 0.93 to 1.00 (see Table 6).  
Table 6. Factor Pattern Matrix for Perceived Behavioral Control Items 
Item Factor 1 Pattern 
Loadings 
Q46. How easy is it for you to counsel clients about Plan B 1.00 
Q47. How easy is it for you refuse to dispense Plan B 0.93 
Q48. How easy is it for you educate clients about Plan B 1.00 
Q49. How easy is it for you dispense Plan B 1.00 
 
Dispensing Practices: Dispensing practices includes the two separate constructs of 
actual dispensing practices and intention to dispense emergency contraception.  Actual 
dispensing practices of emergency contraception is measured by two items (Questions 8 
and 11).  Question 8 asks if a respondent has ever filled a prescription of Plan B and 
question 11 asks if they have ever sold Plan B OTC.  Because the variable, actual 
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dispensing practices, is only measured by two questions, factor analysis does not 
conceptually make sense.  Instead, a cross tabulation, Pearson Chi-Square test of 
association, and Phi coefficient statistic was run to determine the relationship between the 
two questions.  The Chi-Square test revealed a direct and significant relationship (Chi-
Square value 91.33, p<0.001) between the two questions.  The Phi coefficient which is 
the measure of association between the two variables was significant (Phi=0.585, 
p<0.0001).  These findings provide enough evidence to combine them into one construct 
measuring actual dispensing practices.   
As for intention to dispense emergency contraception, the eigenvalues and scree 
plot suggested that one factor was present among the 8 questions aimed at measuring this 
construct (Questions 14-21) as only one factor maintained an eigenvalue over 0.  The 
factor represented 80.5% of the total item variance in the set of questions.  All items 
maintained very high loadings on the one factor ranging from 0.70 to 1.00 (see Table 7).   
Table 7. Factor Pattern Matrix for Intention to Dispense Items 
Item Factor 1  
Q14. Likelihood of dispensing OTC to women who have experienced 
incest or rape 
0.73 
Q15. Likelihood of dispensing OTC to women who have experienced a 
problem with their birth control method 
0.99 
Q16. Likelihood of dispensing OTC to women who request the method 
after having unprotected sexual intercourse 
0.71 
Q17. Likelihood of dispensing OTC to a person other than the ultimate 
consumer of the product such as parents or a boyfriend 
0.98 
Q18. Likelihood of dispensing by prescription to women who have 
experienced incest or rape 
0.99 
Q19. Likelihood of dispensing by prescription to women who have 
experienced a problem with their birth control method 
1.00 
Q20. Likelihood of dispensing by prescription to women who request the 
method after having unprotected sexual intercourse 
1.00 
Q21. Likelihood of dispensing by prescription to sexually active teens 
under age 18 
0.70 
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 In summary, exploratory factor analysis provides evidence of construct validity of 
scores for the pharmacist survey.   
Reliability: Stability and Equivalence  
 
Reliability refers to the dependability or consistency of an instrument and validity 
implies truthfulness and refers to how well the construct and measure fit together 
(Neuman, 2003).  There are two types of reliability that are of concern: stability and 
equivalence reliability.   
Stability reliability is a measure of dependability across time.  That is, will this 
instrument yield the same answers over varying time periods?  Stability reliability was 
measured through a test-retest method where the instrument was re-administered to the 
same group of people to see if the same results were produced multiple times (Neuman, 
2003).  The pharmacist survey was administered online to a group of 18 pharmacists at 
one point in time and then again about one week later.  The sample of pharmacists who 
participated did not practice pharmacy in Florida, so not to impact study results.  Survey 
data were stored in an EXCEL database and were analyzed using SPSS statistical 
analysis software (SPSS 16.0, SPSS Inc., Chicago).  Percentage agreements and Pearson 
product-moment correlation coefficients were calculated to measure the relationship 
between the variables over the two time periods.  Percentage agreements measure the 
proportion of all occasions at which the variables agree across time and are primarily 
used with nominal level data.  A percentage of 80% or higher was deemed as acceptable.  
Pearson product-moment correlation coefficients (represented as r) assess the relationship 
between variables and range from -1 to zero to +1 and are typically employed with rato or 
interval levels of measurement.  A correlation of -1 demonstrates a perfect negative linear 
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relationship, 0 means that there is no relationship, and +1 demonstrates a perfect positive 
linear relationship between variables.  A Pearson correlation of 0.60 or higher was 
deemed as acceptable.   
The survey was tested and was found to have acceptable reliability of scores.  The 
results support dependability of scores that will be procured from the survey.  The results 
are discussed below and have been categorized by survey construct:  background 
characteristics, dispensing practices, knowledge, attitudes, subjective norms, and 
perceived behavioral control. 
 Background Characteristics.   Background characteristics are comprised of 
13 variables including gender, age, ethnicity, years in practice, type of pharmacy, marital 
status, religion, religiosity, political affiliation, employment status, pharmacy school 
attended, year of graduation, and job title.  Percentage agreement tests were performed on 
all 13 variables.  A Table depicting the results for the demographic variables is provided 
below. 
Table 8. Percentage Agreements for Background Characteristics 
 Variable Percentage Agreement 
Gender 100% 
Age 83% 
Ethnicity 100% 
Years in practice 83% 
Type of pharmacy 100% 
Marital status 100% 
Religion 94% 
Religiosity* 72% 
Political affiliation 100% 
Employment status 100% 
Pharmacy school attended 94% 
Year of graduation 100% 
Job title 94% 
*Did not meet the 80% cut off value.  
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All variables except for one (religiosity) met the percentage agreement cut off 
value of 80%.  The percentage agreement for religiosity was 72% in that five out of the 
eighteen participants changed their answer over time.  The question on religiosity asked, 
How would you describe yourself (choose only one).  The answer choices were 1) 
Religious, 2) Spiritual, 3) Religious and spiritual, 4) Undecided, 5) None of the above, 
and 6) Prefer not to respond.  Of the five respondents that changed their answer from one 
administration to the other, the first respondent changed their answer from religious to 
prefer not to respond, two participants changed from religious and spiritual to religious, 
one changed from none of the above to religious and spiritual, and the last respondent 
changed from prefer not to respond to none of the above.  The inconsistency in the 
answers of these five participants seems to be a result of the personal nature of the 
question. 
 Dispensing Practices.  Dispensing practices is measured by 17 questions of which 
percentage agreements were performed on nine questions and Pearson correlations were 
performed for the other eight questions.  Of the nine that received percentage agreements, 
the questions queried about pharmacy stocking of condoms, spermicide, oral 
contraceptive pills, stocking of Plan B, dispensing of Plan B and inquired about how 
many times within the past year that they dispensed it both OTC and by prescription (see 
questions 5-13 in pharmacist survey Appendix N).  All nine questions received 
percentage agreements above the 80% cut off value and are therefore reliable.  In fact, all 
but two questions received 100% agreements across the two survey administrations.  The 
two questions that received less than 100% agreements were the open ended questions 
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querying about how many times they have sold Plan B OTC and by prescription in the 
past 12 months and yielded 88% and 83% agreements, respectively.    
 Pearson correlations were run on the eight questions measuring dispensing 
practices.  Specifically, these questions measure to what extent pharmacists are likely to 
sell Plan B OTC or dispense Plan B by prescription to women in varying circumstances 
such as women who were raped, women who had a problem with their birth control 
method etc. (see questions 14-21 on the pharmacist survey Appendix N).  These 
questions employ a 4-point Likert scale ranging from very unlikely to very likely.  
Correlations were run for each individual item at time one and time two.  In addition, the 
responses were combined to create a new variable and the combined variable was run at 
time one and time two.  All individual questions received a Pearson correlation of 
r=0.686 or higher, demonstrating a positive relationship and all analyses were significant 
at the p=0.01 level.  In addition, the combined score for dispensing practices yielded a 
Pearson correlation coefficient of r=0.820, with significance at the p=0.01 level. 
 Knowledge.   Knowledge of emergency contraception is measured by 10 
questions querying on the basic properties and mechanisms of action of Plan B as well as 
questions that measure if pharmacists have knowledge around issues of dispensing Plan B 
OTC (see questions 22-31 in pharmacist survey Appendix N).  For knowledge, each item 
was awarded one point if the participant responded correctly and zero if they responded 
incorrectly.  The points were added up for each participant yielding a knowledge score 
for each participant at time one and time two.  Then, Pearson correlations were run on 
these knowledge scores.  The Pearson Correlation was r=0.849, demonstrating a positive 
relationship and was significant at the p=0.01 level. 
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 Attitudes.  Attitudes is measured by eight questions querying about how 
pharmacists personally feel about dispensing and about women using Plan B (see 
questions 32-39 in pharmacist survey Appendix N).  Seven of the questions are Likert 
scale questions (questions 32-28) and therefore employed Pearson correlations and one of 
the questions is a nominal level question (question 39) and therefore a percentage 
agreement was calculated.  Of the seven questions employing a 4-point Likert scale, 
responses ranged from completely disagree to completely agree.  First scores had to be 
adjusted such that a higher score demonstrated a more positive attitude towards Plan B.  
The response scale for these items was reflected.  After this process, correlations were 
run for each individual item at time one and time two.  In addition, the responses were 
combined to create a new variable and the combined variable was run at time one and 
time two.  All individual questions received a Pearson correlation of r=0.727 or higher, 
demonstrating a positive relationship and all analyses were significant at the p=0.01 level.  
In addition, the combined score for attitudes yielded a high Pearson correlation 
coefficient of r=0.950, with significance at the p=0.01 level.  The one nominal level 
question received a percentage agreement of 100% and is reliable. 
 Subjective Norms.  The construct subjective norms is measured by six questions 
pertaining to the way people, groups, and pharmacy policy may be associated with 
pharmacist dispensing of Plan B (see questions 40-45 in pharmacist survey Appendix N).  
Pearson correlations were run on four of the questions measured on a 4-point likert scale 
(interval data) and percentage agreements were calculated for the other two questions that 
were measured at the nominal level.  For the analysis of the four likert scale questions 
(questions 40-43), the answers were combined and Pearson correlations were calculated.   
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The Pearson Correlation was 0.820 and were significant at the p=0.01 level, 
demonstrating a positive relationship.  The two questions that were measured at the 
nominal level (questions 44-45) maintained 100% agreement between time one and time 
two.   
 Perceived Behavioral Control.  Perceived behavioral control is measured by four 
questions on a 4-point likert scale depicting how difficult or easy it is to dispense Plan B 
(see questions 46-49 in pharmacist survey Appendix N).  Questions queried about how 
difficult or easy it is to counsel and educate clients, to dispense and refuse to dispense 
Plan B.  Responses to the questions were added up and Pearson correlations were 
calculated.  The Pearson Correlation was 0.831, demonstrating a positive relationship and 
all analyses were significant at the p=0.01 level. 
 In summary, the statewide pharmacist survey was found to have stability 
reliability and thus these results support dependability of scores that will be procured 
from the survey.   
 Equivalence reliability assesses how well variables measure a latent construct.  
Cronbach’s alpha is a statistical measure that can determine equivalence reliability.  This 
measure is a numerical coefficient of reliability ranging from 0 to 1 and the higher the 
score, the more reliable the scale.  A reliability coefficient of .70 is typically viewed as 
acceptable (Nunnaly, 1978).  Reliability analysis through Cronbach’s alpha was 
performed on the four constructs that contained interval and ordinal level data (attitudes, 
subjective norms, perceived behavioral control, and dispensing practices) and all 
coefficients exceeded the acceptable value of .70.  In fact, all reliability coefficients 
exceeded .90.  Given that the construct of knowledge is based on nominal level data in 
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which a composite knowledge score was calculated for each individual, it did not make 
sense to assess scale reliability through Cronbach’s alpha.  Instead, the equivalence 
reliability measure for knowledge will rely on the stability reliability measure and high 
Pearson correlation that was determined through the test-retest method.  However, for the 
other four constructs, reliability estimates were .98 for attitudes, .94 for subjective norms, 
.99 for perceived behavioral control, and .95 for dispensing practices.  Therefore, the 
variables are measuring each construct and the scale is shown to have equivalence 
reliability.  In sum, reliability tests resulted in adequate values and the statewide 
pharmacist survey was found to have stability and equivalence reliability. 
Data Analysis 
 
 Because the proposed research is employing a mixed methods study design, the 
data analysis for this proposal included both qualitative and quantitative techniques.  
Although the first main research question, what do the 91 accredited schools of pharmacy 
in the U.S. teach about emergency contraception, is answered through an electronic 
survey of Deans, the responses from this survey only required basic descriptive statistics 
(frequencies, mean, median, mode) and categorization into typologies.  Frequency 
calculations measure numbers and percentages of schools that teach about emergency 
contraception and a typology categorizes and quantifies the courses that teach this 
content.   
The second major research question, how is emergency contraception course 
content taught at accredited schools of pharmacy as perceived by third or fourth year 
pharmacy students at the four accredited schools of pharmacy in Florida, was explored 
through focus groups with pharmacy students and this information required qualitative 
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analysis techniques.  In addition, the third major research question, what is the 
relationship among emergency contraception knowledge, attitudes, subjective norms, 
perceived behavioral control, and dispensing practices of Florida pharmacists registered 
with the Board of Pharmacy, was measured through a survey of a random sample of 
pharmacists and required quantitative analysis techniques.  Therefore, both the qualitative 
data analysis methods used to analyze the focus group data and the quantitative data 
analysis methods used to analyze the pharmacist survey are outlined below.  
Qualitative Data Analysis Plan 
Qualitative data includes focus group transcripts, observation notes, debriefing 
session notes, participant demographic information, and any other pertinent documents.  
Ethnograph version 5 computer software program was used to help with coding, and 
thematic and content analysis.  The reason an ethnographic computer program was 
chosen is because it can handle project data files in multiple forms such as transcripts, 
field notes, and any other text based documents.  In addition, Ethnograph has a large 
storage capacity that will be good to use with focus group transcripts. 
An editing type of qualitative analysis was employed where the editor begins with 
the text and then from this text develops codes, themes, and concepts.  Preliminary and 
thematic analyses were employed to create a range of themes, typologies, propositions 
and concepts.  A coding template was developed where categories were created from 
questions and from the topical guide.  Each code was defined in the code book including 
the parameters involved in assigning the code.  Later, the data was checked against the 
code template to see if it fit.  The codes were adjusted and new codes were added as they 
emerge.   
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Open coding, axial coding, and selective coding allowed for data reduction and 
categorization of data into themes.  Open coding is the first look at the collected data 
where themes are located and assigned initial codes or labels.  Open coding brings 
themes within the data to the surface.  Axial coding is the second look at the data where 
the researcher already has an organized set of initial codes and focuses more on the coded 
themes than on the data.  In axial coding, the initial codes are reviewed and examined to 
establish linkages between themes and raise new questions.  Selective coding is the last 
look at the data.  With selective coding, the researcher scans the data and previous codes 
and looks to compare and contrast cases.  Selective coding is performed when all or most 
of the data is collected.   
Analytic memos were written and kept throughout the coding process.  Analytic 
memos are thoughts or ideas written down throughout the coding process.  The memos 
contain thoughts and reflections about the data, coding, and coding process.  Each code 
contained a separate memo discussing the theme.  The purpose of an analytic memo is to 
provide a bridge between the raw data and abstract or theoretical thinking.     
In order to check for coding consistency, trustworthy or consistency checks were 
performed where the data was reviewed several times to ensure consistency of the coding 
system.  In addition, a single coder performed most of the analysis but another coder 
analyzed at least 10% of the data to ensure consistency of the data and inter-rater 
reliability.  The second coder was trained to understand the codebook prior to coding and 
analysis.  The same limitation of having the researcher as the moderator of the focus 
groups exists in having the researcher analyze the data for the focus group discussions; 
however employing two people for qualitative coding limited the researcher bias.  After 
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initial data analysis was performed, the analysis moved into an interpretive, theory 
development, and discussion phase. 
Researcher Bias 
 Researcher bias exists in any type of research; however researcher behavior can 
limit the amount of bias that is present.  Neuman (2003) identifies six categories of 
interviewer bias that can be applied to focus groups and focus group moderators.  The six 
categories include: 1) errors by the respondent, 2) unintentional errors by the interviewer, 
3) intentional errors by the interviewer, 4) bias by interviewer’s expectations of 
respondents, 5) lack of interviewer probing, and 6) influence on responses due to 
interviewer behavior.   
In order to limit these biases, the focus group moderator became familiar with 
conducting focus groups and became aware of the potential biases and methods for bias 
reduction.  The first category of bias as outlined in Neuman (2003), errors by the 
respondent, includes errors made because of the presence of others such as lying, 
misunderstanding, or embarrassment.  This bias was avoided through the moderator 
creating an open atmosphere where participants felt comfortable sharing their thoughts, 
feelings, and experiences and where the moderator was clear in stating the focus group 
questions and in explaining how the focus group worked.  The second category of bias, 
unintentional errors by the interviewer, includes the interviewer reading questions out of 
order, mis-recording respondent answers, and misreading questions.  In order to reduce 
this bias, the focus group moderator became familiar with conducting focus groups, 
including becoming familiar with the focus group topical guide and the order of the 
questions.  In addition, the moderator employed a note-taker and a tape recorder to aid in 
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reducing any unintentional error by the moderator.  The third bias, intentional errors by 
the interviewer, includes changing answers on purpose or omitting questions on purpose.  
In order to minimize this bias, the moderator stayed close to the focus group topical 
guide.   
The fourth bias, bias by interviewer’s expectations of respondents, includes the 
moderator expectations about a respondent’s answer based on appearance or perceived 
living situation (Neuman, 2003).  To reduce this bias, the moderator worked to remain 
neutral and refrain from making value judgments about the participants.  The fifth bias, 
lack of interviewer probing, was reduced through the moderators understanding how and 
when to probe properly.  In addition, the moderator developed potential probes to be 
included in the topical guide, should they be needed.  The six and final bias, influence on 
responses due to interviewer behavior, includes changes in respondents answers based on 
moderators tone, comments, appearance, or reactions.  In order to reduce this bias, the 
moderator remained neutral and open to all responses and avoided passing verbal or non-
verbal judgment to the responses given by participants in the focus group discussions.  
And last, in order to obtain a greater understanding of researcher bias in general, a 
detailed journal of research perceptions, biases, and beliefs was kept throughout the 
qualitative research process so that potential bias could be determined, understood, and 
reduced. 
Trustworthiness 
 Trustworthiness in qualitative research is much like validity and reliability in 
quantitative research.  According to Lincoln and Guba (1985), the basic question 
addressed by trustworthiness is, “How can an inquirer persuade his or her audiences that 
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the research findings of an inquiry are worth paying attention to?” (p. 290). 
Trustworthiness establishes confidence in the research findings, applicability of findings 
to other contexts, consistency in findings if research was conducted on similar subjects, 
and neutrality of the researcher so that the findings are determined by participants, not by 
researcher bias (Lincoln & Guba, 1985).  Lincoln and Guba (1985) discuss four criteria 
by which trustworthiness can be operationalized in research: 1) credibility, 2) 
transferability, 3) dependability, and 4) confirmability.  These four criteria were 
employed in the proposed research and will be discussed in greater detail below. 
The first criteria, credibility, determines if the data reflects reality.  In qualitative 
research, the researcher assumes multiple realities and then attempts to represent them 
(Hoepfl, 1997).  Credibility is met through the richness of the information collected and 
can be measured in a number of ways including triangulation, allowing others to analyze 
raw data, and member checks.  Obtaining a second coder aided in establishing credibility 
as well as performing member checks with focus group participants (Lincoln & Guba, 
1085).  After each focus group, the note taker presented a summary of the main ideas that 
had been identified in each question and asked if participants had any changes or 
additions they would like to make to the summary; when changes or additions were 
made, this information was included.  Debriefing between the note-taker and the 
moderator occurred directly after each focus group discussion.  These steps aided in 
increasing the credibility of this study.   
The second criteria, transferability, examines whether research findings are 
applicable to similar situations or in other contexts (Lincoln & Guba, 1985).  In order to 
establish transferability, the proposed research study maintained detailed notes and 
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journaling.  In addition, the researcher will ensure that the code book, focus group topical 
guide, and results of the study be made available to the public so that the study may be 
transferred to varying contexts if warranted.   
The third criteria, dependability, determines if the results stay consistent over time 
and across varying researchers.  Lincoln and Guba (1985) propose one method that they 
term “inquiry audit” (p. 317) where consistency is met through employing additional 
researchers that review the process and product of the research.  Therefore, dependability 
was met in this study by employing an additional researcher to aid in the process of the 
research and in the data analysis.  An additional researcher was present throughout the 
focus group discussions, debriefing sessions, and provided feedback on the focus group 
topical guide.  An additional coder analyzed at least 10% of the data to ensure 
consistency of the data and inter-rater reliability.  The second coder was trained to 
understand the codebook.          
 The fourth criteria, confirmability, refers to the neutrality of the researcher’s 
interpretations in qualitative research.  Lincoln and Guba (1985) suggest that to meet 
confirmability, an audit trail must be generated that includes 1) raw data; 2) analysis 
notes; 3) reconstruction and synthesis products; 4) process notes; 5) personal notes; and 
6) preliminary developmental information (p. 319-320).  In order to meet the 
confirmability criteria, a tape recorder was employed to record the focus groups, field 
notes were written, a note-taker was employed, debriefing sessions I after each focus 
group, a code book was employed, and detailed notes (journal) of a personal nature were 
maintained that included ideas, thoughts, biases, motivations, predications, and 
expectations.  These steps discussed above attributed credibility, transferability, 
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dependability, and confirmability to the qualitative research employed in this study so 
that the study maintained overall trustworthiness. 
Quantitative Data Analysis Plan 
Univariate & Bivariate Analyses 
 Quantitative data analyses were performed primarily using SPSS statistical 
software (SPSS 16.0, SPSS Inc., Chicago), although SAS statistical software (SAS 
Institute Inc, Cary, NC) was used in the factor analysis.  First, frequency distributions 
were performed on all categorical level variables to determine response distributions and 
means and standard deviations were calculated for all continuous variables.  These 
procedures identified any outliers or non-meaningful responses that were recoded if 
necessary.  In addition, for continuous variables, response patterns emerged which 
sometimes called for collapsing of data based on the distribution.   
 Next, bivariate analysis was performed to test associations between all socio-
demographic variables (age, gender, ethnicity, marital status, religious and party 
affiliation, type of pharmacy, pharmacy school and year attended, and length of time in 
practice) and pharmacist dispensing practices.  Because the criterion variable, dispensing 
practices, is measured at both the nominal and ordinal level and the socio-demographic 
variables are measured on the nominal, ordinal, and ratio levels, three statistical tests 
were performed to detect bivariate associations: Chi-Square tests, Kruskal-Wallis Tests, 
and Spearman Correlations.   
A Chi-Square test of independence is the appropriate statistic to use when both 
variables are assessed at the nominal level to determine if there is a relationship between 
the two variables.  The Kruskal-Wallis test is appropriate in bivariate analysis with an 
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ordinal-level criterion variable and a nominal level predictor variable.  Spearman 
correlations are recommended when there is an ordinal-level predictor variable and an 
ordinal-level criterion variable.  This test yields the correlations between two variables 
and will determine the strength of the relationship between two variables (Hatcher & 
Stepanski 1994). 
 Bivariate associations were also be explored between (a) knowledge and 
dispensing practices, (b) attitudes and dispensing practices, (c) subjective norms and 
dispensing practices, (d) perceived behavioral control and dispensing practices, and (e) 
intention to dispense and dispensing practices.  Chi-Square tests and Kruskal-Wallis tests 
were used to assess the relationships between knowledge and dispensing practices, 
attitudes and dispensing practices, subjective norms and dispensing practices.  Kruskal-
Wallis tests were used to assess the relationships between perceived behavioral control 
and dispensing practices and intention to dispense and dispensing practices (Hatcher & 
Stepanski 1994). 
Multivariate Analyses 
 Logistic regression models were constructed to discover whether emergency 
contraception knowledge, attitudes, subjective norms, perceived behavioral control, and 
intention to dispense taken together or separate, are predictive of pharmacists’ dispensing 
practices.  The dependent variable, dispensing practices, was measured by two survey 
questions and was grouped to create dichotomous yes/no variable.   
Logistic regression is the appropriate statistical test to use when the dependent 
variable is dichotomous and when there is a single dependent variable with multiple 
predictor or independent variables.  In addition, logistic regression should be employed 
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when the criterion variable is nominal or ordinal and when the predictor variables are at 
the nominal, interval, or ratio level (Hatcher & Stepanski 1994).   
There are five independent variables, knowledge, attitudes, social norms, 
perceived behavioral control, and intention to dispense.  Knowledge consists of 10 
questions and is measured at the nominal level.  A knowledge score ranging from 1-10 
was created for each study participant based on how many questions they get correct.  
Therefore, knowledge was put into the regression model as a continuous variable.  
Attitude consisted of 8 separate questions and was measured at the nominal and ordinal 
levels.  The 7 ordinal level likert scale questions were treated as continuous variables 
when put into the model.  For the other question, it will be collapsed into categories to 
create a nominal level variable.  Subjective norms consisted of 6 questions and were 
measured at the ordinal and nominal levels.  The 4 likert scale questions were treated as 
continuous variables when put into the model and the two nominal level questions were 
collapsed into categories and run at the nominal level.  Perceived behavioral control 
consisted of 4 questions and was measured at the ordinal level.   Because the 4 questions 
are likert scale questions, they were treated as continuous variables when put into the 
model.  Intention to dispense Plan B consisted of 8 likert scale questions measured at the 
ordinal level and were entered into the model as a continuous variable. 
 In constructing logistical regression models, specific steps should be taken.  
Approximately six models will be created to detect (1) if knowledge is predictive of 
dispensing practices, (2) if attitudes are predictive of dispensing practices, (3) if 
subjective norms are predictive of dispensing practices, (4) if perceived behavioral 
control is predictive of dispensing practices, (5) if intention to dispense is predictive of 
 104
dispensing practices, and (6) if all variables taken together are predictive of dispensing 
practices.  Also, the socio-demographic variables were entered into each model to act as 
control variables.  With each model, appropriate diagnostics were run to test for 
collinearity. 
 The Wald F statistic is the measure in logistic regression that tests the null 
hypothesis: that none of the predictor variables are related to the log odds of the criterion 
variable.  In addition, the Wald F will measure the models’ goodness of fit.  In logistic 
regression, pseudo R-Square is used to measure the strength of association between the 
variables.  The significance between knowledge, attitudes, subjective norms, and 
perceived behavioral control in predicting dispensing practices was measured by odds 
ratios and 95% confidence intervals.  A p-value of less than .05 was employed as a 
measure at which to reject the null hypothesis.   
Linking Datasets 
 Three different yet intimately related datasets were produced upon completion of 
this research.  Data was procured from 1) the curriculum review survey, 2) focus group 
discussions with pharmacy students, and 3) the state-wide pharmacist survey.  Taken 
together, findings demonstrated what is intended to be taught to pharmacy students, what 
is actually being learned by pharmacy students, and how practicing pharmacists’ 
perceptions of emergency contraception are associated with their dispensing practices.   
 In essence, this research examines both the education and practice of pharmacists 
by following the natural progression of pharmacists from education to subsequent 
practice.  It examines the emergency contraception curricula and course content intended 
to teach future pharmacists, surveys pharmacy students to understand how this course 
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content translates into learned knowledge and projected dispensing behavior, and then 
lastly it surveys the practicing pharmacists to understand their emergency contraception 
knowledge, attitudes, and actual dispensing practices.  In total, this research study 
employs a mixed methods design to offer a completed picture of pharmacists and 
emergency contraception from education to practice.   
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Chapter Four:  Results 
 
Introduction 
 
 Chapter four has been partitioned into three sections based on each research 
question.  Thus, Section 1 discusses the pharmacy school curriculum review and answers 
research question 1, Section 2 describes the pharmacy student focus group discussions 
and answers research question 2, and Section 3 describes the statewide pharmacist survey 
and answers research question 3.      
Research Questions 
 
Question 1: What do the 91 accredited schools of pharmacy in the U.S. teach about 
emergency contraception? 
Question 1a: What objectives, course assignments, course readings, and lectures 
concerning emergency contraception are provided in the required courses at the 
91 accredited schools of pharmacy in the U.S.? 
Question 1b: What objectives, course assignments, course readings, and lectures 
concerning emergency contraception are provided in the elective courses at the 91 
accredited schools of pharmacy in the U.S.? 
Question 2: How is emergency contraception course content taught at accredited schools 
of pharmacy, as perceived by fourth year pharmacy students at the four accredited 
schools of pharmacy in Florida?    
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Question 2a: What did pharmacy students learn about emergency contraception in 
their pharmacy school classes? 
Question 2b: How was emergency contraception taught in their pharmacy school 
classes? 
Question 2c: What are the projected emergency contraception dispensing 
practices of pharmacy students? 
Question 3: What is the relationship among emergency contraception knowledge, 
attitudes, subjective norms, perceived behavioral control, intention to dispense, and 
dispensing practices of Florida pharmacists registered with the Board of Pharmacy? 
Question 3a: Is emergency contraception knowledge predictive of dispensing 
practices of Florida pharmacists?  
Question 3b: Are attitudes about emergency contraception predictive of 
emergency contraception dispensing practices of Florida pharmacists?  
Question 3c: Are subjective norms about emergency contraception (whether 
important people such as colleagues, supervisors, corporate headquarters, and 
peers think they should dispense emergency contraception) predictive of 
emergency contraception dispensing practices of Florida pharmacists? 
Question 3d: Is perceived behavioral control, the perceived ease or difficulty of 
dispensing emergency contraception, predictive of dispensing practices of Florida 
pharmacists? 
Question 3e: Is intention to dispense emergency contraception predictive of 
dispensing practices of Florida pharmacists? 
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Question 3f: Are emergency contraception knowledge, attitudes, subjective 
norms, perceived behavioral control, and intention to dispense taken together, 
predictive of emergency contraception dispensing practices of Florida 
pharmacists? 
Section I: Pharmacy School Curricula Review 
 
The first research question was addressed through a web-based survey of Deans 
of accredited schools of pharmacy in the U.S.  As of April 2007, there were 91 accredited 
schools of pharmacy in the U.S.  In this case, the target population, the sampling frame, 
and the sample are the same because the survey acts as a census.  The Deans of all 91 
schools were sent an electronic survey via Ultimate Survey querying them about 
emergency contraception course content in their Pharm. D. programs at their respective 
institutions.  Please see Appendix U for a list of the pharmacy schools that received the 
survey.  Because not all schools had Academic Deans, a decision was made to request 
information from the Deans of all schools.  Of the 91 Deans, 47 responded, yielding a 
52% response rate.  The Dillman Tailored Design Method was employed in data 
collection which included the following four letters: (a) a pre-notice, (b) an abbreviated 
informed consent form, (c) a cover letter and questionnaire, and (d) a thank you/reminder 
letter.  A fifth letter was generated and added to the study design during the data 
collection process to act as a second reminder letter to help yield a higher response rate.  
This letter was submitted and approved by the IRB prior to use.  Please see Appendix V 
to view this second follow-up letter. 
 The Dean’s survey included only three questions with follow-up questions 
depending on the answer provided.  The first two questions asked Deans if they offer 
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required courses and/or elective courses that provide content on emergency 
contraception.  Content was described as including lectures, course readings, course 
objectives etc.  If they answered that they did include content on emergency 
contraception, they were asked to include the title of the course and include the syllabi for 
review.  The third and final question asked Deans if they think that pharmacy school 
curricula in the U.S. should include content material on emergency contraception and to 
explain their answer.  Content was defined as including pharmacology, legal and ethical 
issues, and the continual controversy that surrounds emergency contraception. 
 Of the 47 Deans that responded, 87.2% (n=41) reported that they do offer 
required courses that provide content on emergency contraception, 8.5% (n=4) reported 
that they do not, and 4.3% (n=2) said that they were not sure (Table 9).  In terms of 
elective courses, 17% (n=8) reported that they do offer elective courses that provide 
content on emergency contraception, 72.3% (n=34) reported that they do not offer these 
courses and 10.6% (n=5) said that they were not sure.  All respondents (n=47, 100%) 
reported that they believe that schools of pharmacy in the U.S. should include content 
material on emergency contraception (Table 9).   
Table 9. Quantitative Results from Dean’s Survey (n=47). 
Variable Frequency Percent 
Does school offer required courses that provide content on EC? 
Yes 
No 
Not Sure 
 
41 
4 
2 
 
87.2% 
8.5% 
4.3% 
Does school offer elective courses that provide content on EC? 
Yes 
No 
Not Sure 
 
8 
34 
5 
 
17.0% 
72.3% 
10.6% 
Should pharmacy school curricula include content on EC? 
Yes 
No 
 
47 
0 
 
100.0% 
0.0% 
EC = emergency contraception 
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 Of the 87.2% (n=41) of Deans that said their schools offer required courses that 
provide content on emergency contraception, 34% (n=14) did not list the titles of the 
courses or attach the syllabi for review when asked.  Sixty-five percent (n=27) either 
listed course titles or provided syllabi for review.  Of the 17% (n=8) of schools that 
reported that they do offer elective courses that provide content on emergency 
contraception, 50% (n=4) did not list the titles of the courses or attach the syllabi for 
review.  The lists of courses, both required and elective, that were said to provide content 
on emergency contraception have been classified into a typology based on the course 
titles.  This typology is found in Table 10 below and a full list of courses titles is 
provided in Appendix W. 
Table 10. A Typology of Required and Elective Courses that Contain Content on Emergency 
Contraception per the Responses from the Dean’s Survey. 
 
Classification of Required Courses Number of courses that fall into category 
Pharmacotherapy & Therapeutics 17 
Pharmacy Ethics 6 
Pharmacology  4 
Issues in Contemporary Pharmacy Practice 3 
Over-the-Counter Medications 2 
Women’s Health 2 
Self-care 2 
Professional Skills Development 1 
Early Practice Experience I 1 
 
Classification of Elective Courses 
 
Number of courses that fall into category 
Women’s Health 2 
Contraceptive Management 1 
Self-care 1 
 
The majority of courses that provide content on emergency contraception are 
taught in pharmacotherapy and therapeutics courses.  Specifically, many schools noted 
that within these pharmacotherapy and therapeutics courses, this content was taught in 
the women’s health section.  Although it varies from school to school, most students have 
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taken the pharmacotherapy and therapeutics courses listed by their second year of study. 
After pharmacotherapy and therapeutics, schools listed that material on emergency 
contraception was covered in pharmacy ethics, pharmacology, issues in contemporary 
pharmacy practice, over-the-counter medications, women’s health, self-care, professional 
skills development, and early practice experiment.  One school in particular requires a 
course called early practice experience and in this course students obtain certification 
from the state in emergency contraception.  Specifically, students learn about prescriptive 
authority and are trained to counsel patients. 
 Among the four schools that listed elective courses that provide content on 
emergency contraception, content was taught in a women’s health course (n=2), a 
contraceptive management class (n=1), and a self-care class (n=1).  
Question 1 asked, what do the 91 accredited schools of pharmacy in the U.S. 
teach about emergency contraception?  In addition, sub-questions inquired about what 
objectives, objectives, course assignments, course readings, and lectures concerning 
emergency contraception are provided in the required and elective courses at the 91 
accredited schools of pharmacy in the U.S.?  In order to more fully answer research 
question 1, Deans were asked to submit the syllabi in which they reported to provide 
course content on emergency contraception.  However, only 10 syllabi were received 
from seven schools or from 14% of the sample who reported that they provide course 
content on emergency contraception in either required or elective classes.  Additionally, 
the syllabi that were received did not provide detailed information on objectives, 
objectives, course assignments, course readings, and lectures concerning emergency 
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contraception.  In fact, only four out of the ten syllabi explicitly mentioned emergency 
contraception.   
In order to objectively analyze the syllabi that were retrieved for emergency 
contraception course content, a method for categorization was developed.  First, after 
reviewing course syllabi, the defined categories for course content provided on the Deans 
survey, and with the aid of established pedagogy, course content was defined as: 
• course description 
• objectives 
• lectures 
• readings  
• assignments 
 
Next, each syllabus was examined based on course content area.  Ratings ranged 
from one to four and each area of course content received an individual rating.  The 
specific definition of each numeric rating is listed below and Table 11 displays these 
ratings of course content in a comparative format. 
Rating 1 = No overt mention of emergency contraception in content 
Rating 2 = The topic listed in the content could lend itself to emergency contraception, 
but does not specify 
Rating 3 = The content mentions contraception, but not emergency contraception 
Rating 4 = The content specifically mentions emergency contraception 
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Table 11. Review of Retrieved Syllabi that Reported to Contain Content Material on Emergency 
Contraception from the Dean’s Survey. 
Course Title* Description Objectives Lectures Readings  Assignments 
Contraceptive 
Management 
Elective 
4 n/a** 4 4 1 
Professional Skills 
Development II 
Required 
2 2 2 2 2 
Pharmocotherapy II  
Required 
1 2 3 1 1 
Integrated Science & 
Therapeutics 
Required 
1 1 1 1 1 
Women’s Health 
Some offer required, 
some elective 
3 1 4 3 1 
Endocrinology/ 
Gastroenterology 
Required 
1 3 3 1 1 
Pharmacy Practice IV 
Required 
1 1 1 1 1 
Pharmacy Ethics 
Required 
2 2 2 n/a 2 
Therapeutics I 
Required 
1 4 4 4 1 
Reproductive Course 
Required 
4 4 4 4 4 
*Courses are listed in no particular order 
**n/a is listed if the syllabi did not mention the specific content  
 
 Among all retrieved syllabi which reported to include content on emergency 
contraception, only four of the ten syllabi overtly mentioned emergency contraception in 
any of the content areas.  Two out of ten syllabi cited contraception in a content area, but 
not emergency contraception, three out of ten mentioned a topic area that could lend itself 
to emergency contraception such as ethics or women’s health, and two out of the ten 
syllabi retrieved made no overt mention of emergency contraception or contraception, or 
even contained a topic that could lend itself to a discussion about emergency 
contraception.  In general, there was no particular patterning or clustering of where the 
content was located or described, however courses that contained emergency 
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contraception in one content area were more likely to contain it in another content area 
and vice versa. 
 In addition, although it was not requested that the schools include a description of 
where the emergency contraception course content is taught when attaching syllabi, one 
school did include additional information about how this content is taught in class.  This 
Dean responded that within their course, emergency contraception is used “as an example 
of one of the many ethical dilemmas that pharmacists confront and help them construct a 
thought process on how to deal with the issues, while respecting the patients’ right and 
their own values”.  This depiction provides insight into how this content may be 
addressed in this particular class where students learn to balance patient rights and their 
own values.  It would be interesting to follow up on this and perhaps observe a pharmacy 
class to view how this material is actually taught. 
 The third and final question of the Dean’s survey asked if they believe that 
pharmacy school curricula in the U.S. should include content on emergency 
contraception.  All respondents said yes.  They were then asked to explain their answer in 
an open-ended format.  Of all 47 respondents, 27.7% (n=13) did not answer as to why 
they thought this content should be included in pharmacy school curricula, however 
72.3% (n=34) did.   
Through qualitative coding and analysis, five main themes emerged from the 
open-ended response data.  Overall, pharmacy school Deans answered that school 
curricula should include material on emergency contraception due to 1) pharmacy 
practice and training, 2) the role of pharmacists in terms of counseling and education, 3) 
the controversies that exist about the medication 4) the nature of the medication: it is a 
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drug therapy and, 5) the idea that this curricula will increase pharmacists’ knowledge for 
best patient care.  These five themes are listed in order based on the number of times they 
were mentioned and will be discussed below. 
Pharmacy Practice/Training 
The largest grouping of respondents (mentioned 18 times) answered that 
pharmacy school curricula should include content material on emergency contraception 
because of issues surrounding pharmacy practice and training.  Specifically, the Deans 
expressed that pharmacists will encounter this medication in their practice and therefore 
pharmacists should have this training so that they can perform well in their professional 
practice.  Examples of this sentiment are presented below: 
• Pharmacists need to be trained with respect to all prescribed drugs that they may 
encounter in practice. 
 
• It is a part of practice and each pharmacist should know how to assess the 
situation and safely use these products.   
 
 
• It is a component of pharmacy practice with medical, social, and ethical aspects. 
 
 
• It is in within the scope of practice for pharmacists especially ones that work in 
community settings so the pharmacology, dispensing issues and ethics should be 
discussed. 
 
 
• California pharmacists may dispense emergency contraception under a state 
protocol.  Training is essential. 
 
 
Role of Pharmacists: Counseling/education 
 
 Another major category of response (mentioned 13 times) that emerged from the 
data was the need for training of pharmacists on emergency contraception due to the 
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perceived counseling and educational role of pharmacists.  Specifically, participants 
responded that pharmacists need to be knowledgeable on emergency contraception in 
order to provide accurate information to patients and to be able to discuss, counsel, and 
advise patients on the medication.  Some responses are presented here: 
• This subject arises in all Community Pharmacy settings and pharmacists need to 
be able to intelligently discuss this with patients when questions are asked. 
 
• It is legal and pharmacies are a front line delivery method of EC. Many 
misperceptions abound about these products and pharmacists should know the 
facts if their patients ask them questions. 
 
 
• Pharmacists serve patient health needs in terms of products and accurate 
information.  This area may be very important for many patients and families. 
 
 
• Pharmacists need to be able to give appropriate advice. 
 
 
• …Education in this area of pharmaceutical care will enable the pharmacist to be 
an advisor to the physician and a counselor to the patient. 
 
 
• Because pharmacists will encounter this medication in the pharmacies, it is 
important for them to understand how emergency contraception works.  This will 
enable them to have an informed conversation with a patient considering 
emergency contraception.  Even if they do not plan to work in a retail setting, they 
will inevitably be asked questions regarding emergency contraception at some 
point in their career. 
 
 
Controversy 
 Many respondents alluded to the controversy and dilemma that surrounds 
emergency contraception (mentioned 11 times).  Many respondents noted that pharmacy 
school curricula should include content on emergency contraception despite how 
controversial the medication may be: 
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• …It is our job as educators to expose pharmacy students to as much pharmacy 
knowledge as possible, no matter how controversial. 
 
• Curricula should include all drug therapeutic uses, including mitigation of 
physiologic conditions, where pharmacists play role, no matter how controversial 
their role and the drug’s use might be.  Student pharmacists deserve to have 
information regarding therapeutic indications, legal implications, and discussion 
of various “opinions” provided in their course work. 
 
 
• From a pharmacist’s and pharmacology perspective, it is important for students 
to be aware of the mechanism of action, important counseling points and the 
ethical arguments surrounding EC. 
 
 
Some respondents believed that content should be taught so that pharmacists 
understand that emergency contraception is not the same as a medical termination or 
similarly so that they understand that emergency contraception’s mechanism of action is 
comparable to that of hormonal contraception:  
• …Students should be informed about the product, and most especially, should be 
informed that it is not the same as mifepristone (RU 486). 
 
• Pharmacists now are in the position to not only dispense prescriptions for EC, but 
to also provide it without a prescription to those 18 years and older. Knowledge 
regarding mechanism of action (especially in regards to the mechanism being the 
SAME as all hormonal contraception), appropriate use and counseling is 
essential to the role of a pharmacist…  
 
 
Another pharmacist believed that content should be taught so that pharmacists can 
have knowledge about the medication should they want to refuse dispensing: 
• …Even if a pharmacist engages the right to refuse dispensing (which I do approve 
of based on moral or ethical conflicts ) – pharmacists must have appropriate 
knowledge on why he/she has chosen to refuse and what his/her obligation is to 
the patient at that point in time. 
 
Additionally, these two respondents talk about the balance that some pharmacists 
try to keep between professional responsibilities and personal beliefs. 
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• This is a medication applicable to a sizable portion of the population.  It is a very 
emotional issue as well.  Pharmacists MUST know the information necessary for 
them to be a reasonable counselor on use and MUST be aware of their 
professional responsibilities to provide care for patients while balancing that with 
their own personal beliefs.  If you are a pharmacist, or a pharmacy student you 
do NOT have any choice.  You must know about EC. 
 
• …Factual information is helpful for the patient regardless of religious beliefs and 
should be available.  Informing people of the correct facts does not mean you are 
pushing them one way or the other on the issue. 
 
Drug Therapy 
 It was mentioned 8 times that emergency contraception content should be taught 
in pharmacy schools because it is a drug therapy and many Deanss said flatly that it is the 
duty of pharmacy school curricula to teach about all drug therapies.  Some respondent 
comments are below: 
• It’s a drug therapy! 
• Emergency contraception is an OTC product.  Schools teach about OTC 
products… 
 
• Curricula should include all drug therapeutic uses… 
• It is pharmacological therapy – that’s our job 
• It involves drug therapy 
• Pharmacy schools should educate students on all legal uses of pharmacologic 
therapy 
 
Knowledge for Best Patient Care  
Lastly, it was mentioned 7 times in the open-ended responses that curricula 
should include content on emergency contraception so that each pharmacist has the 
knowledge of the medication for best patient care. 
• Same reasons as any therapeutic topic, so pharmacists can provide the best 
patient care to all patients no matter what the medication is… 
 119
 
• Because pharmacists will encounter this medication in the pharmacies, it is 
important for them to understand how emergency contraception works.  This will 
enable them to have an informed conversation with a patient considering 
emergency contraception.  Even if they do not plan to work in a retail setting, they 
will inevitably be asked questions regarding emergency contraception at some 
point in their career. 
 
• …(pharmacists) must be aware of their professional responsibilities to provide 
care for patients while balancing that with their own personal beliefs… 
 
• …Since emergency contraception is a reality and growing in use, it is critically 
important that the pharmacist is the drug expert in this area of patient care no 
different from diabetes or other conditions… 
 
On the whole there were sentiments that pharmacists must know correct 
information about emergency contraception regardless of personal or religious beliefs and 
regardless of the controversial nature of this topic for best patient care, professional 
practice, and counseling/education of patients.  In addition, given the 52% response rate, 
it is important to note that we did not hear from 48% of the sample.  Therefore, this 
nonresponsiveness is a limitation in that we have no information from the Deans of these 
schools and no way to capture these responses. 
Section II: Pharmacy Student Focus Groups 
The second research question was addressed through focus groups conducted at 
all four accredited Schools of Pharmacy in Florida: Florida Agricultural and Mechanical 
University (FAMU), Nova Southeastern University (NOVA), Palm Beach Atlantic 
University (PBA), and University of Florida (UF).  All four schools were contacted 
regarding participation in the focus groups and letters of support were procured.   
A topical guide was developed prior to the focus group discussions by the 
researcher and a panel of experts, which consisted of pharmacy faculty, recent pharmacy 
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school graduates, practicing pharmacists, and a focus group expert (n=8).  A preliminary 
list of topic areas was generated that began with non-threatening issues leading into more 
specific questions.  Through the topical guide development and feedback from the panel, 
it became clear that there were many close-ended questions that needed to be addressed 
by the focus group participants.  Because focus group discussions lend themselves to 
open-ended questions, a paper and pencil survey was developed that contained these 
close-ended questions.  This paper and pencil survey was administered to students prior 
to starting the focus group.  See Appendix X for the topical guide and the paper and 
pencil pre-survey that was administered to students.  Prior to the actual focus groups, the 
researcher piloted the focus group session with colleagues. 
Paper and Pencil Pre-Survey Results 
 
In total, 21 third and fourth year Pharm. D. students participated in the focus 
group discussions (8 from UF, 4 from FAMU, 5 from PBA, 4 from NOVA).  The paper 
and pencil survey consists of 10 questions, five of which are close-ended and five of 
which are open-ended.  All survey data were entered into a Microsoft® Office 2003 
spreadsheet (Microsoft Corporation, Redmond, Washington).  Data from the five close-
ended questions can be viewed below in Table 12. 
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Table 12. Paper and Pencil Focus Group Survey Data: Close-Ended Questions (N=21) 
Variable N Percent 
Did you take any classes in your Pharm D program which taught you 
about EC? 
Yes 
No 
 
 
19 
2 
 
 
90.5% 
  9.5% 
Have your pharmacy school classes discussed the new OTC status of EC? 
Yes 
No 
Missing 
 
16 
 4 
1 
 
76.2% 
19.0% 
  4.8% 
Have your pharmacy school classes discussed the dispensing issues (e.g. 
pharmacists refusals to dispense) surrounding EC? 
Yes 
No 
Missing 
 
 
14 
6 
1 
 
 
66.7% 
28.5% 
 4.8% 
Will you dispense EC upon becoming a pharmacist? 
Yes 
No 
Not sure 
Missing 
 
16 
1 
3 
1 
 
76.1% 
  4.8% 
14.3% 
  4.8% 
Are pharmacists well enough informed to confidently dispense EC? 
Yes 
No 
Not sure 
Missing 
 
9 
7 
4 
1 
 
42.9% 
33.3% 
19.0% 
  4.8% 
 
 Although 90.5% of students responded that they did learn about emergency 
contraception in their pharm D classes, still nearly 20% answered either that they would 
not or that they were not sure about their future dispensing of the medication.  Similarly, 
while the majority of students responded that they did learn about emergency 
contraception in their classes, over half (52.3%) of participants were either not sure if 
pharmacists were well enough informed to dispense emergency contraception or believed 
that pharmacists were not well enough informed to confidently dispense the medication.  
The first open-ended question asked which classes taught about emergency 
contraception and asked to specify if the class was required or was offered as an elective.  
Of the students who responded that their Pharm D program taught about emergency 
contraception (n=19), nine students said that a required pharmacotherapy course covered 
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this material, six students mentioned that a required therapeutics course covered this 
material, four said that a required ethics course covered it, and three students each 
answered that a required medical chemistry course or a required pharmacy care course, or 
an elective women’s health course covered this material.  Lastly, two students each said 
that a required law course or a required patient care management course or a dynamics 
course covered emergency contraception.  All in all, most students responded that they 
were taught about emergency contraception in a required pharmacotherapy course which 
substantiated findings from the curriculum review survey. 
 When asked what type of instructional method was used, the majority of students 
reported class lectures as the most reported instructional method, followed by discussion 
and class readings.  One student said that they had a debate format in a class.  The bulk of 
the students said that they learned the most from a lecture format and one student noted 
that they learned the most from personal research as the professors did not teach them 
much.  Most students stated that there was more information that they wished they had 
learned including OTC laws, the effects of prolonged use, details on side effects, 
counseling points, contraindictions, time limits, explanation of how it is not an abortion, 
the effect of Plan B on an already pregnant female, laws and regulations, adverse effects, 
interaction with women taking birth control at the same time, industry standards/policies, 
risks associated with repeat use, and ethics. 
Focus Group Discussion Analysis 
 Focus group research questions asked about three major topical areas: 1) 
knowledge about emergency contraception from their pharmacy schools classes, 2) 
teaching instruction on emergency contraception within those classes, and 3) projecting 
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dispensing practices of emergency contraception upon becoming a pharmacist.  
Therefore, the following analyses were partitioned by topical area.  Although responses 
fell into these three categories, new and unexpected themes emerged from the data.   
 Knowledge.  Students were asked both about their specific knowledge of 
emergency contraception from pharmacy schools classes and were queried about their 
general knowledge.  There was a major disconnect between what students reported on the 
quantitative paper and pencil survey and what was shared in the focus group discussions.  
As opposed to what students reported on the paper and pencil survey, the majority of 
pharmacy students reported that they did not learn about emergency contraception from 
their pharmacy school classes when queried in the focus group discussions.  When 
pharmacy students were asked where they have gotten information about emergency 
contraception that they trust, some said they received this information from class; 
however the majority answered from outside sources such as work, print media, internet, 
news, and friends.   
 “I would definitely say that the majority of what we know is from either from working in 
retail or other outside sources. Not necessarily from our curriculum.”  
 
Of the students that did receive some training in required classes, the majority 
commented that it was brief: 
“…I just remember one slide like one bullet point you know during our birth control or 
female hormone lecture…And they haven’t discussed it a lot yet. So…” 
 
The most frequently cited answer to where they received information about 
emergency contraception was work with student’s answering “in the actual workplace” 
and “from working”.  When at work, they either read the package insert, asked a 
pharmacist, read continuing education (CE) credit materials, or a client approached them 
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with questions about the drug and they had to look up information.  Examples of these 
sentiments are below: 
 “Like she said continuing education is usually sponsored by drug companies, um they 
send educational materials to you know where you work, retailer. Also if you’re just 
working in a pharmacy with your… um with a pharmacist and you dispense it, you don’t 
know what it is, you ask them”.   
 
“Customers coming up too. Say oh what about the morning pill and I’m like huh; It’s 
prescription and he’s like not anymore.”  
 
“Package insert… 
(another member) Yeah to educate ourselves.   
(another member) “You know myself. I was like interested in it. So you know reading the 
thing that comes with it you know.”   
 
“…just working experience and having different people coming up and ask us questions 
about it and you have to go look up” 
 
Other outside sources included friends, a Pharmacy Times article, the internet, 
and one student mentioned hearing about the firing of pharmacists who did not dispense 
it in the news: 
“I kinda just looked it up briefly on the internet; about how it works…”  
 
 “I  personally did some internet research just for a law class that we had.  Which was 
kind of um… you know not a required thing but you know if you don’t know what Plan B 
is all about then you as a student you need to take it upon yourself to find the 
information. So that kinda, outside the classroom.”  
 
“um… another way that I had heard about it was… actually it’s been in the news, I think 
several times.  Where pharmacists were actually um…you know fired from their 
positions.  So that has been  kind of a….” 
 
“Yeah, uh my friend…And my friend she knows I’m in pharmacy school so, I looked it up 
for her. So you know I like to… I like to look things up for her and answer any questions, 
you know. I’m her on call pharmacist.                  
 
When asked specifically about the knowledge gained about emergency 
contraception in their pharmacy school classes, pharmacy students described four major 
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areas of knowledge: 1) knowledge about timing and composition, 2) knowledge about 
mechanism of action, 3) no knowledge, and 4) perceived knowledge of others (see Table 
7). 
The topical area of timing and composition represents whether students 
understood the correct timing around administration of emergency contraception and if 
they understood its composition.  Plan B is hormonal contraception, containing high 
doses of progestin (levonorgestrel).  It is 75%-89% effective in preventing pregnancies 
when taken within 72 hours (3 days) to 120 hours (5 days) after sexual intercourse 
(American Medical Women’s Association (AMWA), 1996; Kaiser Family Foundation, 
2000).  Although students seemed to have varying degrees of understanding of the actual 
timeframe, the majority of students understood that there was a time component to 
acquiring the medication after unprotected intercourse.  As shown in Table 7, some 
students had more accurate knowledge around timing and composition than others.    
 Knowledge of mechanism of action refers to comprehension of how emergency 
contraception works in the body.  Although the exact mechanism of action is unknown, it 
is thought that the medication works through the following three mechanisms, 1) through 
a delay or inhibition of ovulation, 2) through inhibition of fertilization, and 3) through 
preventing implantation (American Pharmaceutical Association special report, 2000).  
Although students in one of the focus groups seemed to understand the three mechanisms 
of action of emergency contraception, specific knowledge was not held by the majority of 
students.  In addition, there was some confusion as to the definition of when life begins.  
This argument was most thoroughly represented by a discussion in one of the focus 
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groups where some students believed that life begins at implantation and others believed 
that life begins at fertilization.  See the excerpt below: 
Member 2: But… in order to abort it well first you have to look at the definition of 
pregnancy. To actually be pregnant, as a medical definition, there has to be implantation. 
Is that an agreed statement?                     
                                                 
Member 1: I disagree.                                                                      
 
Member 1: I (unclear)… I’ve read a couple of articles that state that um…the original 
term pregnancy was actually um… the egg and a sperm… you know conception… at that 
point…                                                          
 
Member 2: As defined by…?                  
 
Member 1: and one article said that that definition is changing. So I don’t know.  
 
Member 4: I don’t think it you know…Webster or whoever medical can tell me where I 
think contraception begins. So as defined by… per person I would think is un… is 
sufficient enough for you know… in my opinion. 
 
Member 2: Well, what I was looking at when I did my research… I was looking at the 
American Medical Association, and where they define medically where pregnancy starts. 
Cause there’s many times that you have a fertilized egg that doesn’t get implanted 
naturally…so that’s where they have a hard time drawing pregnancy and starting at         
implantation… at fertilization versus implantation. 
 
Member 5: For them as an organizational body…                                    
 
Member 5: But you could take the analogy of a plant seed… does that seed have the 
capability of growing into a plant?                                   
 
Member 2: Yes. 
 
Member 5: And…but in order for it to happen it must… fall in soil and be watered and 
somewhat…                    
 
Member 2: Correct. 
 
Member 5: So a lot of things have to happen for the plant to grow, but nevertheless the 
possibility was there when it was just a seed. For some people the seed of life is once the      
sperm enters the egg. It’s all an ethical dilemma.                         
 
Member 5: Each person has to make their own belief.                              
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Member 5: You can defer judgment to you know bodies such the AMA or other larger 
institutions but… it’s just a judgment call 
 
Member 2: The question we come back to though is whether or not Plan B, is any 
different than any other birth control method…                          
 
Member 2: and chemically it’s not          
 
Member 2: So the real question is then, if we have a problem with Plan B, we should 
really have a problem with every birth control method out there that’s an oral 
contraceptive. Because it’s literally the same thing. So that’s the problem that…                 
 
Member 5: That is a logical statement. 
 
Member 2: the argument runs into… is that if you’re going to reject this method, you 
have to reject something that’s the same thing. And that’s where our problem lies. As a 
profession because we’re not being consistent.                              
 
Member 1: I agree.                         
 
Member 3: Well being that it has three different mechanisms… again you’d have to go 
back to where you believe conception starts… so if it’s going to work by thickening the 
endometrium, and just preventing the egg from meeting the sperm… I personally don’t 
see why not. But if it’s going to…which I don’t think it’s what you guys (alluded to)… it… 
it aborting… so once the… the sperm is fertilizing the egg…is it gonna… that’s where I 
believe conception starts. Is that where, it’s going to work? And if that’s the case, then 
you’re getting into abortion and being pro-life verus pro-choice. But I think you guys 
said that that’s not how it works.” 
 
The topical area of no knowledge encompasses the idea that some students did not 
learn about emergency contraception in their pharmacy school classes and therefore 
gained no knowledge from this venue.  Some students briefly noted that they were being 
quiet because they did not have knowledge about emergency contraception (Table 13).  It 
is important to acknowledge that what is absent from discussion is sometimes just as 
important as what is present.  In addition, a few students expressed interest in wanting 
more information on emergency contraception, specifically around the ethics of 
dispensing.   
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The theme perceived knowledge of others refers to how the participants described 
emergency contraception knowledge of other pharmacists and the general community.  
Although students were not questioned about what level of knowledge other pharmacists 
and the community had around emergency contraception, these perceptions were 
expressed in the discussions and are worth mentioning.  Most students remarked that 
pharmacists do not have knowledge on how it works and perceived that the wider 
community thinks that it causes an abortion. 
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Table 13. Major Themes of What Students Learned in their Pharmacy School Classes and 
Representative Quotes 
Theme Representative Quote 
Timing & composition  
Accurate “...this is not an abortion pill. This can only be used within the first 
5 days. It can be dispensed two tablets together but all of the 
research has done one pill and then twelve hours later. It can be, 
you know, used in this situation. It’s, you know, effectiveness is only 
85%” 
 “Like you know I remember learning it’s a high dose of the regular 
birth control so it’s that’s one thing that always stink in my head” 
Confusion “You take one, like you take one immediately and you take the other 
one within 72 hours.” 
 “Twenty-two… within twenty-two hours and then twelve hours later 
and then that was pretty much it, right?” 
Mechanism of action  
 “...So we’re not really sure but there’s three or four different 
ways…we believe it works.” 
 “One of them is in…you know like (another member) was saying, 
it’s um… a far as just like thickening the endometrial, you know, 
mucosa so that the um… egg is less uh… less apt to travel um… 
that’s one of ways that it works; just in the same way as birth 
control… works.” 
 “Member 1: I remember one line it said this is not an abortifacient.  
Member 2: I have a question on that.We’re referring to third 
mechanism of action which states that it could or could not effect 
implantation  Member 2: but isn’t that also the same mechanism of 
action of Ortho Tri-Cyclen? If you look at the mechanism of 
action…Member 1: It is.  Member 2: in Plan B and in Ortho Tri-
Cyclen for example, they’re identical.” 
No knowledge  
 “Member 2: We haven’t had this (have we?). Member 3: Yeah, 
that’s why I’m kinda quiet…” 
 “I kinda just looked it up briefly on the internet; about how it 
works..other than that like other than it being brought up in ethics 
class..about how some pharmacists would dispense it, some 
others..some err…others don’t. So that’s why I’m like…I’m kinda 
learning here too” 
Perceived knowledge 
of others 
 
 “The only thing that people have ever heard about emergency 
contraception is that it aborts a baby.” 
 “One thing that I, I think is important um for mostly for pharmacists 
cause a lot of the pharmacists that I’ve come across during 
internships and stuff like that. They don’t, it doesn’t seem like they 
really get how it works….” 
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 Teaching Instruction.  To measure issues around emergency contraception 
teaching instruction, students were asked about particular methods of teaching instruction 
on the paper and pencil survey and were asked if they were aware of any position, 
negative, or even neutral attitudes that they perceived as held about emergency 
contraception by the instructor.   Apart from the survey questions that captured this 
question discussed earlier, two themes emerged from this questioning, 1) professor 
attitude and 2) need to educate.  In terms of the professor attitude when teaching 
emergency contraception, the majority of students answered that the professor was 
neutral in their attitude about emergency contraception. 
“ Yeah, I’d pretty much say they were neutral. I mean I didn’t really see any positive or 
negative thoughts about it when they were teaching us about it. I mean we touched first of 
all how it works (unclear) how the medication works and then we discuss it in open 
group. You know the teacher was neutral he didn’t, he told us not (unclear) you have to 
follow the law um that are under that we practice under.” 
 
“I think they were very cautious because they don’t want to put their biases into it. 
They’re just supposed to teach us what’s out there at this point. And even though we try      
to bring up… well what about the ethical issues and stuff they kinda floated over it and 
didn’t really want to go to far into it.” 
 
 Although it was more of a minority view, a few students felt that the professor 
attitude was more negative than positive or neutral: 
“If anything I felt they erred on the side of against it. Only because of it’s potential for 
abuse and the side effects and things like that…” 
 
 Another theme that was mentioned when discussing emergency contraception 
teaching instruction was the need to educate around emergency contraception.  The 
reason this is included here as this theme was mentioned repeatedly in the discussions 
around dispensing practices and therefore it is practical to mention here as well.  This 
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theme of duty to educate and counsel was a common theme among all focus group 
sessions and will be discussed more thoroughly in the next section. 
“…Basically them (professors) telling us that we need to educate the patient before we 
give it to them so they are aware of what it’s actually doing. That it’s not supposed to be 
a form of regular you know contraception.” 
 
 Projected Dispensing Practices.  Questions around dispensing practices of 
pharmacists by far yielded the most discussion and many non-expected themes emerged 
from these discussions.  Not only were pharmacy students asked a close-ended question 
on the paper and pencil survey about whether they would dispense emergency 
contraception in the future, but many questions throughout the focus group discussions 
focused on their future dispensing practices.  On the paper and pencil survey, almost 20% 
of the sample responded that they were either not sure or that they definitely would not 
dispense emergency contraception upon becoming a pharmacist.  The focus group 
discussions uncovered many hesitations in terms of dispensing, where the majority of 
students said that they would probably dispense, but that they felt hesitancy in doing so. 
“Yeah, don’t get me wrong I will dispense it but I will feel weird in a way, in the back of 
my mind.” 
 
 Hesitancy in dispensing was mainly due to biases held by the study participants.  
Hesitancy in dispensing was due to many issues including: hesitancy due to mechanism 
of action, repeat use, age requirement, due to the situation of a particular woman, due to 
side effects, and due to believing it is wrong (Table 8).  An overall theme of judgment 
emerged from this data.   
Hesitancy in dispensing or not wanting to dispense due to mechanism of action 
refers to the idea that pharmacists may not want to dispense emergency contraception 
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because of not knowing through which mechanism of action that it actually works.  One 
student remarked that if she/he were required to dispense this medication that it may in 
fact change her/his career path (see Table 8).  These comments points towards the belief 
that emergency contraception is a form of abortion. 
The most cited reason for being hesitant to dispense emergency contraception 
came from issues with repeat use.  Participants thought that repeat use was wrong and 
was grounds for refusal.  They employed what they called “professional judgment” to 
decide whether or not to refuse dispensing of the medication.  Participants maintained 
strong judgment against dispensing to women or men who came in repeatedly for the 
medication.      
Following this same idea, many participants were hesitant to dispense due to the 
teenage use.  Students seemed to have a problem with teens using this medication and 
were concerned that someone else would come in and buy the contraception for teens 
under 18 years of age.  Repeat use by teenagers was also frowned upon.          
 Dispensing also varied based on the situation of the woman.  For example, 
students were more likely to have favorable attitudes about dispensing to women who are 
raped than to teenagers.  In the discussion about the situation of the woman, the same bias 
towards women who use it repeatedly came up.   
 Students were hesitant to dispense emergency contraception OTC due to the 
perceived side effects of the medication (Table 14).  Many participants felt that the 
medication should not have gone OTC due to the perceived side effects and that it should 
be controlled by physicians.  Interestingly, students did not mention what particular side 
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effects the medication caused but were sure that they were going to come out with studies 
demonstrating these side effects very soon.   
In addition, a few students did not want to dispense the medication because they 
believed it was wrong and compared dispensing it to being a willing accomplice in a 
crime:  “You do not want to be considered a willing accomplice to something that you 
feel is wrong.” 
 In contrast to these ideas and responses of not wanting to dispense, many students 
reported having no problem with dispensing emergency contraception.  Many had no 
problem dispensing emergency contraception due to the mechanism of action, meaning if 
it works the same as oral contraception and they are willing to dispense that, then they are 
willing to dispense emergency contraception.  In addition, many students that felt that it 
was not their job as pharmacists to judge or refuse to dispense any medication based on 
moral or any other judgment.  Two students noted that dispensing emergency 
contraception is part of a pharmacists’ job: 
“I think for any um… any drug, it’s really… If you have religious reasons for not 
dispensing drugs then why are you a pharmacist?... Like you know that’s part of the job, 
right? You do have to give people drugs.” 
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Table 14. Major Themes of Projected Dispensing Practices and Representative Quotes 
Theme Representative Quote 
Hesitancy in 
dispensing/not wanting to 
dispense 
 
Due to mechanism of action  
 “That’s the problem, we just don’t know… it seems like… we 
just don’t know how it’s going to work, so…” 
                                                
Moderator: So would you say that you feel more hesitant 
towards dispensing because not knowing the true mechanism 
of action? 
                                               
Member 3: “I do.”  
                         
Member 1: “I definitely do. I feel like I could even change my 
career path…because of some places require that, then I feel 
like I couldn’t pursue that career path…” 
Due to repeat use  
 “I’m a little undecided because um… right now there is no 
limitation as to you know if person A can come pick it up 
today and next week come pick it up again or… so I think my 
limitations are you know like I may consider dispensing it you 
know if I you know… you know pending when I was in that 
situation you know and I think… I think I’m okay with it 
because ultimately I think it’s my goal to be um… to counsel 
the person and maybe you know… get… give them another 
perspective. But if it was a situation where I you know was 
always being confronted with you know maybe the same 
person or you know I’m in an area where I have to do as 
often, I don’t know…” 
 “Yeah, I think that’s a little bit despicable, coming every 
weekend and being like yeah I want my Plan B now.” 
 “if I see the same person coming in… I mean I would say 
no…as a medical professional you know that is not healthy 
and I would say absolutely not  you need to go see a doctor”     
Due to teen use  
 “...I will feel uncomfortable in a way. Because you know I see 
a teenager who’s just doing whatever and having sexual 
intercourse and not really caring about themselves and this 
going to be their method, even though you tell them not to. 
You know I’m married and maybe I’m not taking birth control 
and something happens… you know it’s a…it’s a different 
situation I guess. But I wouldn’t want it to be used as the 
teenagers, oh it’s okay now don’t protect yourself because you 
have a birth control pill over the counter.  You know so it’s 
kind of conflicting but by law I would still probably do but just 
feel a little bit guilty if I see a younger person. Like an 18 year 
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old come in.” 
  
 “another thing is that would make me hesitant to dispense is 
the fact that you only have to be 18…”  
Due to the situation of 
women 
 
 “I think, I mean, as a human you would feel different you 
know if you see an 18 year old girl coming in getting one in 
comparison to a female who got raped... I mean there’s gonna 
be a big difference on how you feel about that because I mean 
if a person was raped then I would definitely you know 
understand compared to an 18 year old girl who is immature 
and doesn’t really know all of the consequences…and who 
will probably do it again… you know there’s a difference. I 
mean that’s just my personal opinion…there’s a big difference 
there.” 
Due to side effects  
 “Well I don’t think it should have been over the counter, due 
to the fact that it’s a high dose and with high doses you get the 
most side effect you know. Those are the medications that 
highly need supervision.” 
 
“This way they’re not even going to the doctor to get birth 
control pills for Pete’s sake…” 
                                              
“I just think that you know there has to be studies that shows 
over long periods of time how this drug has affect anybody. 
You know I’m pretty sure… let’s say 5 years down the line 
from now there’s gonna be a big study saying you know… 
some kind of something developed…” 
 
“It’s gonna go… go back to prescription…” 
No problem with 
dispensing 
 
Due to mechanism of action  
 “I don’t have a problem with it. I take a look at it. I have no 
problem dispensing oral contraception…I see it as the same 
drug… I see it as the same mechanism of action. If I’m willing 
to fill birth control, I’m willing to fill Plan B.” 
Because it’s not our job to 
judge 
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 “It’s not our job to judge. It’s not what we’re here for. I 
would never apply that to my job.” 
  
 “...I definitely don’t agree with any pharmacist who refuses to 
dispense any medication…not just the emergency 
contraception…but anything based on your own personal 
beliefs. If you don’t have a medical reason why this person 
shouldn’t take it, then it’s really not your place...” 
 “My personal belief is that we are…when you inject your own 
personal belief into a situation such as this which is not of the 
interest of the patient… we are overstepping our rights pretty 
much as a pharmacist...we’re supposed to be there to provide 
medication and information and protect the patient. And by us 
refusing a product that they’ve already made their mind up 
that they     want and previously their doctor has also agreed 
with that… and provided a prescription for that fact. For us to 
step in an say no we won’t fill this is… we’re abandoning our 
patient in a way. That’s how I feel about.                  
 “..if they meet all the requirements and I feel that they are 
safe as a health…from a health perspective, I have no 
problem dispensing it and I don’t really think of it about if 
they are too young or a it’s a male picking up or anything like 
that. Like I… I just don’t personally feel any sort of moral you 
know thing at all.” 
  
There were other major, yet unexpected themes that emerged from the data.  
These included: 1) duty to counsel, 2) stigma, and 3) the argument between professional 
judgment and mandatory dispensing.  In addition to these themes, participants shared 
stories of refusal that are included below.    
The first major yet unexpected theme that emerged from the discussions around 
dispensing practices was duty to counsel.  Most, if not all participants felt that it was their 
duty to counsel and educate consumers about emergency contraception.  This was an 
interesting finding in that Plan B is not a pharmacy counseled product (Food and Drug 
Administration, 2006).  Although the FDA mandates that a healthcare professional must 
be available to answer questions that a consumer may have about Plan B OTC, 
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counseling for Plan B OTC is not required.  The only thing that is required for OTC 
purchase of Plan B is proof of age 18 or older (Food and Drug Administration, 2006).  
“They absolutely have to get the counseling from the pharmacist, because the technician, 
a cash register person, whatever… someone who’s standing helping out in the pharmacy, 
does not understand why it’s important to educate the person about this drug...”   
 
“I think a little more counseling is needed. At that point you just can’t ask for an ID…ok 
you’re over 18… there you go. You need to ask a little bit more you know questions;   
when did you have intercourse and make sure that it was in the correct time.  And that 
way you’re educating them.” 
 
 Many study participants explained that they felt that it was their duty to educate 
and counsel consumers on this product due to the OTC status of the drug: 
 “…Now if it would have stayed a prescription then you know I know they may deny 
counseling with me however they went to a physician, they were examined, they obviously 
were spoken to about the medication and if they don’t want to hear my counseling that’s 
fine… I’m a little more at ease with that. Than in the sense that now it’s over the counter 
and they just come and buy it and go…” 
 
“And me personally, I think it all comes down to like I personally don’t think that that 
drug should have been placed over the counter just because of the counseling issue.” 
 
Other reasons provided for the need to counsel clients on emergency 
contraception was due to a belief that consumers are ignorant about their health and that 
repeat users and teens are irresponsible.  Examples of the need to counsel due to the 
ignorance of consumers:   
“…Take the pill they think it’s taken care of, they could be… three weeks later out at a           
Dolphins game, tailgating, be drinking most of the morning and half of the afternoon and 
they’ve damage… they’ve potentially caused damage to their fetus because they didn’t 
understand that they needed to follow back up with their doctors…” 
 
“I agree with you. Cause some people may not even know what their cycle is and then 
just probably just wasting their money too and buying something that’s not going to 
work.     You know? Some people don’t even think about when they’re really ovulating or 
what they should look for. So I agree with you on counseling…” 
 
 138
Examples of the belief that education is needed because repeat use and teens are 
irresponsible are included below:  
“I think that… the other major thing that concerns me with the Plan B, especially going 
back to the ignorance in a… in women’s health that a lot of people like to self medicate    
in this country and they might not seek out getting the Plan A, the regular oral 
contraceptives, and just utilize the Plan B frequently and there’s not a lot of data on how          
effective it is if it’s used more frequently; if it becomes less effective and I think that’s 
what the evidence that they’ve been telling us is. That when it’s used more            
frequently it’s not as effective and  I… I think when they have that over the counter the 
pharmacist needs to at least tell the… the patient that they need to seek out a good oral             
contraceptive from that point on.” 
 
“… in some instances I believe that you know it’s a reason for young people to have 
unprotected sex. They feel you know, well I can’t get pregnant; you know I can (either) 
take birth control; I can take emergency contraception… but their not aware of  the other 
things… the outcomes of it…you know STDs, (unclear) for example…I mean I can tell 
you from experience. I see it everyday at the pharmacy… right here… (unclear) right 
now we have to have birth control in stock… I mean this we have to have all of (the) at   
the beginning of the year… birth control… I mean it’s like hot item. Believe it or not 
those same patients within three months after that has to get prescription for STD. So my 
thing is yes, you’re not gonna get pregnant but then again you… you are not protecting 
yourself (about) the other risks. So yeah I mean I think about it but I… well it’s just an 
excuse for them to go ahead and have unprotected sex… but at the same time you know      
it’s not my place to say well you can’t… I cannot dispense it to you.”   
 
“… I think that… I had a lady come in with her boyfriend, young girl she might have 
been maybe just 18. I asked her if she needed any counseling. You know (unclear) wanted 
to know the side effects on it. And she said no, she just kinda wanted to buy it and run 
out. I guess cause of being embarrassed or whatever; so that’s kinda worrisome because 
you know if they over use that, that could cause problems for them health-wise.    So I 
think that’s a big issue. I think somehow, it needs to be… counseling has to be a 
mandatory thing. I think that that… cause they could refuse counseling but I feel that with 
that medication, I don’t think that you should be allowed to refuse.” 
 
Many sentiments such as these below carried a hint of paternalism in the form of 
counseling despite Plan B not being a counseled product.  
“… well they chose to get it, I’m not the one who gave them access to it but I can at least 
tell how to use it right so that they don’t harm themselves. Cause by me not giving it to 
them I’m abiding to my ethical beliefs but them taking it can harm them more than benefit 
them if I don’t give them counseling.” 
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“… I think I’m okay with it because ultimately I think it’s my goal to be um… to counsel 
the person and maybe you know… get… give them another perspective.” 
 
“I think you need to sit and hear ok this is not a drug that you can use every time...”    
 
“… I guess concerned when a male comes in to buy it because we can’t refuse, if he’s   
18, if he shows his ID you know that’s what our discussion was (in lab)… we can’t really 
refuse him but how do we know he’s not gonna you know… you know worse case 
scenario… go out and rape somebody and force a 15 year old to take it…”  
  
One way to perhaps explain this overwhelming need to counsel and educate 
consumers can be found in participant ideas about pharmacy as a profession.  One of the 
first questions asked in the warm up of the focus group discussions is why students want 
to be a pharmacist and almost all students responded that they chose to become 
pharmacists so that they can help and counsel people.   
“… I enjoy helping people and… my (ideal) pharmacist is someone who would get out 
and help the customers.” 
 
“I want to become a pharmacist… once again it’s a helping profession it gives you the 
ability to help people in the way that the pharmacist role is going… rather than just 
standing back behind the counter and filling things out… helping the patients and 
counseling them and helping them…” 
 
“…the counseling piece has always been very important to me and I’ve always kind of 
felt obligated to do some counseling and interaction and this gives me an opportunity to 
do that with more security… this would be something that would give me the opportunity 
to counsel um… and also give me the opportunity to educate…” 
  
The area of stigma took on two forms, one where participants noted the stigma 
that consumers feel when coming in and asking for Plan B and two, the overall stigma 
that participants seemed to have about users of Plan B and around OTC drugs in 
particular.  These quotes embody the noted stigma that consumers may feel when 
requesting the medication:  
“Nobody’s happy… nobody’s smiling going… I want my Plan B.”                                                 
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“They’re usually very quiet about it. They come in and they’re kinda like do you sell the 
Plan B? You kinda see them lurking in the aisle before they come up to make sure 
nobody’s there or if it’s a male pharmacist, they wait till a female at the register.”                 
 
 Upon coming into the focus group, some participants had a preconceived notion 
of what kind of person uses Plan B and therefore already had a stigma towards the person 
using the medication.  When answering the question, what is the first thing that comes to 
mind when you hear the term emergency contraception, all focus groups said that the first 
thing that comes to mind is a young girl or teenager trying to fix their mistake or risky 
sexual behavior.  It is possible that this stigma or notion of a Plan B user may negatively 
impact access to this medication.  Focus group participants mentioned that other stigmas 
were present for other OTC products such as Sudafed, syringes, and nicotine patches.  It 
is strange that there did not seem to be the same stigma around prescription oral 
contraceptives even though prescription oral contraceptives and Plan B are 
compositionally the same.   
When discussing dispensing practices, data from the focus group discussions 
demonstrated a tension between what is called professional judgment and mandatory 
dispensing.  Professional judgment is the idea that pharmacists should be able to decide 
whether or not to dispense medication based on their personal beliefs/religion/values and 
mandatory dispensing is the thought that if you are a pharmacists, you should be required 
to dispense all approved and legal drugs that your pharmacy carries.  There was much 
discussion around both sides of this argument in all of the focus groups, however only 
one excerpt is shown here:   
“… if it’s religious… if they have a religious belief… I know that they is not supposed to 
you know take their religion to the workplace but… however as long as they able to refer 
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the patient you know to where they can get it … I feel like it’s you know it’s their 
professional judgment  and they… they don’t want to dispense it…”                                     
                                                 
Member 4: “I don’t…” 
                                                 
Member 1: “so I don’t think we can force them and say hey you have to do this. They are 
profess… they are professionals and I think their right has to be protected also.”                                      
 
Member 4: “… but a lot of times people use that as an excuse because if you… if it was 
truly that they didn’t want to dispense it because of their religious beliefs…what about all 
the other medications that… you know what I mean, that fall    under that category also… 
like nobody refuses to dispense Viagra… nobody refuses to dispense Cialis… nobody 
refuses to dispense regular birth control… so… then why would your religious beliefs 
only tell you that you can’t dispense Plan B? Like that doesn’t make any sense.” 
 
Member 1: “But the thing is you know…it’s harder like for the older pharmacists… it’s 
harder for them to accept changes. So you know they still have that old mindset.” 
 
Member 4: “They should retire.” 
 
Member 3: “I mean I wouldn’t personally refuse anyone, um however I do feel that 
everyone has their right to believe whatever you believe; but it’s all in how you handle 
the situation.  Ok, if um… if I didn’t want to dispense it and I said to the patient  we just 
don’t have it in stock, let me refer you to blah blah blah. Fine. Ok, I can deal with that 
but… some people are just downright rude and saying I don’t dispense this drug… you 
know and just kinda like…right away catch the attitude…and I don’t think that’s 
appropriate at all. Now if they do you know something like we don’t have it in stock why 
don’t I refer you to this store. That’s okay. I wouldn’t have an issue with that.”                        
 
Member 3: “If that’s your personal religious belief, fine I think you handled it as best as 
you could in that case. But if you’re gonna you know get rude about it… then no…”        
 
Member 4: “I think that the issue… that I have with it is like she said… when you’re… 
when they’re rude… or when they say you know… you shouldn’t take this because I… 
I’m not giving this to you because I don’t believe in it or you shouldn’t be having 
unprotected sex or you’re too young to be taking… you know what I’m saying when they     
say… cause I’ve heard pharmacists say…”  
 
Member 4: “Like they won’t just say I can’t dispense this you know whatever. They’ll… 
they tell the patient… why they think they shouldn’t be taking it and that they shouldn’t be 
taking it and they shouldn’t be doing this and that’s… I mean that’s not our place to   do 
that.”                                
 
Member 1: “But I… on the other side… this is probably gonna be on the side of the 
pharmacy side. I feel like if we just… if we as… as a professional if we allow you know… 
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if we allow them to take all of our rights away… you know what kind of professional we 
are? We just gonna be doing whatever we are told to do. You know our profession is not 
gonna be protected; we not gone have right to do what we feel is       right.”                                  
 
Member 4: “But it’s not about… it’s not about your religious beliefs though.Your right is 
to say… as a pharmacist  I have a right to say… you… I’m not gonna dispense this to you 
because it’s going to cause you to bleed to death… I’m not gonna dispense this to you 
because I can see that you are addicted to narcotics… I’m not going to dispense it to you 
because you’re already taking something that has the same ingredients in it. Not I have a   
right to tell you that I’m not gonna give it to you because I don’t believe you should be 
taking it. That’s not…you know what I mean. So I feel like our professional rights are 
protected because we do have the authority to say we’re not going to dispense anything 
to you that is going to endanger your health or your safety.”   
                         
Member 5: And as far as the patient made up their mind or a doctor wrote in on a 
prescription pad, you’re (unclear) saying that a pharmacist is a mere um…vendor um… 
just there to exchange products and not exchange service. And if the patient made up 
their mind it doesn’t mean that we should necessarily have to follow whatever they 
decide. I’ve seen multiple prescriptions that I would not have dispensed on any day of my 
life… just because it was written on a prescription pad doesn’t mean it was correct. Oh 
and just because a patient makes up their mind doesn’t mean it’s correct…” 
                 
Lastly, many stories of refusals and pharmacists and pharmacies limiting access to 
emergency contraception were expressed during the focus groups and will be shared here.  
Participants noted that they work with pharmacists who refuse to dispense Plan B. 
“And regardless of what everyone would like to say about pharmacists don’t pass 
judgment, there’s a lot of students who pass judgment now; which means they are      
going to be pharmacists who pass judgment. And I’ve worked with pharmacists who 
refuse to dispense...” 
 
 “Yeah, I… I personally work in a pharmacy where we had two pharmacists, when it was 
prescription only, refuse to fill it and… two pharmacists who would. So it was a very 
interesting cause I was involved in the juggling back and forth between…that particular 
situation.” 
 
“… (another) pharmacist that we have, he hides them… when we get in an order.”                                   
All: He hides it? Member 3: Where the heck does he hide it?                                                                 
Member 2: I have no idea. I went to the room the other day and then the pharmacist look 
for it and I thought he had it…I’m like (are those things right there). Cause we made a… 
we made a bet… a hundred dollars that we can…that we can find (whether) he hides     
them at. I know he’s not taking it out of the pharmacy…that’s against the law.                                    
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He puts them somewhere… he… he makes sure he works on Tuesday night    when the 
order gets in…to make sure he takes them out of those box and puts them somewhere we 
don’t know” 
 
 “…(a professor) warned us about there’s this one student on rotation who got a 
prescription um for Plan B, um it was CVS in Gainesville and the pharmacist doesn’t 
want to fill it but she um, the student gave it to their patient anyway and got into so much 
trouble. But the pharmacist kind of just blamed it on the student. Well it’s the student’s 
fault because you’re really not supposed to but um I guess the point is like um don’t do 
anything your like your preceptor wouldn’t do. Just make sure like if your preceptor    
says no I don’t want to fill it then you don’t give it to the patient…” 
 
“It depends on the pharmacist, some pharmacists are totally cool with it but there were      
pharmacists who would just refuse to give it to their patients.” 
 
  “(a professor) just warned us like if your preceptor doesn’t feel comfortable, then don’t 
do it.” 
 
“…I was working with a pharmacist and he mentioned that he had um you know I’m not 
against any religion, that he had a Jewish pharmacist who would just not dispense it at 
all no matter what because he felt that sperm shouldn’t be wasted. So um… it was… he 
just wouldn’t do it at all…” 
 
 “I’ve had some pharmacists that won’t sell it to men… also in that same Jewish place... 
  It has to be a female over 18.” 
 
Summary 
In sum, there was a disconnect between what pharmacy students reported on the 
paper and pencil survey and what was uncovered in the focus group discussions.  On the 
paper and pencil survey students reported learning about emergency contraception in 
their pharmacy school classes, however when queried in the focus groups discussions 
pharmacy students revealed that this learning did not come from their pharmacy school 
classes but rather from outside sources.   
Question 2 asked about how emergency contraception course content was taught 
at accredited schools of pharmacy.  According to the focus group discussions what is 
taught in pharmacy school classes about emergency contraception is brief and over half 
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of the sample felt that pharmacists are not well enough informed to confidently dispense 
emergency contraception.  The majority of participants felt that their professors 
maintained a neutral attitude in teaching about the medication.  In addition, participant 
level of knowledge about emergency contraception was not specific.  Many students 
entered the focus group with a preconceived notion about people who use emergency 
contraception and were hesitant in dispensing the medication.  Many participants held 
biases or judgments towards emergency contraception users.  This stigma may be 
explained through a belief that pharmacists have a duty to educate and counsel clients.  It 
is likely that these beliefs were learned from school.  Refusing to dispense emergency 
contraception is real as noted in many of their stories and the arguments for refusing to 
dispense and for mandatory dispensing were present throughout the focus groups without 
resolution.   
Section III: State-Wide Pharmacist Survey 
The third research question was addressed through a state-wide survey of 
pharmacists.  Although 552 surveys were mailed out to pharmacists around the state of 
Florida, only 146 were returned (138 paper-based and 8 online) yielding a 26% response 
rate.  After speaking with committee members, a second mailing was sent.  The second 
mailing only had one contact point and did not follow Dillman’s method due to budget 
constraints.  Because 185 more surveys were needed at this point, another 712 surveys 
were sent out to a random sample of pharmacists and great care was taken to ensure that 
pharmacists were not double sampled.  Of the 712 surveys mailed out in the second 
mailing, 130 were returned yielding a 18% response rate.  However, 30 surveys were 
either returned by mail or they left messages about how they were retired, sick, or not 
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currently living in Florida.  In total, 1,264 surveys were mailed out, 272 were returned 
and ~30 were incorrect.  Therefore, the final sample size was 272 (which is 82% of the 
original sample hoped for) with a 22% response rate overall.  Because the study was not 
funded and because the research and mailing costs were out of pocket expenses for the 
researcher, surveying more pharmacists could not continue and therefore they desired 
sample of 331 was not reachable.  The following analysis will report on the 272 surveys 
that were returned.   
Quantitative Data Analysis: Univariate & Bivariate Analysis 
 Quantitative data analyses were performed using SPSS statistical software (SPSS 
16.0, SPSS Inc., Chicago).  Frequency distributions were performed on all categorical 
level variables to determine response distributions and means and standard deviations 
were calculated for all continuous variables.  These procedures identified any outliers or 
non-meaningful responses and response patterns which could call for collapsing of data 
based on the distribution.  All collected and entered data as well as frequency distribution 
output data are available on CD.   
 Univariate Analysis.  The sample included 272 pharmacists, female (52.6%) and 
male (47.4%) (Table 15).  Age ranged from 25 to 87 and can be equally distributed into 
thirds with 30.9% under 36 years of age, 34.6% between the ages of 36-50, and 32.7% 
between the ages of 51-87.  The ethnic composition of the sample was primarily White 
(70.6%), followed by Hispanic (10.7%), Asian (7.4%), Black (6.2%), and Other (3.3%).  
A little over 67% of pharmacists were married with the remainder single (27.6%) or 
living with their partner (3.7%).  Almost 38% of the sample were Republican, followed 
by Democrats (25%), Independents (17.3%), and none or undecided (15.8%).  In terms of 
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religion, 67.3% reported some form of Christianity, 8.8% claimed no religion, 7% 
reported being Jewish, 6.2% reported being Hindu or Buddhist, 1.5% Islamic, and 9.2% 
did not answer the question.  When queried about religiosity, 47.4% of the pharmacists 
claimed to be either religious or religious and spiritual, while 25.4% reported to be 
spiritual only, and 25.4% selected undecided, none of the above, or prefer not to respond.   
Table 15.  Sociodemographics Characteristics of Study Sample (N=272) 
Variable Total population N (%)  
Gender 
Female 
Male 
 
  143  (52.6)* 
129  (47.4) 
Age, years  
< 36  
36-50  
51-87  
 
84  (30.9) 
94  (34.6) 
89  (32.7) 
Ethnicity 
White 
Black 
Hispanic 
Asian  
Other 
 
192  (70.6) 
17  (6.2) 
  29  (10.7) 
20  (7.4) 
  9   (3.3) 
Marital status 
Married 
Living with partner 
Divorced or separated 
Widowed 
Never been married 
 
183  (67.3) 
10   (3.7) 
   28    (10.3) 
   4     (1.5) 
  43    (15.8) 
Political Affiliation 
Republican 
Democratic 
Independent 
None/undecided 
Other 
 
103  (37.9) 
   68    (25.0) 
   47    (17.3) 
   43    (15.8) 
   6     (2.2) 
Religion 
Christian 
Hindu or Buddhist 
Jewish 
Islamic 
None 
Missing 
 
183   (67.3) 
 17     (6.2) 
 19     (7.0) 
   4      (1.5) 
 24     (8.8) 
 25     (9.2) 
Religiosity 
Religious 
Spiritual 
Religious and Spiritual 
 
43    (15.8) 
69    (25.4) 
86    (31.6) 
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Undecided 
None of the above 
Prefer not to respond 
                     13     (4.8) 
35    (12.9) 
                      21    (7.7) 
*Some percentages do not add to 100 because of rounding or missing data 
 
The remainder of the demographic questions queried about pharmacists’ current 
positions and their pharmacy education and training (Table 16).  Just over 32% had been 
practicing pharmacy for 8 years or less, 33.5% had been practicing between 9 and 22 
years, and 33.8% had been practicing pharmacy between 23 and 55 years.  Over half of 
the sample (51.8%) was employed at a community-chain pharmacy, almost 20% worked 
at a hospital pharmacy, 15.4% reported working at another type of pharmacy such as 
home infusion, or mail order, and another 12.9% of pharmacists reported working at a 
community-independent pharmacy.  Just over 58% of the sample said that they were staff 
pharmacists, 27.6% reported to be pharmacy managers, and 14.3% reported to have a 
different job title such as clinical pharmacist, pharmacy owner, or medical liaison.  
Almost 81% of the sample claimed to be employed full-time, 17.3% worked part-time, 
and a smaller 1.8% were retired.  In terms of pharmacy school attendance, the top five 
schools attended, which represented 47.8% of the sample, were University of Florida 
(24.6%), Nova Southeastern University (11.8%), Florida Agricultural & Mechanical 
University (4.4%), Mercer University (3.7%), Massachusetts College of Pharmacy 
(3.3%).  Almost a third of the sample (32.4%) graduated between 1949-1982, 28.7% 
graduated between 1983-1998, and 34.6% graduated between 1999-2007.  
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Table 16.  Demographics on Pharmacy Practice and Training (N=272) 
Variable Total population N (%)  
Years in Practice  
<9 
9-22 
23+ 
 
88    (32.4)* 
91    (33.5) 
92    (33.8) 
Type of Pharmacy where Employed 
Community—Chain 
Community—Independent 
Hospital 
Other (e. g. Home Infusion, Mail Order) 
 
141  (51.8) 
35    (12.9) 
54    (19.9) 
42    (15.4) 
Job Title 
Staff Pharmacist 
Pharmacy Manager 
Other (e. g. Clinical Pharmacist) 
 
158  (58.1) 
75    (27.6) 
39    (14.3) 
Current Employment Status 
Full-time 
Part-time 
Retired 
 
220  (80.9) 
47    (17.3) 
5     (1.8) 
Pharmacy School Attended** 
University of Florida 
Nova Southeastern University 
Florida Agricultural & Mechanical University 
Mercer University 
Massachusetts College of Pharmacy 
 
67   (24.6) 
32   (11.8) 
12   (4.4) 
10   (3.7) 
9    (3.3) 
Year Graduated 
1949-1982 
1983-1998 
1999-2007 
 
88   (32.4) 
78   (28.7) 
94   (34.6) 
*Some percentages do not add to 100 because of rounding or missing data 
**Only certain data presented for this variable 
 
 Univariate analysis was performed for each independent variable (knowledge, 
attitudes, subjective norms, and perceived behavioral control).  Knowledge was measured 
by 10 questions.  Higher levels of knowledge were found for comprehension of number 
of pills in Plan B package, timing of administration, percentage of effectiveness, how to 
sell OTC to men who request it, Plan B and it’s relationship to abortion, and the 
relationship between timing and Plan B effectiveness.  Lower levels of knowledge were 
found for understanding Plan B’s true mechanism of action, comprehension of who can 
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sell Plan B to consumers, how to sell OTC to women in advance of need, and the 
relationship between Plan B and birth defects (Table 17).   
Table 17. Categorical Classifications for Knowledge 
Knowledge Items* Total population N (%)  
Number of pills in Plan B package 
Correct 
Incorrect 
 
                      185   (68.0) 
87   (32.0) 
Timing of administration 
Correct 
Incorrect 
 
                       188  (69.1) 
84   (30.9) 
Mechanism of action 
Correct 
Incorrect 
 
120  (44.1) 
152  (55.9) 
Percentage of effectiveness  
Correct 
Incorrect 
 
186   (68.4) 
  86   (31.6) 
Who can sell Plan B to consumers 
Correct 
Incorrect 
 
121  (44.5) 
151  (55.5) 
How to sell OTC to women (in advance of need) 
Correct 
Incorrect 
 
 61  (22.4) 
                      211 (77.6) 
How to sell OTC to men 
Correct 
Incorrect 
 
183  (67.3) 
 89  (32.7) 
Plan B can cause birth defects (True/False) 
Correct 
Incorrect 
 
120  (44.1) 
152  (55.9) 
Plan B can act as an abortifacient (True/False) 
Correct 
Incorrect 
 
146  (53.7) 
126  (46.3) 
The sooner a woman takes Plan B, the more 
effective it will be (True/False) 
Correct 
Incorrect 
 
 
248  (91.2) 
24   (8.8) 
*Missing cases are treated as incorrect 
 
A composite score was developed from the 10 questions that measured 
knowledge such that each participant was given a knowledge score, 0 out of 10.  The 
mean, standard deviation, range as well as the distribution of the knowledge composite 
variable is provided in Table 18.  On a scale of 0-10, the mean knowledge score for 
participants was 5.36, meaning that the sample had average knowledge across the board.  
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The knowledge composite score had a normal distribution with a slight left skew 
meaning that there was a slight skew towards higher level of knowledge about Plan B in 
the sample.  It was assumed that a pharmacist did not know the answer to a question if 
they left the question blank.  Therefore, an unanswered knowledge question was treated 
as don’t know.  Pharmacists received a 1 if they answered the question correctly and a 0 
if they answered the question incorrectly or did not answer the question.  There were 47 
pharmacists who left 1 or more knowledge questions blank.  Of these 47 pharmacists, 27 
only left 1 item blank, 6 left 2 items blank, 3 left 3 items blank, 5 left 4 items blank, 5 left 
7 items blank, and 1 left all items blank.      
Table 18. Univariate Statistics for Knowledge Composite Variable, N=272 
 N (%) Mean (SD) Range Skewness 
Knowledge Composite Variable 
0    
1     
2     
3     
4     
5     
6     
7     
8     
9     
10   
 
  9 (3.3%) 
16 (5.9%) 
19 (7.0%) 
16 (5.9%) 
31 (11.4%) 
40 (14.7%) 
38 (14.0%) 
49 (18.0%) 
30 (11.0%) 
19 (7.0%) 
 5  (1.8%) 
5.36 (2.46) 0-10 -.381 
 
 Table 19 represents the univariate analysis for the items that measured attitudes 
about Plan B.  In general, attitudes about Plan B use and users tended to vary.  While 
over half of the sample (52.9%) disagreed with the statement that easy availability of 
Plan B would discourage the use of regular contraception, 45.5% either agreed or were 
not sure.  A similar finding was found with the statement easy availability of Plan B 
promotes promiscuity.  While 53.7% of the sample disagreed with the statement, the 
other 44.5% either agreed or were not sure.  Over 64% of the sample reported that they 
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did not feel uncomfortable dispensing Plan B because of their religious/ethnical beliefs, 
however 33.8% reported that they either did feel uncomfortable due to their 
religious/ethical beliefs or they didn’t know.  A large percentage of the sample felt that 
repeated use of Plan B is wrong (61%).  In terms of comfort with dispensing Plan B to 
different groups of people, a large proportion of the sample (66.9%) felt comfortable 
dispensing to adult women, less felt comfortable dispensing to men (41.5%), and even 
less felt comfortable dispensing to adolescents (38.6%).  This finding is consistent with 
the dependent variable, dispensing practices which will be discussed below.  In addition, 
the majority of pharmacists (79%) felt that Plan B should be offered to women who are 
raped in all hospital emergency rooms, regardless of hospital affiliation. 
 152
 
Table 19. Categorical Classifications for Attitude 
Attitude Items* Total population N 
(%)  
Easy availability of Plan B will discourage regular contraceptive use 
Agree 
Disagree 
Neither Agree nor Disagree 
 
85 (31.2)** 
144 (52.9) 
39 (14.3) 
Easy availability of Plan B promotes promiscuity 
Agree 
Disagree 
Neither Agree nor Disagree 
 
 74 (27.2) 
146 (53.7) 
47 (17.3) 
I feel uncomfortable dispensing Plan B because of my religious/ethnical 
beliefs 
Agree 
Disagree 
Neither Agree nor Disagree 
 
 
 59 (21.7) 
176 (64.7) 
 33 (12.1) 
Repeated use of Plan B is wrong 
Agree 
Disagree 
Neither Agree nor Disagree 
 
166   (61.0) 
66   (24.3) 
34   (12.5) 
I feel comfortable dispensing Plan B to adult women 
Agree 
Disagree 
Neither Agree nor Disagree 
 
182  (66.9) 
63   (23.2) 
23   (8.5) 
I feel comfortable dispensing Plan B to adolescents (teens <18 yrs old) 
Agree 
Disagree 
Neither Agree nor Disagree 
 
105  (38.6) 
133  (48.9) 
 30  (11.0) 
I feel comfortable dispensing Plan B to men 
Agree 
Disagree 
Neither Agree nor Disagree 
 
113  (41.5) 
117  (43.0) 
 38   (14.0) 
Should Plan B be offered to women who are raped in all hospital 
emergency rooms, regardless of hospital affiliation? 
Yes 
No/Not sure 
 
 
215 (79.0) 
 53 (19.5) 
*The first seven questions were measured on a 5-point Likert scale from completely agree to completely 
disagree and were collapsed for easier comprehension 
**Some percentages do not add to 100 because of rounding or missing data 
  
A composite score was developed from the 7 questions that measured attitudes.  
Since the attitude questions were measured on a 5-point Likert scale, each respondent 
received a score from 1-5 for each individual question and the composite score included a 
total score for all attitude questions.  The attitude composite score ranged 7 to 21 where a 
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higher score equates to more positive attitudes about Plan B.  The mean, standard 
deviation, and range is provided in Table 20 for this new continuous variable attitudes 
about Plan B.  On a scale of 7-21, the mean attitude score for participants was 14.87, 
meaning that the sample had average attitudes across the board.  The attitude composite 
score had a normal distribution with a slight left skew meaning that there was a slight 
skew towards more positive attitudes about Plan B in the sample. 
Table 20. Univariate Statistics for Attitude Composite Variable 
Study Sample (N=272) Mean (SD) Range Skewness 
Attitude Composite Variable 14.87 (3.98) 7-21 -.327 
 
Figure 5 represents the univariate analysis of some of the items measuring 
subjective norms.  Overall, the majority of the sample perceived that their 
partners/business colleagues, professional organizations that they are most active in, their 
supervisor, and their close friends and family think that they should dispense Plan B.  In 
addition, 11.4% of the sample reported that there is someone at their pharmacy who 
refuses to dispense Plan B, 41.2% reported that there is no one at their pharmacy who 
refuses to dispense, 26.7% were not sure, and 18.4% of the sample reported that their 
pharmacy does not carry Plan B (data not listed in chart).  When asked if there is a policy 
in place at their pharmacy if someone refuses to dispense Plan B, 29.4% said yes, 24.3% 
said no, 23.5% were not sure, and 19.1% of the sample reported that their pharmacy does 
not carry Plan B (data not listed in chart). 
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A composite score was developed from the 4 questions that measured subjective 
norms such that each participant was given an composite score ranging from 4 to 16.  The 
mean, standard deviation, and range is provided in Table 21 for this new continuous 
variable subjective norms about Plan B.  On a scale of 4-16, the mean subjective norms 
score for participants was 12.99.  The subjective norms composite score had a normal 
distribution with a left skew meaning that there was a skew towards pharmacists thinking 
that influential people think that they should dispense Plan B. 
Table 21. Univariate Statistics for Subjective Norms Composite Variable 
Study Sample (N=272) Mean (SD) Range Skewness 
Subjective Norms Composite Variable 12.99 (2.71) 4-16 -1.115 
 
Figure 6 represents the univariate analysis of the items measuring the construct 
perceived behavioral control.  A large proportion of pharmacists reported that it was easy 
for them to counsel (69.5%) and educate (72.4%) clients about Plan B, while 14.3% and 
10.7% felt that it was difficult to counsel and educate respectively.  In addition, 67.6% of 
pharmacists reported that it is easy to dispense Plan B and 25.4% reported that it is easy 
to refuse to dispense the medication.  
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 A composite score was developed from the 4 questions that measured perceived 
behavioral control such that each participant was given an composite score ranging from 
4 to 16.  The mean, standard deviation, and range is provided in Table 22 for this new 
continuous variable perceived behavioral control.  On a scale of 4-16, the mean perceived 
behavioral control score for participants was 12.73.  The perceived behavioral control 
composite score had a normal distribution with a left skew meaning that there was a skew 
towards pharmacists responding that they have a higher comfort level in dispensing Plan 
B. 
Table 22. Univariate Statistics for Perceived Behavioral Control Composite Variable 
Study Sample (N=272) Mean (SD) Range Skewness 
Perceived Behavioral Control Composite 
Variable 
12.73 (2.74) 4-16 -.912 
 
Dispensing practices can be divided into two separate measures, 1) self reported 
dispensing practices of pharmacists (dependent variable) and 2) intention to dispense 
Plan B.  Table 23 and 24 summarize the univariate analysis for the self-reported 
dispensing practices including both the frequency distribution for the categorical level 
items and the means, standard deviations, and ranges for the continuous level questions.   
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A similar proportion of pharmacists have ever been asked to fill a prescription of 
Plan B (55.1%) or sell Plan B OTC (56.6%).  Although these proportions of pharmacists 
have been asked to dispense Plan B, strangely, less have actually filled a prescription 
(47.1%) or sold Plan B OTC (51.8%).  Almost 60% of the sample have ever dispensed 
emergency contraception either by prescription or OTC.  In addition, 70.6% of the 
sample would have the opportunity to come in contact with Plan B at their workplace.   
Table 23. Categorical Classifications for Dispensing Practices 
Dispensing Practices Items Total population N (%) 
Ever been asked to fill a prescription of Plan B 
Yes 
No 
 
150 (55.1)* 
122 (44.9) 
Ever personally filled a prescription of Plan B 
Yes 
No 
 
128 (47.1) 
144 (52.9) 
Ever been asked to sell Plan B over-the-counter 
Yes 
No 
 
154 (56.6) 
115 (42.3) 
Ever personally sold Plan B over-the-counter 
Yes 
No 
 
141   (51.8) 
128   (46.3) 
Ever dispensed by prescription OR over-the-counter 
Yes 
No 
 
162   (59.6) 
105   (38.6) 
Would you ever have the opportunity at your workplace to come 
into contact (see, dispense, fill a prescription) with Plan B? 
Yes 
No 
 
 
192   (70.6) 
74   (27.2) 
*Some percentages do not add to 100 because of rounding or missing data 
 
 Table 24 summarizes the means, standard deviations, and ranges for self-reported 
dispensing practices by prescription and OTC over the past 12 months.  When asked how 
many Plan B prescriptions pharmacists have personally filled in the past 12 months, 
answers ranged from 0 to 100 with a mean of 2.33 and a standard deviation of 9.29.  
When asked how many times pharmacists have sold Plan B OTC in the past 12 months, 
answers ranged from 1 to 200 with a mean of 5.64 and a standard deviation of 16.91. 
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  Table 24. Means, Standard Deviations, and Ranges for Dependent Variable Dispensing 
Practices 
Characteristic Mean SD Range Skewness 
Number of Plan B prescriptions 
filled in past 12 months 
2.33 9.29 0-100 9.169 
Number of times sold Plan B over-
the-counter in past 12 months 
5.64 16.91 0-200 7.466 
 
Table 25 shows the number of times pharmacists have dispensed emergency 
contraception in the last 12 months.  Over the last year, pharmacists have dispensed 
emergency contraception OTC more than they have by prescription which may mean that 
the OTC measure has increased use and access to this medication.  Of the pharmacists 
that reported that they have ever filled a prescription of Plan B, 60.7% have not filled any 
prescriptions in the past 12 months, 29.8% have filled 1-5 prescriptions, 7.7% have filled 
6-10 prescriptions, 1.1% reported filling between 11-50 prescriptions, and 0.7% filled 
between 51-100 prescriptions.  No pharmacist reported filling more than 100 
prescriptions of Plan B over the past 12 months.  Of the pharmacists that reported that 
they have ever sold Plan B OTC, 48.5% have not sold emergency contraception OTC 
over the past 12 months, 29.4% sold 1-5 packages of Plan B, 9.9% sold 6-10 packages, 
10.7% reported selling 11-50 packages, 1.1% sold between 51-100 packages, and over 
0.4% of pharmacists sold between 101-200 prescriptions over the past year.  No 
pharmacist reported dispensing more than 200 prescriptions of Plan B over the past 12 
months.   
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Table 25. Number of Times Pharmacists have Dispensed EC in the Last 12 Months 
 By Prescription N (%)  Over-the-counter N (%) 
0 165 (60.7) 132 (48.5) 
1-5   81 (29.8)   80 (29.4) 
6-10 21 (7.7) 27 (9.9) 
11-50 3 (1.1)   29 (10.7) 
51-100 2 (0.7)  3 (1.1) 
101-200 0 (0.0)  1 (0.4) 
 
Table 26 summarizes the univariate analysis for intention to dispense.  Intention 
to dispense measures the likelihood or intention of dispensing Plan B to varying groups 
of people and was partitioned into categories based on dispensing by prescription or 
OTC.  Intention or likelihood of dispensing Plan B does vary by the consumer requesting 
the medication or by the situation of use.  For example, when viewing intentions of OTC 
dispensing of Plan B, a greater percentage of pharmacists reported being likely to 
dispense to women who have experienced incest or rape (71%), followed by women who 
have experienced a problem with their birth control method (67.3%), followed by women 
who request the method after having unprotected sexual intercourse (66.2%) and last to a 
person other than the ultimate consumer of the product such as parents or a boyfriend 
(46.7%).  Interestingly, it was almost split half and half in terms of pharmacists 
likelihood of dispensing OTC to a person other than the ultimate consumer of the product 
such as parents or a boyfriend.   
When viewing intention to dispense by prescription to varying groups of people, 
pharmacists were most likely to dispense to women who have experienced incest or rape 
(72.4%), followed by women who request the method after having unprotected sexual 
intercourse (71%), followed by women who have experienced a problem with their birth 
control method (68.4%), and lastly to sexually active teens under age 18 (61.8%).  
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Interestingly, a greater proportion of pharmacists were likely to dispense to all groups by 
prescription than OTC.   
It is important to note that some of the items that measure intention to dispense 
are not real-life examples as pharmacists may never know if a woman is raped or not or if 
a woman has had unprotected intercourse or if her birth control method failed.  However, 
a pharmacist would know if the person requesting Plan B is a teenager or if it is a person 
is a male.  In addition, it is assumed that the consumer has had some sort of unprotected 
intercourse if they are requesting the medication in the first place.  That being said, the 
variable intention to dispense measures hypothetical bias of intention should pharmacists 
be privy to this information about the consumer. 
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Table 26. Categorical Classifications for Intention to Dispense  
Intention to Dispense Items Total population N 
(%)  
Likelihood of dispensing OTC to women who have experienced incest or 
rape 
Likely 
Unlikely 
N/A 
 
 
193 (71.0)* 
47 (17.3) 
30 (11.0) 
Likelihood of dispensing OTC to women who have experienced a 
problem with their birth control method 
Likely 
Unlikely 
N/A 
 
 
183 (67.3) 
60 (22.1) 
27 (9.9) 
Likelihood of dispensing OTC to women who request the method after 
having unprotected sexual intercourse 
Likely 
Unlikely 
N/A 
 
 
180 (66.2) 
65 (23.9) 
24 (8.8) 
Likelihood of dispensing OTC to a person other than the ultimate 
consumer of the product such as parents or a boyfriend 
Likely 
Unlikely 
N/A 
 
 
127 (46.7) 
116 (42.6) 
28 (10.3) 
Likelihood of dispensing by prescription to women who have 
experienced incest or rape 
Likely 
Unlikely 
N/A 
 
 
197 (72.4) 
43 (15.8) 
31 (11.4) 
Likelihood of dispensing by prescription to women who have 
experienced a problem with their birth control method 
Likely 
Unlikely 
N/A 
 
 
186 (68.4) 
55 (20.2) 
30 (11.0) 
Likelihood of dispensing by prescription to women who request the 
method after having unprotected sexual intercourse 
Likely 
Unlikely 
N/A 
 
 
193 (71.0) 
51 (18.8) 
27 (9.9) 
Likelihood of dispensing by prescription to sexually active teens under 
age 18 
Likely 
Unlikely 
N/A 
 
 
168 (61.8) 
72 (26.5) 
30 (11.0) 
*Some percentages do not add to 100 because of rounding or missing data 
 
A composite score was developed from the 8 questions that measured intention to 
dispense Plan B such that each participant was given an intention score ranging from 4 to 
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16.  The mean, standard deviation, and range is provided in Table 27 for this new 
continuous variable intention to dispense Plan B.  On a scale of 4-16, the mean attitude 
score for participants was 12.70.  The intention composite score had a normal distribution 
with a left skew meaning that there was a skew towards a greater intention or likelihood 
to dispense Plan B. 
Table 27. Univariate Statistics for Intention to Dispense Plan B Composite Variable 
Study Sample (N=272) Mean (SD) Range Skewness 
Intention Composite Variable 12.70 (4.12) 4-16 -1.199 
 
 Bivariate Analysis.  Chi-square tests were used to estimate the associations 
between sociodemographic variables, demographic practice and training variables and the 
dichotomous dependent variable dispensing practices.  Results for socio-demographic 
variables and dispensing are summarized in Tables 28-30 and results for practice and 
training variables and dispensing are summarized in Table 31.  Overall, gender, ethnicity, 
political affiliation, religion, and religiosity were not found to be significantly associated 
with dispensing of emergency contraception.  The only socio-demographic variables 
associated with emergency contraception dispensing was pharmacist age, where younger 
pharmacists (under 36 years of age) were more likely to have ever dispensed emergency 
contraception as compared to older pharmacists and marital status, where individuals who 
have never been married and individuals who are living with their partner were more 
likely to have ever dispensed emergency contraception.  
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Table 28. Chi Square Results of Ever Dispensed EC by Sociodemographic Variables 
 Ever Dispensed EC   
Characteristic % Yes 
Chi –
Square(df) Pattern of Finding (p value) 
Gender    
Female 56.7% 1.94(1) Not Significant (p=0.164) 
Male 65.1%   
Age, years     
< 36  74.7% 9.12(2)* Pharmacists under 36 years of 
age are more likely to have 
ever dispensed EC (p=0.010) 
36-50  53.8%  
51-87  56.8%  
Ethnicity    
White 59.1% 0.99(4) Not Significant (p=0.911) 
Black 70.6%   
Hispanic 62.1%   
Asian  63.2%   
Other 66.7%   
Marital status    
Married 59.4% 7.85(3)* Individuals who have never 
been married are more likely 
to have ever dispensed EC 
(p=0.049) 
Living with partner 70.0%  
Divorced/Separated/Widowed 45.2%  
Never been married 76.2%  
Political Affiliation    
Republican 58.0% 3.92(3) Not Significant (p=0.270) 
Democratic 56.1%   
Independent 61.7%   
None/undecided/other 72.9%   
Religion    
Christian 57.0% 6.44(5) Not Significant (p=0.265) 
Hindu  60.0%   
Buddhist 100.0%   
Jewish 68.4%   
Islamic 50.0%   
None 66.7%   
Religiosity    
Religious 50.0% 6.24(3) Not Significant (p=0.100) 
Spiritual 71.0%   
Religious and Spiritual 55.4%   
Undecided/ None of the 
above/ Prefer not to respond 63.2%   
*Indicates statistical significance at p<.05.   
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Although future analysis will focus only on combined dispensing, Tables 34 and 
35 provide a breakdown of socio-demographic variables by prescription and OTC.  No 
socio-demographic variables were found to be associated with dispensing emergency 
contraception by prescription.  For OTC dispensing, pharmacist age was significantly 
associated with dispensing emergency contraception where younger pharmacists (under 
36 years old) were more likely to have dispensed emergency contraception OTC as 
compared to older pharmacists.  This finding demonstrates that the association with 
dispensing and age is only significant for dispensing OTC.  Marital status was no longer 
significant for either dispensing by prescription or OTC. 
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Table 29. Chi Square Results of Dispensing EC by Prescription by Sociodemographic Variables 
 
Ever Dispensed EC by 
Prescription  
Characteristic % Yes Chi –Square(df) Pattern of Finding (p value) 
Gender    
Female 44.8% 0.64(1) Not Significant (p=0.423) 
Male 49.6%     
Age, years     
< 36  58.3% 5.33(2) Not Significant (p=0.069) 
36-50  42.6%   
51-87  43.8%     
Ethnicity    
White 46.9% 2.78(4) Not Significant (p=0.595) 
Black 52.9%   
Hispanic 37.9%   
Asian  60.0%   
Other 55.6%     
Marital status    
Married 45.4% 3.86(3) Not Significant (p=0.276) 
Living with partner 50.0%   
Divorced/Separated/Widowed 40.6%   
Never been married 60.5%   
Political Affiliation    
Republican 40.8% 5.41(3) Not Significant (p=0.144) 
Democratic 45.6%   
Independent 51.1%   
None/undecided/other 60.4%   
Religion    
Christian 46.4% 2.61(5) Not Significant (p=0.759) 
Hindu  60.0%   
Buddhist 71.4%   
Jewish 47.4%   
Islamic 50.0%   
None 50.0%     
Religiosity    
Religious 39.5% 9.98(5) Not Significant (p=0.076) 
Spiritual 60.9%   
Religious and Spiritual 40.7%   
Undecided 46.2%   
None of the above 54.3%   
Prefer not to respond 33.3%     
*Indicates statistical significance at p<.05.   
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Table 30. Chi Square Results of Dispensing EC OTC by Sociodemographic Variables 
 Ever Dispensed EC OTC  
Characteristic % Yes Chi –Square(df) Pattern of Finding (p value) 
Gender    
Female 49.6% 1.2(1) Not Significant (p=0.273) 
Male 56.3%     
Age, years     
< 36  68.7% 12.26(2)* Pharmacists under 36 years 
of age were more likely to 
have ever dispensed EC 
OTC (p=0.002) 
36-50  42.9%  
51-87  50.0%   
Ethnicity    
White 51.1% 2.11(4) Not Significant (p=0.715) 
Black 64.7%   
Hispanic 55.2%   
Asian  57.9%   
Other 66.7%     
Marital status    
Married 52.8% 5.03(3) Not Significant (p=0.169) 
Living with partner 70.0%   
Divorced/Separated/Widowed 38.7%   
Never been married 61.9%   
Political Affiliation    
Republican 47.0% 6.56(3) Not Significant (p=0.087) 
Democratic 50.0%   
Independent 55.3%   
None/undecided/other 68.8%   
Religion    
Christian 49.7% 5.08(5) Not Significant (p=0.406) 
Hindu  50.0%   
Buddhist 83.3%   
Jewish 68.4%   
Islamic 50.0%   
None 58.3%     
Religiosity    
Religious 42.9% 2.94(5) Not Significant (p=0.710) 
Spiritual 58.0%   
Religious and Spiritual 51.8%   
Undecided 53.8%   
None of the above 58.8%   
Prefer not to respond 52.4%     
*Indicates statistical significance at p<.05.   
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Results for practice and training variables by dispensing are summarized in Table 
31.  The number of years a pharmacist is in practice, the type of pharmacy where 
employed, job title, and current employment status all were significantly associated with 
dispensing emergency contraception.  No relationship was found between dispensing and 
pharmacy school attended or year of graduation.  Specifically, pharmacists with fewer 
years of practice, who were employed at a community-chain pharmacy, and part-time 
staff pharmacists were more likely to have ever dispensed emergency contraception.  
These findings stayed consistent when these variables were analyzed separately by 
prescription and OTC. 
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Table 31. Chi Square Results of Dispensing EC by Practice and Training Variables 
 Ever Dispensed EC  
Characteristic % Yes Chi –
Square(df) 
Pattern of Finding (p 
value) 
Years in Practice     
<9 72.4% 9.01(2)* Pharmacists with less 
years of practice were 
more likely to have 
ever dispensed EC 
(p=0.011) 
9-22 59.1%  
23+ 50.5%  
Type of Pharmacy where Employed    
Community—Chain 87.1% 94.93(3)* Pharmacists 
employed at a 
community-chain 
pharmacy are more 
likely to have ever 
dispensed EC 
(p<0.0001) 
Community—Independent 54.3%  
Hospital 26.4%  
Other (e. g. Home Infusion, Mail Order) 20.0%   
Job Title    
Staff Pharmacist 61.7% 16.14(2)* Staff pharmacists are 
more likely to have 
ever dispensed EC 
(p<0.0001) 
Pharmacy Manager 31.5%  
Other (e. g. Clinical Pharmacist) 6.8%   
Current Employment Status    
Full-time 87.7% 15.74(2)* Full-time pharmacists 
are more likely to 
have ever dispensed 
EC (p<0.0001) 
Part-time 12.3%  
Retired 0.0%   
Pharmacy School Attended**    
University of Florida 51.1% 78.09(82) Not Significant 
(p=0.602) 
Nova Southeastern University 62.5%   
Florida Agricultural & Mechanical 
University 
83.3%   
Mercer University 60.0%   
Massachusetts College of Pharmacy 66.7%     
Year Graduated    
1949-1982 54.0% 3.58(2) Not Significant 
(p=0.167) 
1983-1998 60.0%   
1999-2007 67.7%     
*Indicates statistical significance at p<.05.    
**Only certain data presented for this variable   
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Bivariate associations were also explored between (a) knowledge and dispensing 
practices, (b) attitudes and dispensing practices, (c) subjective norms and dispensing 
practices, and (d) perceived behavioral control and dispensing practices.  Results are 
summarized in Tables 37-40.   
 Bivariate analysis was computed for knowledge as an ordinal level variable on a 
scale of 0-10 with 0 representing low knowledge and 10 representing high knowledge 
and with knowledge as a categorical variable with low knowledge representing scores 
from 0-3, average knowledge for those that answered between 4-7 knowledge questions 
correctly, and 8-10 were said to have high knowledge.  Kruskal-Wallis analysis of 
variance was computed for the ordinal level analysis and chi-square analyses were 
computed for the categorical level knowledge variable.  Both categorizations of 
knowledge yielded significant results where knowledge about emergency contraception 
was found to be significantly related to having ever dispensed it.  Similarly significant 
results were found when dispensing practices were separated by prescription and OTC 
(Table 32).   
 Table 32. Bivariate Results of Dispensing EC and Knowledge 
 Ever Dispensed EC 
 % Yes Chi –
Square(df) 
Pattern of Finding (p 
value) 
Knowledge (ordinal  level scale 0-10) n/a 69.48(10)* Significant 
(p<0.0001) 
Knowledge (categorical level)    
Low Knowledge  25.4% 49.58(2)* Significant 
(p<0.0001) Average Knowledge  64.3%  
High Knowledge  88.9%  
*Indicates statistical significance at p<.05.    
 
 To test the associations between attitudes about emergency contraception and 
dispensing practices, Kruskal-Wallis analysis of variance tests were computed for the 
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ordinal level subjective norm questions and Pearson chi-squares were computed for the 
one categorical level question (see Table 33).  The Kruskal-Wallis test can be used in 
bivariate analysis with an ordinal-level predictor variable and a nominal level criterion 
variable.  Table 33 reveals that attitudes about emergency contraception are significantly 
related to whether a pharmacist has ever dispensed emergency contraception, irrespective 
of whether it was dispensed by prescription or OTC.  Because there was one question on 
the pharmacist survey measuring attitudes on a nominal level, a chi-square test of 
association was performed between this question and having ever dispended emergency 
contraception.  The question asked if Plan B should be offered to women who are raped 
in all hospital emergency rooms, regardless of hospital affiliation.  Pharmacists’ thoughts 
about whether Plan B should be offered to women in hospital emergency rooms was 
found to be significantly related to having ever dispensed emergency contraception where 
pharmacists that answered that Plan B should be offered to women who are raped in all 
hospital emergency rooms were more likely to have ever dispensed emergency 
contraception than pharmacists who did not think that it should be offered.  
Table 33. Bivariate Results of Dispensing EC and Attitudes 
 Ever Dispensed EC 
 % Yes Chi –
Square(df) 
Pattern of Finding 
(p value) 
Attitude Composite Variable n/a 37.56(14)* Significant 
(p=0.001) 
Should Plan B be Offered to Women who 
are Raped in Hospital Emergency Rooms? 
Yes 
No 
 
 
64.3% 
45.3% 
 
 
6.39(1)* 
 
 
Significant 
(p=0.011) 
*Indicates statistical significance at p<.05.    
 
To test the associations between subjective norms and dispensing practices, 
Kruskal-Wallis analysis of variance tests were computed for the ordinal level subjective 
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norm questions and Pearson chi-squares were computed for categorical level questions 
(Table 34).  Subjective norms or perceived social pressures around dispensing of 
emergency contraception are significantly related to having ever dispensed it.  In 
addition, whether there is an employee at their pharmacy who refuses to dispense 
emergency contraception and whether there is a policy in place at a pharmacists’ 
workplace if a refusal should occur are both significantly related to having ever dispensed 
emergency contraception.  Specifically, pharmacists were more likely to dispense the 
medication if there were no employees at their pharmacy who refuses to dispense 
emergency contraception.  In addition, more pharmacists were likely to have ever 
dispensed emergency contraception if there was a policy in place should a pharmacist 
refuse to dispense the medication. 
Table 34. Bivariate Results of Dispensing EC and Subjective Norms 
 Ever Dispensed EC 
 % Yes Chi –
Square(df) 
Pattern of Finding (p 
value) 
Subjective Norms Composite Variable n/a 40.23(10)* Significant 
(p<0.0001) 
Employee at Pharmacy who Refuses to 
Dispense EC 
Yes 
No 
 
 
60.0% 
77.1% 
 
 
3.96(3)* 
 
 
Significant (p=0.046) 
Policy at Workplace if Refusal Occurs 
Yes 
No 
 
88.8% 
67.7% 
 
11.85(3)* 
 
Significant (p=0.001) 
*Indicates statistical significance at p<.05.    
 
 To test associations between dispensing emergency contraception and perceived 
behavioral control (how difficult or easy it is to dispense emergency contraception), 
Kruskal-Wallis analysis of variance was computed (Table 35).  Perceived behavioral 
control was significantly related to ever dispensing emergency contraception.  However, 
when dispensing was separated out, perceived behavioral control was not found to be 
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related to dispensing by prescription but stayed significant for dispensing OTC.  It makes 
some intuitive sense that dispensing OTC would be related to perceived behavioral 
control as a pharmacist is more likely to have control dispensing OTC when there is no 
prescription or patient doctor relationship in the way of dispensing the medication. 
Table 35. Bivariate Results of Dispensing EC and Perceived Behavioral Control (PBC) 
 Chi –
Square(df) 
Pattern of Finding (p 
value) 
Perceived Behavioral Control (PBC) 23.54(11)* Significant (p=0.015) 
PBC By Prescription Only     18.34(11) Not Significant 
(p=0.074) 
PBC OTC Only 20.76(11)* Significant (p=0.036) 
*Indicates statistical significance at p<.05.   
 
To test associations between intention or likelihood to dispense and dispensing 
Plan B, Kruskal-Wallis analysis of variance was computed (Table 36).  Intention to 
dispense Plan B was found to be significantly related to ever dispensing Plan B by 
prescription or OTC.  Findings stayed significant when individual analysis was 
performed for dispensing just by prescription or only OTC.   
Table 36. Bivariate Results of Intention to Dispense and Dispensing EC  
 Chi –
Square(df) 
Pattern of Finding (p 
value) 
Ever Dispensed EC by Prescription or OTC 50.49(12)* Significant (p<0.001) 
*Indicates statistical significance at p<.05.   
 
 Multivariate Analysis.  Question 3: What is the relationship among emergency 
contraception knowledge, attitudes, subjective norms, perceived behavioral control, 
intention to dispense, and dispensing practices of Florida pharmacists registered with the 
Board of Pharmacy? 
Question 3a: Is emergency contraception knowledge predictive of dispensing 
practices of Florida pharmacists?  
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Question 3b: Are attitudes about emergency contraception predictive of 
emergency contraception dispensing practices of Florida pharmacists?  
Question 3c: Are subjective norms about emergency contraception (whether 
important people such as colleagues, supervisors, corporate headquarters, and 
peers think they should dispense emergency contraception) predictive of 
emergency contraception dispensing practices of Florida pharmacists? 
Question 3d: Is perceived behavioral control, the perceived ease or difficulty of 
dispensing emergency contraception, predictive of dispensing practices of Florida 
pharmacists? 
Question 3e: Is intention to dispense emergency contraception predictive of 
dispensing practices of Florida pharmacists? 
Question 3f: Are emergency contraception knowledge, attitudes, subjective 
norms, perceived behavioral control, and intention to dispense taken together, 
predictive of emergency contraception dispensing practices of Florida 
pharmacists? 
Six logistic regression models were computed to directly answer the above 
research questions to detect (1) if knowledge is predictive of dispensing practices, (2) if 
attitudes are predictive of dispensing practices, (3) if subjective norms are predictive of 
dispensing practices, (4) if perceived behavioral control is predictive of dispensing 
practices, (5) if intention to dispense is predictive of dispensing practices, and (6) if all 
variables taken together are predictive of dispensing practices.  The socio-demographic 
variables identified in Tables 33 and 36 to be statistically significant (p<0.05) (age, 
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marital status, years in practice, type of pharmacy where employed, job title, and current 
employment status) acted as control variables in each of the regression models. 
Knowledge and Dispensing Practices: It was hypothesized that pharmacists with 
high levels of knowledge about emergency contraception would be more likely to 
dispense it (Table 37).  To test this hypothesis, the dependent variable was regressed 
against the continuous variable knowledge (scale 0-10) while controlling for socio-
demographic variables.  Knowledge was found to be a significant predictor of having 
ever dispensed emergency contraception.  Specifically, for every one point increase in 
knowledge score, the odds of a pharmacist dispensing emergency contraception were 
increased by a factor of 1.7 (p< 0.001).  
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Table 37. Logistic Regression Analysis for Knowledge and Dispensing Practices while 
Controlling for Socio-demographic Variables 
 
B S.E. Wald df Sig. OR 
95.0% C.I.for OR
 Lower Upper 
Knowledge .538 .102 27.760 1 p<0.001 1.713 1.402 2.093
Age, years   1.148 2 p<0.563    
< 36 (ref group)      
36-50  .095 .675 .020 1 p<0.888 1.100 .293 4.131
51-87  .827 .951 .756 1 p<0.385 2.287 .354 14.756
Marital status   7.404 3 p<0.060    
Married (ref group)      
Living with partner .632 1.069 .350 1 p<0.554 1.881 .232 15.281
Divorced/Separated/Widowed -.479 .618 .600 1 p<0.438 .620 .185 2.079
Never been married 1.689 .682 6.139 1 p<0.013 5.414 1.423 20.593
Years in Practice   .834 2 p<0.659    
<9 (ref group)      
9-22 .319 .647 .243 1 p<0.622 1.376 .387 4.890
23+ -.248 .897 .076 1 p<0.782 .780 .135 4.526
Type of Pharmacy Employed*   45.011 3 p<0.001    
Community—Chain (ref 
group) 
     
Community—Independent -1.743 .548 10.130 1 p<0.001 .175 .060 .512
Hospital -3.121 .542 33.129 1 p<0.001 .044 .015 .128
Other (e. g. Home Infusion) -3.597 .662 29.555 1 p<0.001 .027 .007 .100
Job Title   4.972 2 p<0.083    
Staff Pharmacist (ref group)      
Pharmacy Manager -1.092 .497 4.836 1 p<0.028 .335 .127 .888
Other (e. g. Clinical 
Pharmacist) -.144 .645 .050 1 p<0.823 .866 .244 3.067
Current Employment Status*   10.172 2 p<0.006    
Full-time (ref group)      
Part-time -1.750 .549 10.172 1 p<0.001 .174 .059 .509
Retired -20.807 16947 .000 1 p<0.999 .000 .000 .
*Indicates statistical significance at p<.05 for the whole group variable  
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The model was rerun limiting potential confounders to those with a p-value of 
0.05 and there was a slight decrease in the OR for each level of increased knowledge 
(Table 38).  Pharmacists who have never been married were more likely to dispense 
emergency contraception as compared to married individuals.  Pharmacists working at a 
community independent, hospital, or other pharmacy were not as likely to dispense 
emergency contraception as compared to pharmacists who work at a community chain 
pharmacy.  Pharmacy managers were not as likely to dispense emergency contraception 
as compared to staff pharmacists and part-time pharmacists were not as likely to dispense 
as compared to pharmacists who were employed full-time. 
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Table 38. Logistic Regression Analysis for Knowledge and Dispensing Practices while 
Controlling for Marital Status, Type of Pharmacy where Employed, Job Title, and Current 
Employment Status 
 
B S.E. Wald df Sig. OR 
95.0% C.I.for OR
 Lower Upper 
Knowledge .519 .096 29.302 1 p<0.001 1.680 1.392 2.027
Marital status   6.795 3 p<0.079    
Married (ref group)      
Living with partner .532 1.069 .248 1 p<0.619 1.702 .210 13.822
Divorced/Separated/Widowed -.375 .572 .430 1 p<0.512 .687 .224 2.108
Never been married 1.445 .613 5.556 1 p<0.018 4.242 1.276 14.107
Type of Pharmacy where 
Employed* 
  
44.690 3 p<0.001
   
Community—Chain (ref 
group) 
     
Community—Independent -1.62 .530 9.370 1 p<0.002 .197 .070 .558
Hospital -3.03 .522 33.817 1 p<0.001 .048 .017 .134
Other (e. g. Home Infusion, 
Mail Order) -3.24 .608 28.443 1 p<0.001 .039 .012 .129
Job Title*   10.630 2 p<0.005    
Staff Pharmacist (ref group)      
Pharmacy Manager -1.63 .502 10.630 1 p<0.001 .195 .073 .521
Other (e. g. Clinical 
Pharmacist) -20.6 17037.97 .000 1 p<0.999 .000 .000 .
Current Employment Status   4.508 2 p<0.105    
Full-time (ref group)      
Part-time -.997 .470 4.487 1 p<0.034 .369 .147 .928
Retired -.252 .616 .167 1 p<0.683 .777 .232 2.600
*Indicates statistical significance at p<.05 for the whole group variable 
 
Attitudes and Dispensing Practices: It was hypothesized that pharmacists with 
positive attitudes about emergency contraception would be more likely to dispense it.  To 
test this hypothesis, the dependent variable was regressed against the continuous variable 
attitudes (scale 7-21) and one categorical level question around attitudes while 
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controlling for the socio-demographic control variables (Table 39).  Pharmacist attitudes 
about emergency contraception were found to be a significant predictor of having ever 
dispensed emergency contraception.  Specifically, for every one point increase in attitude 
score, the odds of dispensing increased by 1.2 (p<0.001).  The categorical question that 
measured attitudes that queried about if Plan B should be offered to women who are 
raped in hospital emergency rooms was not statistically significant. 
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Table 39. Logistic Regression Analysis for Attitudes and Dispensing Practices while Controlling 
for Socio-demographic Variables 
 
B S.E. Wald df Sig. OR 
95.0% C.I.for OR
 Lower Upper 
Attitudes .209 .056 14.025 1 p<0.001 1.233 1.105 1.376
Age, years   .497 2 p<0.780    
< 36 (ref group)      
36-50  -.294 .621 .224 1 p<0.636 .745 .221 2.516
51-87  .085 .916 .009 1 p<0.926 1.089 .181 6.553
Marital status   5.353 3 p<0.148    
Married (ref group)      
Living with partner -.657 .944 .485 1 p<0.486 .518 .081 3.297
Divorced/Separated/Widowed -.256 .608 .177 1 p<0.674 .774 .235 2.551
Never been married 1.295 .619 4.370 1 p<0.037 3.651 1.084 12.291
Years in Practice   .339 2 p<0.844    
<9 (ref group)      
9-22 .180 .620 .084 1 p<0.772 1.197 .355 4.038
23+ -.192 .887 .047 1 p<0.829 .825 .145 4.700
Type of Pharmacy where 
Employed* 
  
57.842 3 p<0.001
   
Community—Chain (ref 
group) 
     
Community—Independent -1.539 .531 8.399 1 p<0.004 .215 .076 .608
Hospital -3.627 .545 44.253 1 p<0.0001 .027 .009 .077
Other (e. g. Home Infusion) -4.280 .678 39.821 1 p<0.001 .014 .004 .052
Job Title   5.080 2 p<0.079    
Staff Pharmacist (ref group)      
Pharmacy Manager* -1.096 .486 5.077 1 p<0.024 .334 .129 .867
Other (e. g. Clinical 
Pharmacist) -.340 .573 .352 1 p<0.553 .712 .231 2.189
Current Employment Status*   10.261 2 p<0.006    
Full-time (ref group)      
Part-time -1.767 .552 10.261 1 p<0.001 .171 .058 .504
Retired -21.03 15894.85 .000 1 p<0.999 .000 .000 .
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Should Plan B be Offered to 
Women who are Raped in 
Hospital Emergency Rooms? 
.278 .539 .265 1 p<0.607 1.320 .459 3.800
*Indicates statistical significance at p<.05 for the whole group variable 
 
The model was rerun limiting potential confounders to those with a p-value of 
0.05 and there was no change in the OR for attitudes (Table 40).  Much like the 
knowledge variables, pharmacists who have never been married were more likely to 
dispense emergency contraception as compared to married individuals.  Pharmacists 
working at a community independent, hospital, or other pharmacy were not as likely to 
dispense emergency contraception as compared to pharmacists who work at a community 
chain pharmacy.  Pharmacy managers were not as likely to dispense emergency 
contraception as compared to staff pharmacists and part-time pharmacists were not as 
likely to dispense as compared to pharmacists who were employed full-time. 
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Table 40. Logistic Regression Analysis for Attitudes and Dispensing Practices while Controlling 
for Marital Status, Type of Pharmacy where Employed, Job Title, and Current Employment 
Status 
 
B S.E. Wald df Sig. OR 
95.0% C.I.for OR
 Lower Upper 
Attitudes .208 .051 17.003 1 p<0.001 1.232 1.116 1.360
Marital status   5.981 3 p<0.113    
Married (ref group)      
Living with partner -.596 .932 .409 1 p<0.523 .551 .089 3.423
Divorced/Separated/Widowed -.299 .567 .277 1 p<0.599 .742 .244 2.254
Never been married 1.234 .564 4.783 1 p<0.029 3.435 1.137 10.381
Type of Pharmacy where 
Employed* 
  
59.698 3 p<0.001
   
Community—Chain (ref 
group) 
     
Community—Independent -1.43 .511 7.844 1 p<0.005 .239 .088 .651
Hospital -3.49 .514 46.279 1 p<0.001 .030 .011 .083
Other (e. g. Home Infusion, 
Mail Order) -3.92 .620 40.050 1 p<0.001 .020 .006 .067
Job Title   3.666 2 p<0.160    
Staff Pharmacist (ref group)      
Pharmacy Manager -.861 .452 3.621 1 p<0.057 .423 .174 1.026
Other (e. g. Clinical 
Pharmacist) -.369 .555 .442 1 p<0.506 .691 .233 2.053
Current Employment Status*   12.514 2 p<0.002    
Full-time (ref group)      
Part-time -1.75 .497 12.514 1 p<0.001 .172 .065 .456
Retired -21.0 16126.07 .000 1 p<0.999 .000 .000 .
*Indicates statistical significance at p<.05 for the whole group variable 
 
Subjective Norms and Dispensing Practices: It was hypothesized that pharmacists 
who have influential people in their life who think they should dispense emergency 
contraception would be more likely to dispense it.  To test this hypothesis, the dependent 
variable was regressed against the continuous variable subjective norms (scale 4-16) and 
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two categorical level questions around subjective norms while controlling for the socio-
demographic control variables (Table 41).  The variable subjective norms was found to 
be a significant predictor of having ever dispensed emergency contraception.  
Specifically, for every one point increase in subjective norms or important people 
thinking they should dispense emergency contraception, the odds of dispensing 
emergency contraception increased by 1.3 (p<0.018).  Neither of the two categorical 
questions measuring subjective norms was significant.  
Table 41. Logistic Regression Analysis for Subjective Norms and Dispensing Practices while 
Controlling for Socio-demographic Variables 
 
B S.E. Wald df Sig. OR 
95.0% C.I.for OR
 Lower Upper 
Subjective Norms Total Score .321 .136 5.580 1 p<0.018 1.379 1.056 1.801
Age, years   .936 2 p<0.626    
< 36 (ref group)      
36-50  -.472 .789 .358 1 p<0.549 .624 .133 2.926
51-87  .251 1.084 .053 1 p<0.817 1.285 .153 10.762
Marital status   4.870 3 p<0.182    
Married (ref group)      
Living with partner .776 1.309 .352 1 p<0.553 2.174 .167 28.280
Divorced/Separated/Widowed 1.733 1.121 2.387 1 p<0.122 5.655 .628 50.923
Never been married 1.715 .938 3.342 1 p<0.068 5.555 .884 34.924
Years in Practice   .751 2 p<0.687    
<9 (ref group)      
9-22 .442 .762 .337 1 p<0.561 1.556 .350 6.923
23+ -.233 1.042 .050 1 p<0.823 .792 .103 6.104
Type of Pharmacy where 
Employed* 
  
10.449 3 p<0.015
   
Community—Chain (ref 
group) 
     
Community—Independent -.997 .712 1.957 1 p<0.162 .369 .091 1.491
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Hospital -1.90 .758 6.329 1 p<0.012 .148 .034 .656
Other (e. g. Home Infusion, 
Mail Order) -2.81 1.061 7.020 1 p<0.008 .060 .008 .481
Job Title   2.721 2 p<0.257    
Staff Pharmacist (ref group)      
Pharmacy Manager -1.04 .648 2.575 1 p<0.109 .354 .099 1.259
Other (e. g. Clinical 
Pharmacist) -.705 .853 .684 1 p<0.408 .494 .093 2.628
Current Employment Status* 7.089 2 p<0.029  
Full-time (ref group)      
Part-time -1.56 .588 7.089 1 p<0.008 .209 .066 .662
Retired -21.0 28301.60 .000 1 p<0.999 .000 .000 .
Is there anyone in your 
pharmacy who refuses to 
dispense EC? 
-.217 .797 .074 1 p<0.785 .805 .169 3.839
Is there a policy in place at your 
pharmacy if someone refuses to 
dispense EC? 
-.907 .609 2.213 1 p<0.137 .404 .122 1.334
*Indicates statistical significance at p<.05 for the whole group variable 
 
The model was rerun limiting potential confounders to those with a p-value of 
0.05 and there was a very slight decrease in the OR for subjective norms (Table 42).  In 
addition, pharmacists working at a community independent, hospital, or other pharmacy 
were not as likely to dispense emergency contraception as compared to pharmacists who 
work at a community chain pharmacy.  Part-time pharmacists were not as likely to 
dispense as compared to pharmacists who were employed full-time. 
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Table 42. Logistic Regression Analysis for Subjective Norms and Dispensing Practices while 
Controlling for Type of Pharmacy where Employed and Current Employment Status 
 
B S.E. Wald df Sig. OR 
95.0% C.I.for OR
 Lower Upper 
Subjective Norms Total Score .287 .081 12.658 1 p<0.001 1.332 1.137 1.560
Type of Pharmacy where 
Employed* 
  
39.024 3 p<0.001
   
Community—Chain (ref 
group) 
     
Community—Independent -1.11 .559 3.971 1 p<0.046 .329 .110 .982
Hospital -2.66 .502 28.076 1 p<0.001 .070 .026 .187
Other (e. g. Home Infusion, 
Mail Order) -2.96 .603 24.120 1 p<0.001 .052 .016 .168
Current Employment Status*   9.438 2 p<0.009    
Full-time (ref group)      
Part-time -1.52 .495 9.438 1 p<0.002 .218 .083 .577
Retired -20.3 28378.23 .000 1 p<0.999 .000 .000 .
*Indicates statistical significance at p<.05 for the whole group variable 
 
Perceived Behavioral Control and Dispensing Practices: It was hypothesized that 
pharmacists that find that it is easy to dispense emergency contraception will be more 
likely to dispense it.  To test this hypothesis, the dependent variable was regressed against 
the continuous variable that measured perceived behavioral while controlling for the 
socio-demographic control variables (Table 43).  The variable perceived behavioral 
control was found to be a significant predictor of having ever dispensed emergency 
contraception.  Specifically, for every one point increase in perceived behavioral control 
or perceived ease in dispensing Plan B, the odds of dispensing it increased by 1.1 
(p<0.022).   
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Table 43. Logistic Regression Analysis for Perceived Behavioral Control (PBC) and Dispensing 
Practices while Controlling for Socio-demographic Variables 
 
B S.E. Wald df Sig. OR 
95.0% C.I.for OR
 Lower Upper 
PBC Total Score .160 .070 5.212 1 p<0.022 1.173 1.023 1.346
Age, years   .098 2 p<0.952    
< 36 (ref group)      
36-50  -.207 .685 .091 1 p<0.763 .813 .212 3.114
51-87  -.122 .907 .018 1 p<0.893 .885 .150 5.233
Marital status   3.343 3 p<0.342    
Married (ref group)      
Living with partner 1.128 1.275 .782 1 p<0.376 3.089 .254 37.626
Divorced/Separated/Widowed .062 .639 .010 1 p<0.922 1.064 .304 3.723
Never been married 1.066 .636 2.812 1 p<0.094 2.903 .835 10.091
Years in Practice   .344 2 p<0.842    
<9 (ref group)      
9-22 .382 .661 .334 1 p<0.563 1.466 .401 5.354
23+ .382 .875 .190 1 p<0.663 1.464 .263 8.140
Type of Pharmacy Employed*   37.170 3 p<0.001    
Community—Chain (ref 
group) 
     
Community—Independent -1.78 .547 10.677 1 p<0.001 .167 .057 .489
Hospital -2.87 .551 27.137 1 p<0.001 .057 .019 .167
Other (e. g. Home Infusion, 
Mail Order) -3.12 .649 23.223 1 p<0.001 .044 .012 .156
Job Title   5.548 2 p<0.062    
Staff Pharmacist (ref group)      
Pharmacy Manager -1.10 .490 5.105 1 p<0.024 .331 .127 .864
Other (e. g. Clinical 
Pharmacist) -.805 .585 1.892 1 p<0.169 .447 .142 1.408
Current Employment Status*   9.850 2 p<0.007    
Full-time (ref group)      
Part-time -1.78 .570 9.850 1 p<0.002 .167 .055 .511
Retired -21.3 23058.79 .000 1 p<0.999 .000 .000 .
*Indicates statistical significance at p<.05 for the whole group variable 
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Type of pharmacy where employed, job title, and current employment status were 
the only socio-demographic variables that were significant and therefore a logistic 
regression with only these variables were computed to find if there were any significant 
associations present (Table 44).  Pharmacists working at a community independent, 
hospital, or other pharmacy were not as likely to dispense emergency contraception as 
compared to pharmacists who work at a community chain pharmacy.  Pharmacy 
managers were not as likely to dispense emergency contraception as compared to staff 
pharmacists and part-time pharmacists were not as likely to dispense as compared to 
pharmacists who were employed full-time. 
Table 44. Logistic Regression Analysis for Perceived Behavioral Control (PBC) and Dispensing 
Practices while Controlling for Type of Pharmacy where Employed, Job Title, and Current 
Employment Status 
 
B S.E. Wald df Sig. OR 
95.0% C.I.for OR
 Lower Upper 
PBC Total Score .161 .066 6.017 1 p<0.014 1.175 1.033 1.337
Type of Pharmacy where 
Employed* 
  
37.918 3 p<0.001
   
Community—Chain (ref group)      
Community—Independent -1.70 .519 10.751 1 p<0.001 .182 .066 .504
Hospital -2.79 .524 28.428 1 p<0.001 .061 .022 .171
Other (e. g. Home Infusion) -2.81 .581 23.510 1 p<0.001 .060 .019 .187
Job Title*   6.653 2 p<0.036    
Staff Pharmacist (ref group)      
Pharmacy Manager -1.12 .466 5.774 1 p<0.016 .326 .131 .814
Other  -.982 .561 3.061 1 p<0.080 .374 .125 1.125
Current Employment Status*   12.125 2 p<0.002    
Full-time (ref group)      
Part-time -1.87 .537 12.125 1 p<0.001 .154 .054 .442
Retired -21.2 2268 .000 1 p<0.999 .000 .000 .
*Indicates statistical significance at p<.05 for the whole group variable  
 186
Intention to Dispense and Dispensing Practices: It was hypothesized that 
pharmacists that have a greater intention to dispense emergency contraception will in fact 
be more likely to dispense it.  To test this hypothesis, the dependent variable was 
regressed against each of the eight questions that measured intention to dispense (Table 
45).  For every one increment increase in intention to dispense or likelihood to dispense 
Plan B, the odds of dispensing increased by 1.2 (p<0.001).   
Table 45. Logistic Regression Analysis for Intention to Dispense Plan B and Dispensing 
Practices while Controlling for Socio-demographic Variables 
 
B S.E. Wald df Sig. OR 
95.0% C.I.for OR
 Lower Upper 
Intention to Dispense Plan B  .249 .053 22.333 1 p<0.001 1.283 1.157 1.423
Age, years   .472 2 p<0.790    
< 36 (ref group)      
36-50  -.248 .705 .124 1 p<0.725 .780 .196 3.108
51-87  .181 .978 .034 1 p<0.853 1.199 .176 8.146
Marital status   4.379 3 p<0.223    
Married (ref group)      
Living with partner -.248 1.028 .058 1 p<0.809 .780 .104 5.845
Divorced/Separated/Widowed -.708 .634 1.244 1 p<0.265 .493 .142 1.708
Never been married 1.037 .651 2.539 1 p<0.111 2.820 .788 10.095
Years in Practice   .111 2 p<0.946    
<9 (ref group)      
9-22 .117 .717 .027 1 p<0.870 1.124 .276 4.584
23+ -.105 .941 .012 1 p<0.911 .900 .143 5.690
Type of Pharmacy where 
Employed* 
  
43.056 3 p<0.001
   
Community—Chain (ref 
group) 
     
Community—Independent -1.09 .575 3.604 1 p<0.058 .335 .109 1.036
Hospital -3.28 .576 32.470 1 p<0.001 .037 .012 .116
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Other (e. g. Home Infusion, 
Mail Order) -3.53 .676 27.250 1 p<0.001 .029 .008 .110
Job Title   1.459 2 p<0.482    
Staff Pharmacist (ref group)      
Pharmacy Manager -.440 .508 .750 1 p<0.386 .644 .238 1.743
Other (e. g. Clinical 
Pharmacist) -.654 .626 1.092 1 p<0.296 .520 .153 1.772
Current Employment Status*   7.586 2 p<0.023    
Full-time (ref group)      
Part-time -1.58 .575 7.586 1 p<0.006 .205 .066 .633
Retired -20.6 18155.73 .000 1 p<0.999 .000 .000 .
*Indicates statistical significance at p<.05 for the whole group variable 
 
In the analysis between intention to dispense Plan B and ever dispensing, type of 
pharmacy where employed and current employment status were the only two socio-
demographic variables that were significant and therefore a logistic regression with only 
these variables was computed to find if there were any significant associations present 
(Table 46).  For intention to dispense Plan B, pharmacists working at a community 
independent, hospital, or other pharmacy were not as likely to dispense emergency 
contraception as compared to pharmacists who work at a community chain pharmacy.  In 
addition, part-time pharmacists were not as likely to dispense as compared to pharmacists 
who were employed full-time. 
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Table 46. Logistic Regression Analysis for Intention to Dispense Plan B and Dispensing 
Practices while Controlling for Type of Pharmacy where Employed and Current Employment 
Status 
 
B S.E. Wald df Sig. OR 
95.0% C.I.for OR
 Lower Upper 
Intention to Dispense Plan B  .251 .049 26.417 1 p<0.001 1.285 1.168 1.414
Type of Pharmacy where 
Employed* 
  
53.300 3 p<0.001
   
Community—Chain (ref group)      
Community—Independent -1.11 .533 4.347 1 p<0.037 .329 .116 .936
Hospital -3.17 .512 38.493 1 p<0.001 .042 .015 .114
Other (e. g. Home Infusion) -3.50 .590 35.254 1 p<0.001 .030 .009 .096
Current Employment Status*   7.563 2 p<0.023    
Full-time (ref group)      
Part-time -1.36 .494 7.563 1 p<0.006 .257 .097 .677
Retired -21.3 17382 .000 1 p<0.999 .000 .000 .
*Indicates statistical significance at p<.05 for the whole group variable 
 
Final Model 
All variables in model together and dispensing practices:  Even after controlling 
for all predictor and potentially confounding variables, knowledge, intention or likelihood 
to dispense Plan B, marital status, type of pharmacy where employed, and employment 
status still maintained a statistically significant relationship with ever dispensing Plan B  
(Table 47).  Specifically, for every one increment increase in knowledge score, the odds 
of dispensing increased by 1.7.  Likewise, for every one unit increase in intention to 
dispense or likelihood to dispense Plan B, the odds of dispensing increased by 1.1.  For 
marital status, pharmacists who have never been married were more likely to have ever 
dispensed Plan B as compared to marriage pharmacists.  Pharmacists working at a 
hospital or other type of pharmacy were less likely to have ever dispensed Plan B as 
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compared to pharmacists working at a community chain pharmacy and pharmacists 
working full-time were more likely to have ever dispensed Plan B as compared to 
pharmacists working part-time.  No statistical significance was found for attitudes, 
subjective norms, perceived behavioral control, intention to dispense by prescription, age, 
years in practice, or job title when all the variables were in the model together. 
Multicollinearity or the linear relationships between explanatory variables was 
determined through a tolerance computation (Table 47).  Since all tolerances for the 
predictor variables were high, there is no problem with multicollinearity in this study.  
This finding means that the relationship between the predictor variables and the 
dependent variable, ever-dispensed, are direct and therefore, strong linear dependencies 
are not seen among the independent variables.      
In order to better understand and offer a complete picture for the last research 
question and model, (Question 3f: Are emergency contraception knowledge, attitudes, 
subjective norms, perceived behavioral control, and intention to dispense taken together, 
predictive of emergency contraception dispensing practices of Florida pharmacists?), it 
was necessary to take a few components into consideration, 1) the logistic regression 
analysis with all variables in the model (Table 47), 2) a goodness of fit test, and 3) a 
likelihood ratio test.  Together, these elements can aid in understanding the relative fit of 
the final model.  The Hosmer and Lemeshow goodness of fit test demonstrated a non-
significant relationship between the predictor variables (Chi-square 5.91, p=0.658), 
which suggests that the variables are fitting the model.  In addition, the likelihood ratio 
test was significant (Chi-square 129.70, p<0.001, also signifying that the variables are 
fitting the model.  These three components suggest that overall the variables are fitting 
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the model and that all predictor variables taken together are associated with dispensing 
practices of Florida pharmacists.      
 Table 47. Logistic Regression Analysis for All Variables in Model      
  
Wald Sig. OR 
95.0% C.I.for OR  
 Main Research Variables Lower Upper Tolerance
Knowledge 13.89 p<0.001 1.745 1.302 2.338 .770 
Attitudes 0 p<0.993 0.999 0.837 1.193 .592 
Subjective Norms 0.911 p<0.340 1.16 0.855 1.574 .642 
Perceived Behavioral Control 0.155 p<0.694 1.039 0.858 1.259 .780 
Intention to Dispense Plan B 4.4 p<0.036 1.192 1.012 1.404 .554 
Confounders       
Age, years      .323 
< 36 (ref group) 0.983 p<0.612     
36-50 0.954 p<0.329 2.543 0.391 16.55  
51-87 0.637 p<0.425 2.958 0.206 42.393  
Marital status 5.181 p<0.159    .885 
Married (ref group)       
Living with partner 0.475 p<0.490 2.767 0.153 49.939  
Divorced/Separated/Widow 0.282 p<0.596 1.727 0.229 13.01  
Never been married 4.889 p<0.027 10.574 1.307 85.535  
Years in Practice 0.294 p<0.863    .318 
<9 (ref group)       
10-22 0.105 p<0.746 1.35 0.22 8.27  
23+ 0.018 p<0.892 0.845 0.075 9.581  
Type of Pharmacy where 
Employed* 12.803 p<0.005    .703 
Community—Chain (ref 
group)       
Community—Independent 0.997 p<0.318 0.456 0.098 2.129  
Hospital 9.313 p<0.002 0.075 0.014 0.395  
Other (e. g. Home Infusion) 7.602 p<0.006 0.068 0.01 0.46  
Job Title 2.128 p<0.345    .791 
Staff Pharmacist (ref group)       
Pharmacy Manager 1.113 p<0.291 0.491 0.131 1.84  
Other (e. g. Clinical 
Pharmacist) 1.588 p<0.208 0.31 0.05 1.914  
Current Employment Status* 6.187 p<0.045    .800 
Full-time (ref group)       
Part-time 6.187 p<0.013 0.17 0.042 0.686  
Retired 0 p<1.000 0 0 .  
*Indicates statistical significance at p<.05 for the whole group variable 
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Table 48. Summary Table of Main Findings 
Main Variables 
Crude 
OR 
OR for Single 
Predictor 
Model* 
OR with All Predictors in 
Model* 
Knowledge 1.57 
(1.38, 
1.78) 
1.68 (1.39, 
2.02) 
1.74 (1.30, 2.33) 
Attitudes 1.12 
(1.05, 
1.19) 
1.23 (1.11, 
1.36) 
0.99 (0.83, 1.19) 
Subjective Norms 1.42 
(1.24, 
1.63) 
1.33 (1.13, 
1.56) 
1.16 (0.85, 1.57) 
Perceived Behavioral Control 1.19 
(1.07, 
1.32) 
1.17 (1.03, 
1.33) 
1.03 (0.85, 1.25) 
Intention to Dispense 1.24 
(1.15, 
1.33) 
1.28 (1.16, 
1.41) 
1.19 (1.01, 1.40) 
*Model is adjusted for confounders 
 
Summary of Results 
 Table 48 provides a summary of the main findings in this study.  It includes the 
crude ORs for each main predictor variable, the ORs for the single predictor model while 
controlling for confounder variables, and the ORs for the final model with all predictors 
in the model while controlling for confounder variables. 
 In the end, knowledge about emergency contraception was the most important 
predictor of ever having dispensed emergency contraception.  After knowledge, intention 
to dispense was the second most important predictor of having ever dispensed the 
medication.  Although attitudes, subjective norms, and perceived behavioral control were 
statistically significant in each of their own single predictor models, they failed to reach 
statistical significance in the full model. 
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 The following confounder variables were consistently significant in every single 
predictor model and the full model: type of pharmacy where employed and current 
employment status.  For type of pharmacy, pharmacists working at a community 
independent, hospital, or other pharmacy were not as likely to dispense emergency 
contraception as compared to pharmacists who worked a at community chain pharmacy.  
For employment status, part-time pharmacists were not as likely to dispense as compared 
to pharmacists who were employed full-time.   
Although marital status was not significant for all models, it was significant for 
the single predictor models for knowledge and attitudes and was also significant in the 
final model where never married individuals were much more likely to dispense as 
compared to married individuals.  The last confounding variable, job title, was not 
significant in the full model but was significant for the single predictor models for 
knowledge, attitudes, and perceived behavioral control where pharmacy managers were 
not as likely to dispense emergency contraception as compared to staff pharmacists. 
Additional Analyses   
Table 49. Summary Table of Two Knowledge Items 
Main Variables Crude OR 
OR for Single 
Predictor Model* 
OR with All 
Predictors in 
Model* 
Plan B can cause birth 
defects if taken by a 
pregnant woman 
1.76 (1.06, 2.91) 2.25 (1.10, 4.61) 1.44 (0.66, 3.12) 
Plan B can act as an 
abortifacient 
3.83 (2.28, 6.44) 5.17 (2.47, 10.8) 4.64 (2.15, 10.0) 
*Model is adjusted for confounders 
 
 Because discussion in the focus groups centered around two key issues: side 
effects resulting from plan B and the potential for Plan B to induce and abortion, 
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independent associations were computed for the two knowledge questions addressing 
these issues: whether or not pharmacists thought that Plan B could cause birth defects if 
taken by a pregnant woman and whether or not they thought Plan B acted as an 
abortifacient.  Table 49 includes the crude ORs for each item, the ORs for the single 
predictor model while controlling for confounder variables, and the ORs for a model with 
both items in the model while controlling for confounder variables.   
Understanding that Plan B does not cause an abortion was the most important 
predictor of ever having dispensed it.  Although both items were statistically significant 
in each of their own single predictor models, thinking Plan B causes birth defects failed 
to reach statistical significance in the full model.  Since the OR is so high for pharmacists 
who thought that Plan B can cause an abortion, this item may be causing much of the 
association between knowledge and dispensing practices which has implications for 
future research and intervention efforts. 
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Chapter Five: Discussion and Conclusions 
 
Section I: Synthesis of Research Findings 
 
 Chapter five has been partitioned into three distinct sections.  Section I provides a 
synthesis of research findings for each of the three major research questions and methods, 
key findings and conclusions for the study as a whole, and study limitations and 
strengths.  Section II discusses the holistic perspective that this study captures and 
Section III provides broader conclusions and implications for public health as well as 
future direction for research, policy, and practice. 
Research Question 1: Pharmacy School Curriculum Review 
Question 1: What do the 91 accredited schools of pharmacy in the U.S. teach about 
emergency contraception? 
Question 1a: What objectives, course assignments, course readings, and lectures 
concerning emergency contraception are provided in the required courses at the 
91 accredited schools of pharmacy in the U.S.? 
Question 1b: What objectives, course assignments, course readings, and lectures 
concerning emergency contraception are provided in the elective courses at the 91 
accredited schools of pharmacy in the U.S.? 
 The findings from the pharmacy school curriculum review were as expected in 
that the majority of accredited schools of pharmacy in the U.S. reported that they do offer 
required courses that provide content on emergency contraception.  A much smaller 
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percentage reported offering elective courses that provide this content.  All (100%) 
respondents reported that pharmacy schools in the U.S. should include content material 
on emergency contraception, however not all respondents reported doing so in their own 
schools.   
Participants in the curricula review reported that the majority of courses that 
provide content on emergency contraception are taught in pharmacotherapy and 
therapeutics courses.  This finding was substantiated by data collected from the focus 
group discussions.  Understanding which courses teach emergency contraception content 
to pharmacy students is important in terms of future educational and intervention efforts.  
Although the curriculum review survey asked respondents to attach syllabi that 
included content on emergency contraception, many did not.  Only 10 syllabi (or 14% of 
the sample) were retrieved across seven schools who reported that they provide course 
content on emergency contraception in their classes.  Even among the limited retrieved 
syllabi, only four of the ten syllabi overtly mentioned emergency contraception in any of 
the content areas.   
In sum, important findings from the pharmacy school curriculum review included 
the following: 1) that accredited schools of pharmacy in the U.S. report teaching about 
emergency contraception in their pharmacy school classes, 2) that this content is taught 
primarily in required pharmacotherapy and therapeutics courses, and 3) not enough 
participants included syllabi in the review and the information that was detected from the 
limited course syllabi was not helpful. 
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Research Question 2: Pharmacy Student Focus Groups 
Question 2: How is emergency contraception course content taught at accredited schools 
of pharmacy, as perceived by fourth year pharmacy students at the four accredited 
schools of pharmacy in Florida?    
Question 2a: What did pharmacy students learn about emergency contraception in 
their pharmacy school classes? 
Question 2b: How was emergency contraception taught in their pharmacy school 
classes? 
Question 2c: What are the projected emergency contraception dispensing 
practices of pharmacy students? 
 The pharmacy student focus groups uncovered rich information on the knowledge 
pharmacy students reported learning about emergency contraception from their pharmacy 
school classes, the teaching instruction from these classes, and the projected future 
dispensing practices of pharmacy students.   
 Each focus group included an initial paper and pencil survey and a focus group 
discussion.  The paper and pencil survey revealed that although 90.5% of students 
responded that they did learn about emergency contraception in their pharm D classes, 
still over half (52.3%) of participants were either not sure or believed that pharmacists 
were not well enough informed to confidently dispense emergency contraception and 
nearly 20% answered either that they would not or that they were not sure about their 
future dispensing of the medication.  In addition, most students reported that there was 
more information they wished they had received about emergency contraception.  These 
findings alone demonstrate that what is taught in pharmacy school classes is perceived as 
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insufficient in providing pharmacists with the tools to confidently dispense emergency 
contraception.   
The focus group discussions revealed an important discrepancy or disconnect 
between what students reported on their paper and pencil survey and what they reported 
in the focus group discussions.  Although the majority of students reported that they did 
learn about emergency contraception in their pharmacy school classes on the paper and 
pencil survey, the focus group discussions revealed the exact opposite; that for the most 
part, students did not learn about emergency contraception in their pharmacy school 
classes.  In the focus group discussions, students reported that they received information 
on emergency contraception from outside sources such as work, print media, internet, 
news, and friends.  This discrepancy between what the students reported on the paper and 
pencil survey and what was reported in the focus group discussions is noteworthy.  This 
finding may be related to social-desirability bias and will be discussed in detail later in 
this section. 
 Another important finding from the focus group discussions is that specific 
knowledge was not reported by the majority of the students.  Knowledge from pharmacy 
school classes was disparate and only students in one of the focus groups seemed to 
understand the three mechanisms of action of emergency contraception. 
 In terms of teaching instruction in pharmacy school classes, most students 
responded that the professor attitude was neutral.  A neutral attitude seems like the 
desirable answer yet most likely unachievable.  Although professors are supposed to 
maintain a neutral attitude in class, students may be aware of their professor’s views on a 
given topic, especially a topic as controversial as emergency contraception.   
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Questions around dispensing practices of pharmacists by far yielded the most 
discussion and many unexpected themes emerged from these discussions.  In terms of 
emergency contraception dispensing, participants held major biases and judgments 
depending on the situation of the person purchasing the contraception.  Participants were 
hesitant to dispense due to many issues including: hesitancy due to 1) mechanism of 
action, 2) repeat use, 3) age requirement, 4) the situation of a particular woman, 5) side 
effects, and 6) believing it is wrong.  These biases could have a direct impact on access to 
this form of contraception.   
 The focus group discussions revealed two other important and surprising findings: 
1) that refusals to dispense this medication are common and 2) that pharmacists feel a 
duty to educate about this medication even though it is not a pharmacist-counseled 
product.  In the literature review, refusals to dispense seemed isolated; however within 
only four focus groups, unsolicited stories of refusals were present in each discussion.  
This finding is alarming and indicates that uncovering the true prevalence of refusals is 
critical.  In addition, students reported a strong desire to educate and counsel consumers 
about emergency contraception even though there is no legal need to do so.  Future 
research could focus on whether or not consumers want counseling/education from 
pharmacists if it is not warranted.  Also, perhaps there could be an important role for 
pharmacists in providing accurate information to consumers who request it.   
 In sum, the focus group discussions with pharmacy students were revealing: First, 
much of what pharmacy students learn about emergency contraception does not come 
from their pharmacy school classes but comes from outside sources.  Second, what is 
taught in pharmacy school classes about emergency contraception is brief and over half 
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of the sample felt that pharmacists are not well enough informed to confidently dispense 
emergency contraception.  Third, student knowledge about emergency contraception was 
not specific.  Fourth, many students entered the focus group with a preconceived notion 
about people who use emergency contraception and would hesitate to dispense the 
medication.  Fifth, many participants held biases or judgments towards emergency 
contraception users which may limit access.  Sixth, participants feel a need to counsel 
consumers about a medication that is not a pharmacy-counseled product.  And last, 
refusing to dispense emergency contraception is real and has the potential to limit access 
to women in need. 
Research Question 3: State-Wide Pharmacist Survey 
 
Question 3: What is the relationship among emergency contraception knowledge, 
attitudes, subjective norms, perceived behavioral control, intention to dispense, and 
dispensing practices of Florida pharmacists registered with the Board of Pharmacy? 
Question 3a: Is emergency contraception knowledge predictive of dispensing 
practices of Florida pharmacists?  
Question 3b: Are attitudes about emergency contraception predictive of 
emergency contraception dispensing practices of Florida pharmacists?  
Question 3c: Are subjective norms about emergency contraception (whether 
important people such as colleagues, supervisors, corporate headquarters, and 
peers think they should dispense emergency contraception) predictive of 
emergency contraception dispensing practices of Florida pharmacists? 
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Question 3d: Is perceived behavioral control, the perceived ease or difficulty of 
dispensing emergency contraception, predictive of dispensing practices of Florida 
pharmacists? 
Question 3e: Is intention to dispense emergency contraception predictive of 
dispensing practices of Florida pharmacists? 
Question 3f: Are emergency contraception knowledge, attitudes, subjective 
norms, perceived behavioral control, and intention to dispense taken together, 
predictive of emergency contraception dispensing practices of Florida 
pharmacists? 
  Of all the independent variables, knowledge about Plan B had the strongest 
relationship to dispensing Plan B.  Specifically, for every one point increase in 
knowledge score, the odds of a pharmacist dispensing Plan B were increased by a factor 
of 1.69 (p<0.001).  Pharmacists had low levels of knowledge about understanding Plan 
B’s true mechanism of action, limited awareness of who can sell Plan B to consumers and 
how to sell OTC to women in advance of need, and the relationship between Plan B and 
birth defects.  These areas of low knowledge are of concern and should be addressed.   
Pharmacist attitudes about Plan B were found to be a significant predictor of 
having ever dispensed it.  Specifically, for every one point increase in more positive 
attitudes about Plan B, the odds of dispensing increased by 1.23 (p<0.001).  Although the 
sample had a slight skew towards more favorable attitudes about the medication, many 
pharmacists felt uncomfortable dispensing to different groups of people.  For example, a 
third of the sample felt uncomfortable dispensing to adult women, 58.5% felt 
uncomfortable dispensing to men, and 61.4% felt uncomfortable dispensing to 
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adolescents.  The variation in comfort dispensing Plan B based on the person requesting 
the medication found in the state-wide survey is similar to the hesitancy in dispensing the 
medication based on person found in the focus group discussions.   
The variables subjective norms and perceived behavioral control were found to be 
significant predictors of having ever dispensed Plan B (1.33, p<0.001 and 1.17 p<0.014 
respectively).  Interestingly, pharmacists were less likely to dispense Plan B when there is 
an employee at their pharmacy who refuses to dispense it.  Additionally, pharmacists 
were more likely to have ever dispensed Plan B if the pharmacy in which they work had a 
policy in place regarding what to do if a refusal should occur.  These two findings 
together demonstrate that both policy and pharmacy culture are associated with 
dispensing practices and potentially access to care.  Understanding this has major 
implications for the development of intervention strategies.   
Intention or likelihood to dispense Plan B varied by the consumer requesting the 
medication.  For every one increment increase in intention to dispense or likelihood to 
dispense Plan B, the odds of dispensing increased by 1.28 (p<0.001).  In general, a 
greater percentage of pharmacists reported being likely to dispense to women who have 
experienced incest or rape, followed by women who have experienced a problem with 
their birth control method, followed by women who request the method after having 
unprotected sexual intercourse, followed by dispensing (by prescription) to sexually 
active teens under age 18, and last to a person other than the ultimate consumer of the 
product such as parents or a boyfriend.  In fact, almost half of pharmacists reported that 
they were unlikely to dispense to a person other than the ultimate consumer of the 
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product such as parents or a boyfriend.  This finding is problematic in that any person 
over 18 can purchase Plan B OTC.   
Overall, the state-wide pharmacist survey was conclusive in finding that 
knowledge, attitudes, subjective norms, perceived behavioral control, and intention to 
dispense are all predictive of dispensing Plan B among Florida pharmacists.  Although 
each single predictor model tells a story, when all variables were in the model together, 
knowledge about emergency contraception was the most important predictor of ever 
having dispensed it.  After knowledge, intention to dispense was the second most 
important predictor of having ever dispensed the medication.  Although attitudes, 
subjective norms, and perceived behavioral control were statistically significant in each 
of their own single predictor models, they failed to reach statistical significance in the full 
model.   
Key Findings/Conclusions for Entire Study 
 
When viewing the study in totality, there are five main findings that should be 
highlighted.  The first main finding from the study as a whole is that there is a disconnect 
between what pharmacy schools say they are teaching and what pharmacy students report 
learning in their pharmacy school classes.  However, the true dynamic of this discrepancy 
is not known.  For instance, are pharmacy schools teaching the content and the students 
are not retaining the information or are pharmacy schools not effectively teaching the 
information to students?   
The second major finding that was found in both the focus groups and the 
pharmacist survey is that soon-to-be pharmacists and already practicing pharmacists 
report to be more or less likely to dispense Plan B based on the situation of the person 
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requesting the medication.  This finding demonstrates that pharmacists are potentially 
allowing personal values or judgments to guide their practice through making dispensing 
decisions based on the consumer purchasing it.  These reported biases and the hesitancies 
in dispensing are troubling. 
The third important finding that was also mentioned above is that pharmacist 
knowledge, attitudes, subjective norms, perceived behavioral control, and intention to 
dispense all are predictive of having ever dispensed Plan B.  Specifically, high levels of 
knowledge, positive attitudes, an increased perception of important people thinking they 
should dispense, perceived ease of dispensing, as well as an increased likelihood to 
dispense all increase the odds that a pharmacist has ever dispensed Plan B.  However, 
high levels of knowledge had the greatest odds of ever dispensing Plan B.  It is of 
concern that pharmacists had limited knowledge in some critical areas such as how to 
dispense Plan B OTC and comprehension of its true mechanism of action. 
Viewing these three findings simultaneously, that low knowledge and decreased 
intention to dispense (due to the situation of the consumer) of pharmacists equates to less 
dispensing, that pharmacy students perception is that they are not learning about the 
medication in their pharmacy school classes, and that there are major biases and 
hesitancy about dispensing to varying groups of people, provides evidence of a major 
problem that has the potential to limit access of emergency contraception to the women 
who need it. 
A fourth key finding that should be discussed is social desirability response bias.  
This type of bias is typically seen when surveys employ threatening or sensitive questions 
which can lead respondents to change their responses to appear socially or politically 
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correct or more agreeable (Van de Mortel, 2008).  Social desirability response may be 
occurring in all three components of this research.  For example, in the focus group 
discussions students responded that they did receive information on emergency 
contraception in their pharmacy school classes on the initial paper and pencil survey but 
then the focus group discussions revealed that didn’t learn about emergency 
contraception from their coursework, but more from outside sources.  It is possible that 
the paper and pencil survey question, did you take any classes in your Pharm D program 
which taught you about EC?, led students to the pick the socially desirable answer but 
when they started discussing it as a group, it became clear that they either did not receive 
this information or that if they did, it was brief and not comprehensive.  Even though the 
curricula review survey and state-wide pharmacist surveys were completely anonymous, 
it is possible that the same bias was occurring in these surveys.  For example, perhaps a 
greater proportion of Deans responded that they include content on emergency 
contraception due to the social desirability of the answer thereby inflating the response.   
The last key finding concerns not the data but the study design, specifically, the 
importance of the mixed methods study design.  In this case, the mixed methods study 
design strengthened this study in that it allowed for the most complete analysis of this 
issue.  The quantitative elements captured important statistics and the qualitative findings 
enriched the data by giving voice to the numbers.  The study would not have been as 
powerful without the focus group qualitative data.  That is, the finding that pharmacy 
students are not truly acquiring information on emergency contraception in their 
pharmacy school classes would not have come to light.  This study demonstrates the need 
for mixed methods study design in order to fully understand the complexity of any issue. 
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Study Limitations 
 Results from the study should be interpreted with caution due to several 
limitations, the first of which is response rate.  The state-wide pharmacist survey had a 
low response rate (22%) even after employing the Dillman Tailored Design Method and 
reviewing response rates from other studies that surveyed pharmacists.  No data are 
available for non-responders and therefore no calculations can be performed to detect 
non-responder bias.  Perhaps incentives provided for completing the survey may have 
increased the response rate, however the study was not funded and therefore incentives 
were not possible.   
Although there was no problem with the response rate for the pharmacy school 
curricula review, the lack of syllabi received is a limitation.  Only 10 syllabi (14%) were 
received from seven schools who reported that they provide course content on emergency 
contraception in their courses.  This limited number of syllabi made it difficult to make 
generalizations about specific emergency contraception course content taught in U.S. 
pharmacy schools.  In addition, the syllabi that were received did not have detailed 
information on how the emergency contraception course content was presented in class.  
This finding was unexpected and in order to fully understand how emergency 
contraception course content is taught in pharmacy schools, class observations as well as 
interviews with professors may be needed.   
A second limitation in this study is generalizablilty.   Specifically, the state-wide 
pharmacist survey does not procure a national sample and therefore results cannot be 
generalized to all pharmacists in the U.S.  Likewise, the pharmacy student focus groups 
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cannot be generalized to all pharmacy students in the U.S.  In addition, findings from this 
research study cannot be generalized to non-English speaking individuals. 
A third limitation only related to the focus group discussions is that cause and 
effect relationships or statistical relationships could not be calculated.  However, this 
limitation is true for qualitative research in general and was expected.  A fourth limitation 
is that this study was not able to directly link the curricula review to the schools where 
the focus groups were conducted.  Although this process would have not provided 
anonymity to the schools, it would have been stronger in demonstrating relationships 
between teaching and learning.   
A fifth limitation is the difficulty in identifying temporal sequence given the 
cross-sectional nature of this research.  For example, although there is a significant 
relationship between knowledge and emergency contraception dispensing, does 
knowledge lead to increased dispensing or does increasing dispensing lead to increased 
knowledge?  The same is true for the other significant relationships.   
A sixth limitation that was discussed previously is the potential for social-
desirability bias where participants may have adjusted their true answer to reflect what 
they thought was the more social desirable answer given the potentially sensitive subject 
matter.   
A last limitation that parallels social-desirability bias is that data collected in this 
study was self-reported which means that it may be prone to some inaccuracy due to 
inaccurate recall or discomfort in disclosing personal information.  For example, the 
information received from the pharmacy students is based solely on self-reporting, 
meaning that what pharmacy students report learning about in their classes may not be 
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reflective of actual classroom instruction.  However, the focus groups provided an 
accurate picture of what pharmacy students remember learning about emergency 
contraception and how they remember being taught this information.   
Study Strengths 
 This study had many strengths and the first of which is its mixed methods study 
design.  Employing mixed methods deeply enriched this study and the findings.  The big 
picture or complete perspective could not have been obtained without the focus group 
discussions as the qualitative data is the link to understanding that there is a disconnect 
between what pharmacy schools say they are teaching and what pharmacy students report 
learning.  Overall this study was well designed, informed by theory and literature and 
produced significant results that can be used to inform research, policy, and practice.   
A second strength of this study comes from the study design.  For one, the 
randomization of the state-wide pharmacist study was a strength.  Random selection of 
pharmacists allows for generalization to all Florida pharmacists which provides a piece to 
the puzzle in terms of understand dispensing practices on a national and geographical 
level.  In addition, the curriculum review study acted as a census of all accredited schools 
of pharmacy in the nation which is useful in that not many studies are able to survey the 
whole population in their sample.   
A third strength is the unique universal perspective this study provides.  Each 
piece of this research study alone is significant, but together it offers a holistic 
perspective.  This study provides a three-pronged holistic view of pharmacy teaching, 
education, and practice.  It is through this perspective that the whole picture can be 
captured, providing opportunities for intervention on multiple levels.  It should be noted 
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that emergency contraception is just one of the many drugs that should be addressed in 
pharmacy education and training interventions.  It is understood that this is one of the 
many competing demands on pharmacy school curricula and practice.    
A final strength of this study its substantial contribution to the literature on 
pharmacist education, practice, and policy as it is the first known study of its kind.  No 
other study has been so comprehensive in its comprehension of pharmacist education and 
practice.  Although Van Riper and Hellerstedt’s (2005) South Dakota study assessed 
pharmacists’ attitudes, knowledge, and dispensing practices of emergency contraception, 
they failed to determine whether pharmacist knowledge and attitudes about emergency 
contraception predict dispensing practices.  The proposed study not only tested these 
relationships but found statistical significance which has major implications for policy, 
education, and practice.   
Section II: Discussion of Universal Perspective 
 
 This research offers a unique perspective of three different but related datasets.  
Taken together, findings demonstrate that teaching may be associated with student 
learning, which in turn may be associated with dispensing practices of pharmacists which 
inevitably may be associated with access to care.  Figure 7 provides a model which can 
act as a metaphor to describe this process.  The model depicts a game of pool.  In this 
model, each pool ball represents a key element that is associated with the other eventually 
leading to ‘the pocket’ or in this case, leading to health access or lack of health access 
depending on how each cue ball is handled.  However this depiction is telling, in that if 
all of these elements are not in place, the health access ball may never make the pocket, 
thereby limiting health access to those who need it.  Of course there are other balls that 
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could be added to this model (e. g. health insurance, poverty etc.); however this study and 
this model demonstrates how these particular elements are associated with each other to 
potentially impact health access.  It is important to note that intervention strategies can be 
applied to any of the pool balls in order to address health access, not just to the teaching 
ball.  Although a multi-pronged approach addressing the pharmacy school curricula, 
student learning, and pharmacist practice is ideal, an intervention at any point would be 
beneficial.  
This research followed the natural progression of pharmacists from education to 
subsequent practice.  It examined the emergency contraception curricula and course 
content intended to teach future pharmacists, surveyed pharmacy students to understand 
how this course content translates into learned knowledge and projected dispensing 
behavior, and then lastly it surveyed practicing pharmacists to understand their 
emergency contraception knowledge, attitudes, and actual dispensing practices.  In total, 
this research study employs a mixed methods design to offer a complete picture of 
pharmacists and emergency contraception from education to practice.  
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Figure 7. Pharmacist and EC Access Model 
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Section III: Broader Implications for Public Health and Future Direction 
 
Broader Implications for Public Health 
 
 Although this study is concerned with one health access issue and one group of 
health service providers, it has broader implications for public health as a whole as well 
as other areas and health service professionals.  That is, education and training may be 
associated with clinical practice for any health profession, for nurses, doctors, social 
workers and the list goes on.  The importance of effective teaching, translating to 
efficient learning and informed practice and policy is important.  As demonstrated in this 
study, the best intention of pharmacy school teaching does not lead to best practice.  
Practicing professionals should be trained to meet the needs of the public.      
Access to health care should not be mitigated by personal beliefs and lack of 
knowledge.  Personal perspective and beliefs should not drive clinical practice, science 
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should drive clinical practice.  Specifically concerning is the lack of awareness around 
how to dispense Plan B OTC where 77.6% of pharmacists did not understand how to 
dispense Plan B OTC to women and 55.5% did not know who at the pharmacy could sell 
Plan B to consumers.  Also concerning was the lack of knowledge about Plan B in 
general where 55.9% did not understand the correct mechanism of action, 55.9% 
incorrectly reported that Plan B can cause birth defects and just over 46% reported that 
Plan B can cause an abortion.   
 Another broad implication of this research concerns the idea of bias and issues of 
self-report data.  There are varying levels of bias to be aware of when researching a 
controversial topic such as this one.  This study uncovered three potentially varying 
levels of bias, 1) professor bias, 2) student bias, and 3) pharmacist bias.  The professor 
bias can present itself in a few ways.  For one, the professor may report that they teach 
certain content but they really do not cover it.  Secondly, a professor may teach content 
but insert their biases in the content such that the true content is not taught correctly.  
Student bias may occur when a student may incorrectly report that she/he did not receive 
the information in class.  Alternately, a student may come to class with a pre-set view or 
bias about the medication that is different from the teachers’ view.  Pharmacist bias may 
be such that a pharmacist may have a bias towards a medication that no amount of 
training will change.  In addition, a pharmacist may skim important material just enough 
to answer the questions in his/her continuing education courses so that they never gain 
new knowledge.  These types of bias are not only present for this particular issue and this 
particular health profession but may be present with other health fields and topics as well.  
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Also, limited knowledge about other drugs may be associated with health across many 
varying professions. 
 Future Direction.  Results from this study have implications for future research, 
policy, and practice.  Figure 6 can be used as a model to guide this discussion around the 
overall conceptual model and potential areas for intervention. 
 Research.  There is a need to better understand what is being taught to pharmacy 
students in terms of emergency contraception course content.  The curriculum review 
survey did not fully capture what is being taught to students due to the low number of 
syllabi provided by pharmacy schools.  However, even after reviewing the limited 
number of syllabi that were collected, pertinent information on course content could not 
be obtained.  Therefore, more information could potentially be gathered through 
interviewing professors to determine what content is presented in class and perhaps 
observing some pharmacotherapy courses where the content is said to be taught to better 
understand the dissemination of this content.   
• In addition, because the majority of respondents from the curriculum survey 
reported that they are teaching about emergency contraception, schools should 
review their course outline to ensure that what they think is being taught within 
their courses is actually being taught.  Schools could look to see if there is a 
disparity between formal objectives and what is being taught in class. 
• It would also be helpful to track the number of actual refusals that are taking place 
at our local pharmacies or develop a ‘turn-it-in’ hotline or webpage where 
consumers can report refusals that occur.  This way, the magnitude of this 
problem could be captured. 
 213
• One main element missing in this study is the voice of the consumer.  How do 
consumers feel about pharmacists and Plan B dispensing?  Do consumers want to 
be counseled?  Do consumers feel that pharmacists should assume their perceived 
role of the counselor/educator?  Does fear of pharmacist bias and stigma impact 
consumer Plan B seeking behaviors?  It would be interesting to either conduct a 
consumer study or even link results from a consumer study with the results from 
this study to make appropriate inferences.  A study aimed at understanding the 
role of pharmacists from both the practitioner and consumer perspective may 
provide additional insights. 
• It would also be interesting to review the stories of refusal from the pharmacy 
student focus groups and layer these stories with the pharmacist professional code 
of ethics.  This may demonstrate how policy is translated (or not translated) into 
practice. 
• Another potential research avenue would be to compare knowledge, attitudes, and 
dispensing practices of Plan B with another OTC medication that does not have 
the same moral implications to see if there are any differences or similarities. 
 Policy.  There are also implications for pharmacy policy.  This study uncovered 
some important information regarding the way that pharmacy culture and policy are 
associated with practice.  Pharmacists that worked at a pharmacy with an existing 
policy regarding refusals of emergency contraception were more likely to have ever 
dispensed the medication and a pharmacist who worked at a pharmacy where a 
colleague refuses to dispense the medication was less likely to have ever dispensed 
Plan B.  Since policy is associated with practice, a next step would be to contact the 
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American Pharmacists Association (AphA), the American Medical Association 
(AMA), and the American College of Obstetricians and Gynecologists (ACOG) and 
work together to ensure that all pharmacies create policies regarding dispensing Plan 
B and that there is protocol in place should pharmacists refuse to dispense a 
medication.   
 Practice.  There are also implications for better teaching.  For example, it would 
be helpful to bring together pharmacy school faculty and students to create a teaching 
module that will be most effective in teaching students about emergency 
contraception.  This module could then be tested and implemented in pharmacy 
school classrooms.  Employing students in the development of this module along with 
faculty may ensure effective teaching by the professor and efficient learning and 
retention of material by the student.  If it worked and was evaluated, this type of 
module development and curriculum enhancement could be used by a variety of 
controversial topics in science. 
• In terms of reaching already practicing pharmacists, better continuing education 
credit opportunities to learn about this material would be helpful, although there is 
already an informative and well-written one available through Postgraduate 
Healthcare Education, LLC which is accredited to provide continuing pharmacy 
education by the Accreditation Council for Pharmacy Education.  Ensuring that 
pharmacists are picking this particular CEU or a comparable one would be 
helpful.  Also, developing a training that can be provided to already practicing 
pharmacists would be useful.  This training could focus on the deficiencies in 
knowledge found in this study, increasing pharmacist comfort level in dispensing 
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to varying groups of people, along with a discussion of unfair and unjust bias 
placed on a consumer and how this bias might limit access to those in need.  
Requiring that pharmacists go through this training is essential.   
 Dissemination.  The findings from this study will be widely disseminated.  In 
terms of education, providing findings to the accredited schools of pharmacy in the 
U.S. will increase awareness about the disparity between teaching and student 
learning.  Pharmacy schools may use the results to enhance already existing curricula 
or develop new curricula for students.  These findings will also be disseminated to 
pertinent organizations such as national and state pharmacy associations and other 
like minded organizations in the field such as the American Medical Association.  
The findings can then be used to support and implement new policy that will increase 
access to this medication.  Lastly, this research and its effective use of the Theory of 
Planned Behavior can be added to the knowledge on the use of this theoretical 
framework. 
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Figure 8. Emergency Contraception Health Access Model 
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In sum, this study uncovered a disconnect between pharmacist education and 
practice.  It also uncovered important findings regarding pharmacist biases which are 
associated with dispensing and inevitably health access.  Research from this study 
suggested that knowledge, attitudes, social norms, perceived ease with dispensing, and 
dispensing intention are associated with dispensing and access to care.  Figure 8 
pictorially demonstrates that effective teaching may be associated with efficient learning, 
which creates informed practice, which may be associated to health access.  Preconceived 
bias or beliefs should also be considered in the model.  Additionally, there are potential 
areas for intervention at each stage.  This study was well designed, informed by theory 
and literature and produced important results that can be used to inform future research, 
policy, and practice. 
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Appendix A. 
Table 50: Oral contraceptives that can be used for emergency contraception in the 
United Statesa 
Brand Company Pills per Doseb 
Ethinyl 
Estradiol per 
Dose (µg)
Levonorgestrel 
per Dose 
(mg)c</B< TD>  
Progestin-only pills: Take 1 doseb
Plan B Barr/Duramed 2 white pills 0 0.75 
Ovrette Wyeth-Ayerst 40 yellow pills 0 0.75 
Combined progestin and estrogen pills: take 2 doses, 12 hours apart 
Alesse Wyeth-Ayerst 5 pink pills 100 0.50 
Aviane Barr/Duramed 5 orange pills 100 0.50 
Cryselle Barr/Duramed 4 white pills 120 0.60 
Enpresse Barr/Duramed 4 orange pills 120 0.50 
Lessina Barr/Duramed 5 pink pills 100 0.50 
Levlen Berlex 4 light-orange 
pills 
120 0.60 
Levlite Berlex 5 pink pills 100 0.50 
Levora Watson 4 white pills 120 0.60 
Lo/Ovral Wyeth-Ayerst 4 white pills 120 0.60 
Low-
Ogestrel 
Watson 4 white pills 120 0.60 
Lutera Watson 5 white pills 100 0.50 
Ogestrel Watson 2 white pills 100 0.50 
Ovral Wyeth-Ayerst 2 white pills 100 0.50 
Nordette Wyeth-Ayerst 4 light-orange 
pills 
120 0.60 
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Portia Barr/Duramed 4 pink pills 120 0.60 
Seasonale Barr/Duramed 4 pink pills 120 0.60 
Seasonique Barr/Duramed 4 light-blue-
green pills 
120 0.60 
Tri-Levlen Berlex 4 yellow pills 120 0.50 
Triphasil Wyeth-Ayerst 4 yellow pills 120 0.50 
Trivora Watson 4 pink pills 120 0.50 
*Source: Princeton University and The Association of Reproductive Health 
Professionals: Not2late.com, The Emergency Contraception Website. 
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Package Insert for Plan B and RU-486 
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Appendix C. 
Figure 9. History of Emergency Contraception 
Appendix D 
 
Table 51. Emergency contraception studies in a comparative context: Client knowledge & 
attitude studies 
Author Study Description Major Findings 
   
Abbott et 
al (2004) 
Survey (self-administered 
paper-based) of 158 
women at an inner-city ED 
in the US 
77% of women had heard of EC, although only half 
of those knew how to use it.  Of those who had heard 
of it, 26% were not aware of the correct timing, 24% 
were not aware that it was available in the U.S., and 
45% were not aware that a prescription was required 
for use.  51% of women reported that they would 
think about using EC if they needed it; however 17% 
reported moral or religious objections to its use  
Aiken et 
al (2005) 
Survey (interview) of 133 
women in 1996 and 139 
women in 2002 from a 
hospital-based clinic and 
drug treatment center in the 
US 
Between 1996 and 2002, the percentage of clients 
who had ever heard of EC grew from 44% in 1996 to 
73% in 2002 and comprehension of timing for use 
also increased from 20% in 1996 to 51% in 2002. 
Over half of  women thought that there may be a 
future need to use EC and of these, 95% reported 
that they would use it if needed  
Aziken et 
al (2003) 
Survey (self-administered 
paper-based) of 880 female 
students attending a 
University in Nigeria 
58% of students were familiar with EC but only 18% 
knew the 72 hour protocol for use and 49% believed 
that the pills needed to be taken within 24 hours of 
unprotected intercourse  
Babaee 
et al 
(2003) 
Survey (interview) of 250 
married women (ages 15-
48) in a health center in Iran 
8% of women knew about EC and 77% of women 
reported that they would be willing to use it in the 
future  
Chuang 
& Freund 
(2005) 
Survey (self-administered 
paper-based) of 188 
women (ages 18-44) in a 
Boston neighborhood in the 
US 
82% of women in a Boston community had heard of 
EC but only about half of those women knew how it 
worked  
Corbett et 
al (2005) 
Survey (25-item self-
administered paper-based 
questionnaire) of 97 college 
students between 18-21 
years old in the US 
Almost half of participants thought that EC was the 
same as RU-486 and of women who reported to be 
less likely to choose EC, 100% said that they would 
feel judged or embarrassed if they had to ask for it  
Harper & 
Ellertson 
(1995) 
Survey (telephone) of 550 
undergraduate and 
graduate students in the US 
52% of respondents did not know the difference 
between EC and RU-486.  Democrats and people 
who reported to be not religious had more favorable 
attitudes towards EC than Republicans or highly 
religious individuals.  As knowledge about EC went 
up, so did the positive attitudes about EC. 
Jackson 
et al 
(2000) 
Survey (self-administered 
paper-based) of 371 post-
partum women from an 
inner-city public hospital in 
the US 
36% of women had heard of EC and only 7% 
understood the appropriate timing for use. Two-thirds 
of these women reported a willingness to use EC in 
the future 
Larsson 
et al 
(2004) 
Survey (mail questionnaire) 
of 800 women attending a 
family planning clinic in 
Sweden 
98% of women were aware of EC but 38% 
were not aware its effectiveness when taken 
on the first day and 59% were not aware its 
effectiveness when taken on the third day.  
90% agreed that access to EC is positive 
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Mathew 
& 
Urquhart 
(2005) 
 
 
 
Survey (self-administered 
paper-based) of 78 women 
attending an abortion clinic 
in the UK 
 
 
 
78% of women were familiar with EC and 90% of  
women said they would consider using EC in the 
future  
Nguyen 
et al 
(2003) 
Survey (self-administered 
paper-based) of 365 
women who requested EC 
in Switzerland 
Knowledge of EC was satisfactory but 42% thought it 
had to be taken within 24 hours of unprotected 
intercourse and 13% thought that EC was 100% 
effective in preventing pregnancy 
Ottesen 
et al 
(2002) 
Nationally representative 
population-based study 
(n=4283) in Switzerland 
surveying (computerized 
questionnaire) 16- to 20- 
year-olds 
89% of sexually active girls and 75% of sexually 
active boys had heard of EC 
Romo et 
al (2004) 
Survey (self-administered 
paper-based) of 297 Latina 
women ages 18-43 from a 
clinic in the US 
17% of Spanish-speaking women and 41% of 
English-speaking Latina women had heard of EC 
and 25% believed that EC would end an existing 
pregnancy. Only half of the women who have heard 
of EC said that they would be willing to use it in the 
future and those who did not comprehend the action 
of EC were even less likely to say that they would 
use it in the future  
Tripathi 
et al 
(2003)    
Survey (self-administered 
paper-based questionnaire) 
of 500 patients seeking 
abortion services and 110 
college students in India 
none of the clients surveyed were familiar w/ EC 
EC, Emergency contraception; ED, Emergency department 
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Table 52. Emergency contraception studies in a comparative context: Provider knowledge, 
attitudes, & practice. 
Author Study Description Major Findings 
   
Beckman 
et al 
(2001) 
Survey (self-administered 
paper-based) of 102 providers 
(physicians, registered nurse 
practitioners, certified nurse 
midwives, & physician 
assistants) in the U.S. 
At baseline, one-third of the sample did not know 
the correct timing for EC & only 7% of providers 
reported prescribing EC once a month.  At follow-
up, knowledge about EC & prescribing frequency 
of EC significantly increased.  However, providers 
still had limited knowledge side effects and modes 
of action.  Attitudes about EC showed little 
change.   
Chuan et 
al (2004) 
Survey (mail survey) of 282 
providers (OB-GYN, family 
practitioners, & general 
internists) in the U.S. 
94% of Ob-gins, 76% of family practitioners, & 
63% of general internists ever prescribed EC. 
Being female was a positive predictor & being 
Catholic was a negative predictor for prescribing 
EC. 75% of the physicians reported infrequent 
prescribing of EC (less than five times a year), 
regardless of their specialty  
Delbanco 
et al 
(1998) 
Survey (telephone) of 754 
women's health professionals 
(Ob-gyn, family physicians, 
nurse practitioners, & 
physician assistants) 
Although the number of physicians that prescribed 
EC once in the last year increased, very few 
commonly prescribe EC, regardless of specialty.  
Gold et al 
(1997) 
Survey (interview) of 167 
physicians with expertise in 
adolescent health in the U.S. 
Attitude variables are predictors of failure to 
prescribe EC. 
Golden et 
al (2001) 
Survey (mail survey) of 233 
Pediatricians in the U.S.  
72.9% of respondents could not identify the FDA 
approved methods for EC and roughly 72% could 
not identify the correct timing for the drug.  68% of 
respondents felt uncomfortable prescribing EC, 
17% did not prescribe due to perceived 
teratogenic effects & 12% did not prescribe due to 
moral or religious reasons. 22% agreed that EC 
provision encourages adolescent risk taking 
behavior & 52.4% said they would place 
restrictions on how many times they would 
dispense the drug to a patient.  
Onwuhafu
a et al 
(2005) 
Survey (self-administered 
paper-based) of 232 
community health extension 
workers in Nigeria  
EC was not known about  
Sable et al 
(2006) 
Survey (paper-based) of 96 
faculty physicians from one 
Southern & three Midwestern 
Universities 
42% intended to prescribe EC for teens but 65-
77% intended for other specified groups.  High 
intention to prescribe was significantly associated 
with positive attitudes but knowledge was not. 
Sevil et al 
(2006) 
Survey (interviews & paper-
based questionnaire) of 72 
providers (general 
practitioners, nurses, & 
midwives) in Turkey 
Almost 1 in 10 providers were unfamiliar with the 
words ‘emergency contraception’  
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Sills et al 
(2000) 
 
 
 
Survey (mail survey) of 121 
Pediatricians in the U.S. 
 
 
 
All but 1 doctor had heard of EC but about half did 
not know the timing of EC or that it was FDA 
approved.  Knowledge, not attitudes, are 
significant predictors of EC prescribing. 
Tripathi et 
al (2003) 
Survey (self-administered 
paper-based) of 405 health 
care workers in India 
84% of gynecologists & 41% of general 
practitioners were vaguely familiar with EC though 
of those who had knowledge, most were unsure of 
how to prescribe it.  51% of gynecologists & 17% 
of practitioners reported ever prescribing it  
Uzuner et 
al (2005) 
Survey (interviews) of 180 
family planning providers in 
Turkey  
Only half of providers knew the correct timing and 
dose interval of EC.  39.4% of respondents 
believed that EC causes abortion, 31.1% thought 
that it was harmful for the fetus, 78.9% incorrectly 
thought that pill use may increase unprotected 
intercourse & that use will lead to men giving up 
on condom use (75%).   
Wallace et 
al (2004) 
Survey (self-administered 
paper-based) of 78 providers 
(family physicians and nurse 
providers)  
96% reported that they were knowledgeable on 
the indications & 78% reported that they 
understood the protocols for prescribing EC 
although knowledge inaccuracies were found 
between perceived and actual knowledge. 44% 
inaccurately thought that EC was an abortifacient.  
90% thought that EC was an appropriate topic of 
discussion at women’s exams and felt that the 
benefits of EC outweighed the risks.  59% of 
providers said they would restrict how many times 
they prescribed EC, 14% thought that EC use 
would discourage regular contraceptive use, 16% 
were uncomfortable prescribing EC for religious or 
ethical reasons, & 7% said that they would not 
prescribe it under any circumstances   
Webb et al 
(1993) 
National study of British health 
authorities  
The majority of physicians surveyed report that 
they prescribe EC a few times per week. 74% 
reported that they have prescribed EC in the past, 
with an average of 3.2 times in the past year 
   
EC, Emergency contraception; ED, Emergency department; FDA, Food and Drug Administration 
OB-GYN, Obstetricians/gynecologists  
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Table 53. Emergency contraception studies in a comparative context: Pharmacists' knowledge, 
attitudes, and dispensing practices. 
Author Study Description Major Findings 
   
Aneblo
m et al 
(2003) 
Survey (mail-based) of 
pharmacy staff 
(n=237) & nurse-
midwives (n=163) in 
Sweden 
Both study groups had positive attitudes towards EC and 
towards the OTC administration of EC; however nurse 
midwives demonstrated more favorable attitudes than the 
pharmacist group.  In addition, verbal information and 
counseling to clients on issues of EC was more commonly 
reported by the nurse-midwife group than by the pharmacist 
group and both groups reported that they wanted more 
collaboration between health care providers.    
Bennett 
et al 
(2003) 
Survey (employed 
mystery callers) of 315 
pharmacists in the 
U.S. 
Knowledge about & access to EC was limited. 30% of 
pharmacists did not provide the correct timing required for 
EC administration: 23% thought it needed to be taken within 
24 hours & 7% thought it needed to be taken within 48 hours.  
Also, 13% of the pharmacists said that EC would cause an 
abortion.  65% (n=201) of pharmacists reported that they 
would not be able to fill a prescription of EC that day.   
Borrego 
et al 
(2006) 
Survey (mail-based) of 
523 pharmacists in the 
U.S. 
Pharmacists from New Mexico had positive attitudes and 
beliefs about prescribing EC but their knowledge was 
average.  40% of the sample had an interest in becoming 
certified to prescribe EC in their state-approved prescribing 
training program.  Of those pharmacists would wanted to be 
certified, they were more likely to be male, non-Hispanic, 
non-Christian, to report liberal or moderate political views, 
and to say that they had employer approval, time, and 
privacy at their pharmacy to prescribe EC. 
Conard 
at al 
(2003) 
Survey (mail-based) of 
948 pharmacists in the 
U.S. 
48% of the pharmacists surveyed did not dispense EC.  
Pharmacists under 45 years of age were more likely to report 
dispensing EC; however no differences were found for sex. 
Of the 59% of pharmacists who have dispensed EC to 
adolescents, 83% said that they felt uncomfortable doing so.  
There were no differences in feelings of comfort based on 
age or sex. 
Draut 
(1999) 
Survey (telephone) of 
100 pharmacists in the 
U.S. 
Only 3 out of 100 pharmacists surveyed provided correct 
information about EC and 38 (38%) pharmacists did not 
know it was available in the U.S.  
Van 
Riper et 
al 
(2005) 
Survey (mail-based) of 
501 pharmacists in the 
U.S. 
Only 54% of pharmacists worked in pharmacies that carried 
EC.  Of those, 67% had dispensed EC in 2003 but 24% 
reported that they were not comfortable providing counseling 
about the medication. 37% were unaware that the 
medication is similar in its mechanism to oral contraceptives, 
74% either incorrectly agreed or were uncertain about 
whether EC causes birth defects when administered to 
pregnant women & 85% of respondents either incorrectly 
agreed or were uncertain about whether repeated use of EC 
poses health risks.  Only 5% of the sample correctly 
answered all five of the knowledge questions on the survey. 
EC, Emergency contraception  
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Appendix G. 
 
Pre-notice to Academic Deans* 
 
Date: 
To: JaneDoe@mail.edu 
From: Alice Richman arichman@hsc.usf.edu 
Subject: Academic Dean Survey 
 
 
Hello and greetings.  As part of my dissertation research, I am interested in learning 
about the teaching of emergency contraception in our pharmacy school classrooms.  I am 
committed to identifying which classes, if any, within pharmacy school curricula 
provides instruction on emergency contraception.  This information is being sought as we 
currently have little information on what classes cover this information or the extent of 
this instruction.  In order to reach these aims, I am asking you to help me gather this 
information. 
 
Within the next couple of days you will be receiving a brief three question survey from 
the University of South Florida from this same email address.  We would greatly 
appreciate if you could take a few moments to complete it.  By doing so you will help 
ensure that we have the best information possible.  Please be assured that your answers 
are confidential and only group data will be reported. 
 
If you have questions, feel free to contact Alice Richman or Ellen Daley at the University 
of South Florida at the contact information provided below. 
 
Thank you in advance for your cooperation. 
 
Sincerely, 
 
Alice R. Richman     Ellen Daley, Ph.D. 
USF College of Public Health   USF College of Public Health 
Phone: (813) 732-1903    Phone: (814) 974-8518 
Email: arichman@hsc.usf.edu   Email: edaley@hsc.usf.edu 
 
 
*The template for this letter was taken from Dillman (2000). 
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Appendix H. 
Academic Dean Informed Consent Form 
 
Researchers at the University of South Florida (USF) study many topics.  We want to 
learn about the instruction of emergency contraception in our pharmacy school 
classrooms.   
 
Title of research study:    The Role of Pharmacists and Emergency Contraception:  
An Assessment of Pharmacy School Curricula in the U.S. and the Knowledge, Attitudes, 
and Dispensing Practices of Florida Pharmacists. 
Person in charge of study:   Alice R. Richman 
Study staff who can act on behalf of the person in charge: Dr. Ellen Daley 
Where the study will be done:  In Florida 
 
The purpose of this study is to review pharmacy school curricula in the U.S. for course 
content related to emergency contraception. All Academic Deans from the 91 accredited 
school of pharmacy in the U.S. will be sent a three question web-based survey that will 
ask questions about their program curricula.  In addition, Academic Deans will be asked 
to provide course syllabi where applicable.   
 
During this study, you will be asked to complete a three question survey pertaining to the 
curricula and course content concerning emergency contraception at your institution.  
You may also be asked to provide electronic copies of course syllabi.  The survey should 
not take more than 10 minutes to complete.  If you decide not to take part in this study, 
that is okay.    
 
It will not cost you anything to take part in the study.  Although there will not be any 
immediate benefit to you, your participation in this study will be helpful in understanding 
pharmacy school curricula and course content related to emergency contraception and 
will advance the state of knowledge in this area.  Your participation is greatly 
appreciated. There are no known risks to those who take part in this study.   
 
We may publish what we find out from this study.  If we do, we will not use your name 
or anything else that would let people know who you are. 
 
If you have any questions about this study, call Alice Richman at (813) 732-1903 or Ellen 
Daley at (813) 974-8518.  If you have questions about your rights as a person who is 
taking part in a study, call USF Research Compliance at (813) 974-5638. 
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Academic Dean Cover Letter & Survey—Curricula Review 
Date: 
To: JaneDoe@mail.edu 
From: Alice Richman arichman@hsc.usf.edu 
Subject: Academic Dean Survey 
 
Below you will find the brief three question survey on how emergency 
contraception is being taught at pharmacy schools in the U.S. which Alice 
Richman notified you about via email a few days ago.  We found that there is 
limited information on the current instruction on emergency contraception at 
pharmacy schools, and thus we are asking for your help via this brief survey.  
Please take a few minutes to answer the following questions.  Your answers will 
be kept confidential and data will only be reported in aggregate form.   
 
Definition of Emergency Contraception: Emergency contraception is a type of hormonal 
contraception, containing high doses of estrogen and progestin or progestin only.  This 
medication is 75%-89% effective in preventing pregnancies when taken within 120 hours 
after sexual intercourse. 
 
1) Does your School of Pharmacy offer required courses that provide content on 
emergency contraception? Content can include lectures, course readings, course 
objectives etc..  
 
No  _____ 
Not sure _____ 
Yes _____  
If you answered Yes, please list the titles of courses and attach syllabi or link to 
syllabi:  
        __________________ 
        __________________ 
         
         
        __________________ 
 
2) Does your School of Pharmacy offer elective classes that provide content on 
emergency contraception? Content can include lectures, course readings, course 
objectives etc.. 
No  _____ 
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Not sure _____ 
Yes _____  
If you answered Yes, please list the titles of courses and attach syllabi or link to 
syllabi:  
        __________________ 
        __________________ 
        __________________ 
         
         
 
3) In your opinion, do you believe that School of Pharmacy curricula in the U.S. 
should include content material on emergency contraception (including 
pharmacology, legal and ethical issues, and the continual controversy that 
surrounds the medication)? 
 
Yes           Please explain         
                  
No            Please explain         
                  
 
Important: If you answered yes to either question 1 or 2, would you kindly attach an 
electronic copy of the course syllabi listed to this email and forward them to Alice 
Richman at arichman@hsc.usf.edu.  If you do not have an electronic copy of the 
syllabi of your courses, please tell me from where I may procure the syllabi (e.g., 
from a specific web site, URL). 
 
Thank you for your time and attention.  All identifying information will be kept 
confidential.  If you have questions about the study or would like a copy of the 
study’s findings, please contact Alice Richman at arichman@hsc.usf.edu or call (813) 
732-1903. 
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Thank you/Reminder Email to Academic Deans* 
 
Date: 
To: JaneDoe@mail.edu 
From: Alice Richmanarichman@hsc.usf.edu 
Subject: Academic Dean Survey 
 
About a week ago we sent you a survey via email.  We are asking Academic Deans of the 
schools of pharmacy in the U.S. about the curricula that addresses instruction on 
emergency contraception.  As of today, we have not received a completed survey from 
you.  I realize that we all have busy schedules, however we have contacted you and 
others now in hopes of obtaining the insights that only Academic Deans, like yourself, 
can provide.  As we mentioned before, answers are confidential and will be combined 
with others before disseminating the results.  In case the previous questionnaire has been 
deleted from your email account, we have included it again and hope you will respond. 
 
Should you have any questions or concerns, feel free to contact me (Alice Richman) or 
Ellen Daley at the contact information provided below.  Thank you for your cooperation. 
 
Alice R. Richman     Ellen Daley, Ph.D. 
USF College of Public Health   USF College of Public Health 
Phone: (813) 732-1903    Phone: (814) 974-8518 
Email: arichman@hsc.usf.edu   Email: edaley@hsc.usf.edu 
 
(Link to Survey Inserted Here) 
 
*The template for this letter was taken from Dillman (2000). 
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Are you a 3rd or 4th year Pharm D. student in 
Pharmacy School? 
 
Then we need YOU to be part of a focus group of 3rd & 
4th year Pharm D. students @ the University of Florida.  
 
Who is eligible? 
? 3rd or 4th year Pharm D. students. 
? English speaking individuals. 
 
What will I have to do? 
? Participate in a focus group discussion with 7 other students. 
? Discuss your perceptions of emergency contraception course instruction and 
projected dispensing practices. 
 
How much time will this take?   
? Participation will take approximately 1 hour.  
  
Do I get anything for my time? 
? Students will receive a $10 gift certificate to Starbucks. 
? Help add to the scientific body of knowledge. 
 
When will the group meet? 
? Wednesday, August 29th at 10am Room 115A. 
 
How can I sign up? 
E-mail Alice Richman at arichman@health.usf.edu  or call at (813) 732-1903. 
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Focus Group Informed Consent Form 
Informed Consent for an Adult 
Social and Behavioral Sciences  
University of South Florida 
 
Information for People Who Take Part in Research Studies 
 
Researchers at the University of South Florida (USF) study many topics.  We want to 
learn more about pharmacy students’ perception of emergency contraception course 
content taught at accredited schools of pharmacy. To do this, we need the help of people 
who agree to take part in a research study.  
Title of research study:   The Relationship among Emergency Contraception 
Knowledge, Attitudes, and Dispensing Practices of Florida Pharmacists and Pharmacy 
School Curricula in the U.S. 
Person in charge of study:   Alice R. Richman 
Study staff who can act on behalf of the person in charge: Dr. Ellen Daley 
Where the study will be done:  Focus groups will be held at all four accredited Schools 
of Pharmacy in Florida: Florida Agricultural and Mechanical University, Nova 
Southeastern University, Palm Beach Atlantic University, and University of Florida 
Should you take part in this study? 
This form tells you about this research study.  You can decide if you want to take part in 
it.  You do not have to take part.  Reading this form can help you decide. 
Before you decide: 
• Read this form. 
• Talk about this study with the person in charge of the study or the person explaining the 
study.  You can have someone with you when you talk about the study. 
• Find out what the study is about. 
You can ask questions: 
• You may have questions this form does not answer.  If you do, ask the person in charge 
of the study or study staff as you go along. 
• You don’t have to guess at things you don’t understand.  Ask the people doing the study 
to explain things in a way you can understand. 
After you read this form, you can: 
• Take your time to think about it.  
• Have a friend or family member read it. 
• Talk it over with someone you trust. 
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It’s up to you.  If you choose to be in the study, then you can sign the form.  If you do not 
want to take part in this study, do not sign the form.   
Why is this research being done? 
The purpose of this study is to find out what and how emergency contraception course 
content is taught at accredited schools of pharmacy as perceived by third or fourth year 
pharmacy students.  In reaching this aim, you are being asked to participate in an hour 
long focus group where you will be asked questions about the pharmacy school 
instruction and course content related to emergency contraception.  The focus group 
discussions will be tape recorded but no identifying information will be used or linked to 
the study results.    
Why are you being asked to take part? 
We are asking you to take part in this study because you are a third or fourth year Pharm. 
D. student enrolled at an accredited school of pharmacy.  We want to find out more about 
what type of emergency contraception instruction you were taught in your pharmacy 
school classes. 
How long will you be asked to stay in the study? 
You will be asked to spend about 1.5 hours in this study.  The focus group itself will run 
about one hour.  The other thirty minutes will be spent at the beginning of the focus 
group acquainting each other and explaining the process of the focus group discussion. 
How often will you need to come for study visits? 
A study visit is one you have with the person in charge of the study or study staff.  You 
will need to come for one study visit in all and that is today for the focus group 
discussion.   
• Questions will be asked pertaining to course instruction on emergency contraception in 
your pharmacy school classes such as any lectures, course assignments, and discussions 
that you may have had in class.  Questions will inquire about what you learned, what and 
how you were taught, and questions will also ask about your projected dispensing 
practices and perceptions of emergency contraception. 
What other choices do you have if you decide not to take part? 
If you decide not to take part in this study, that is okay.  There are no other choices, such 
as becoming involved in another focus group, that are offered by this study. 
How do you get started?  
If you decide to take part in this study, you will need to sign this consent form.  After 
consenting, you will be able to participate in the focus group. 
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What will happen during this study? 
During the study, you will be asked questions pertaining to your course instruction at 
your institution in a group setting. 
Here is what you will need to do during this study 
In order to take part in the study, all you have to do is participate in the group discussion 
that will last about an hour.   
Will you be paid for taking part in this study? 
We will pay you for the time you volunteer in this study in the form of a $10 gift card to 
Starbucks.  You will be given the gift card prior to your participation in the focus group. 
What will it cost you to take part in this study? 
It will not cost you anything to take part in the study.  
What are the potential benefits if you take part in this study? 
Although there will not be any immediate benefit to you, your participation in this study 
will be helpful in understanding pharmacy school curricula and course content related to 
emergency contraception and will advance the state of knowledge in this area.  Your 
participation is greatly appreciated.  
What are the risks if you take part in this study? 
There are no known risks to those who take part in this study.   
What will we do to keep your study records private? 
Federal law requires us to keep your study records private.  All identifying information 
will be kept confidential and will not be disseminated with the research findings.  Your 
name or school affiliation will not be used or linked to the study results.  However, 
certain people may need to see your study records.  By law, anyone who looks at your 
records must keep them confidential.  The only people who will be allowed to see these 
records are: 
• The study staff. 
• People who make sure that we are doing the study in the right way.  They also make sure 
that we protect your rights and safety: 
o The USF Institutional Review Board (IRB) 
o The United States Department of Health and Human Services (DHHS) 
We may publish what we find out from this study.  If we do, we will not use your name 
or anything else that would let people know who you are. 
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What happens if you decide not to take part in this study? 
You should only take part in this study if you want to take part.   
If you decide not to take part: 
• You won’t be in trouble or lose any rights you normally have. 
What if you join the study and then later decide you want to stop? 
If you decide you want to stop taking part in the study, tell the study staff as soon as you 
can. 
• We will tell you how to stop safely.  We will tell you if there are any dangers if you stop 
suddenly. 
Are there reasons we might take you out of the study later on? 
Even if you want to stay in the study, there may be reasons we will need to take you out 
of it.  You may be taken out of this study: 
• If we find out it is not safe for you to stay in the study.  For example, your health may get 
worse. 
• If you act in an inappropriate manner in the focus group discussions. 
You can get the answers to your questions. 
If you have any questions about this study, call Alice Richman at (813) 732-1903. 
If you have questions about your rights as a person who is taking part in a study, call USF 
Research Compliance at (813) 974-5638. 
Consent to Take Part in this Research Study 
It’s up to you.  You can decide if you want to take part in this study. 
I freely give my consent to take part in this study.  I understand that this is research.  I have 
received a copy of this consent form. 
 
________________________ ________________________ ___________ 
Signature Printed Name Date 
of Person taking part in study of Person taking part in study 
 
Statement of Person Obtaining Informed Consent 
I have carefully explained to the person taking part in the study what he or she can 
expect.  
The person who is giving consent to take part in this study 
• Understands the language that is used. 
Reads well enough to understand this form.  Or is able to hear and understand  
 254
Appendix L (Continued) 
• when the form is read to him or her. 
• Does not have any problems that could make it hard to understand what it means 
to take part in this study.  
• Is not taking drugs that make it hard to understand what is being explained.   
To the best of my knowledge, when this person signs this form, he or she understands: 
• What the study is about. 
• What needs to be done. 
• What the potential benefits might be.  
• What the known risks might be. 
• That taking part in the study is voluntary. 
 
________________________ _____________________________ __________ 
Signature of Investigator  Printed Name of Investigator  Date 
or authorized research 
investigator designated by 
the Principal Investigator 
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Final Pharmacist Pre-Notice Letter* 
Date 
Inside Address 
 
A few days from now you will receive in the mail a request to fill out a brief 
questionnaire for an important research project being conducted by the University of 
South Florida. 
 
It concerns the perceptions and experiences of pharmacists in relation to dispensing the 
medication emergency contraception. 
 
I am writing in advance because we have found many people like to know ahead of time 
that they will be contacted.  The study is an important one that will help add to the body 
of knowledge on pharmacists and dispensing practices.  The study is also anonymous as 
your name, pharmacy, or affiliations will be kept confidential and will not be linked to 
the study results.   
 
Thank you for your time and consideration.  It’s only with the generous help of people 
like you that our research can be successful. 
 
Sincerely, 
 
 
Alice R. Richman 
University of South Florida 
College of Public Health 
 
*The template for this letter was taken from Dillman (2000). 
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Final Pharmacist Informed Consent Form 
 
Researchers at the University of South Florida (USF) study many topics.  In this study, 
we want to learn more about pharmacists’ perceptions and experiences and how they may 
or may not impact emergency contraception dispensing practices.  
  
Title of research study:    The Role of Pharmacists and Emergency Contraception: An 
Assessment of Pharmacy School Curricula in the U.S. and the Knowledge, Attitudes, and 
Dispensing Practices of Florida Pharmacists. 
Person in charge of study:   Alice R. Richman, MPH, Ph.D. Candidate 
Study staff who can act on behalf of the person in charge:  Ellen Daley, Ph.D., MPH 
Where the study will be done:  In the State of Florida 
 
The purpose of this study is to understand pharmacists’ perceptions and experiences 
surrounding emergency contraception and to understand how these perceptions are 
related to dispensing practices.  This study involves sending a questionnaire to 
pharmacists registered with the Florida Board of Pharmacy.   
 
Questions on the survey inquire about issues of perceptions about emergency 
contraception and your dispensing practices of the medication.  Questions also request 
some demographic information; however any identifying information including your 
name or pharmacy will be kept confidential and all data will be de-identified meaning it 
will be rendered anonymous and will not be linked to the study results.  The survey 
should take you about 10 minutes to complete. 
 
You may decline to take part in this study.  You will neither be compensated nor have to 
pay anything to participate in this study.  Although your participation will not accrue any 
immediate benefit to you, your participation in this study will be helpful in understanding 
pharmacists’ perceptions and dispensing practices related to emergency contraception 
and will advance the state of knowledge in this area.  Your participation is greatly 
appreciated. There are no known risks to those who take part in this study.   
 
We may publish the results and findings from this study.  If we do, we will not use your 
name or anything else that would let people know who you are. 
 
Authorized research personnel, employees of the Department of Health and Human 
Services, and the USF Institutional Review Board and its staff, and any other individuals 
acting on behalf of USF, may inspect the records from this research project. 
 
If you have any questions about this study, call Alice R. Richman at (813) 732-1903 or 
Ellen Daley at (813) 974-8518. 
 
If you have questions about your rights as a person who is taking part in a study, call USF 
Office of Research Compliance at (813) 974-5638. 
 
Thank you so much for your time and participation. 
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Final Cover Letter to Pharmacists* 
Inside Address 
I am writing to ask your help in a study of pharmacists being conducted by researchers 
from the University of South Florida (USF).  This study aims to understand Florida 
pharmacists’ perceptions of emergency contraception and their dispensing practices. 
 
It’s my understanding that you are a pharmacist practicing in Florida.  We are contacting 
a random sample of pharmacists in Florida and are requesting that they help us by 
completing a brief questionnaire on their perceptions and dispensing practices concerning 
emergency contraception.   
 
Results from the survey will be used to understand pharmacists’ perceptions and 
dispensing practices related to emergency contraception and will advance the state of 
knowledge in this area.  Your participation is greatly appreciated.  
 
Your answers are completely anonymous and no identifying information about you will 
be collected.  This survey is voluntary.  However, you can help us very much by taking a 
few minutes to share your perceptions about emergency contraception with us.  
 
There is a paper survey attached in this packet for you to fill out and return in the 
enclosed and stamped envelope.   
 
If you have any questions or comments about this study, we would be happy to talk with 
you.  Feel free to call Alice R. Richman at (813) 732-1903 or contact via email at 
arichman@health.usf.edu. 
 
Thank you very much for helping with this important study. 
 
Sincerely, 
 
 
Alice R. Richman 
University of South Florida 
 
*The template for this letter was taken from Dillman (2000). 
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Final Pharmacist Survey 
 
Thank you for taking the time to complete this survey.  Your opinions and responses 
are important to us.  All responses will remain anonymous.  Please complete this 
survey and return it in the enclosed self-addressed and stamped envelope.   
 
In order to complete this survey, please circle the number that corresponds to the 
answer you choose or if there is no number listed, please write in your answer. 
 
First, I’d like to ask you some questions about your practice and workplace. 
 
1. How many years have you been a practicing registered pharmacist? 
____ year/years 
 
2. The type of pharmacy where you work could be best described as (if you have 
more than one job, please circle the number that corresponds to your primary type 
of pharmacy) 
____ 1 Community -- Chain   
____ 2 Community -- Independent  
____ 3 Hospital    
____ 4 Government (e.g., US Public Health Service, military) 
____ 5 Indian Health Service 
____ 6 Not currently working in a pharmacy 
____ 7 Other: Please specify _______________________ 
 
3. What is your job title?  
____ 1 Staff Pharmacist 
____ 2 Pharmacy Manager 
____ 3 Other: Please specify _______________________ 
 
4. What is your current employment status? 
____ 1 Full-time 
____ 2 Part-time 
____ 3 Retired 
 
5. Does your pharmacy stock any of the following products?    
Condoms ____1 Yes ____0 No   
Spermicide ____1 Yes ____0 No   
Oral contraceptive pills    ____1 Yes ____0 No  
 
6. Does your pharmacy stock Plan B? 
____ 1 Yes 
____ 0 No 
 
 259
Appendix P (Continued) 
7. Have you ever been asked to fill a prescription of Plan B? 
____ 1 Yes 
____ 0 No 
 
8. Have you personally ever filled a prescription of Plan B? 
____ 1 Yes 
____ 0 No (skip to question #10) 
 
9. Approximately how many Plan B prescriptions have you personally filled in the 
past 12 months? ____________ 
 
10. Have you ever been asked to sell Plan B over-the-counter? 
____ 1 Yes 
____ 0 No 
 
11. Have you personally ever sold Plan B over-the-counter? 
____ 1 Yes 
____ 0 No (skip to question #13) 
 
12. Approximately how many times have you sold Plan B over-the-counter in the past 
12 months? ____________ 
 
13. Would you ever have the opportunity at your workplace to come in contact (sell, 
dispense, fill a prescription) of Plan B? 
____ 1 Yes 
____ 0 No 
 
Next, I would like to ask you about your intention to dispense Plan B to each of the following 
groups.  Please check the box that corresponds to the answer you choose.  
 
To what extent are you likely to sell Plan B over-the-counter to… 
 Very 
Unlikely
Somewhat 
Unlikely 
Somewhat 
Likely 
Very 
Likely
N/A
14. Women who have experienced 
incest or rape.  
     
15. Women who have experienced a 
problem with their birth control 
method. 
     
16. Women who request the method 
after having unprotected sexual 
intercourse. 
     
17. A person other than the ultimate 
consumer of the product such as 
parents or a boyfriend. 
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To what extent are you likely to dispense Plan B by prescription to… 
 
 Very 
Unlikely
Somewhat 
Unlikely 
Somewhat 
Likely 
Very 
Likely
N/A
18. Women who have experienced 
incest or rape. 
     
19. Women who have experienced a 
problem with their birth control 
method. 
     
20. Women who request the method 
after having unprotected sexual 
intercourse. 
     
21. Sexually active teens under age 
18. 
     
 
Now I’d like to ask you some questions about what you generally know about Plan B.  
Please answer these questions to the best of your ability without looking up the answer. 
 
22. How many pills are in a Plan B package? 
____ 1 One 
____ 2 Two 
____ 3 Three 
____ 4 Four 
____ 5 Five 
____ 6 Six 
____ 7 Twelve 
____ 8 Not Sure 
 
23. According to the Plan B label, Plan B is effective if taken within how many hours 
of unprotected intercourse? 
____ 1 Up to 12 hours 
____ 2 Up to 24 hours 
____ 3 Up to 36 hours 
____ 4 Up to 72 hours 
____ 5 Not Sure 
 
24. Plan B prevents pregnancy via which of the following mechanisms? 
____ 1 Inhibition or delay in ovulation 
____ 2 Disruption of an implanted embryo 
____ 3 Changes in the endometrial lining of the uterus 
____ 4 All of the above 
____ 5 Not sure 
 
 261
Appendix P (Continued) 
 
25. According to the Plan B label, what percentage of the time does Plan B prevent 
pregnancy if used properly? 
____ 1 <25%  
____ 2 25%-49%  
____ 3 50%-74%  
____ 4 75%-89% 
____ 5 >89%  
 
26. Sales of Plan B to eligible consumers may be made by: 
____ 1 Pharmacists only 
____ 2 Pharmacists or pharmacy technicians only 
____ 3 Any member of the pharmacy staff working behind the pharmacy counter, 
as long as a pharmacist is on duty 
____ 4 Sales clerks, but only if a pharmacist is not on duty 
 
27. A woman asking to buy Plan B in advance of need: 
____ 1 Must wait for a contraceptive emergency before buying it 
____ 2 Should be advised to take a pregnancy test before taking it 
____ 3 May purchase more than one package 
____ 4 Can only make a purchase if she is using it for herself 
 
28. When selling Plan B without a prescription to a man, pharmacists: 
____ 1 Need to see proof that he is at least 18 years of age 
____ 2 Must limit sales to one package 
____ 3 Must ask for the name of the person who will be taking the product 
____ 4 Are violating the law 
 
Do you think the following statements are true or false? 
 
29. Plan B can cause birth defects if taken by a pregnant woman. 
____ 1 True 
____ 2 False 
____ 3 Not sure 
 
30. Plan B can act as an abortifacient. 
____ 1 True 
____ 2 False 
____ 3 Not sure 
 
31. The sooner a woman takes Plan B, the more effective it will be. 
____ 1 True 
____ 2 False 
____ 3 Not sure 
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The next few questions will ask you about how you personally feel about Plan B. Please check 
the box that corresponds to the answer you choose.  
 Completely 
Disagree 
Somewhat 
Disagree 
Neither 
Agree 
nor 
Disagree
Somewhat 
Agree 
Completely 
Agree 
32. Easy availability of 
Plan B will 
discourage regular 
contraceptive use. 
     
33. Easy availability of 
Plan B promotes 
promiscuity. 
     
34. I feel uncomfortable 
dispensing Plan B 
because of my 
religious/ethical 
beliefs. 
     
35. Repeated use of 
Plan B is wrong. 
     
36. I feel comfortable 
dispensing Plan B to 
adult women. 
     
37. I feel comfortable 
dispensing Plan B to 
adolescents (teens 
<18 years old). 
     
38. I feel comfortable 
dispensing Plan B to 
men. 
     
 
 
39. Should Plan B be offered to women who are raped in all hospital emergency 
rooms, regardless of hospital affiliation? 
____ 1 Yes 
____ 2 No 
____ 3 Not sure 
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The next questions will ask you about your perceptions of what other people think. 
 
The people and groups listed below may be influential in your dispensing decision-making.  
Please indicate (by checking the box) how you think the following consider Plan B dispensing 
practices, either by prescription or over-the-counter. 
 Definitely 
Should 
Not 
Probably 
Should 
Not 
Probably 
Should 
Definitely 
Should 
40. My partners/business colleagues 
think that I _________ dispense 
Plan B. 
    
41. The professional organization I am 
most active in recommends that 
I  dispense Plan B. 
    
42. My supervisor thinks that 
I  dispense Plan B. 
    
43. In general, my close friends and 
family think that I_________ 
dispense Plan B. 
    
 
 
44. Is there anyone in your pharmacy who refuses to dispense Plan B? 
____ 1 Yes 
____ 2 No 
____ 3 Not sure 
____ 4 My pharmacy does not carry Plan B 
 
45. Is there a policy in place at your pharmacy if someone refuses to dispense Plan B? 
____ 1 Yes 
____ 2 No 
____ 3 Not sure 
____ 4 My pharmacy does not carry Plan B 
 
Some pharmacists may feel that where they work affects their dispensing practices of Plan B.  
The following questions will ask you about your comfort level in dispensing Plan B. 
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How easy is it for you to… 
 Very 
Difficult
Somewhat 
Difficult 
Somewhat 
Easy 
Very 
Easy 
N/A 
46. Counsel clients about Plan 
B. 
     
47. Refuse to dispense Plan B.      
48. Educate clients about Plan 
B. 
     
49. Dispense Plan B. 
 
     
The last group of questions will ask some basic questions about you. 
 
50. What is your gender? 
____ 1 Female 
____ 2 Male 
 
51. How old are you? 
____________ 
 
52. What pharmacy school did you graduate from? 
________________________ 
 
53. What year did you graduate from pharmacy school? 
____________ 
 
54. How would you describe yourself (choose only one)? 
____ 1 Religious 
____ 2 Spiritual 
____ 3 Religious and Spiritual 
____ 4 Undecided 
____ 5 None of the above 
____ 6 Prefer not to respond 
 
55. Which religious group do you most closely identify with (choose only one)? 
____ 1 Roman Catholic 
____ 2 Baptist 
____ 3 Methodist 
____ 4 Episcopalian 
____ 5 Lutheran 
____ 6 Quaker 
____ 7 Presbyterian 
____ 8 Assembly of God 
____ 9 Hindu 
____ 10 Buddhist 
 265
Appendix P (Continued) 
 
____ 11 Jewish 
____ 12 Islamic 
____ 13 Mormon 
____ 14 Non-Denominational 
____ 15 None 
____ 16 Prefer not to respond 
____ 17 Other please specify (___________________) 
 
56. What is your race/ethnicity (choose all that apply)? 
____ 1 Caucasian 
____ 2 African American 
____ 3 Hispanic 
____ 4 Asian 
____ 5 Other please specify (___________________) 
 
57. What is your current marital status? 
____ 1 Married 
____ 2 Living with a partner 
____ 3 Divorced 
____ 4 Separated 
____ 5 Widowed 
____ 6 Never been married 
 
58. What is your political affiliation? 
____ 1 Republican 
____ 2Democratic 
____ 3 Independent 
____ 4 Green Party 
____ 5 None/Undecided 
____ 6 Other please specify (___________________) 
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Pharmacist Thank you/Reminder Postcard* 
Date 
 
Last week, a questionnaire seeking your perceptions about emergency contraception was 
mailed to you.  Your name was randomly drawn from a list of all pharmacists registered 
with the Florida Board of Pharmacy. 
 
If you have already completed and returned the questionnaire to us, please accept our 
sincere thanks.  If not, please do so today.  We are especially grateful for your help 
because it is only by asking people like you to share your thoughts and experiences that 
we can understand pharmacists’ perceptions and practices concerning emergency 
contraception in the state of Florida. 
 
If you did not receive a questionnaire, or if it was misplaced, please call Alice R. 
Richman (813) 732-1903 and we will get another one in the mail to you today.  Also, you 
are welcome to go online at www.ultimatesurveyor.com and complete the survey there. 
 
 
 
Alice R. Richman 
University of South Florida 
 
*The template for this letter was taken from Dillman (2000). 
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Panel of Experts Q&A 
 
Questions for Pharmacist Panel of Experts 
Combined Interview Responses  
1) Male (blue) , 2) Male (purple), 3) Female (green) 
 
Male works at a CVS in Boston, MA 
Male who works at Walgreens in Lakeland, Florida 
Female works at Kaiser and formally worked with Kroger (Kings Super) 
 
Date: May 26, 2006 
 
General Questions: 
 
1. Is there a National professional society or association that impacts/establishes 
policy re: pharmacist practices? 
 
#1: The American Pharmaceutical Association (APhA) has a big impact politically as 
they work at the national level but most pharmacies are regulated by their local state 
Board of Pharmacies.  In fact, pharmacies in general are regulated more by state law 
then from national policy.   
 
#2: There are national pharmacy organizations but pharmacist procedures come from 
the State Board.  Each state has its own Board of Pharmacy.  First there are federal 
laws created and then each state makes sure the laws are followed. 
 
#3 No, there isn’t one large association that impacts policy but there is APha.  Female 
thought that the employer can influence policy over anyone else (over both the state 
and the national authorities) 
 
Knowledge Questions: 
 
2. When you were in school, what courses taught you the pharmacology of basic 
pharmaceuticals?  What courses taught you about ethics and legality? 
 
#1: Male didn’t exactly remember which courses taught him basic pharmacology 
because he’s been practicing pharmacy since 1975 but he remembers biology, 
chemistry, and biochemistry as the courses that covered this material.  Also he thinks 
that now pharmacy students get this information from courses on biotheraputics and 
pharmacology.  Male remembers taking a pharmacy law class that taught him about 
pharmacy ethics and legality but now he thinks Pharmacy schools offer ethics classes. 
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#2: Pharmacotherapy covered the pharmacology of basic pharmaceuticals and he took 
2 semesters of pharmacy law that taught ethics and legality.  He also mentioned that 
information on ethics was worked in to case studies and group assignments from 
other classes.  He did not take an ethics course. 
 
Pharmacotherapy: teaches which drugs cure which disease 
Medical Chemistry: teaches how drugs work chemically 
Pharmacology: teaches how drugs work in body 
 
#3: Pharmacology taught her the basic pharmacology of pharmaceuticals and she’s 
had no formal ethics class though she thinks that in her pharmacy management class, 
they may have discussed ethics.  She did take pharmacy law that discussed dispensing 
issues.  She was in school 20 years ago so she thought it was a little difficult to 
remember. 
 
As I also plan to do a curriculum review of the accredited schools of pharmacy in  
the U.S., what courses should I be looking for that teach the pharmacology or  
mechanism of EC and what courses may teach the ethics or legality of dispensing  
or not dispensing a medication? 
 
#1: Male has been out of school for too long to answer this question. 
 
#2: The pharmacology or mechanism of EC was taught in pharmacotherapy and 
ethics or legality of dispensing was learned in law class (when it’s okay not to fill) but 
Male said that ethics were applied throughout curriculum and he did not have an 
ethics class.  
 
#3: She thinks that pharmacology is the course that will teach the mechanism of EC 
and pharmacy law may teach the ethics or legality of dispensing EC.  When she went 
to school, she was just taught about dispensing; now students learn a lot more. 
 
3. How do pharmacists acquire the required CEUs?  How many are needed per year? 
 
#1: Male is a pharmacist in Boston, Massachusetts, and he needs 15 per year. And 5 
of those 15 credits must be live and 2 must be about pharmacy law.  Most CEUs are 
good for 2 credits (2 hours) and he can do them on the internet by reading an article 
and answering questions or can attend conferences for example.  He receives mailings 
for different programs offering CEUs and he can find out about CEUs from Journals.  
He has noticed that there are a lot on EC dispensing, especially since Massachusetts is 
about to have Collaborative Drug Therapy Agreements (CDTA) where a pharmacist 
will be able to counsel and prescribe EC at a pharmacy in conjunction with a 
physician.  He mentioned one CEU course on EC dispensing training offered through 
Northeastern University: www.ace.neu.edu/rxce/index.php 
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#2: Regular pharmacists need 12 hours/year in Florida.  A consulting pharmacist, like 
a pharmacist who works in a nursing home checking charts of patients, needs 24 
hours/year.  5 credits must be live, 2 credits must involve AIDS or terminal illnesses, 
and 1 credit must involve medication errors.   
Pharmacists can find CEUs online, from the Hills County Pharmacy Association 
Office.  Also, national organizations have meetings twice per year and he can get all 
live credits for a 2 year period completed in one conference. 
(Random note: pharmacists call CEUs, CE’s.) 
 
#3: Pharmacists in Colorado need 12 CEUs per year and these contact hours can be 
procured however they want.  Colorado doesn’t differ between live and not live. 
She procures her CEUs from a Journal she prescribes to called Pharmacist Letter.  It 
comes out monthly and covers all sorts of issues and then she takes the quiz at the end 
and gets her CEU credits.  The remainder of her CEUs comes internally from Kaiser. 
 
Here is the information for CEUs for Florida Pharmacists as found on the Florida 
Board of Pharmacy Florida Department of Health website 
http://www.doh.state.fl.us/mqa/pharmacy/ph ceu.html 
Pharmacist: - 30 hours of CE per biennium (two year licensure period) ten 
(10) hours must be live, one (1) hour HIV/AIDS, and 2 hours Pharmaceutical 
Education on medication errors per biennium (maybe counted toward 
required CE hours). 
 
4. What are the typical journals that pharmacists read?  In your opinion, do they tend 
to read practice or professional journals?  Or is there even a distinction made?   
a. What kinds of issues are out there being circulated in the field, for 
example are there a lot of reproductive, contraception, or reproductive 
pharmaceutical related articles? 
 
#1: Typical Journals include Application of Clinical Pharmacy, Pharmacy Times, or 
American Druggists.  There is no real distinction made between practice or 
professional journals and there are not a lot of reproductive or contraception related 
articles out there.  He guesses that the amount of reproductive related articles is 
within the accepted percentage for the Journals.  He also noted that he doesn’t read a 
lot of Journals and if he does, it’s for CEU credits. 
 
#2: Male says that some pharmacists read the same main medical journals as we do 
such as New England Journal of Medicine, AGHP, and American Pharmacist 
Association.  He says that these Journals are more research based.  Then there are 
other Journals such as Pharmacy Today and Drug Topics that keep pharmacists up-to-
date on new drugs and medications.  He says that these Journals are sent to Walgreens 
for free. 
 
 
 270
Appendix R (Continued) 
 
In terms of reproductive related articles in Journals he said that whatever is typically 
in the news is also in the Journals.  He remembers seeing a lot of EC related articles 
when it almost went OTC in the general news.   
 
#3: Pharmacists typically read Pharmacy Times or the Journal put out by APha.  
Pharmacists read both practice and professional journals and she doesn’t think that 
there is a distinction made between the two. 
Female doesn’t think that there are a lot of reproductive pharmaceutical related 
articles out there and since we last spoke she’s kept her eye out for articles on EC and 
hasn’t noticed any. 
 
5. How do pharmacists get information on changes to contraception (for example the 
upcoming change of birth control pills)?  How do pharmacists find out about all 
new medications? 
 
#1: Surprisingly, no one ever really tells pharmacists about changes to medication.  
He will typically notice a change on a prescription a doctor writes and then if he 
doesn’t recognize the prescription or drug he will sometimes tries to self educate 
through looking medication up.  Some drug salespeople do come by the store but he 
doesn’t usually talk to them because they are just pushing their drug.  Sometimes, 
CVS will send a corporate letter saying what new drugs they will be carrying. 
 
#2: Both changes to medication and new medications are found out through the 
following avenues: 
i. Package inserts on the new drugs when they arrive at the store 
ii. Drug companies will send information to pharmacists 
iii. Magazines will talk about new magazines 
iv. CEUs may come out on the particular drug or topic 
 
#3: Pharmacists get information on changes to contraception from the following 
mechanisms: 
 
? Reading Journals 
? See new prescription that was written 
? See it through practice 
 
When she worked with Kroger, she found out about new medications through drug 
reps and Journals but now that she works for Kaiser it’s a closed formulary so no reps 
are allowed. 
 
Attitude Questions:  
 
6. Is there a National policy or code of ethics for pharmacist?  
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#1: He thinks that there is something like the Hippocratic Oath for pharmacists but 
doesn’t know for sure.  He recommends that we search for a code of ethics by state 
because everything is deferred to the state level. He also thinks that CVS has its own 
code of ethics and he’s going to search for it and send it to me if he can find it. 
 
#2: Yes, there is a code of ethics for pharmacists (he’s going to see if he can find it).  
It’s given to pharmacy students when they start the program and when they graduate. 
 
#3: Yes, they say it when students graduate from pharmacy school (she’s going to try 
and find it and get back to me). 
 
 
7. How would you say an individual’s moral or ethical beliefs would impact their 
professional practice as a pharmacist? 
 
#1: Male thinks that it’s dependent on where you live.  He noted that Boston is very 
open and liberal and he doesn’t think that professional opinion affects practice.  He 
talked about women getting repeat prescriptions of EC and how that bothered him a 
little bit but he never has changed his dispensing practices.  At the same time, he also 
said that there are some people who will not dispense birth control pills or EC.  
(These seem to be conflicting statements that on the one hand he says that he doesn’t 
think beliefs impact practice but then on the other hand he has heard of people who 
will not dispense BCPs). 
 
#2: Male thinks that BC and EC are the only times that moral or ethical beliefs would 
impact professional practice but he also mentioned that there is sometimes an issue 
with pain killers/relievers and cancer patients but not as much as with BC and EC. 
 
He has never known anyone who refused to fill prescriptions but he has heard of it a 
lot around Lakeland.  He knows of one Publix in Lakeland doesn’t stock EC because 
the pharmacist will not fill EC.  So, Publix then sends these customers to Walgreens 
to fill the prescription.  Because his store has 24 hour access, they have 3 pharmacists 
around and available so if one person will not fill it, someone else will. 
 
#3: Female thinks that an individual’s moral or ethical beliefs are impacting practice 
more than it use to, that is, you are more likely to see refusal to fill now then before.  
She said that it use to be that you got a prescription and you filled it.  Now a 
pharmacist has the option to refuse based on ethical, moral, or drug based 
(contraindications) reasons. 
 
Kaiser has no policy or record and no suggested policy but Kroger did have a policy that 
was not accessible to the public.  The policy was that if you refuse to fill a prescription, 
it’s your responsibility to find someone who would fill it, either within  
 272
Appendix R (Continued) 
 
your own pharmacy or some other nearby pharmacy.  So, for example, Walmart (who 
up until recently did not carry EC) would call Kroger with a client asking to fill EC.  
She herself has never known anyone to refuse but has heard about it.   
 
Dispensing Practice Questions: 
 
8. What are the general policies on dispensing at pharmacies?  Is the policy 
corporate or state-driven?  Is it accessible to the public? 
 
#1: There is no general policy on dispensing at CVS.  Dispensing hasn’t been a real 
issue or problem so there’s been no policy created BUT there has been a suggested 
method of handling a situation where a pharmacists is uncomfortable filling a 
prescription for religious or moral reasons.  CVS suggested that if you’re 
uncomfortable filling a prescription (for religious or moral reasons), you first see if 
someone else is available to fill it (For Male at his CVS, there’s only 1 pharmacist on 
duty at any given time so there wouldn’t be anyone to fill it).  Then, if there’s no one 
else to fill it, you give the client directions to another CVS store where they will fill 
it.  This is the suggested guideline by CVS as they sent a letter around, but no formal 
policy has been set yet. 
 
He also noted that policy is corporate driven and is not accessible to the public. 
 
This is very interesting to me, that they suggest women to go to another pharmacy.  
How would this policy be affective in rural areas? 
 
#2: There are no policies on dispensing at Walgreens though he feels that Walgreens 
would not be happy if you refuse to fill a prescription especially after hearing about 
how pharmacies were sued for it.  If the pharmacy doesn’t stock it, then they send 
women to another store that does. 
 
Male told me that he doesn’t agree with EC unless in cases of rape.  He thinks that his 
store gets about 1 or 2 prescriptions of EC per month. 
 
#3: There are no real policies created until there’s a problem.  No company policy at 
Kaiser but at Kroger there was one.  If there is a policy, it’s corporate and not 
accessible to the public. 
 
9. How do you think corporate policy affects personal behavior?   
 
#1: Male believes that corporate policy would be a VERY STRONG motivator that 
affects personal behavior and he noted that you can not buck the system very long 
until you will get thrown out.  
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#2: He thinks that fear of losing your job does have a large affect on personal 
behavior and he also thinks that if there were no consequences that more people 
would refuse to fill it. 
 
#3: She thinks that corporate policy does affect personal behavior by making 
pharmacists aware of the need to take care of the client regardless of personal beliefs. 
 
10. What is the recourse or ramifications if you refuse to fill a prescription for a 
client?  In your opinion, why would a pharmacist not want to fill a prescription? 
 
#1: If you refuse to fill a prescription, you need to find another person or pharmacy to 
fill it. 
 
If Males opinion, a pharmacist may not want to fill a prescription based on: 
• Religious Beliefs 
• Moral Beliefs 
• Political Beliefs 
 
#2: Male thinks that if you refuse to fill a prescription for a client that it would 
depend on the situation but he thinks that you may lose your job over it.  He heard 
that Eckerd fired someone for not filling a prescription. 
 
In his opinion, a pharmacist would not fill a prescription due to religious or moral 
reasons.  Also, if the patient is currently taking one drug and the prescription is for 
another drug that could harm the patient if these drugs were taken together, that is 
another reason for refusal (harm to the patient or contraindications).  An example of 
this is that he’s refused Viagra to someone before b/c the combination of his two 
medications is known to be lethal. 
 
#3: She thinks that refusing to fill prescriptions may be breaking state law and may 
result in a termination of your job but she doesn’t know. 
 
A pharmacist may not want to fill a prescription based on moral or pro-life beliefs. 
 
11. Are all OTC medications placed differently in a pharmacy?  Meaning, are all 
OTC medications placed in front the counter or are some placed behind the 
counter.  If some are placed in front and some behind, what distinguishes these 
differences?  
 
#1: The only OTC medications required to be behind the counter are tobacco and 
Sudafed.  However, some medications are placed behind the counter because they are 
worth a lot of money and people try to steal them.  For example, powdered baby 
formula and crest white strips are held behind the counter because of their high ticket  
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value and because they will walk right out the door if not held behind the counter.  
Male believes if EC ever went OTC that it would be held behind the counter as well. 
 
#2: In the past, all OTC medications were placed in front of the counter but now they 
have to keep Sudafed behind the counter. They also place home drug tests behind the 
counter because people were stealing them. 
 
#3: Sudafed is the OTC drug required to be behind the counter but sometimes high 
priced items such as nicoderm and diabetic supplies will be behind the counter.  She 
also thinks that if EC with OTC, that it would be held behind the counter b/c it would 
be in little packages that would be easy to steal. 
 
Final Questions:  
 
12. In the survey of pharmacists, we will need to ask questions about knowledge, 
attitudes, and dispensing practices of EC.  Can you help think of ways to ask these 
questions most effectively to pharmacists (have some examples ready to help 
prompt ideas including existing questions on these variables as well as factors 
such as age of recipient, repetition of filling prescription, and OTC status)? 
 
#1: Male said that he would be willing to edit some questions on the survey after we 
put it together and provide suggestions if the questions don’t seem to ask what we 
think they’re asking. 
 
#2: Male mentioned that he is willing to help with the survey development when we 
have some questions for him to look at.  He also mentioned, like Male, that if he saw 
a woman using EC repeatedly, he may choose to talk to her or to contact her doctor to 
have him/her talk to the patient.  He also noted that there may have been negative 
attitudes towards HIV/AIDS patients thinking that they were promiscuous or dirty 
because they had HIV/AIDS but he said that think negative thinking was cleared up. 
 
His email address is: buie933@hotmail.com 
 
#3: If there are what a pharmacist perceives to be too many refills, some pharmacists 
personally call the doctor to make sure that’s what they meant to write on the 
prescription. 
 
Also if a pharmacist notices that a woman is getting EC twice/month, she has called 
her doctor and spoken to the doctor before.  (I think Female was telling me that she 
herself has called a doctor before to question why a women has been using EC 
repeatedly—this finding was in the other interviews and is interesting) 
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13. Is it possible that I call you or email you a couple more questions in a few weeks 
if I need to? 
 
#1: Yes, Male is more than willing for me to call him with questions anytime. 
 
#2: Yes. 
 
#3: Yes.  She’s very interested in seeing the survey. 
 
14. Do you have any questions for me? 
 
#1: No. 
#2: No. 
#3: No. 
 
Other: 
 
#1: 
• He noted that pharmacy is very regulated by drug companies and corporations. 
• Noted that they don’t have access to the internet at work because they run a very 
tight system (Condour System) 
• There are 5,000 CVS stores 
• Additional website to check out: CVS.net (find CVS learn net) for good pharmacy 
information 
• 6 of the top 18 drugs filled are birth control pills 
• Most prescriptions for EC are filled on Monday and Tuesday (right after the 
weekend).  He fills around 5 on Monday and 2-3 on Tuesday. 
 
#2: 
• Male Graduated in 2001 but then chose to do a 1-year residency to become more 
specialized in community pharmacy.  He received his education from University 
of Florida (one of the 4 accredited Schools of Pharmacy in Florida). 
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Table 54. Description of Survey Variables 
 
Model Item (Question) Responses Level of 
Measurement 
I. 
Background 
Variables 
    
Gender What is your gender? Female/Male Nominal 
      
Age How old are you? List age  Ratio 
      
Ethnicity What is your 
race/ethnicity 
(choose all that 
apply)? 
 
____ 1 Caucasian 
____ 2 African American 
____ 3 Hispanic 
____ 4 Asian 
____ 5 Other please specify 
(___________________) 
Nominal 
      
Years in 
Practice 
How many years 
have you been a 
practicing registered 
pharmacist? 
list # of years Ratio 
      
Type of 
Pharmacy 
The type of 
pharmacy where you 
work could be best 
described as (if you 
have more than one 
job, please circle the 
number that 
corresponds to your 
primary type of 
pharmacy) 
 
 
____ 1 Community -- Chain 
  
____ 2 Community -- 
Independent  
____ 3 Hospital  
  
____ 4 Government (e.g., US 
Public Health Service, military) 
____ 5 Indian Health Service 
____ 6 Not currently working 
in a pharmacy 
____ 7 Other: Please specify 
 
Nominal 
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Marital 
Status 
What is your current 
marital status? 
 
____ 1 Married 
____ 2 Living with a partner 
____ 3 Divorced 
____ 4 Separated 
____ 5 Widowed 
____ 6 Never been married 
Nominal 
      
Religion Which religious 
group do you most 
closely identify with 
(choose only one)? 
 
____ 1 Roman Catholic 
____ 2 Baptist 
____ 3 Methodist 
____ 4 Episcopalian 
____ 5 Lutheran 
____ 6 Quaker 
____ 7 Presbyterian 
____ 8 Assembly of God 
____ 9 Hindu 
____ 10 Buddhist 
____ 11 Jewish 
____ 12 Islamic 
____ 13 Mormon 
____ 14 Non-
Denominational 
____ 15 None 
____ 16 Other please specify 
( ) 
Nominal 
    
 Religiosity How would you 
describe yourself 
(choose only one)? 
 
____ 1 Religious 
____ 2 Spiritual 
____ 3 Religious and Spiritual 
____ 4 Undecided 
____ 5 None of the above 
 6 Prefer not to respond 
 Nominal 
    
Political 
Affiliation 
What is your political 
affiliation? 
____ 1 Republican 
____ 2Democratic 
____ 3 Independent 
____ 4 Green Party 
____ 5 None/Undecided 
___   6 Other please specify 
( ) 
Nominal 
    
Employment 
Status 
What is your current 
employment status? 
____ 1 Full-time 
____ 2 Part-time 
____ 3 Retired 
Nominal 
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Pharmacy 
School 
Attended 
What pharmacy 
school did you 
graduate from? 
 
Open-ended Nominal 
    
Year of 
Graduation 
What year did you 
graduate from 
pharmacy school? 
List year Ratio 
    
Job Title What is your job 
title?  
 
____ 1 Staff Pharmacist 
____ 2 Pharmacy Manager 
____ 3 Other: Please specify 
_______________________ 
Nominal 
II. 
Dispensing 
Practices  
    
  Does your pharmacy 
stock any of the 
following products?   
 
Condoms   
Spermicide  
Oral contraceptive 
pills  
Yes/No Nominal 
      
  Does your pharmacy 
stock Plan B? 
Yes/No Nominal 
    
 Have you personally 
ever filled a 
prescription of Plan 
B? 
Yes/No Nominal 
      
  Have you ever been 
asked to fill a 
prescription of Plan 
B? 
Yes/No Nominal 
      
  Approximately how 
many Plan B 
prescriptions have 
you personally filled 
in the past 12 
Open-ended Ratio 
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months? 
    
 Have you ever been 
asked to sell Plan B 
over-the-counter? 
Yes/No Nominal 
    
 Have you personally 
ever sold Plan B 
over-the-counter? 
Yes/No Nominal 
    
  Approximately how 
many times have you 
sold Plan B over-the-
counter in the past 12 
months? 
 
Open-ended 
 
Ratio 
    
 Would you ever have 
the opportunity at 
your workplace to 
come in contact (sell, 
dispense, fill a 
prescription) of Plan 
B? 
Yes/No  Nominal 
III. 
Intention to 
Dispense 
Plan B 
   
 To what extent are 
you likely to sell Plan 
B over-the-counter 
to… 
 
4-point Likert 
Scale, with 1 = Very 
Unlikely, 2= 
Somewhat Unlikely, 
3= Somewhat 
Likely, 4= Very 
Likely, 5=N/A  
Women who have experienced 
incest or rape. 
Women who have experienced 
a problem with their birth 
control method. 
Women who request the 
method after having 
unprotected sexual intercourse. 
A person other than the 
ultimate consumer of the 
product such as parents or a 
boyfriend. 
Ordina/Interval 
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  To what extent are 
you likely to dispense 
Plan B by 
prescription to… 
 
4-point Likert 
Scale, with 1 = 
Very Unlikely, 2= 
Somewhat 
Unlikely, 3= 
Somewhat Likely, 
4= Very Likely, 
5=N/A 
 
Women who have experienced 
incest or rape. 
Women who have experienced 
a problem with their birth 
control method. 
Women who request the 
method after having 
unprotected sexual intercourse. 
Sexually active teens under age 
18. 
Ordinal/Interval
IV. 
Knowledge 
    
  How many pills are 
in a Plan B package? 
 
____ 1 One 
____ 2 Two 
____ 3 Three 
____ 4 Four 
____ 5 Five 
____ 6 Six 
____ 7 Twelve 
 8 Not Sure 
Nominal 
    
  According to the 
Plan B label, Plan B 
is effective if taken 
within how many 
hours of unprotected 
intercourse? 
 
____ 1 Up to 12 hours 
____ 2 Up to 24 hours 
____ 3 Up to 36 hours 
____ 4 Up to 72 hours 
____ 5 Not Sure 
Nominal 
    
 Plan B prevents 
pregnancy via which 
of the following 
mechanisms? 
 
____ 1 Inhibition or delay in 
ovulation 
____ 2 Disruption of an 
implanted embryo 
____ 3 Changes in the 
endometrial lining of 
the uterus 
____ 4 All of the above 
 5 Not sure 
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 Sales of Plan B to 
eligible consumers 
may be made by: 
 
____ 1 Pharmacists only 
____ 2 Pharmacists or 
pharmacy technicians only 
____ 3 Any member of the 
pharmacy staff working behind 
the pharmacy counter, as long 
as a pharmacist is on duty 
____ 4 Sales clerks, but only if 
a pharmacist is not on duty 
Nominal 
    
  According to the 
Plan B label, what 
percentage of the 
time does Plan B 
prevent pregnancy if 
used properly? 
 
____ 1 <25%  
____ 2 25%-49%  
____ 3 50%-74%  
____ 4 75%-89% 
____ 5 >89%  
Nominal 
    
 A woman asking to 
buy Plan B in 
advance of need: 
 
____ 1 Must wait for a 
contraceptive emergency 
before buying it 
____ 2 Should be advised to 
take a pregnancy test before 
taking it 
____ 3 May purchase more 
than one package 
____ 4 Can only make a 
purchase if she is using it for 
herself 
Nominal 
    
 When selling Plan B 
without a 
prescription to a 
man, pharmacists: 
 
____ 1 Need to see proof that 
he is at least 18 years of age 
____ 2 Must limit sales to one 
package 
____ 3 Must ask for the name 
of the person who will be 
taking the product 
 4 Are violating the law 
Nominal 
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  Do you think the 
following statements 
are true or false? 
 
True 
False 
Not Sure 
Emergency contraceptive pills 
cause birth defects if taken by a 
pregnant woman. 
Emergency contraception can 
act as an abortifacient. 
The sooner a woman takes 
emergency contraception, the 
more effective it will be. 
Nominal 
V. Attitudes    
  The next few 
questions will ask 
you about how you 
personally feel about 
emergency 
contraception. 
Please check the box 
that corresponds to 
the answer you 
choose.  
 
5-point Likert 
Scale, with 1 = 
Completely 
Disagree, 2= 
Somewhat Disagree, 
3= Neither Agree 
nor Disagree, 4= 
Somewhat Agree, 
5= Completely 
Agree 
--Easy availability of 
emergency contraception will 
discourage regular 
contraceptive use. 
--Easy availability of 
emergency contraception 
promotes promiscuity. 
--I feel uncomfortable 
dispensing Plan B because of 
my religious/ethical beliefs. 
--Repeated use of emergency 
contraception is wrong. 
--I feel comfortable dispensing 
Plan B to adult women. 
--I feel comfortable dispensing 
Plan B to adolescents (teens 
<18 years old). 
--I feel comfortable dispensing 
Plan B to men. 
Ordinal/Interval
    
  Should emergency 
contraception be 
offered to women 
who are raped in all 
hospital rooms, 
regardless of hospital 
affiliation? 
____ 1 Yes 
____ 2 No 
____ 3 Not sure 
 
Nominal 
    
VI. 
Subjective 
Norms 
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  The next questions 
will ask you about 
your perceptions of 
what other people 
think. 
 
The people and 
groups listed below 
may be influential in 
your dispensing 
decision-making.  
Please indicate (by 
checking the box) 
how you think the 
following consider 
emergency 
contraception 
dispensing practices, 
either by prescription 
or over-the-counter. 
 
5-point Likert scale 
1=Definitely should 
not, 2=Probably 
should not, 3= 
Probably should, 
4=Definitely should)
59. My partners/business 
colleagues think that I 
 dispense Plan 
B. 
60. The professional 
organization I am most 
active in recommends that 
I  dispense Plan 
B. 
61. My supervisor thinks that 
I_________ dispense Plan 
B. 
62. In general, my close 
friends and family think 
that I_________ dispense 
Plan B. 
 
Ordinal/Interval
    
 Is there anyone in 
your pharmacy who 
refuses to dispense 
Plan B? 
____ 1 Yes 
____ 2 No 
____ 3 Not sure 
____ 4 My pharmacy does not 
carry Plan B 
 
    
 Is there a policy in 
place at your 
pharmacy if someone 
refuses to dispense 
Plan B? 
 
____ 1 Yes 
____ 2 No 
____ 3 Not sure 
____ 4 My pharmacy does not 
carry Plan B 
 
VII. 
Perceived 
Behavioral 
Control 
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  Some pharmacists 
may feel that where 
they work effects 
their dispensing 
practices of Plan B.  
The following 
questions will ask 
you about your 
comfort level in 
dispensing Plan B. 
 
How easy is it for 
you to… 
 
4-point Likert scale 
with N/A option 
1=Very Difficult, 2= 
Somewhat Difficult, 
3= Somewhat Easy, 
4= Somewhat Easy, 
5= N/A 
Counsel clients about Plan B. 
 
Refuse to dispense Plan B. 
 
Educate clients about Plan B. 
 
Dispense Plan B. 
 
Ordinal/Interval
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Appendix T 
 
Focus Group Topical Guide 
 
1) Introduction  
 
Good morning, evening, afternoon and welcome to our session.  Thank you for taking 
the time to join our discussion.  Your assistance is important; the ideas you share today 
will help us understand the perceptions about emergency contraception among 
pharmacy students.  My name is Alice Richman and assisting me today is Lisa Nugent.   
 
2) Purpose 
 
I am a doctoral student at the University of South Florida and I am conducting research 
on pharmacists and access to emergency contraception.  I am trying to understand what 
pharmacy students learn about emergency contraception in their pharmacy school 
classes.   
 
We are interested in all of your thoughts and comments.  There are no right or wrong 
answers but rather differing points of view.  Please feel free to share your point of view 
even if it differs from what others have said.  Before we begin, let me remind you of 
some groundrules… 
 
3) Procedure & Ground Rules 
 
Group discussion – so don’t wait to be called on, but please speak one at a time so I can 
get your opinions on the tape. 
 
Audiotape: we’re tape recording the session b/c we don’t want to miss any of your 
comments.  Although we may use your first names in the discussion, no names will be 
attached to comments.  You may be assured of complete confidentiality. 
 
No right or wrong answers: want both positive and negative comments 
 
Please feel free to disagree with each other, respectfully of course, and ask the group 
questions. 
 
If you have to use the bathroom, please feel free to get up at any time during our 
discussion. 
 
About 1 hour 
 
4) Questions 
Opening Question 
Tell us your first name and why you want to be a pharmacist? (5 min) 
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Appendix T (Continued) 
 
Introductory Question:  
 
When I say emergency contraception which is also sometimes referred to as the 
morning after pill, what is the first thing that comes to your mind?  
 
Warm up: 
 
What have you learned about emergency contraception that you think is important for 
people to know? 
 
Probe Questions: What is it?  How does it work?  Who should use it? When should 
people take it? Mechanism of action? Purpose?  
 
Warm up:  
 
Where have you gotten information this information?   
 
Probe Questions: could be a range of people and places: in school, from pharmacy 
practice experience, pharmacy representatives, magazines, from friends, teachers, 
parents? Where else have you learned about it? 
 
Key Question:  
 
Thinking back to the courses you have taken in your Pharm D program, what do you 
remember learning about emergency contraception? 
 
Things I am looking for: Timing of administration? Mechanism of action? Purpose? 
Elective or required? 
 
Key Question:  
 
Think back to any instruction you received on emergency contraception in your 
pharmacy school classes.  Were you aware of any attitudes towards the medication by 
the instructor?   
 
Positive/negative/neutral 
 
Key Question: 
 
How do you feel about dispensing emergency contraception? 
Probe Questions: There are a number of circumstances where EC is thought to be 
controversial: feelings about dispensing to adolescents, rape victims, women whose birth 
control fails, women who use it repeatedly.  
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Appendix T (Continued) 
Key Question: 
 
Do you feel any differently about dispensing emergency contraception than you do 
dispensing any other medications? 
 
Probe Question if they feel negatively: Where do your feelings about dispensing come 
from? 
 
Key Question: 
 
The Food and Drugs Administration (FDA) recently approved for emergency 
contraception to be administered over-the-counter to women 18 years of age and over 
in the U.S.  What do you think about this decision? 
 
Key Question: 
 
Does that (OTC status) change your views about it?   
 
Key Question: 
 
Some pharmacists have refused to dispense emergency contraception.  How do you feel 
about this? 
 
Key Question: 
 
Should moral or religious views guide dispensing of pharmaceutical products? What 
about dispensing of emergency contraception?  
 
Recap  
Brief summary of key issues. How well does that description capture what we have 
talked about? Have we missed anything? Any other comments? 
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Appendix T (Continued) 
 
Initial Paper & Pencil Survey for Focus Groups 
 
1. Did you take any classes in your Pharm D program which taught you about 
emergency contraception? (please check a box) 
 
⁪   Yes 
 
⁪   No (skip to question 9) 
 
⁪  Not sure (skip to question 9) 
 
 
2. Which classes taught you about emergency contraception? (please list below)  
Please also check the box if these classes were required or offered as an elective. 
 
             ⁪ required         
⁪elective 
 
             ⁪ required         
⁪elective 
 
             ⁪ required         
⁪elective 
 
 
3. In your estimation, how much time would you say was spent on learning about 
emergency contraception in a given class? 
             
 
 
4. What types of instructional methods were used to teach you about emergency 
contraception in your pharmacy school classes? (e. g. lectures, course readings, 
power point discussions, videos, course discussions) 
           
           
           
     
 
 
5. Of the instructional methods that taught you about emergency contraception in 
your pharmacy school classes, which method/s did you learn the most from and 
why? 
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6. Was there any information concerning emergency contraception that you wished 
you had learned or had more detailed instruction on? 
           
           
   
 
 
 
 
 
 
 
7. Have your pharmacy school classes discussed the new over-the-counter status of 
emergency contraception? 
 
⁪   Yes 
 
⁪   No  
 
⁪   Not sure 
 
 
8. Have your pharmacy school classes discussed the dispensing issues (e. g. 
pharmacists refusals to dispense) surrounding emergency contraception? 
 
⁪   Yes 
 
⁪   No  
 
⁪   Not sure 
 
 
9. Do you think you will dispense emergency contraception upon becoming a 
pharmacist?  
 
⁪   Yes 
 
⁪   No  
 
⁪   Not sure 
 
 
10. Do you think pharmacists are well enough informed to confidently dispense 
emergency contraception? 
 
⁪   Yes 
 
⁪   No  
 
⁪   Not sure 
 
 
Thank you for completing this survey!! 
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Appendix U (p. 290-293) 
 
List of 91 pharmacy schools that received Dean’s survey* 
Alabama 
Auburn University 
Harrison School of 
Pharmacy 
2316 Walker Building 
Auburn , AL 36849 
334-844-8348 
Samford University 
McWhorter School of 
Pharmacy 
800 Lakeshore Drive 
Birmingham, AL 35229 
205-726-2820 
Arizona 
The University of Arizona 
College of Pharmacy 
1295 N. Martin Avenue 
PO Box 210202 
Tucson, AZ 85721 
520-626-1427 
Midwestern University 
College of Pharmacy - 
Glendale 
19555 North 59th Avenue 
Glendale, AZ 85308 
623-572-3500 
Arkansas 
University of Arkansas for 
Medical Sciences 
College of Pharmacy 
4301 West Markham - #522 
Little Rock, AR 72205 
501-686-5557 
Kentucky
University of Kentucky 
College of Pharmacy 
725 Rose Street  
Pharmacy Building 
Lexington, KY 40536-0082 
859-257-2736 
Louisiana 
The University of Louisiana 
at Monroe 
College of Pharmacy 
700 University Avenue 
Monroe, LA 71209 
318-342-1600 
Xavier University of 
Louisiana 
College of Pharmacy 
1 Drexel Drive 
New Orleans, LA 70125 
504-520-7500 
Maryland 
University of Maryland 
School of Pharmacy 
20 North Pine Street 
Baltimore, MD 21201 
410-706-7651 
Massachusetts 
Massachusetts College of 
Pharmacy and Health Scien 
School of Pharmacy-Boston
179 Longwood Avenue 
Boston, MA 02115-5896 
617-732-2781 
The University of Toledo 
College of Pharmacy 
2801 West Bancroft Street 
Mail Stop #608 
Toledo, OH 43606 
419-530-1904 
Oklahoma 
University of Oklahoma 
College of Pharmacy 
PO Box 26901 
Oklahoma City, OK 73190 
405-271-6485 
Southwestern Oklahoma 
State University 
College of Pharmacy 
100 Campus Drive 
Weatherford, OK 73096 
580-774-3760 
Oregon 
Oregon State University 
College of Pharmacy 
203 Pharmacy Building 
Corvallis, OR 97331 
541-737-3424 
Pennsylvania 
Duquesne University 
Mylan School of Pharmacy 
306 Bayer Learning Center 
Pittsburgh, PA 15282 
412-396-6380 
Lake Erie College of 
Osteopathic Medicine 
LECOM School of Pharmacy
1858 West Grandview 
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California 
University of California, 
San Diego 
Skaggs School of Pharmacy 
& Pharmaceutical Science 
9500 Gilman Drive, MC 
0657 
La Jolla, CA 92093-0657 
858-822-4900 
University of California at 
San Francisco 
School of Pharmacy 
521 Parnassus Avenue 
Clincial Sciences, Room C-
156 
San Francisco, CA 94143 
415-476-2733 
Loma Linda University 
School of Pharmacy 
West Hall 
11262 Campus Street 
Loma Linda, CA 92350 
909-558-1300 
University of the Pacific 
Thomas J. Long School of 
Pharmacy & Health Science 
3601 Pacific Avenue 
Stockton, CA 95211 
209-946-2561 
University of Southern 
California 
School of Pharmacy 
1985 Zonal Avenue 
Los Angeles, CA 90089-
9121 
323-442-1369 
Touro University-California 
School of Pharmacy 
1310 Johnson Lane, Mare 
Massachusetts College of 
Pharmacy and Health Scien 
School of Pharmacy-
Worcester 
19 Foster Street 
Worcester, MA 01608 
508-890-8855 
Northeastern University 
Bouve College of Health 
Sciences, School of Pharma 
360 Huntington Avenue 
206 Mugar Hall 
Boston, MA 02115 
617-373-3380 
Michigan 
Ferris State University 
College of Pharmacy 
220 Ferris Drive 
Big Rapids, MI 49307 
231-591-2254 
The University of Michigan 
College of Pharmacy 
428 Church Street 
Ann Arbor, MI 48109 
734-764-7312 
Wayne State University 
Eugene Applebaum College 
of Pharmacy and Health Sc 
259 Mack Avenue 
Detroit, MI 48201 
313-577-1574 
Minnesota 
University of Minnesota 
College of Pharmacy 
5-130 Weaver-Densford Hall
308 Harvard Street SE 
Minneapolis, MN 55455 
Boulevard 
Erie, PA 16509-1025 
814-866-6641 
University of the Sciences in 
Philadelphia 
Philadelphia College of 
Pharmacy 
600 South 43rd Street 
Philadelphia, PA 19104 
215-596-8870 
University of Pittsburgh 
School of Pharmacy 
1104 Salk Hall 
3501 Terrace Street 
Pittsburgh, PA 15261 
412-624-2400 
Temple University of the 
Commonwealth of Higher Ed
School of Pharmacy 
3307 North Broad Street 
Philadelphia, PA 19140 
215-707-4990 
Wilkes University 
Nesbitt School of Pharmacy
84 West South Street 
Wilkes-Barre, PA 18766 
570-408-4280 
Puerto Rico 
University of Puerto Rico 
School of Pharmacy 
PO Box 365067 
San Juan, PR 00936 
787-758-2525 
Rhode Island 
University of Rhode Island 
College of Pharmacy 
41 Lower College Road 
 292
Island 
Vallejo, CA 94592 
707-638-5200 
Western University of 
Health Sciences 
College of Pharmacy 
College Plaza, 309 East 
Second Street 
Pomona, CA 91766 
909-469-5214 
Colorado 
University of Colorado at 
Denver & Health Sciences 
School of Pharmacy 
C238 
4200 East Ninth Avenue 
Denver, CO 80262 
303-315-5055 
Connecticut 
The University of 
Connecticut 
School of Pharmacy 
69 North Eagleville Road 
Unit 3092 
Storrs, CT 06269 
860-486-2129 
District of Columbia 
Howard University 
School of Pharmacy 
College of Pharmacy, 
Nursing & AHS 
2300 4th Street NW 
Washington, DC 20059 
202-806-5431 
Florida 
University of Florida 
612-624-1900 
Mississippi 
The University of 
Mississippi 
School of Pharmacy 
Thad Cochran Research 
Center 
Room 1026, PO Box 1848 
University, MS 38677 
662-915-7265 
Missouri 
University of Missouri - 
Kansas City 
School of Pharmacy 
5005 Rockhill Road 
Kansas City, MO 64110 
816-235-1609 
St. Louis College of 
Pharmacy 
4588 Parkview Place 
St. Louis, MO 63110 
314-367-8700 
Montana 
The University of Montana 
Skaggs School of Pharmacy
32 Campus Drive #1512 
Missoula, MT 59812 
406-243-4621 
Nebraska 
Creighton University 
School of Pharmacy and 
Health Professions 
2500 California Plaza 
Omaha, NE 68178 
402-280-2950 
Fogarty Hall 
Kingston, RI 02881 
401-874-2614 
South Carolina 
South Carolina College of 
Pharmacy 
MUSC Campus 
280 Calhoun Street, PO Box 
250141 
Charleston, SC 29425-2301 
843-792-8450 
South Carolina College of 
Pharmacy 
USC Campus 
Columbia, SC 29208 
803-777-4151 
South Dakota 
South Dakota State 
University 
College of Pharmacy 
Pharmacy Building - Room 
125 
Box 2202C 
Brookings, SD 57007 
605-688-6197 
Tennessee 
University of Tennessee 
College of Pharmacy 
847 Monroe Avenue, Suite 
226 
Memphis, TN 38163 
901-448-6036 
Texas 
University of Houston 
College of Pharmacy 
141 Science & Research 2 
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College of Pharmacy 
PO Box 100484, JHMHC 
101 South Newell Drive, 
#4334 
Gainesville, FL 32611 
352-273-6601 
Florida Agricultural and 
Mechanical University 
College of Pharmacy and 
Pharmaceutical Sciences 
333 New Pharmacy 
Building 
Tallahassee, FL 32307-3800 
850-599-3301 
Nova Southeastern 
University 
College of Pharmacy 
Health Professions Division 
3200 South University 
Drive 
Fort Lauderdale, FL 33328 
954-262-1300 
Palm Beach Atlantic 
University 
School of Pharmacy 
901 South Flagler Drive 
West Palm 
Beach, FL 33416 
561-803-2700 
Georgia 
The University of Georgia 
College of Pharmacy 
Green Street 
Athens, GA 30602 
706-542-1911 
Mercer University 
College of Pharmacy and 
Health Sciences 
3001 Mercer University 
University of Nebraska  
College of Pharmacy 
986000 Nebraska Medical 
Center 
Omaha, NE 68198 
402-559-4333 
Nevada 
University of Southern 
Nevada 
College of Pharmacy 
11 Sunset Way 
Henderson, NV 89014 
702-990-4433 
New Jersey 
Rutgers, the State University 
of New Jersey 
Ernest Mario School of 
Pharmacy 
160 Frelinghuysen Road 
Piscataway, NJ 08854-8020 
732-445-2675 
New Mexico 
University of New Mexico 
College of Pharmacy 
MSC09 5360 
1 University of New Mexico
Albuquerque, NM 87131 
505-272-3241 
New York 
University at Buffalo 
School of Pharmacy and 
Pharmaceutical Sciences 
126 Cooke Hall - Box 
601200 
Buffalo, NY 14260-1200 
716-645-2823 
Building 
Houston, TX 77204 
713-743-1300 
The University of Texas at 
Austin 
College of Pharmacy 
1 University Station A1900 
Austin, TX 78712 
512-471-3718 
Texas Southern University 
College of Pharmacy and 
Health Sciences 
3100 Cleburne 
Houston, TX 77004 
713-313-7559 
Texas Tech University 
Health Sciences Center 
School of Pharmacy 
1300 S. Coulter Street 
Amarillo, TX 79106 
806-354-5463 
Utah 
University of Utah 
College of Pharmacy 
30 South 2000 East 
Room 201 
Salt Lake City, UT 84112 
801-581-6731 
Virginia 
Hampton University 
School of Pharmacy 
Kittrell Hall 
Hampton, VA 23668 
757-727-5071 
Shenandoah University 
Bernard J. Dunn School of 
Pharmacy 
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Drive 
Atlanta, GA 30341 
678-547-6304 
South University 
School of Pharmacy 
709 Mall Boulevard 
Savannah, GA 31406 
912-201-8120 
Idaho 
Idaho State University 
College of Pharmacy 
Stop 8288 
921 S. 8th Avenue 
Pocatello, ID 83209 
208-282-2175 
Illinois 
University of Illinois at 
Chicago 
College of Pharmacy (M/C 
874) 
833 South Wood Street 
Suite 145 
Chicago, IL 60612 
312-996-7240 
Midwestern University 
Chicago College of 
Pharmacy 
555 31st Street 
Downers Grove, IL 60515 
630-971-6417 
Southern Illinois University 
Edwardsville 
School of Pharmacy 
200 University Park Drive 
Campus Box 2000 
Edwardsville, IL 62026 
618-650-5150 
Long Island University 
Arnold & Marie Schwartz 
College of Pharmacy and He
75 DeKalb Avenue 
Brooklyn, NY 11201 
718-488-1234 
St. John's University 
College of Pharmacy and 
Allied Health Professions 
8000 Utopia Parkway 
Jamaica, NY 11439 
718-990-1415 
Union University 
Albany College of Pharmacy
106 New Scotland Avenue 
Albany, NY 12208 
518-694-7200 
North Carolina 
Campbell University 
School of Pharmacy 
PO Box 1090 
205 Day Dorm Road, Room 
101 
Buies Creek, NC 27506 
910-893-1685 
University of North Carolina
School of Pharmacy 
Beard Hall, CB#7360 
Chapel Hill, NC 27599 
919-966-1121 
Wingate University 
School of Pharmacy 
Campus Box 3087 
Wingate, NC 28174 
704-233-8331 
North Dakota 
North Dakota State 
1775 N. Sector Court 
Winchester, VA 22601 
540-665-1282 
Virginia Commonwealth 
University 
School of Pharmacy 
MCV Campus - Box 980581
410 North 12th Street 
Richmond, VA 23298 
804-828-3006 
Washington 
University of Washington 
School of Pharmacy 
H-364 Health Science 
Building  
Box 357631 
Seattle, WA 98195 
206-543-2030 
Washington State University
College of Pharmacy 
PO Box 646510 
105 Wegner Hall 
Pullman, WA 99164 
509-335-5901 
West Virginia 
West Virginia University 
School of Pharmacy 
Room 1136 HSN, Health 
Science Center 
PO Box 9500 
Morgantown, WV 26506 
304-293-5101 
Wisconsin 
University of Wisconsin - 
Madison 
School of Pharmacy 
777 Highland Avenue 
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Indiana 
Butler University 
College of Pharmacy and 
Health Sciences 
4600 Sunset Avenue 
Indianapolis, IN 46208 
317-940-9322 
Purdue University 
School of Pharmacy and 
Pharmaceutical Sciences 
Heine Pharmacy Building 
575 Stadium Mall Drive 
West Lafayette, IN 47907 
765-494-1368 
Iowa 
Drake University 
College of Pharmacy and 
Health Sciences 
2507 University Avenue 
Des Moines, IA 50311 
515-271-2172 
The University of Iowa 
College of Pharmacy 
115 South Grand Avenue 
Iowa City, IA 52242 
319-335-8794 
Kansas 
University of Kansas 
School of Pharmacy 
1251 Wescoe Hall Drive 
Malott Hall #2056 
Lawrence, KS 66045-7582 
785-864-3591 
University 
College of Pharmacy, 
Nursing, and Allied Sciences
123 Sudro Hall 
1401 Albrecht Boulevard 
Fargo, ND 58105 
701-231-6469 
Ohio 
University of Cincinnati 
James L. Winkle College of 
Pharmacy 
3225 Eden Avenue 
PO Box 670004 
Cincinnati, OH 45267-0004 
513-558-3784 
Ohio Northern University 
College of Pharmacy 
525 South Main 
Ada, OH 45810 
419-772-2275 
The Ohio State University 
College of Pharmacy 
217 Parks Hall 
500 West 12th Avenue 
Columbus, OH 43210 
614-688-4756 
Madison, WI 53705-2222 
608-262-1416 
Wyoming 
University of Wyoming 
School of Pharmacy 
Department 3375 
1000 E. University Avenue 
Laramie, WY 82071 
307-766-6120 
*List of pharmacy schools taken from American Association of Colleges of Pharmacy (AACP) 
website www.aacp.org The listing includes colleges and schools of pharmacy whose professional 
degree programs have been granted full or candidate accredited status by the Accreditation 
Council for Pharmacy Education (ACPE) and whose requests for membership have been 
approved by the AACP House of Delegates. 
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Appendix V 
 
Second follow-up letter to Deans 
 
About two weeks ago we sent you a survey via email.  We are asking Deans of the 
schools of pharmacy in the U.S. about the curricula that addresses instruction on 
emergency contraception.   
 
As of today, we have not received a completed survey from you.  I realize that we all 
have busy schedules; however we are hoping for at least a 50% response rate on this brief 
3-question survey.  As we mentioned before, answers are confidential and will be 
combined with others before disseminating the results.  In case the previous questionnaire 
has been deleted from your email account, we have included it again and hope you will 
respond. 
 
Should you have any questions or concerns, feel free to contact me (Alice Richman) or 
Ellen Daley at the contact information provided below.  Thank you for your cooperation. 
 
Alice R. Richman     Ellen Daley, Ph.D. 
USF College of Public Health   USF College of Public Health 
Phone: (813) 732-1903    Phone: (814) 974-8518 
Email: arichman@health.usf.edu   Email: edaley@health.usf.edu 
 
 
(Link to Survey Inserted Here) 
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Appendix W (p. 297-298) 
 
List of course titles containing emergency contraception course content 
 
Questions on Deans Survey:  
 
You answered yes that your School does offer required courses that provide content on 
emergency contraception.  Would you please list the titles of these courses in the box 
below. 
 
You answered yes that your School does offer elective courses that provide content on 
emergency contraception. Would you please list the titles of these courses in the box 
below 
 
Answers provided for required courses that contain emergency contraception content: 
Women's Health (a combination course with Men's Health). 
1)  Pharmacologic Basis of Therapeutics III:  The endocrinology section of this basic 
science course includes a lecture that addresses the mechanism of action of emergency 
contraceptives, the period of time during which they can be effectively used, and their 
side effects. 
2)  Early Practice Experience I:  As part of this early clinical course, the students obtain 
certification from the State in emergency contraception.  They learn about prescriptive 
authority, and are trained to counsel patients appropriately. 
Professional Skills Development II  
Health Assessment and Pharmacotherapy II 
Integrated Science and Therapeutics II.   It's part of a 2-hr contraception lecture. 
Therapeutics - Women's Health  
Syllabi not available at this time. 
PHA 5930--Issues in Contemporary Pharmacy Practice. 
Clinical Therapeutics 
IPDM (Integrated Pharmacology & Disease Management III - 
Endocrinology/Gastroenterology 
Princles of Pharmacotherapy 1: Selfcare and Alternative Medicine 
Princles of Pharmacotherapy 8: Special Populations 
Ethics and Professional  Responsibility 
Pharmacotherapy II 
Pharmacy Ethics 
It is in one of our Pharmacotherapy courses 
It is contained within a pathophysiology and therapeutics course that has a section on 
women's health.  The syllabus only states that the topic of contraception is covered. 
see printed out syllabus -- reproductive health course. 
There are a couple of lectures in Pharmacy 505  which is a pharmacy practice course 
titled Pharmaceutical Care and a case discussion in pharmacy 514 - Pharmacy Ethics.   
Pharmacotherapy 4: contemporary topics 2hours, 5th year spring semester class 
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Phrm 6206 includes endocrine and reproductive medicine. 
Material Covered in Over-the-Counter Medications Course under OTC Contraception.  
Not specifically mentioned in the syllabus. 
Integrated Sequence 4 
To the best of my knowledge, I believe we are teaching this in these courses. 
PHA 551 Endocrine Disorders 
PHA 502 Pharmacy Law and Ethics 
PHA 566 Women's Health 
Therapeutics I 
It is taught in our Self Care course in the lecture covering the prevention of unintended 
pregnancy.  I apologize for not being able to attach the syllabus. 
In PHR 920 (Communication and Behavior in Pharmacy Practice) from a social 
behavioral aspect, in PHR 930 (Legal, Ethical and Access Issues in Pharmacay), in 
PHR 933 (Pharmacological Basis for Therapeutics: Endocrine Systems) from a 
pharmacologic perspective and in PHR 946 (Advanced Pharmacotherapy I) in the 
block on "women's health" from a pharmacological and therapeutic perspective.  The 
course syllabi are not very descriptive of the topics - they only indicate "contraception" 
or "Plan B". 
Integrated Therapeutics III Course and Laboratory offers review of material regarding 
emergency contraception. It may also be discussed in the mandatory Healthcare Ethics 
class. 
PHP 414 - Therapeutic Core /Endocrinology/Women's Health 
PHP 518 - Self Care 1  
PHP 519 - Elective - Self Care 2 
Pathophysiciology and Therapeutics III under Women's Health 
NonPrescriptions Drug Products under contraception 
Possibly in phamacology, not sure 
I know we teach this but I dont know specifics on courses since several have changed 
recently. 
Topic is covered in our Pharmacotherapy- Disease State management course. The topic 
is not listed in the syllabus- it is discussed as part of the contraception discussion 
 
 
Answers provided for elective courses that contain emergency contraception content: 
Overview of Contraceptive Management; I'll send the syllabus via email attachment 
"Women's Health"  
Women's Health 
PHP 519 - Self Care 2 
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Appendix X (p. 299-313) 
 
Panel of Experts Interview Guide for Review of Pharmacists’ Questionnaire  
 
You are being asked to be part of a special panel of experts that will review a 
questionnaire to make sure it is valid.  The survey you are reviewing will be administered 
to Florida pharmacists and it is designed to measure emergency contraception knowledge, 
attitudes, and dispensing practices of pharmacists who practice in the state of Florida.  
Your honest input and feedback is essential to producing a valid instrument and I want to 
personally thank you for your participation.   
This review will inquire about five six main topics:  
(1) level of knowledge about emergency contraception, 
(2) personal attitudes held about emergency contraception and about emergency 
contraception dispensing,  
(3) perceived social pressures around issues of dispensing,  
(4) perceived behavioral control over the behavior of dispensing emergency 
contraception,  
(5) emergency contraception dispensing practices and (6) basic demographics and 
background questions.  
Directions:  
First, rate each question on the instrument according to the extent to which you 
think it looks as if it is measuring the designated topic (i.e., face validity), with 1 = this 
item does not look as if it has anything to do with measuring the topic, and 7 = this item 
looks very much as if it is on-target with measuring the topic.  Please explain your ratings 
that are below 5, that is, items that you do not think look as if they are measuring the 
designated topic.  What would you do, if anything, to fix them? 
Second, are there important aspects of the designated topic that the instrument is 
not measuring (i.e., content validity)? 
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Topic 1: Knowledge about Emergency 
Contraception 
Rating  
1 2 3 4 5 6 7 
Explain ratings <5, 
what would you do to 
fix them? 
Q1: How many pills are dispensed in Plan 
B® packaging?    ____ 
 
  
Q2: Emergency contraception or Plan B® is 
effective if taken within how many hours of 
unprotected intercourse? 
____ 1 Up to 24 hours 
____ 2 Up to 36 hours 
____ 3 Up to 72 hours 
____ 4 Up to 120 hours 
____ 5 Not Sure 
 
  
Q3: The mechanism of action of emergency 
contraception is most similar to (please 
choose one): 
____ 1 Spermicides 
____ 2 Oral Contraceptives 
____ 3 Mifepristone (RU-486) 
____ 4 Not Sure 
 
  
Q4: If used properly, emergency 
contraception or Plan B® prevents 
pregnancy what percentage of the time? 
____ 1 <25%  
____ 2 25%-49%  
____ 3 50%-74%  
____ 4 75%-89% 
____ 5 >89%  
 
  
Q5: To what extent do you think the 
following statements are true or false?   
 
Repeated use of emergency contraceptive 
pills can pose health risks. 
____ 1 True 
____ 2 False 
 
  
Q6: To what extent do you think the 
following statements are true or false?   
 
Emergency contraceptive pills cause birth 
defects if taken by a pregnant woman. 
 1 True 
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____ 2 False 
 
Q7: To what extent do you think the 
following statements are true or false?   
 
Emergency contraception can act as an 
abortifacient. 
____ 1 True 
____ 2 False 
 
  
Q8: To what extent do you think the 
following statements are true or false?  
  
The sooner a woman takes emergency 
contraception, the more effective it will be. 
____ 1 True 
____ 2 False 
 
  
Q9: To what extent do you think the 
following statements are true or false? 
   
Plan B® is the same as the abortion pill 
(RU-486). 
____ 1 True 
____ 2 False 
 
  
Q10: To what extent do you think the 
following statements are true or false? 
   
Emergency contraception can protect against 
HIV and other sexually transmitted 
infections (STIs). 
____ 1 True 
____ 2 False 
 
  
 
Are there important aspects of the topic emergency contraception knowledge that the 
instrument is not measuring (i.e., content validity)?       
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Topic 2: Attitudes about Emergency 
Contraception 
Rating  
1 2 3 4 5 6 7 
Explain ratings <5, 
what would you do to 
fix them? 
Q1: ____ I feel the benefits of emergency 
contraception outweigh the risks. 
1=Completely Disagree 
2=Somewhat Disagree 
3=Not sure 
4=Somewhat Agree 
5=Completely Agree 
 
  
Q2: ____ Emergency contraception will 
discourage regular contraceptive use. 
1=Completely Disagree 
2=Somewhat Disagree 
3=Not sure 
4=Somewhat Agree 
5=Completely Agree 
 
  
Q3: ____ Emergency contraception will 
promote promiscuity. 
1=Completely Disagree 
2=Somewhat Disagree 
3=Not sure 
4=Somewhat Agree 
5=Completely Agree 
 
  
Q4: ____ I feel uncomfortable prescribing 
emergency contraception for religious/ethical 
reasons. 
1=Completely Disagree 
2=Somewhat Disagree 
3=Not sure 
4=Somewhat Agree 
5=Completely Agree 
 
  
Q5: ____ Repeated use of emergency 
contraception by adolescents is wrong. 
1=Completely Disagree 
2=Somewhat Disagree 
3=Not sure 
4=Somewhat Agree 
5=Completely Agree 
 
  
Q6:  I feel comfortable dispensing   
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emergency contraception to women. 
1=Completely Disagree 
2=Somewhat Disagree 
3=Not sure 
4=Somewhat Agree 
5=Completely Agree 
 
Q7: ____ I feel comfortable dispensing 
emergency contraception to adolescents. 
1=Completely Disagree 
2=Somewhat Disagree 
3=Not sure 
4=Somewhat Agree 
5=Completely Agree 
 
  
Q8: In general, I think that dispensing 
emergency contraception for clients is… 
____ 1 Good 
____ 2 Positive 
____ 3 Beneficial 
____ 4 Harmful 
____ 5 Negative 
____ 6 Bad 
 
  
Q9: What is the maximum number of times 
emergency contraception should be given to 
one individual woman over her lifetime? 
____ 1  0 times 
____ 2  1 time 
____ 3  2-5 times 
____ 4  6-10 times 
____ 5  10+ times 
____ 6  Not sure 
 
  
 
Are there important aspects of the topic emergency contraception attitudes that the 
instrument is not measuring (i.e., content validity)?       
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Topic 3: Emergency Contraception 
Dispensing Practices (includes both 
intention to dispense and actual dispensing 
practices) 
Rating  
1 2 3 4 5 6 
7 
Explain ratings <5, 
what would you do to 
fix them? 
Q1: Does your pharmacy dispense any forms 
of emergency contraception (e. g. Plan B®)? 
____ 1 Yes 
____ 2 No 
 
  
Q2: Have you ever been asked to fill a 
prescription of emergency contraception? 
____ 1 Yes 
____ 2 No 
 
  
Q3: Have you personally ever filled a 
prescription of emergency contraception? 
____ 1 Yes 
____ 2 No  
 
  
Q4: Approximately how many emergency 
contraceptive pill prescriptions have you 
personally filled in the past 12 months? 
____________ 
 
  
Q5: Have you ever been asked to dispense 
emergency contraception over-the-counter? 
____ 1 Yes 
____ 2 No 
 
  
Q6: Have you personally ever dispensed 
emergency contraception over-the-counter? 
____ 1 Yes 
____ 2 No  
 
  
Q7: Approximately how many times have 
you dispensed emergency contraceptive pills 
over-the-counter in the past 12 months? 
____________ 
 
  
Q8: To what extent are you likely to dispense 
emergency contraception over-the-counter 
to… 
 
Women who have experienced incest or rape 
1=Very Unlikely 
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2=Unlikely 
3=Not sure 
4=Likely 
5=Very Likely 
 
Q9: To what extent are you likely to dispense 
emergency contraception over-the-counter 
to… 
 
Women who have experienced a problem 
with their birth control method 
1=Very Unlikely 
2=Unlikely 
3=Not sure 
4=Likely 
5=Very Likely 
 
  
Q10: To what extent are you likely to 
dispense emergency contraception over-the-
counter to… 
 
Sexually active 18, 19, and 20 year olds 
1=Very Unlikely 
2=Unlikely 
3=Not sure 
4=Likely 
5=Very Likely 
 
  
Q11: To what extent are you likely to 
dispense emergency contraception over-the-
counter to… 
 
Women who request the method after having 
unprotected sexual intercourse 
1=Very Unlikely 
2=Unlikely 
3=Not sure 
4=Likely 
5=Very Likely 
 
  
Q12: To what extent are you likely to 
dispense emergency contraception over-the-
counter to… 
 
Men requesting emergency contraception 
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over-the-counter for their partner 
1=Very Unlikely 
2=Unlikely 
3=Not sure 
4=Likely 
5=Very Likely 
 
Q13: To what extent are you likely to 
dispense emergency contraception by 
prescription to… 
 
Women who have experienced incest or rape 
1=Very Unlikely 
2=Unlikely 
3=Not sure 
4=Likely 
5=Very Likely 
 
  
Q14: To what extent are you likely to 
dispense emergency contraception by 
prescription to… 
 
Women who have experienced a problem 
with their birth control method 
1=Very Unlikely 
2=Unlikely 
3=Not sure 
4=Likely 
5=Very Likely 
 
  
Q15: To what extent are you likely to 
dispense emergency contraception by 
prescription to… 
 
Sexually active teens under age 18 
1=Very Unlikely 
2=Unlikely 
3=Not sure 
4=Likely 
5=Very Likely 
 
  
Q16: To what extent are you likely to 
dispense emergency contraception by 
prescription to… 
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Women who request the method after having 
unprotected sexual intercourse 
1=Very Unlikely 
2=Unlikely 
3=Not sure 
4=Likely 
5=Very Likely 
 
 
Are there important aspects of the topic emergency contraception dispensing practices 
that the instrument is not measuring (i.e., content validity)?     
            
            
     
 
Topic 4: Perceived Social Pressures 
Concerning Dispensing Practices of 
Emergency Contraception 
Rating  
1 2 3 4 5 6 
7 
Explain ratings <5, 
what would you do to 
fix them? 
Q1: My partners/colleagues think that I 
_________ dispense emergency contraception. 
1=Definitely Should Not 
2=Probably Should Not 
3=Neutral 
4=Probably Should 
5=Definitely Should 
 
  
Q2: My professional organization recommends 
that I_________ dispense emergency 
contraception. 
1=Definitely Should Not 
2=Probably Should Not 
3=Neutral 
4=Probably Should 
5=Definitely Should 
 
  
Q3: My boss thinks that I  dispense 
emergency contraception. 
1=Definitely Should Not 
2=Probably Should Not 
3=Neutral 
4=Probably Should 
5=Definitely Should 
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Q4: My corporation or pharmacy thinks that 
I  dispense emergency contraception. 
1=Definitely Should Not 
2=Probably Should Not 
3=Neutral 
4=Probably Should 
5=Definitely Should 
 
  
Q5: In general, most people or groups that are 
important to me think that I  
dispense emergency contraception. 
1=Definitely Should Not 
2=Probably Should Not 
3=Neutral 
4=Probably Should 
5=Definitely Should 
 
  
Q6: My clients or customers thinks that 
I_________ dispense emergency contraception. 
1=Definitely Should Not 
2=Probably Should Not 
3=Neutral 
4=Probably Should 
5=Definitely Should 
 
  
 
Are there important aspects of the topic perceived social pressures concerning dispensing 
practices of emergency contraception that the instrument is not measuring (i.e., content 
validity)?            
            
            
     
 
Topic 5: Perceived Ease or Difficulty 
(comfort level) with Dispensing Emergency 
Contraception 
Rating  
1 2 3 4 5 6 
7 
Explain ratings <5, 
what would you do to 
fix them? 
Q1: How easy would it be for you to… 
____ Counsel clients about emergency 
contraception 
1=Very Difficult 
2=Difficult 
3=Not sure 
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4=Easy 
5=Very Easy 
 
Q2: How easy would it be for you to… 
____ Dispense emergency contraception 
1=Very Difficult 
2=Difficult 
3=Not sure 
4=Easy 
5=Very Easy 
 
  
Q3: How easy would it be for you to… 
____ Refuse to dispense emergency 
contraception 
1=Very Difficult 
2=Difficult 
3=Not sure 
4=Easy 
5=Very Easy 
 
  
Q4: How easy would it be for you to… 
____ Educate clients about emergency 
contraception 
1=Very Difficult 
2=Difficult 
3=Not sure 
4=Easy 
5=Very Easy 
 
  
Q5: How comfortable are you talking about 
emergency contraception with customers? 
1=Very Uncomfortable 
2=Somewhat Uncomfortable 
3=Somewhat Comfortable 
4=Very Comfortable 
 
  
 
Are there important aspects of the topic perceived ease or difficulty (comfort level) with 
dispensing emergency contraception that the instrument is not measuring (i.e., content 
validity)?            
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Note: This last section titled ‘Demographic & Background Questions’ is a little different 
as each topic is listed for each question in blue. 
Topic 6: Demographic & Background 
Questions 
Rating  
1 2 3 4 5 6 7
Explain ratings 
<5, what would 
you do to fix 
them? 
Topic Measuring: Years in Practice 
 
Q1: How many years have you been in practice 
(registered as a pharmacist)? 
____ year/years 
 
  
Topic Measuring: Type of Pharmacy  
 
Q2: The type of pharmacy where you work could 
be best described as (if you have more than one 
job, please circle the number that corresponds to 
your primary type of pharmacy) 
____ 1 Retail    
____ 2 Independent   
____ 3 Chain    
____ 4 Hospital    
____ 5 Nuclear 
____ 6 Government 
____ 7 VA 
____ 8 Academia 
____ 9 HIS 
____ 10 Home Infusion 
____ 11 Other: Please specify 
_______________________ 
 
  
Topic Measuring: Employment Status 
 
Q3: What is your current employment status? 
____ 1 Full-time 
____ 2 Part-time 
____ 3 Retired 
 
  
Topic Measuring: Pharmacy Availability of Birth 
Control Products 
 
Q4: Does your pharmacy carry any of the 
following birth control products? 
   
Condoms 1 Yes 0 No   
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Spermicide ____1 Yes ____0 No   
Oral contraceptive pills    ____1 Yes ____0 No  
 
Topic Measuring: Gender  
 
Q5: What is your gender? 
____ 1 Female 
____ 2 Male 
 
  
Topic Measuring: Age 
 
Q6: How old are you? 
____________ 
 
  
Topic Measuring: School of Attendance  
 
Q7: Where did you go to school to become a 
pharmacist? 
________________________ 
 
  
Topic Measuring: Year of Graduation  
 
Q8: What year did you graduate school to become 
a pharmacist? 
____________ 
 
  
Topic Measuring: Religion  
 
Q9: If you had to choose only one, which would it 
be? 
____ 1 Religious 
____ 2 Spiritual 
____ 3 Religious and Spiritual 
____ 4 Undecided 
____ 5 None of the above 
____ 6 Not religious or Spiritual 
 
  
Topic Measuring: Religious Identity  
 
Q10: If you had to choose one, which religious 
group do you most closely identify with? 
____ 1 Roman Catholic 
____ 2 Baptist 
____ 3 Methodist 
 4 Episcopalian 
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____ 5 Lutheran 
____ 6 Quaker 
____ 7 Presbyterian 
____ 8 Assembly of God 
____ 9 Hindu 
____ 10 Buddhist 
____ 11 Jewish 
____ 12 Islamic 
____ 13 Mormon 
____ 14 Neo-Pagan/Wicca 
____ 15 Non-Denominational 
____ 16 Not Religious 
____ 17 Other 
 
Topic Measuring: Ethnicity  
 
Q11: What is your ethnicity? 
____ 1 Caucasian 
____ 2 African American 
____ 3 Hispanic 
____ 4 Asian 
____ 5 Multi-Racial 
____ 6 Other please specify 
(___________________) 
 
  
Topic Measuring: Marital Status  
 
Q12: What is your marital status? 
____ 1 Married 
____ 2 Living with a partner 
____ 3 Divorced 
____ 4 Separated 
____ 5 Widowed 
____ 6 Never been married 
 
  
Topic Measuring: Ethnicity  
 
Q13: To what extent are you likely to dispense 
emergency contraception by prescription to… 
 
Women who have experienced incest or rape 
1=Very Unlikely 
2=Unlikely 
3=Not sure 
4=Likely 
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5=Very Likely 
 
Topic Measuring: Political Affiliation 
 
Q14: What is your political affiliation? 
____ 1 Republican 
____ 2Democratic 
____ 3 Independent 
____ 4 None/Undecided 
 
  
 
Are there important aspects of the questions asked in this last section titled Demographic 
& Background Questions that the instrument is not measuring (i.e., content validity)?  
            
            
            
     
 
Thank you for your time.  Please save your answers and follow the directions outlined in 
the email provided. 
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